<?xml version="1.0" encoding="UTF-8"?><search-results xmlns="http://www.w3.org/2005/Atom" xmlns:cto="http://www.elsevier.com/xml/cto/dtd" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/" xmlns:opensearch="http://a9.com/-/spec/opensearch/1.1/" xmlns:dc="http://purl.org/dc/elements/1.1/"><opensearch:totalResults>2992343</opensearch:totalResults><opensearch:startIndex>1200</opensearch:startIndex><opensearch:itemsPerPage>100</opensearch:itemsPerPage><opensearch:Query role="request" searchTerms="heart" startPage="1200"/><link ref="self" href="http://api.elsevier.com:80/content/search/index:scopus?start=1200&amp;count=100&amp;query=heart&amp;view=COMPLETE&amp;httpAccept=application/xml&amp;apiKey=b50e60b193e884e6d78948e916d816a0" type="application/xml"/><link ref="first" href="http://api.elsevier.com:80/content/search/index:scopus?start=0&amp;count=100&amp;query=heart&amp;view=COMPLETE&amp;httpAccept=application/xml&amp;apiKey=b50e60b193e884e6d78948e916d816a0" type="application/xml"/><link ref="prev" href="http://api.elsevier.com:80/content/search/index:scopus?start=1100&amp;count=100&amp;query=heart&amp;view=COMPLETE&amp;httpAccept=application/xml&amp;apiKey=b50e60b193e884e6d78948e916d816a0" type="application/xml"/><link ref="next" href="http://api.elsevier.com:80/content/search/index:scopus?start=1300&amp;count=100&amp;query=heart&amp;view=COMPLETE&amp;httpAccept=application/xml&amp;apiKey=b50e60b193e884e6d78948e916d816a0" type="application/xml"/><link ref="last" href="http://api.elsevier.com:80/content/search/index:scopus?start=4900&amp;count=100&amp;query=heart&amp;view=COMPLETE&amp;httpAccept=application/xml&amp;apiKey=b50e60b193e884e6d78948e916d816a0" type="application/xml"/><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929154881"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929154881?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929154881&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929154881&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929154881</prism:url><dc:identifier>SCOPUS_ID:84929154881</dc:identifier><eid>2-s2.0-84929154881</eid><dc:title>Transforming and Simplifying the Treatment of Pulmonary Embolism: “Safe Dose” Thrombolysis Plus New Oral Anticoagulants</dc:title><dc:creator>Sharifi M.</dc:creator><prism:publicationName>Lung</prism:publicationName><prism:issn>03412040</prism:issn><prism:eIssn>14321750</prism:eIssn><prism:volume>193</prism:volume><prism:issueIdentifier>3</prism:issueIdentifier><prism:pageRange>369-374</prism:pageRange><prism:coverDate>2015-06-16</prism:coverDate><prism:coverDisplayDate>16 June 2015</prism:coverDisplayDate><prism:doi>10.1007/s00408-015-9702-1</prism:doi><dc:description>© 2015, Springer Science+Business Media New York. Background: Administration of systemic thrombolysis in pulmonary embolism (PE) has been limited to severe forms due to the risk of intracerebral hemorrhage (ICH). There is growing evidence from small studies that low-dose systemic thrombolysis has equal efficacy to standard dose, while eliminating the risk of ICH. Little data exists on the combined use of low-dose systemic thrombolysis and new oral anticoagulants (NOAC). We evaluated the clinical and echocardiographic outcome of patients treated with low or “safe dose” thrombolysis (SDT) and NOAC at intermediate term. Methods: We retrospectively identified 159 patients with massive and submassive PE who were treated with SDT and NOAC over a 2-year period by our group. They were followed prospectively for PE-related mortality, recurrent PE, bleeding, change in right/left ventricle (RV/LV) size, pulmonary artery systolic pressure (PASP), and clinical improvement at a mean follow-up of 18 ± 3 months. Results: At 6 months, the RV/LV size was reduced from 1.29 ± 0.28 to 0.89 ± 0.03 (p &lt; 0.001). The PASP dropped from 53.12 ± 3.85 mmHg to 30.39 ± 3.93 mmHg (p &lt; 0.001). There was no ICH or in-hospital major or minor bleeding. At 18 months, three patients died of cancer. Recurrent PE developed in one patient who had been later switched to warfarin. The duration of hospitalization was 1.8 ± 0.3 days. Conclusion: With combination of SDT and NOAC, treatment of massive and submassive PE becomes identical and is transformed from an “anticoagulation first” to a “thrombolysis first” approach, thereby making treatment streamlined, simple, safe and effective, accessible and inexpensive.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:115235338</affiliation-url><afid>115235338</afid><affilname>Arizona Cardiovascular Consultants &amp; Vein Clinic</affilname><name-variant>Arizona Cardiovascular Consultants &amp; Vein Clinic</name-variant><affiliation-city/><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60022026</affiliation-url><afid>60022026</afid><affilname>A. T. Still University, Mesa</affilname><name-variant>A. T. Still University</name-variant><affiliation-city>Mesa</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">7</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:7006324584</author-url><authid>7006324584</authid><authname>Sharifi M.</authname><surname>Sharifi</surname><given-name>Mohsen</given-name><initials>M.</initials><afid>115235338</afid><afid>60022026</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:7006324584</author-url><authid>7006324584</authid><authname>Sharifi M.</authname><surname>Sharifi</surname><given-name>Mohsen</given-name><initials>M.</initials><afid>115235338</afid><afid>60022026</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56487574400</author-url><authid>56487574400</authid><authname>Vajo Z.</authname><surname>Vajo</surname><given-name>Zoltan</given-name><initials>Z.</initials><afid>115235338</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56486954200</author-url><authid>56486954200</authid><authname>Freeman W.</authname><surname>Freeman</surname><given-name>Wilbur</given-name><initials>W.</initials><afid>60022026</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56487376800</author-url><authid>56487376800</authid><authname>Bay C.</authname><surname>Bay</surname><given-name>Curt</given-name><initials>C.</initials><afid>60022026</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56487127700</author-url><authid>56487127700</authid><authname>Sharifi M.</authname><surname>Sharifi</surname><given-name>Mirali</given-name><initials>M.</initials><afid>115235338</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:55877468100</author-url><authid>55877468100</authid><authname>Schwartz F.</authname><surname>Schwartz</surname><given-name>Frederic</given-name><initials>F.</initials><afid>60022026</afid></author><authkeywords>New oral anticoagulants | Pulmonary embolism | Pulmonary hypertension | Safe dose thrombolysis</authkeywords><intid>1785917387</intid><source-id>18533</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929170196"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929170196?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929170196&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929170196&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929170196</prism:url><dc:identifier>SCOPUS_ID:84929170196</dc:identifier><eid>2-s2.0-84929170196</eid><dc:title>In Situ Evidence of Pulmonary Endothelial Activation in Patients with Granulomatosis with Polyangiitis and Systemic Sclerosis</dc:title><dc:creator>Kawano-Dourado L.</dc:creator><prism:publicationName>Lung</prism:publicationName><prism:issn>03412040</prism:issn><prism:eIssn>14321750</prism:eIssn><prism:volume>193</prism:volume><prism:issueIdentifier>3</prism:issueIdentifier><prism:pageRange>355-359</prism:pageRange><prism:coverDate>2015-06-16</prism:coverDate><prism:coverDisplayDate>16 June 2015</prism:coverDisplayDate><prism:doi>10.1007/s00408-015-9718-6</prism:doi><dc:description>© 2015, Springer Science+Business Media New York. Introduction: The aim of this study was to investigate the in situ pulmonary endothelial activation in lung lesions of granulomatosis with polyangiitis (GPA) and systemic sclerosis (SScl). Methods: We examined the endothelial expression of ICAM-1, VCAM-1, and E-selectin using immunohistochemistry on formalin-fixed, paraffin-embedded sections of lung lesions of GPA, interstitial lung disease associated with SScl and controls. Results: A significantly enhanced expression of ICAM-1 and E-selectin was observed in GPA and SScl pulmonary endothelium compared to controls. VCAM-1 was more pronouncedly expressed in GPA compared to SScl. Conclusion: These observations are an evidence of in situ pulmonary vascular endothelial activation in lesions of GPA and SScl, adding information to the pathogenic knowledge of both diseases.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60008088</affiliation-url><afid>60008088</afid><affilname>Universidade de Sao Paulo - USP</affilname><name-variant>University of São Paulo</name-variant><affiliation-city>Sao Paulo</affiliation-city><affiliation-country>Brazil</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60008088</affiliation-url><afid>60008088</afid><affilname>Universidade de Sao Paulo - USP</affilname><name-variant>University of São Paulo</name-variant><affiliation-city>Sao Paulo</affiliation-city><affiliation-country>Brazil</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">5</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:45561384900</author-url><authid>45561384900</authid><authname>Kawano-Dourado L.</authname><surname>Kawano-Dourado</surname><given-name>Leticia</given-name><initials>L.</initials><afid>60008088</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56641773200</author-url><authid>56641773200</authid><authname>Ab’Saber A.</authname><surname>Ab’Saber</surname><given-name>Alexandre M.</given-name><initials>A.M.</initials><afid>60008088</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56240249900</author-url><authid>56240249900</authid><authname>Capelozzi V.</authname><surname>Capelozzi</surname><given-name>Vera Luiza</given-name><initials>V.L.</initials><afid>60008088</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56640860100</author-url><authid>56640860100</authid><authname>Valeri C.</authname><surname>Valeri</surname><given-name>Carla</given-name><initials>C.</initials><afid>60008088</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56640839600</author-url><authid>56640839600</authid><authname>Barbas C.</authname><surname>Barbas</surname><given-name>Carmen Sílvia Valente</given-name><initials>C.S.V.</initials><afid>60008088</afid></author><authkeywords>Cell adhesion molecules | E-selectin | Granulomatosis with polyangiitis | ICAM-1 | Systemic sclerosis | VCAM-1 | Wegener’s granulomatosis</authkeywords><intid>1785917458</intid><source-id>18533</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929178370"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929178370?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929178370&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929178370&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0032591015003460"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929178370</prism:url><dc:identifier>SCOPUS_ID:84929178370</dc:identifier><eid>2-s2.0-84929178370</eid><dc:title>Discovery of allostery in PKA signaling</dc:title><dc:creator>Zhang P.</dc:creator><prism:publicationName>Biophysical Reviews</prism:publicationName><prism:issn>18672450</prism:issn><prism:eIssn>18672469</prism:eIssn><prism:volume>7</prism:volume><prism:issueIdentifier>2</prism:issueIdentifier><prism:pageRange>227-238</prism:pageRange><prism:coverDate>2015-06-16</prism:coverDate><prism:coverDisplayDate>16 June 2015</prism:coverDisplayDate><prism:doi>10.1007/s12551-015-0170-x</prism:doi><dc:description>© 2015, International Union for Pure and Applied Biophysics (IUPAB) and Springer-Verlag Berlin Heidelberg. Cyclic AMP (cAMP)-dependent protein kinase (PKA) was the second protein kinase to be identified, and the PKA catalytic (C)-subunit serves as a prototype for the large protein kinase superfamily that contains over 500 gene products. The protein kinases regulate many biological functions in eukaryotic cells and are now also a major therapeutic target. The discovery of PKA nearly 50 years ago was quickly followed by the identification of the regulatory subunits that bind cAMP and release the catalytic activity from the holoenzyme. Thus in PKA we see the convergence of two major signaling mechanisms—protein phosphorylation and second messenger signaling through cAMP. Crystallography provides a foundation for understanding function, and detailed knowledge of the structure of the isolated regulatory (R)- and catalytic (C)-subunits has been extremely informative. Yet it is the R&lt;inf&gt;2&lt;/inf&gt;C&lt;inf&gt;2&lt;/inf&gt; holoenzyme that predominates in cells, and the allosteric features of PKA signaling can only be fully appreciated by seeing the full-length protein. The symmetry and the quaternary constraints that one R:C heterodimer exerts on the other in the holoenzyme simply are not present in the isolated subunits or even in the R:C heterodimer.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60030612</affiliation-url><afid>60030612</afid><affilname>University of California, San Diego</affilname><name-variant>University of California San Diego</name-variant><affiliation-city>San Diego</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60030612</affiliation-url><afid>60030612</afid><affilname>University of California, San Diego</affilname><name-variant>University of California San Diego</name-variant><affiliation-city>San Diego</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>re</subtype><subtypeDescription>Review</subtypeDescription><author-count limit="100">5</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55661473300</author-url><authid>55661473300</authid><authname>Zhang P.</authname><surname>Zhang</surname><given-name>Ping</given-name><initials>P.</initials><afid>60030612</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:7005597798</author-url><authid>7005597798</authid><authname>Kornev A.</authname><surname>Kornev</surname><given-name>Alexandr P.</given-name><initials>A.P.</initials><afid>60030612</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:55757782636</author-url><authid>55757782636</authid><authname>Wu J.</authname><surname>Wu</surname><given-name>Jian</given-name><initials>J.</initials><afid>60030612</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:7404756487</author-url><authid>7404756487</authid><authname>Taylor S.</authname><surname>Taylor</surname><given-name>Susan S.</given-name><initials>S.S.</initials><afid>60030612</afid><afid>60030612</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:7404756487</author-url><authid>7404756487</authid><authname>Taylor S.</authname><surname>Taylor</surname><given-name>Susan S.</given-name><initials>S.S.</initials><afid>60030612</afid><afid>60030612</afid></author><authkeywords>Allostery | cAMP-dependent protein kinase | Cyclic AMP | PKA catalytic subunit | PKA regulatory subunit</authkeywords><intid>535919066</intid><source-id>19400158558</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929207110"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929207110?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929207110&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929207110&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929207110</prism:url><dc:identifier>SCOPUS_ID:84929207110</dc:identifier><eid>2-s2.0-84929207110</eid><dc:title>Kinetics of microRNA Expression in Bronchoalveolar Lavage Fluid Samples</dc:title><dc:creator>Brock M.</dc:creator><prism:publicationName>Lung</prism:publicationName><prism:issn>03412040</prism:issn><prism:eIssn>14321750</prism:eIssn><prism:volume>193</prism:volume><prism:issueIdentifier>3</prism:issueIdentifier><prism:pageRange>381-385</prism:pageRange><prism:coverDate>2015-06-16</prism:coverDate><prism:coverDisplayDate>16 June 2015</prism:coverDisplayDate><prism:doi>10.1007/s00408-015-9719-5</prism:doi><dc:description>© 2015, Springer Science+Business Media New York. Levels of microRNAs (miRNAs) are increasingly assessed in biological fluids, for example, in samples obtained by bronchoalveolar lavage (BAL). “Post-collection kinetics” of miRNA expression levels, however, have not been investigated to date. In these experiments, we analyzed the dynamic expression profile of 5 different miRNAs (miR-17, miR-19b, miR-20b, miR-125a, and miR-223-3p) in BAL within the first 24 h following collection by routine bronchoscopy. miRNAs were quantified 0, 1, 4, 8, and 24 h after collection in samples that were kept at 4 °C or at room temperature. The expression of all five miRNAs was found to remain stable between the first 8 h after collection. 24 h after collection miRNAs faced substantial alterations in their expression profile. These data emphasize that BAL samples intended for further miRNA analysis can be handled at room temperature within the first 8 h after bronchoscopy.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60019619</affiliation-url><afid>60019619</afid><affilname>UniversitatsSpital Zurich</affilname><name-variant>University Hospital Zurich</name-variant><affiliation-city>Zurich</affiliation-city><affiliation-country>Switzerland</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">5</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:7103150980</author-url><authid>7103150980</authid><authname>Brock M.</authname><surname>Brock</surname><given-name>Matthias</given-name><initials>M.</initials><afid>60019619</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:36965766300</author-url><authid>36965766300</authid><authname>Rechsteiner T.</authname><surname>Rechsteiner</surname><given-name>Thomas</given-name><initials>T.</initials><afid>60019619</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56533184900</author-url><authid>56533184900</authid><authname>Kohler M.</authname><surname>Kohler</surname><given-name>Malcolm</given-name><initials>M.</initials><afid>60019619</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:12766183800</author-url><authid>12766183800</authid><authname>Franzen D.</authname><surname>Franzen</surname><given-name>Daniel</given-name><initials>D.</initials><afid>60019619</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:9241878800</author-url><authid>9241878800</authid><authname>Huber L.</authname><surname>Huber</surname><given-name>Lars C.</given-name><initials>L.C.</initials><afid>60019619</afid></author><authkeywords>Biofluid samples | Bronchoalveolar lavage | Kinetics | microRNAs</authkeywords><intid>35918032</intid><source-id>18533</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929176632"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929176632?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929176632&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929176632&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929176632</prism:url><dc:identifier>SCOPUS_ID:84929176632</dc:identifier><eid>2-s2.0-84929176632</eid><dc:title>Assessing Mindfulness in Multiple Contexts: a Comment on Christopher, Woodrich, and Tiernan (2014)</dc:title><dc:creator>Baer R.</dc:creator><prism:publicationName>Mindfulness</prism:publicationName><prism:issn>18688527</prism:issn><prism:eIssn>18688535</prism:eIssn><prism:volume>6</prism:volume><prism:issueIdentifier>3</prism:issueIdentifier><prism:pageRange>687-692</prism:pageRange><prism:coverDate>2015-06-16</prism:coverDate><prism:coverDisplayDate>16 June 2015</prism:coverDisplayDate><prism:doi>10.1007/s12671-014-0326-y</prism:doi><dc:description>© 2014, Springer Science+Business Media New York. This paper comments on a recent study by Christopher et al. (Mindfulness 5:145–160, 2014), in which 14 Zen Buddhist priests and laypersons residing in a monastery in the Northwestern US were interviewed about the extent to which the Five Facet Mindfulness Questionnaire and the Toronto Mindfulness Scale capture the nature of mindfulness as they understand and practice it. Participants identified strengths and weaknesses of both questionnaires; findings were discussed in terms of the cultural validity of the measures. Because mindfulness is taught, practiced, and studied in both Buddhist and Western contexts, including contemporary medical, mental health, educational, and research environments, this commentary argues that at least three domains of knowledge are important in developing measures of mindfulness with broad applicability: (1) knowledge of mindfulness as described, taught, and practiced in Buddhist traditions; (2) knowledge of mindfulness as described, taught, and practiced in contemporary Western interventions and training programs; and (3) knowledge of psychological assessment, especially psychometrics and questionnaire construction. A balanced perspective that explicitly acknowledges the value for health and well-being of both Buddhist and Western psychological conceptions of mindfulness is recommended.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60015941</affiliation-url><afid>60015941</afid><affilname>University of Kentucky</affilname><name-variant>University of Kentucky</name-variant><affiliation-city>Lexington</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">1</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:7201636073</author-url><authid>7201636073</authid><authname>Baer R.</authname><surname>Baer</surname><given-name>Ruth A.</given-name><initials>R.A.</initials><afid>60015941</afid></author><authkeywords>Buddhism | Cultural validity | Mindfulness | Mindfulness questionnaires</authkeywords><intid>1535918319</intid><source-id>19600166326</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929147210"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929147210?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929147210&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929147210&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929147210</prism:url><dc:identifier>SCOPUS_ID:84929147210</dc:identifier><eid>2-s2.0-84929147210</eid><dc:title>Promoting Attachment-Related Mindfulness and Compassion: a Wait-List-Controlled Study of Women Who Were Mistreated During Childhood</dc:title><dc:creator>Caldwell J.</dc:creator><prism:publicationName>Mindfulness</prism:publicationName><prism:issn>18688527</prism:issn><prism:eIssn>18688535</prism:eIssn><prism:volume>6</prism:volume><prism:issueIdentifier>3</prism:issueIdentifier><prism:pageRange>624-636</prism:pageRange><prism:coverDate>2015-06-16</prism:coverDate><prism:coverDisplayDate>16 June 2015</prism:coverDisplayDate><prism:doi>10.1007/s12671-014-0298-y</prism:doi><dc:description>© 2014, Springer Science+Business Media New York. Numerous studies have shown that mindfulness-based interventions contribute to a variety of positive outcomes in physical, cognitive, and affective domains. Less is known about how mindfulness influences variables associated with close interpersonal relationships. The present study evaluated a novel mindfulness-based intervention for promoting cognitive-emotional processes that are underdeveloped in people who have experienced unhealthy attachment relationships. In a sample of women who were mistreated in childhood, baseline measures confirmed that attachment anxiety was related to rumination and negative emotion; attachment avoidance was related to emotion suppression and lack of emotional clarity; and both kinds of insecurity were related to emotion dysregulation and lower levels of mindfulness. Across three measurement periods, a treatment group (N = 17), relative to a wait-list control group (N = 22), evinced significant improvements in the domains of rumination, emotion suppression, clarity of emotions, emotion regulation, and mindfulness. A multiple mediation analysis showed that, of these variables, improvements in rumination and emotional clarity mediated the gains in mindfulness for the treatment group. Also, participants in the treatment group showed significant changes in their use of mindfulness-based language when writing about stressful or traumatic childhood attachment experiences. Taken together, the results suggest that the intervention led to increases in mindfulness, primarily due to decreased rumination and increased emotional clarity, and these treatment-related changes were specifically related to participants’ thoughts and emotions regarding attachment.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:</affiliation-url><afid/><affilname>The Meadows</affilname><name-variant>Department of Psychiatry</name-variant><affiliation-city>Wickenburg</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60014439</affiliation-url><afid>60014439</afid><affilname>UC Davis</affilname><name-variant>University of California</name-variant><affiliation-city>Davis</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">2</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:24741121500</author-url><authid>24741121500</authid><authname>Caldwell J.</authname><surname>Caldwell</surname><given-name>Jon G.</given-name><initials>J.G.</initials><afid/></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56235573900</author-url><authid>56235573900</authid><authname>Shaver P.</authname><surname>Shaver</surname><given-name>Phillip R.</given-name><initials>P.R.</initials><afid>60014439</afid></author><authkeywords>Adult attachment | Compassion | Emotion regulation | Emotion suppression | Emotional clarity | Mindfulness | Rumination</authkeywords><intid>2035910927</intid><source-id>19600166326</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929157410"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929157410?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929157410&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929157410&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929157410</prism:url><dc:identifier>SCOPUS_ID:84929157410</dc:identifier><eid>2-s2.0-84929157410</eid><dc:title>The Myth of the Present Moment</dc:title><dc:creator>Purser R.</dc:creator><prism:publicationName>Mindfulness</prism:publicationName><prism:issn>18688527</prism:issn><prism:eIssn>18688535</prism:eIssn><prism:volume>6</prism:volume><prism:issueIdentifier>3</prism:issueIdentifier><prism:pageRange>680-686</prism:pageRange><prism:coverDate>2015-06-16</prism:coverDate><prism:coverDisplayDate>16 June 2015</prism:coverDisplayDate><prism:doi>10.1007/s12671-014-0333-z</prism:doi><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60027627</affiliation-url><afid>60027627</afid><affilname>San Francisco State University</affilname><name-variant>San Francisco State University</name-variant><affiliation-city>San Francisco</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ed</subtype><subtypeDescription>Editorial</subtypeDescription><author-count limit="100">1</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:7004211285</author-url><authid>7004211285</authid><authname>Purser R.</authname><surname>Purser</surname><given-name>Ronald</given-name><initials>R.</initials><afid>60027627</afid></author><intid>1785917734</intid><source-id>19600166326</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929145601"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929145601?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929145601&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929145601&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929145601</prism:url><dc:identifier>SCOPUS_ID:84929145601</dc:identifier><eid>2-s2.0-84929145601</eid><dc:title>Mindfulness-Based Therapy in Adults with an Autism Spectrum Disorder: Do Treatment Effects Last?</dc:title><dc:creator>Kiep M.</dc:creator><prism:publicationName>Mindfulness</prism:publicationName><prism:issn>18688527</prism:issn><prism:eIssn>18688535</prism:eIssn><prism:volume>6</prism:volume><prism:issueIdentifier>3</prism:issueIdentifier><prism:pageRange>637-644</prism:pageRange><prism:coverDate>2015-06-16</prism:coverDate><prism:coverDisplayDate>16 June 2015</prism:coverDisplayDate><prism:doi>10.1007/s12671-014-0299-x</prism:doi><dc:description>© 2014, Springer Science+Business Media New York. Individuals with autism spectrum disorders (ASD) have a higher incidence of comorbid disorders in comparison with other patient groups. Empirical evidence on treatments targeting comorbid symptoms is however scarce. Earlier research showed that mindfulness-based therapy for individuals on the autism spectrum (MBT-AS) is effective in reducing symptoms of depression, anxiety, and rumination. In the current study, it was examined whether MBT-AS is effective in alleviating a variety of psychosomatic symptoms and whether these effects were still evident after 9 weeks. Fifty participants took part in a nine-week MBT-AS training. Self-reported symptoms were evaluated at three intervals: (1) before the first session, (2) after the last session, and (3) 9 weeks after the last session. Results showed that symptoms of anxiety, depression, agoraphobia, somatization, inadequacy in thinking and acting, distrust and interpersonal sensitivity, sleeping problems, and general psychological and physical well-being declined significantly during intervention. Positive affect increased, and rumination declined significantly during treatment. Hostility symptoms did not decline significantly during treatment. All symptoms remained stable between post intervention and follow-up. This would seem to indicate that MBT-AS is effective in reducing psychological and physical symptoms and keeping them stable over the longer term. Furthermore, the outcome indicates that rumination is an important mediating factor. In conclusion, MBT-AS appears to be an effective method for reducing a variety of symptoms, and treatment gains remain stable over the longer term.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:115234716</affiliation-url><afid>115234716</afid><affilname>Adult Autism Center</affilname><name-variant>Adult Autism Center</name-variant><affiliation-city>Eindhoven</affiliation-city><affiliation-country>Netherlands</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">3</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56641874000</author-url><authid>56641874000</authid><authname>Kiep M.</authname><surname>Kiep</surname><given-name>Michelle</given-name><initials>M.</initials><afid>115234716</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:25930658600</author-url><authid>25930658600</authid><authname>Spek A.</authname><surname>Spek</surname><given-name>Annelies A.</given-name><initials>A.A.</initials><afid>115234716</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56641669400</author-url><authid>56641669400</authid><authname>Hoeben L.</authname><surname>Hoeben</surname><given-name>Lisette</given-name><initials>L.</initials><afid>115234716</afid></author><authkeywords>ASD | Depression | Mindfulness | Psychological and physical well-being | Rumination</authkeywords><intid>1535916268</intid><source-id>19600166326</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929144750"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929144750?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929144750&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929144750&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929144750</prism:url><dc:identifier>SCOPUS_ID:84929144750</dc:identifier><eid>2-s2.0-84929144750</eid><dc:title>A Framework for Supervision for Mindfulness-Based Teachers: a Space for Embodied Mutual Inquiry</dc:title><dc:creator>Evans A.</dc:creator><prism:publicationName>Mindfulness</prism:publicationName><prism:issn>18688527</prism:issn><prism:eIssn>18688535</prism:eIssn><prism:volume>6</prism:volume><prism:issueIdentifier>3</prism:issueIdentifier><prism:pageRange>572-581</prism:pageRange><prism:coverDate>2015-06-16</prism:coverDate><prism:coverDisplayDate>16 June 2015</prism:coverDisplayDate><prism:doi>10.1007/s12671-014-0292-4</prism:doi><dc:description>© 2014, The Author(s). Over recent decades, there has been an exponential growth in mindfulness-based interventions (MBIs). To disseminate MBIs with fidelity, care needs to be taken with the training and supervision of MBI teachers. A wealth of literature exists describing the process and practice of supervision in a range of clinical approaches, but, as of yet, little consideration has been given to how this can best be applied to the supervision of MBI teachers. This paper articulates a framework for supervision of MBI teachers. It was informed by the following: the experience of eight experienced mindfulness-based supervisors, the literature and understandings from MBIs, and by the authors’ experience of training and supervision. It sets out the nature and distinctive features of mindfulness-based supervision (MBS), representing this complex, multilayered process through a series of circles that denote its essence, form, content and process. This paper aims to be a basis for further dialogue on MBS, providing a foundation to increase the availability of competent supervision so that MBIs can expand without compromising integrity and efficacy.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60026479</affiliation-url><afid>60026479</afid><affilname>University of Exeter</affilname><name-variant>University of Exeter</name-variant><affiliation-city>Exeter</affiliation-city><affiliation-country>United Kingdom</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60025779</affiliation-url><afid>60025779</afid><affilname>Bangor University</affilname><name-variant>Bangor University</name-variant><affiliation-city>Bangor</affiliation-city><affiliation-country>United Kingdom</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60026851</affiliation-url><afid>60026851</afid><affilname>University of Oxford</affilname><name-variant>Oxford University</name-variant><affiliation-city>Oxford</affiliation-city><affiliation-country>United Kingdom</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:112865241</affiliation-url><afid>112865241</afid><affilname>Central Adelaide Local Health Network</affilname><name-variant>Southern Adelaide Local Health Network</name-variant><affiliation-city>Adelaide</affiliation-city><affiliation-country>Australia</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">8</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:7404363011</author-url><authid>7404363011</authid><authname>Evans A.</authname><surname>Evans</surname><given-name>Alison</given-name><initials>A.</initials><afid>60026479</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:35810177200</author-url><authid>35810177200</authid><authname>Crane R.</authname><surname>Crane</surname><given-name>Rebecca</given-name><initials>R.</initials><afid>60025779</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:55349543300</author-url><authid>55349543300</authid><authname>Cooper L.</authname><surname>Cooper</surname><given-name>Lucinda</given-name><initials>L.</initials><afid>60025779</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56641750500</author-url><authid>56641750500</authid><authname>Mardula J.</authname><surname>Mardula</surname><given-name>Jody</given-name><initials>J.</initials><afid>60025779</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56597683400</author-url><authid>56597683400</authid><authname>Wilks J.</authname><surname>Wilks</surname><given-name>Jenny</given-name><initials>J.</initials><afid>60026479</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:6602641647</author-url><authid>6602641647</authid><authname>Surawy C.</authname><surname>Surawy</surname><given-name>Christina</given-name><initials>C.</initials><afid>60026851</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:56640823800</author-url><authid>56640823800</authid><authname>Kenny M.</authname><surname>Kenny</surname><given-name>Maura</given-name><initials>M.</initials><afid>112865241</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:6701734558</author-url><authid>6701734558</authid><authname>Kuyken W.</authname><surname>Kuyken</surname><given-name>Willem</given-name><initials>W.</initials><afid>60026479</afid></author><authkeywords>Framework | Good practice guidance | Mindfulness-based cognitive therapy | Mindfulness-based interventions | Mindfulness-based stress reduction | Supervision | Training</authkeywords><intid>1035913144</intid><source-id>19600166326</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84928548185"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84928548185?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84928548185&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84928548185&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84928548185</prism:url><dc:identifier>SCOPUS_ID:84928548185</dc:identifier><eid>2-s2.0-84928548185</eid><dc:title>Self-Compassion and Body Dissatisfaction in Women: A Randomized Controlled Trial of a Brief Meditation Intervention</dc:title><dc:creator>Albertson E.</dc:creator><prism:publicationName>Mindfulness</prism:publicationName><prism:issn>18688527</prism:issn><prism:eIssn>18688535</prism:eIssn><prism:volume>6</prism:volume><prism:issueIdentifier>3</prism:issueIdentifier><prism:pageRange>444-454</prism:pageRange><prism:coverDate>2015-06-16</prism:coverDate><prism:coverDisplayDate>16 June 2015</prism:coverDisplayDate><prism:doi>10.1007/s12671-014-0277-3</prism:doi><dc:description>© 2014, Springer Science+Business Media New York. Body dissatisfaction is a major source of suffering among women of all ages. One potential factor that could mitigate body dissatisfaction is self-compassion, a construct that is garnering increasing research attention due to its strong association with psychological health. This study investigated whether a brief 3-week period of self-compassion meditation training would improve body satisfaction in a multigenerational group of women. Participants were randomized either to the meditation intervention group (N = 98; M age = 38.42) or to a waitlist control group (N = 130; M age = 36.42). Results suggested that compared to the control group, intervention participants experienced significantly greater reductions in body dissatisfaction, body shame, and contingent self-worth based on appearance, as well as greater gains in self-compassion and body appreciation. All improvements were maintained when assessed 3 months later. Self-compassion meditation may be a useful and cost-effective means of improving body image in adult women.</dc:description><citedby-count>1</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60006619</affiliation-url><afid>60006619</afid><affilname>Fielding Graduate University</affilname><name-variant>Fielding Graduate University</name-variant><affiliation-city>Santa Barbara</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60013372</affiliation-url><afid>60013372</afid><affilname>University of Texas at Austin</affilname><name-variant>University of Texas</name-variant><affiliation-city>Austin</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">3</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56641745200</author-url><authid>56641745200</authid><authname>Albertson E.</authname><surname>Albertson</surname><given-name>Ellen R.</given-name><initials>E.R.</initials><afid>60006619</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:7004252781</author-url><authid>7004252781</authid><authname>Neff K.</authname><surname>Neff</surname><given-name>Kristin D.</given-name><initials>K.D.</initials><afid>60013372</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56641635000</author-url><authid>56641635000</authid><authname>Dill-Shackleford K.</authname><surname>Dill-Shackleford</surname><given-name>Karen E.</given-name><initials>K.E.</initials><afid>60006619</afid></author><authkeywords>Body appreciation | Body dissatisfaction | Body image | Body shame | Meditation | Mindfulness | Self-compassion</authkeywords><intid>35809676</intid><source-id>19600166326</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929166485"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929166485?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929166485&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929166485&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929166485</prism:url><dc:identifier>SCOPUS_ID:84929166485</dc:identifier><eid>2-s2.0-84929166485</eid><dc:title>The Stages of Insight: Clinical Relevance for Mindfulness-Based Interventions</dc:title><dc:creator>Grabovac A.</dc:creator><prism:publicationName>Mindfulness</prism:publicationName><prism:issn>18688527</prism:issn><prism:eIssn>18688535</prism:eIssn><prism:volume>6</prism:volume><prism:issueIdentifier>3</prism:issueIdentifier><prism:pageRange>589-600</prism:pageRange><prism:coverDate>2015-06-16</prism:coverDate><prism:coverDisplayDate>16 June 2015</prism:coverDisplayDate><prism:doi>10.1007/s12671-014-0294-2</prism:doi><dc:description>© 2014, Springer Science+Business Media New York. The increased demand for and proliferation of mindfulness-based interventions (MBIs) within clinical treatment programs underscores the need for MBI clinicians to better understand the Buddhist psychological and theoretical underpinnings of such treatments. Of particular importance is familiarity with the stages of insight, the predictable developmental sequence of the Theravada Buddhist practices from which MBIs derive their core curricular components. This paper outlines the primary reasons why MBI clinicians need to be aware of the stages of insight, including: (1) some MBI participants appear to progress through the initial stages of insight, even during a relatively short period of time, such as an 8-week program; (2) knowledgeable clinicians may be better able to recognize the stages of insight and adjust practice instructions to facilitate participants’ navigation of these stages; (3) clinically significant symptoms that may be encountered during progress through the stages of insight need to be recognized by clinicians and appropriately addressed. Modifications to standards for clinician competency are suggested, and areas for future clinical and neurobiological research related to the stages of insight are explored. The risks and ethical issues associated with delivering MBIs in a health care setting, and informed consent regarding potential progress along the stages of insight, are discussed.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60010365</affiliation-url><afid>60010365</afid><affilname>The University of British Columbia</affilname><name-variant>University of British Columbia</name-variant><affiliation-city>Vancouver</affiliation-city><affiliation-country>Canada</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">1</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:6507417850</author-url><authid>6507417850</authid><authname>Grabovac A.</authname><surname>Grabovac</surname><given-name>Andrea</given-name><initials>A.</initials><afid>60010365</afid></author><authkeywords>Clinical implications | Insight meditation | Mindfulness-based interventions | Stages of insight | Vipassana</authkeywords><intid>1535915527</intid><source-id>19600166326</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929149255"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929149255?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929149255&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929149255&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929149255</prism:url><dc:identifier>SCOPUS_ID:84929149255</dc:identifier><eid>2-s2.0-84929149255</eid><dc:title>The Relationship Between Mindfulness and Posttraumatic Growth with Respect to Contemplative Practice Engagement</dc:title><dc:creator>Hanley A.</dc:creator><prism:publicationName>Mindfulness</prism:publicationName><prism:issn>18688527</prism:issn><prism:eIssn>18688535</prism:eIssn><prism:volume>6</prism:volume><prism:issueIdentifier>3</prism:issueIdentifier><prism:pageRange>654-662</prism:pageRange><prism:coverDate>2015-06-16</prism:coverDate><prism:coverDisplayDate>16 June 2015</prism:coverDisplayDate><prism:doi>10.1007/s12671-014-0302-6</prism:doi><dc:description>© 2014, Springer Science+Business Media New York. Facilitation of posttraumatic growth (PTG) is an encouraging area of research, yet little is known about the relationship between mindfulness and PTG. While recent studies support the effectiveness of mindfulness-based interventions with trauma-exposed populations and further findings link mindfulness with a variety of PTG outcomes, how these multidimensional constructs relate remains unclear. As such, the primary aim of this study was to investigate the relationship between mindfulness, specifically exploring differences between contemplative practitioners and nonpractitioners. Nonpractitioners (n = 248) and practitioners (n = 65) completed self-report measures of mindfulness, PTG, and trauma history online. Canonical correlation analyses indicate that contemplative practitioners reported higher levels of trait mindfulness and PTG as well as a stronger relationship between mindfulness and PTG in comparison with noncontemplative respondents. Results further indicate that the mindfulness dimensions were uniquely associated with PTG across the two groups. In summation, contemplative practitioners and nonpractitioners engaged different elements of mindfulness with respect to PTG and the mindfulness dimensions addressing behavioral regulation and evaluation appeared to be most closely associated with PTG. A hypothesized developmental trajectory in the relationship between mindfulness and PTG is discussed.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:115235369</affiliation-url><afid>115235369</afid><affilname>Educational Psychology &amp; Learning Systems</affilname><name-variant>Educational Psychology &amp; Learning Systems</name-variant><affiliation-city/><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60019012</affiliation-url><afid>60019012</afid><affilname>University of Utah Health Sciences Center</affilname><name-variant>University of Utah Medical Center</name-variant><affiliation-city>Salt Lake City</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">4</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55777557600</author-url><authid>55777557600</authid><authname>Hanley A.</authname><surname>Hanley</surname><given-name>Adam W.</given-name><initials>A.W.</initials><afid>115235369</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56640602700</author-url><authid>56640602700</authid><authname>Peterson G.</authname><surname>Peterson</surname><given-name>Gary W.</given-name><initials>G.W.</initials><afid>115235369</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:35758518900</author-url><authid>35758518900</authid><authname>Canto A.</authname><surname>Canto</surname><given-name>Angela I.</given-name><initials>A.I.</initials><afid>115235369</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:35764524000</author-url><authid>35764524000</authid><authname>Garland E.</authname><surname>Garland</surname><given-name>Eric L.</given-name><initials>E.L.</initials><afid>60019012</afid></author><authkeywords>Coping | Meditation | Mindfulness | Posttraumatic growth | Trauma</authkeywords><intid>1035911768</intid><source-id>19600166326</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929222884"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929222884?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929222884&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929222884&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0167527315006634"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929222884</prism:url><dc:identifier>SCOPUS_ID:84929222884</dc:identifier><eid>2-s2.0-84929222884</eid><dc:title>Characteristics, quality of care, and in-hospital outcomes of Asian-American heart failure patients: Findings from the American Heart Association Get With The Guidelines-Heart Failure Program</dc:title><dc:creator>Qian F.</dc:creator><prism:publicationName>International Journal of Cardiology</prism:publicationName><prism:issn>01675273</prism:issn><prism:eIssn>18741754</prism:eIssn><prism:volume>189</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>141-147</prism:pageRange><prism:coverDate>2015-06-15</prism:coverDate><prism:coverDisplayDate>15 June 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijcard.2015.03.400</prism:doi><dc:description>© 2015 Elsevier Ireland Ltd. All rights reserved. Background: Because little was previously known about Asian-American patients with heart failure (HF), we compared clinical profiles, quality of care, and outcomes between Asian-American and non-Hispanic white HF patients using data from the American Heart Association Get With The Guidelines-Heart Failure (GWTG-HF) program. Methods: We analyzed 153,023 HF patients (149,249 whites, 97.5%; 3774 Asian-Americans, 2.5%) from 356 U.S. centers participating in the GWTG-HF program (2005-2012). Baseline characteristics, quality of care metrics, inhospital mortality, discharge to home, and length of stay were examined. Results: Relative to white patients, Asian-American HF patients were younger, more likely to be male, uninsured or covered by Medicaid, and recruited in the western region. They had higher prevalence of diabetes, hypertension, and renal insufficiency, but similar ejection fraction. Overall, Asian-American HF patients had comparable quality of care except that they were less likely to receive aldosterone antagonists at discharge (relative risk &lt;RR&gt;, 0.88; 95% confidence interval &lt;CI&gt;, 0.78-0.99), and anticoagulation for atrial fibrillation (RR, 0.91; 95% CI, 0.85-0.97) even after risk adjustment. Compared with white patients, Asian-American patients had comparable risk adjusted in-hospital mortality (RR, 1.11; 95% CI, 0.91-1.35), lengthofstay&gt; 4 days (RR, 1.01; 95% CI, 0.95-1.08), and were more likely to be discharged to home (RR, 1.08; 95% CI, 1.06-1.11). Conclusions: Despite some differences in clinical profiles, Asian-American patients hospitalized with HF receive very similar quality of care and have comparable health outcomes to their white counterparts.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60011666</affiliation-url><afid>60011666</afid><affilname>University at Albany State University of New York</affilname><name-variant>University at Albany</name-variant><affiliation-city>Albany</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60032023</affiliation-url><afid>60032023</afid><affilname>UCLA Medical Center</affilname><name-variant>UCLA Medical Center</name-variant><affiliation-city>Los Angeles</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60015859</affiliation-url><afid>60015859</afid><affilname>Ochsner Medical Center - New Orleans</affilname><name-variant>Alton Ochsner Medical Foundation</name-variant><affiliation-city>New Orleans</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60008724</affiliation-url><afid>60008724</afid><affilname>Duke University</affilname><name-variant>Duke University</name-variant><affiliation-city>Durham</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60007363</affiliation-url><afid>60007363</afid><affilname>Northwestern University</affilname><name-variant>Northwestern University</name-variant><affiliation-city>Evanston</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60016782</affiliation-url><afid>60016782</afid><affilname>Brigham and Women's Hospital</affilname><name-variant>Brigham and Women's Hospital</name-variant><affiliation-city>Boston</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">11</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:36126683300</author-url><authid>36126683300</authid><authname>Qian F.</authname><surname>Qian</surname><given-name>Feng</given-name><initials>F.</initials><afid>60011666</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:7004451284</author-url><authid>7004451284</authid><authname>Fonarow G.</authname><surname>Fonarow</surname><given-name>Gregg C.</given-name><initials>G.C.</initials><afid>60032023</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:23670257100</author-url><authid>23670257100</authid><authname>Krim S.</authname><surname>Krim</surname><given-name>Selim R.</given-name><initials>S.R.</initials><afid>60015859</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:23670750000</author-url><authid>23670750000</authid><authname>Vivo R.</authname><surname>Vivo</surname><given-name>Rey P.</given-name><initials>R.P.</initials><afid>60032023</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:53866123200</author-url><authid>53866123200</authid><authname>Cox M.</authname><surname>Cox</surname><given-name>Margueritte</given-name><initials>M.</initials><afid>60008724</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:7005779022</author-url><authid>7005779022</authid><authname>Hannan E.</authname><surname>Hannan</surname><given-name>Edward L.</given-name><initials>E.L.</initials><afid>60011666</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:7202493180</author-url><authid>7202493180</authid><authname>Shaw B.</authname><surname>Shaw</surname><given-name>Benjamin A.</given-name><initials>B.A.</initials><afid>60011666</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:7401831506</author-url><authid>7401831506</authid><authname>Hernandez A.</authname><surname>Hernandez</surname><given-name>Adrian F.</given-name><initials>A.F.</initials><afid>60032023</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:28267733500</author-url><authid>28267733500</authid><authname>Eapen Z.</authname><surname>Eapen</surname><given-name>Zubin J.</given-name><initials>Z.J.</initials><afid>60008724</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:56550232400</author-url><authid>56550232400</authid><authname>Yancy C.</authname><surname>Yancy</surname><given-name>Clyde W.</given-name><initials>C.W.</initials><afid>60007363</afid></author><author seq="11"><author-url>http://api.elsevier.com/content/author/author_id:7102974175</author-url><authid>7102974175</authid><authname>Bhatt D.</authname><surname>Bhatt</surname><given-name>Deepak L.</given-name><initials>D.L.</initials><afid>60016782</afid></author><authkeywords>Asian-American | Clinical characteristics | Heart failure | Outcome | Quality of care</authkeywords><intid>535918762</intid><source-id>23774</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929155828"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929155828?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929155828&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929155828&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0167527315007834"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929155828</prism:url><dc:identifier>SCOPUS_ID:84929155828</dc:identifier><eid>2-s2.0-84929155828</eid><dc:title>Myocardial factor revisited: The importance of myocardial fibrosis in adults with congenital heart disease</dc:title><dc:creator>Broberg C.</dc:creator><prism:publicationName>International Journal of Cardiology</prism:publicationName><prism:issn>01675273</prism:issn><prism:eIssn>18741754</prism:eIssn><prism:volume>189</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>204-210</prism:pageRange><prism:coverDate>2015-06-15</prism:coverDate><prism:coverDisplayDate>15 June 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijcard.2015.04.064</prism:doi><dc:description>© 2015 Elsevier Ireland Ltd. All rights reserved. Pioneers in congenital heart surgery observed that exercise capacity did not return to normal levels despite successful surgical repair, leading some to cite a "myocardial factor" playing a role. They conjectured that residual alterations in myocardial function would be significant for patients' long-term outlook. In fulfillment of their early observations, today's adult congenital heart disease (ACHD) population shows well-recognized features of heart failure, even among patients without clear residual anatomic or hemodynamic abnormalities, demonstrating the vital role of the myocardium in their morbidity and mortality. Whereas the 'myocardial factor' was an elusive concept in the early history of congenital heart care, we now have imaging techniques to detect and quantify one such factor - myocardial fibrosis. Understanding the importance of myocardial fibrosis as a final common pathway in a variety of congenital lesions provides a framework for both the study and treatment of clinical heart failure in this context. While typical heart failure pharmacology should reduce or attenuate fibrogenesis, efforts to show meaningful improvements with standard pharmacotherapy in ACHD repeatedly fall short. This paper considers the importance of myocardial fibrosis and function, the current body of evidence for myocardial fibrosis in ACHD, and its implications for research and treatment.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60016733</affiliation-url><afid>60016733</afid><affilname>Oregon Health and Science University</affilname><name-variant>Oregon Health and Science University</name-variant><affiliation-city>Portland</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>re</subtype><subtypeDescription>Review</subtypeDescription><author-count limit="100">2</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:6602638135</author-url><authid>6602638135</authid><authname>Broberg C.</authname><surname>Broberg</surname><given-name>Craig S.</given-name><initials>C.S.</initials><afid>60016733</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:24166540800</author-url><authid>24166540800</authid><authname>Burchill L.</authname><surname>Burchill</surname><given-name>Luke J.</given-name><initials>L.J.</initials><afid>60016733</afid></author><authkeywords>Cardiac magnetic resonance | Congenital | Heart defects | Heart failure | Myocardial fibrosis</authkeywords><intid>1035912219</intid><source-id>23774</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929192601"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929192601?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929192601&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929192601&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0167527315006397"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929192601</prism:url><dc:identifier>SCOPUS_ID:84929192601</dc:identifier><eid>2-s2.0-84929192601</eid><dc:title>Adaptive cardiovascular hormones in a spectrum of heart failure phenotypes</dc:title><dc:creator>Zabarovskaja S.</dc:creator><prism:publicationName>International Journal of Cardiology</prism:publicationName><prism:issn>01675273</prism:issn><prism:eIssn>18741754</prism:eIssn><prism:volume>189</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>6-11</prism:pageRange><prism:coverDate>2015-06-15</prism:coverDate><prism:coverDisplayDate>15 June 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijcard.2015.03.381</prism:doi><dc:description>© 2015 Published by Elsevier Ireland Ltd. Background/objectives: In heart failure (HF), activation of brain natriuretic peptide (BNP), atrial natriuretic peptide (ANP) and adrenomedullin (ADM) is adaptive. The activation of these peptides in relation to different HF phenotypes such as HF with preserved ejection fraction (HFpEF), reduced ejection fraction (HFrEF) and after left ventricular assist device (LVAD) and heart transplantation (HTx) remains poorly characterized. Methods: We measured and compared N-terminal (NT)-proBNP, mid-regional (MR)-proANP and mid-regional (MR)-proADM in 86 patients with HFpEF, 49 patients with HFrEF, 13 patients one year post-LVAD and 22 patients one year post-HTx. We assessed their prognostic impact using Kaplan-Meier analysis and multivariable Cox regression. Results: In HFpEF, HFrEF, LVAD and HTx, NT-proBNP, median (inter-quartile range), was 1000 (465-2335), 3145 (1475-5190), 1430 (986-2570), and 208 (127-353) pmol/L, p &lt; 0.001. MR-proANP was 313 (192-381), 449 (325-596), 276 (216-305), and 118 (96-163) pmol/L, p &lt; 0.001. MR-proADM was 1.2 (0.9-1.6), 1.3 (0.9-2.0), 0.9 (0.7-1.4), and 0.7 (0.6-0.9) nmol/L, p &lt; 0.001 overall and p = 0.212 HFpEF versus HFrEF. In both HFpEF and HFrEF, NT-proBNP and MR-proANP predicted survival free from HTx or LVAD, independent of age, gender, NYHA class and eGFR, whereas MR-proADM did not. Conclusions: Patterns of the cardiomyocyte stress hormones NT-proBNP and MR-proANP suggest that compared to HFrEF, HFpEF may represent milder disease and LVAD and HTx may represent progressive resolution of HFseverity. NT-proBNP and MR-proANP independently predicted prognosis inboth HFpEF and HFrEF. In contrast, MR-proADM did not distinguish between HFpEF and HFrEF, did not predict prognosis in either, and may be more non-specific in HF.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60012311</affiliation-url><afid>60012311</afid><affilname>Karolinska Institutet</affilname><name-variant>Karolinska Institutet</name-variant><affiliation-city>Stockholm</affiliation-city><affiliation-country>Sweden</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60019295</affiliation-url><afid>60019295</afid><affilname>Karolinska University Hospital</affilname><name-variant>Karolinska University Hospital</name-variant><affiliation-city>Stockholm</affiliation-city><affiliation-country>Sweden</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60028893</affiliation-url><afid>60028893</afid><affilname>Centre Hospitalier Universitaire de Rennes</affilname><name-variant>CHU</name-variant><affiliation-city>Rennes</affiliation-city><affiliation-country>France</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">13</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55325484300</author-url><authid>55325484300</authid><authname>Zabarovskaja S.</authname><surname>Zabarovskaja</surname><given-name>Stanislava</given-name><initials>S.</initials><afid>60012311</afid><afid>60019295</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55325484300</author-url><authid>55325484300</authid><authname>Zabarovskaja S.</authname><surname>Zabarovskaja</surname><given-name>Stanislava</given-name><initials>S.</initials><afid>60012311</afid><afid>60019295</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:26433468300</author-url><authid>26433468300</authid><authname>Hage C.</authname><surname>Hage</surname><given-name>Camilla</given-name><initials>C.</initials><afid>60012311</afid><afid>60019295</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:26433468300</author-url><authid>26433468300</authid><authname>Hage C.</authname><surname>Hage</surname><given-name>Camilla</given-name><initials>C.</initials><afid>60012311</afid><afid>60019295</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:19735913300</author-url><authid>19735913300</authid><authname>Linde C.</authname><surname>Linde</surname><given-name>Cecilia</given-name><initials>C.</initials><afid>60012311</afid><afid>60019295</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:19735913300</author-url><authid>19735913300</authid><authname>Linde C.</authname><surname>Linde</surname><given-name>Cecilia</given-name><initials>C.</initials><afid>60012311</afid><afid>60019295</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:7004652563</author-url><authid>7004652563</authid><authname>Daubert J.</authname><surname>Daubert</surname><given-name>Jean Claude</given-name><initials>J.C.</initials><afid>60028893</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:7003337454</author-url><authid>7003337454</authid><authname>Donal E.</authname><surname>Donal</surname><given-name>Erwan</given-name><initials>E.</initials><afid>60028893</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:7005549908</author-url><authid>7005549908</authid><authname>Gabrielsen A.</authname><surname>Gabrielsen</surname><given-name>Anders</given-name><initials>A.</initials><afid>60012311</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:15119015900</author-url><authid>15119015900</authid><authname>Mellbin L.</authname><surname>Mellbin</surname><given-name>Linda</given-name><initials>L.</initials><afid>60012311</afid><afid>60019295</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:15119015900</author-url><authid>15119015900</authid><authname>Mellbin L.</authname><surname>Mellbin</surname><given-name>Linda</given-name><initials>L.</initials><afid>60012311</afid><afid>60019295</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:7102206508</author-url><authid>7102206508</authid><authname>Lund L.</authname><surname>Lund</surname><given-name>Lars H.</given-name><initials>L.H.</initials><afid>60012311</afid><afid>60019295</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:7102206508</author-url><authid>7102206508</authid><authname>Lund L.</authname><surname>Lund</surname><given-name>Lars H.</given-name><initials>L.H.</initials><afid>60012311</afid><afid>60019295</afid></author><authkeywords>Heart failure with preserved ejection fraction | Heart transplantation | MR-proADM | MR-proANP | Nt-proBNP | Ventricular assist device</authkeywords><intid>2035912196</intid><source-id>23774</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929192602"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929192602?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929192602&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929192602&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0167527315006853"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929192602</prism:url><dc:identifier>SCOPUS_ID:84929192602</dc:identifier><eid>2-s2.0-84929192602</eid><dc:title>Impact of chronic obstructive pulmonary disease on exercise ventilatory efficiency in heart failure</dc:title><dc:creator>Apostolo A.</dc:creator><prism:publicationName>International Journal of Cardiology</prism:publicationName><prism:issn>01675273</prism:issn><prism:eIssn>18741754</prism:eIssn><prism:volume>189</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>134-140</prism:pageRange><prism:coverDate>2015-06-15</prism:coverDate><prism:coverDisplayDate>15 June 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijcard.2015.03.422</prism:doi><dc:description>© 2015 Published by Elsevier Ireland Ltd. Background: Heart failure (HF) and chronic obstructive pulmonary disease (COPD) coexistence increases morbidity and mortality. The intercept of ventilation (VEint) on the VE vs. carbon dioxide production (VCO&lt;inf&gt;2&lt;/inf&gt;) relationship during exercise has been found to vary in proportion with dead space (VD) in HF. Considering that increased VD is the key pathophysiological abnormality in COPD but a secondary finding in HF we hypothesized that a high VEint would be useful in suggesting COPD as HF co-morbidity. Our aim was to assess whether an elevated VEint suggests the presence of COPD in HF. Methods: In a multicenter retrospective study, the VE-VCO2 relationship was analyzed both as slope and intercept in HF (n = 108), HF-COPD (n = 106) and COPD (n = 95). Patients with pulmonary arterial hypertension (PAH) (n = 85) and healthy subjects (HF) (n = 56) served as positive and negative controls relative to VE-VCO&lt;inf&gt;2&lt;/inf&gt; abnormalities, respectively. Results: Slope and VEint varied in opposite directions in all groups (p &lt; 0.05) being VE-VCO&lt;inf&gt;2&lt;/inf&gt; slope highest and lowest in PAH and healthy subjects, respectively. No slope differences were observed among HF, HF-COPD and COPD (32 ± 7, 31 ± 7, and 31 ± 6, respectively). VEint was higher in HF-COPD and COPD compared to HF, PAH and controls (4.8 ± 2.4 L/min, 5.9 ± 3.0 L/min, 3.0 ±2.6 L/min, 2.3 ± 3.3 L/min and 3.9 ±2.5 L/min, respectively; p &lt; 0.01). A VEint ≥4.07 L/min identified patients with high probability of having COPD or HF-COPD (sensitivity of 71.6% and specificity of 72.0%). Conclusion: These data provide novel evidence that a high VEint (≥4.07 L/min) should be valued to suggest coexistent COPD in HF patients.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60030318</affiliation-url><afid>60030318</afid><affilname>Universita degli Studi di Milano</affilname><name-variant>University of Milan</name-variant><affiliation-city>Milan</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60013430</affiliation-url><afid>60013430</afid><affilname>Hopital de Bicetre</affilname><name-variant>Hôpital de Bicêtre</name-variant><affiliation-city>Le Kremlin-Bicetre</affiliation-city><affiliation-country>France</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60001422</affiliation-url><afid>60001422</afid><affilname>Universite Pierre et Marie Curie</affilname><name-variant>Université Pierre et Marie Curie</name-variant><affiliation-city>Paris</affiliation-city><affiliation-country>France</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60000905</affiliation-url><afid>60000905</afid><affilname>Inserm</affilname><name-variant>INSERM</name-variant><affiliation-city>Paris</affiliation-city><affiliation-country>France</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60015622</affiliation-url><afid>60015622</afid><affilname>Hopital Pitie Salpetriere</affilname><affiliation-city>Paris</affiliation-city><affiliation-country>France</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60032350</affiliation-url><afid>60032350</afid><affilname>Universita degli Studi di Roma La Sapienza</affilname><affiliation-city>Rome</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60068815</affiliation-url><afid>60068815</afid><affilname>University of Belgrade</affilname><name-variant>University of Belgrade</name-variant><affiliation-city>Belgrade</affiliation-city><affiliation-country>Serbia</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60082964</affiliation-url><afid>60082964</afid><affilname>Fondazione San Raffaele del Monte Tabor</affilname><name-variant>Fondazione San Raffaele del Monte Tabor</name-variant><affiliation-city>Milan</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:100341145</affiliation-url><afid>100341145</afid><affilname>Dipartimento di Scienze Cardiovascolari</affilname><name-variant>Dipto. di Scienze Cardiovascolari</name-variant><affiliation-city>Rome</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60014992</affiliation-url><afid>60014992</afid><affilname>Universidade Federal de Sao Paulo</affilname><name-variant>Federal University of São Paulo</name-variant><affiliation-city>Sao Paulo</affiliation-city><affiliation-country>Brazil</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60018317</affiliation-url><afid>60018317</afid><affilname>Faculte de Medecine Paris-Sud</affilname><name-variant>Université Paris-Sud</name-variant><affiliation-city>Le Kremlin-Bicetre</affiliation-city><affiliation-country>France</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60000905</affiliation-url><afid>60000905</afid><affilname>Inserm</affilname><name-variant>INSERM</name-variant><affiliation-city>Paris</affiliation-city><affiliation-country>France</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60016005</affiliation-url><afid>60016005</afid><affilname>Queen's University, Kingston</affilname><name-variant>Queen's University</name-variant><affiliation-city>Kingston</affiliation-city><affiliation-country>Canada</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60030318</affiliation-url><afid>60030318</afid><affilname>Universita degli Studi di Milano</affilname><name-variant>University of Milan</name-variant><affiliation-city>Milan</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">26</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:7801309227</author-url><authid>7801309227</authid><authname>Apostolo A.</authname><surname>Apostolo</surname><given-name>Anna</given-name><initials>A.</initials><afid>60030318</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:15725680600</author-url><authid>15725680600</authid><authname>Laveneziana P.</authname><surname>Laveneziana</surname><given-name>PierAntonio</given-name><initials>P.</initials><afid>60013430</afid><afid>60001422</afid><afid>60000905</afid><afid>60015622</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:15725680600</author-url><authid>15725680600</authid><authname>Laveneziana P.</authname><surname>Laveneziana</surname><given-name>PierAntonio</given-name><initials>P.</initials><afid>60013430</afid><afid>60001422</afid><afid>60000905</afid><afid>60015622</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:15725680600</author-url><authid>15725680600</authid><authname>Laveneziana P.</authname><surname>Laveneziana</surname><given-name>PierAntonio</given-name><initials>P.</initials><afid>60013430</afid><afid>60001422</afid><afid>60000905</afid><afid>60015622</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:15725680600</author-url><authid>15725680600</authid><authname>Laveneziana P.</authname><surname>Laveneziana</surname><given-name>PierAntonio</given-name><initials>P.</initials><afid>60013430</afid><afid>60001422</afid><afid>60000905</afid><afid>60015622</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56577942900</author-url><authid>56577942900</authid><authname>Palange P.</authname><surname>Palange</surname><given-name>Paolo</given-name><initials>P.</initials><afid>60032350</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56641691900</author-url><authid>56641691900</authid><authname>Agalbato C.</authname><surname>Agalbato</surname><given-name>Cecilia</given-name><initials>C.</initials><afid>60030318</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56641322200</author-url><authid>56641322200</authid><authname>Molle R.</authname><surname>Molle</surname><given-name>Roberta</given-name><initials>R.</initials><afid>60030318</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:56370937600</author-url><authid>56370937600</authid><authname>Popovic D.</authname><surname>Popovic</surname><given-name>Dejana</given-name><initials>D.</initials><afid>60068815</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:6508203817</author-url><authid>6508203817</authid><authname>Bussotti M.</authname><surname>Bussotti</surname><given-name>Maurizio</given-name><initials>M.</initials><afid>60082964</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:55866257400</author-url><authid>55866257400</authid><authname>Internullo M.</authname><surname>Internullo</surname><given-name>Mattia</given-name><initials>M.</initials><afid>60032350</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:6701734741</author-url><authid>6701734741</authid><authname>Sciomer S.</authname><surname>Sciomer</surname><given-name>Susanna</given-name><initials>S.</initials><afid>100341145</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:56577750400</author-url><authid>56577750400</authid><authname>Bonini M.</authname><surname>Bonini</surname><given-name>Matteo</given-name><initials>M.</initials><afid>60032350</afid></author><author seq="11"><author-url>http://api.elsevier.com/content/author/author_id:23983985500</author-url><authid>23983985500</authid><authname>Alencar M.</authname><surname>Alencar</surname><given-name>Maria Clara</given-name><initials>M.C.</initials><afid>60014992</afid></author><author seq="12"><author-url>http://api.elsevier.com/content/author/author_id:56626060000</author-url><authid>56626060000</authid><authname>Godinas L.</authname><surname>Godinas</surname><given-name>Laurent</given-name><initials>L.</initials><afid>60013430</afid><afid>60018317</afid><afid>60000905</afid></author><author seq="12"><author-url>http://api.elsevier.com/content/author/author_id:56626060000</author-url><authid>56626060000</authid><authname>Godinas L.</authname><surname>Godinas</surname><given-name>Laurent</given-name><initials>L.</initials><afid>60013430</afid><afid>60018317</afid><afid>60000905</afid></author><author seq="12"><author-url>http://api.elsevier.com/content/author/author_id:56626060000</author-url><authid>56626060000</authid><authname>Godinas L.</authname><surname>Godinas</surname><given-name>Laurent</given-name><initials>L.</initials><afid>60013430</afid><afid>60018317</afid><afid>60000905</afid></author><author seq="13"><author-url>http://api.elsevier.com/content/author/author_id:16240708000</author-url><authid>16240708000</authid><authname>Arbex F.</authname><surname>Arbex</surname><given-name>Flavio</given-name><initials>F.</initials><afid>60014992</afid></author><author seq="14"><author-url>http://api.elsevier.com/content/author/author_id:7202755259</author-url><authid>7202755259</authid><authname>Garcia G.</authname><surname>Garcia</surname><given-name>Gilles</given-name><initials>G.</initials><afid>60013430</afid><afid>60018317</afid><afid>60000905</afid></author><author seq="14"><author-url>http://api.elsevier.com/content/author/author_id:7202755259</author-url><authid>7202755259</authid><authname>Garcia G.</authname><surname>Garcia</surname><given-name>Gilles</given-name><initials>G.</initials><afid>60013430</afid><afid>60018317</afid><afid>60000905</afid></author><author seq="14"><author-url>http://api.elsevier.com/content/author/author_id:7202755259</author-url><authid>7202755259</authid><authname>Garcia G.</authname><surname>Garcia</surname><given-name>Gilles</given-name><initials>G.</initials><afid>60013430</afid><afid>60018317</afid><afid>60000905</afid></author><author seq="15"><author-url>http://api.elsevier.com/content/author/author_id:6603784121</author-url><authid>6603784121</authid><authname>Neder J.</authname><surname>Neder</surname><given-name>J. Alberto</given-name><initials>J.A.</initials><afid>60030318</afid><afid>60014992</afid><afid>60016005</afid></author><author seq="15"><author-url>http://api.elsevier.com/content/author/author_id:6603784121</author-url><authid>6603784121</authid><authname>Neder J.</authname><surname>Neder</surname><given-name>J. Alberto</given-name><initials>J.A.</initials><afid>60030318</afid><afid>60014992</afid><afid>60016005</afid></author><author seq="15"><author-url>http://api.elsevier.com/content/author/author_id:6603784121</author-url><authid>6603784121</authid><authname>Neder J.</authname><surname>Neder</surname><given-name>J. Alberto</given-name><initials>J.A.</initials><afid>60030318</afid><afid>60014992</afid><afid>60016005</afid></author><author seq="16"><author-url>http://api.elsevier.com/content/author/author_id:7005884379</author-url><authid>7005884379</authid><authname>Agostoni P.</authname><surname>Agostoni</surname><given-name>Piergiuseppe</given-name><initials>P.</initials><afid>60030318</afid><afid>60030318</afid></author><author seq="16"><author-url>http://api.elsevier.com/content/author/author_id:7005884379</author-url><authid>7005884379</authid><authname>Agostoni P.</authname><surname>Agostoni</surname><given-name>Piergiuseppe</given-name><initials>P.</initials><afid>60030318</afid><afid>60030318</afid></author><authkeywords>Dead space | Exercise | Heart failure | Lung diseases | Ventilatory efficiency</authkeywords><intid>535917194</intid><source-id>23774</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929470769"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929470769?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929470769&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929470769&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0024320515002222"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929470769</prism:url><dc:identifier>SCOPUS_ID:84929470769</dc:identifier><eid>2-s2.0-84929470769</eid><dc:title>The investigation of the possible protective influence of selenium on antioxidant barrier in heart of rats exposed to lithium</dc:title><dc:creator>Musik I.</dc:creator><prism:publicationName>Life Sciences</prism:publicationName><prism:issn>00243205</prism:issn><prism:eIssn>18790631</prism:eIssn><prism:volume>132</prism:volume><prism:pageRange>1-5</prism:pageRange><prism:coverDate>2015-06-15</prism:coverDate><prism:coverDisplayDate>15 June 2015</prism:coverDisplayDate><prism:doi>10.1016/j.lfs.2015.03.025</prism:doi><pii>S0024320515002222</pii><dc:description>© 2015 Elsevier Inc. All rights reserved. Abstract Aims Selenium is an essential element possessing antioxidant properties and the treatment with it has displayed protective effects against toxicity of different substances occurring in the environment and food as well as against the side effects of some drugs. Lithium is used in medicine although numerous side effects can occur during therapy, including disturbances of the heart. For these reasons studies to find protective adjuvants have been performed. In the current study the possibility of selenium (as sodium selenite) application as a protective adjuvant in lithium treatment was studied. Main methods Male Wistar rats were treated: control - with saline; Li-group - with Li&lt;inf&gt;2&lt;/inf&gt;CO&lt;inf&gt;3&lt;/inf&gt; (2.7 mg Li/kg b.w.); Se-group - with Na&lt;inf&gt;2&lt;/inf&gt;SeO&lt;inf&gt;3&lt;/inf&gt; (0.5 mg Se/kg b.w.); Li + Se-group simultaneously with Li&lt;inf&gt;2&lt;/inf&gt;CO&lt;inf&gt;3&lt;/inf&gt; and Na&lt;inf&gt;2&lt;/inf&gt;SeO&lt;inf&gt;3&lt;/inf&gt; (2.7 mg Li/kg b.w. and 0.5 mg Se/kg b.w., respectively) by a stomach tube for a period of three weeks, once a day. In heart homogenate activities of antioxidant enzymes - catalase (CAT), superoxide dismutase (SOD) and glutathione peroxidase (GPx), concentrations of low-molecular-weight antioxidants - ascorbic acid (AA) and reduced glutathione (GSH) as well as total antioxidant status (TAS) values were determined. GPx/SOD and CAT/SOD ratios were evaluated. Key findings In comparison with control selenium caused no significant changes of the studied parameters except for GPx, whereas lithium slightly disturbed TAS and markedly GPx, CAT and CAT/SOD ratio. In Li-treated rats co-administration of selenium displayed tendency towards restoring the impaired parameters. Significance The results suggest that research on selenium application as an adjuvant in lithium therapy is worthy to be continued.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60069011</affiliation-url><afid>60069011</afid><affilname>Medical University of Lublin</affilname><name-variant>Medical University</name-variant><affiliation-city>Lublin</affiliation-city><affiliation-country>Poland</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">5</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:6602069940</author-url><authid>6602069940</authid><authname>Musik I.</authname><surname>Musik</surname><given-name>Irena</given-name><initials>I.</initials><afid>60069011</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56245653500</author-url><authid>56245653500</authid><authname>Kocot J.</authname><surname>Kocot</surname><given-name>Joanna</given-name><initials>J.</initials><afid>60069011</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:7005097554</author-url><authid>7005097554</authid><authname>Lewandowska A.</authname><surname>Lewandowska</surname><given-name>Anna</given-name><initials>A.</initials><afid>60069011</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56076862000</author-url><authid>56076862000</authid><authname>Zelazowska R.</authname><surname>Zelazowska</surname><given-name>Renata</given-name><initials>R.</initials><afid>60069011</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:6603229466</author-url><authid>6603229466</authid><authname>Kiełczykowska M.</authname><surname>Kiełczykowska</surname><given-name>Małgorzata</given-name><initials>M.</initials><afid>60069011</afid></author><authkeywords>Antioxidants | Heart | Lithium carbonate | Rats | Sodium selenite</authkeywords><intid>35963443</intid><article-number>14356</article-number><source-id>20473</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929155465"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929155465?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929155465&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929155465&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0167527315007123"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929155465</prism:url><dc:identifier>SCOPUS_ID:84929155465</dc:identifier><eid>2-s2.0-84929155465</eid><dc:title>Involvement of BAG3 and HSPB7 loci in various etiologies of systolic heart failure: Results of a European collaboration assembling more than 2000 patients</dc:title><dc:creator>Garnier S.</dc:creator><prism:publicationName>International Journal of Cardiology</prism:publicationName><prism:issn>01675273</prism:issn><prism:eIssn>18741754</prism:eIssn><prism:volume>189</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>105-107</prism:pageRange><prism:coverDate>2015-06-15</prism:coverDate><prism:coverDisplayDate>15 June 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijcard.2015.04.003</prism:doi><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60000905</affiliation-url><afid>60000905</afid><affilname>Inserm</affilname><name-variant>INSERM</name-variant><affiliation-city>Paris</affiliation-city><affiliation-country>France</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60001422</affiliation-url><afid>60001422</afid><affilname>Universite Pierre et Marie Curie</affilname><name-variant>Université Pierre et Marie Curie</name-variant><affiliation-city>Paris</affiliation-city><affiliation-country>France</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:113324054</affiliation-url><afid>113324054</afid><affilname>Institute of Cardiometabolism and Nutrition</affilname><name-variant>ICAN Institute for Cardiometabolism and Nutrition</name-variant><affiliation-city>Paris</affiliation-city><affiliation-country>France</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60030807</affiliation-url><afid>60030807</afid><affilname>Universitat Regensburg</affilname><name-variant>Universität Regensburg</name-variant><affiliation-city>Regensburg</affiliation-city><affiliation-country>Germany</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60010479</affiliation-url><afid>60010479</afid><affilname>Hopital Cardiologique</affilname><name-variant>Hopital Cardiologique</name-variant><affiliation-city>Lille</affiliation-city><affiliation-country>France</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60003335</affiliation-url><afid>60003335</afid><affilname>Hopital Ambroise Pare, Boulogne-Billancourt</affilname><name-variant>Hôpital Ambroise-Paré</name-variant><affiliation-city>Boulogne-Billancourt</affiliation-city><affiliation-country>France</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60029937</affiliation-url><afid>60029937</afid><affilname>Universite de Versailles Saint-Quentin-en-Yvelines</affilname><name-variant>Université de Versailles</name-variant><affiliation-city>Versailles</affiliation-city><affiliation-country>France</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60032530</affiliation-url><afid>60032530</afid><affilname>Universite Francois-Rabelais Tours</affilname><name-variant>Université de Tours</name-variant><affiliation-city>Tours</affiliation-city><affiliation-country>France</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60000905</affiliation-url><afid>60000905</afid><affilname>Inserm</affilname><name-variant>INSERM</name-variant><affiliation-city>Paris</affiliation-city><affiliation-country>France</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60026556</affiliation-url><afid>60026556</afid><affilname>Fondazione IRCCS Policlinico San Matteo</affilname><name-variant>IRCCS Policlinico S. Matteo</name-variant><affiliation-city>Pavia</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60029204</affiliation-url><afid>60029204</afid><affilname>NHS Foundation Trust</affilname><name-variant>NHS Foundation Trust</name-variant><affiliation-city>Leeds</affiliation-city><affiliation-country>United Kingdom</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60003280</affiliation-url><afid>60003280</afid><affilname>Universitatsklinikum Heidelberg</affilname><affiliation-city>Heidelberg</affiliation-city><affiliation-country>Germany</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60001422</affiliation-url><afid>60001422</afid><affilname>Universite Pierre et Marie Curie</affilname><name-variant>Université Pierre et Marie Curie</name-variant><affiliation-city>Paris</affiliation-city><affiliation-country>France</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60010719</affiliation-url><afid>60010719</afid><affilname>National Heart and Lung Institute</affilname><name-variant>National Heart and Lung Institute</name-variant><affiliation-city>London</affiliation-city><affiliation-country>United Kingdom</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60004409</affiliation-url><afid>60004409</afid><affilname>National Heart Centre, Singapore</affilname><name-variant>National Heart Centre Singapore</name-variant><affiliation-city>Singapore City</affiliation-city><affiliation-country>Singapore</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60017161</affiliation-url><afid>60017161</afid><affilname>National University of Singapore</affilname><name-variant>National University of Singapore</name-variant><affiliation-city>Singapore City</affiliation-city><affiliation-country>Singapore</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>le</subtype><subtypeDescription>Letter</subtypeDescription><author-count limit="100">38</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:35847190200</author-url><authid>35847190200</authid><authname>Garnier S.</authname><surname>Garnier</surname><given-name>Sophie</given-name><initials>S.</initials><afid>60000905</afid><afid>60001422</afid><afid>113324054</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:35847190200</author-url><authid>35847190200</authid><authname>Garnier S.</authname><surname>Garnier</surname><given-name>Sophie</given-name><initials>S.</initials><afid>60000905</afid><afid>60001422</afid><afid>113324054</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:35847190200</author-url><authid>35847190200</authid><authname>Garnier S.</authname><surname>Garnier</surname><given-name>Sophie</given-name><initials>S.</initials><afid>60000905</afid><afid>60001422</afid><afid>113324054</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:7003528759</author-url><authid>7003528759</authid><authname>Hengstenberg C.</authname><surname>Hengstenberg</surname><given-name>Christian</given-name><initials>C.</initials><afid>60030807</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:6602759623</author-url><authid>6602759623</authid><authname>Lamblin N.</authname><surname>Lamblin</surname><given-name>Nicolas</given-name><initials>N.</initials><afid>60010479</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:7005428061</author-url><authid>7005428061</authid><authname>Dubourg O.</authname><surname>Dubourg</surname><given-name>Olivier</given-name><initials>O.</initials><afid>60003335</afid><afid>60029937</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:7005428061</author-url><authid>7005428061</authid><authname>Dubourg O.</authname><surname>Dubourg</surname><given-name>Olivier</given-name><initials>O.</initials><afid>60003335</afid><afid>60029937</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:7006255630</author-url><authid>7006255630</authid><authname>De Groote P.</authname><surname>De Groote</surname><given-name>Pascal</given-name><initials>P.</initials><afid>60010479</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:7005282545</author-url><authid>7005282545</authid><authname>Fauchier L.</authname><surname>Fauchier</surname><given-name>Laurent</given-name><initials>L.</initials><afid>60032530</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:18036119300</author-url><authid>18036119300</authid><authname>Trochu J.</authname><surname>Trochu</surname><given-name>Jean Noël</given-name><initials>J.N.</initials><afid>60000905</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:7006508645</author-url><authid>7006508645</authid><authname>Arbustini E.</authname><surname>Arbustini</surname><given-name>Eloisa</given-name><initials>E.</initials><afid>60026556</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:36628062500</author-url><authid>36628062500</authid><authname>Esslinger U.</authname><surname>Esslinger</surname><given-name>Ulrike</given-name><initials>U.</initials><afid>60000905</afid><afid>113324054</afid><afid>60030807</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:36628062500</author-url><authid>36628062500</authid><authname>Esslinger U.</authname><surname>Esslinger</surname><given-name>Ulrike</given-name><initials>U.</initials><afid>60000905</afid><afid>113324054</afid><afid>60030807</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:36628062500</author-url><authid>36628062500</authid><authname>Esslinger U.</authname><surname>Esslinger</surname><given-name>Ulrike</given-name><initials>U.</initials><afid>60000905</afid><afid>113324054</afid><afid>60030807</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:7102864091</author-url><authid>7102864091</authid><authname>Barton P.</authname><surname>Barton</surname><given-name>Paul J.</given-name><initials>P.J.</initials><afid>60029204</afid><afid>60010719</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:7102864091</author-url><authid>7102864091</authid><authname>Barton P.</authname><surname>Barton</surname><given-name>Paul J.</given-name><initials>P.J.</initials><afid>60029204</afid><afid>60010719</afid></author><author seq="11"><author-url>http://api.elsevier.com/content/author/author_id:6602409026</author-url><authid>6602409026</authid><authname>Meder B.</authname><surname>Meder</surname><given-name>Benjamin</given-name><initials>B.</initials><afid>60003280</afid></author><author seq="12"><author-url>http://api.elsevier.com/content/author/author_id:24299225600</author-url><authid>24299225600</authid><authname>Katus H.</authname><surname>Katus</surname><given-name>Hugo</given-name><initials>H.</initials><afid>60003280</afid></author><author seq="13"><author-url>http://api.elsevier.com/content/author/author_id:45461179000</author-url><authid>45461179000</authid><authname>Frese K.</authname><surname>Frese</surname><given-name>Karen</given-name><initials>K.</initials><afid>60003280</afid></author><author seq="14"><author-url>http://api.elsevier.com/content/author/author_id:7102980352</author-url><authid>7102980352</authid><authname>Komajda M.</authname><surname>Komajda</surname><given-name>Michel</given-name><initials>M.</initials><afid>60000905</afid><afid>113324054</afid><afid>60001422</afid></author><author seq="14"><author-url>http://api.elsevier.com/content/author/author_id:7102980352</author-url><authid>7102980352</authid><authname>Komajda M.</authname><surname>Komajda</surname><given-name>Michel</given-name><initials>M.</initials><afid>60000905</afid><afid>113324054</afid><afid>60001422</afid></author><author seq="14"><author-url>http://api.elsevier.com/content/author/author_id:7102980352</author-url><authid>7102980352</authid><authname>Komajda M.</authname><surname>Komajda</surname><given-name>Michel</given-name><initials>M.</initials><afid>60000905</afid><afid>113324054</afid><afid>60001422</afid></author><author seq="15"><author-url>http://api.elsevier.com/content/author/author_id:56640538400</author-url><authid>56640538400</authid><authname>Cook S.</authname><surname>Cook</surname><given-name>Stuart A.</given-name><initials>S.A.</initials><afid>60010719</afid><afid>60004409</afid><afid>60017161</afid></author><author seq="15"><author-url>http://api.elsevier.com/content/author/author_id:56640538400</author-url><authid>56640538400</authid><authname>Cook S.</authname><surname>Cook</surname><given-name>Stuart A.</given-name><initials>S.A.</initials><afid>60010719</afid><afid>60004409</afid><afid>60017161</afid></author><author seq="15"><author-url>http://api.elsevier.com/content/author/author_id:56640538400</author-url><authid>56640538400</authid><authname>Cook S.</authname><surname>Cook</surname><given-name>Stuart A.</given-name><initials>S.A.</initials><afid>60010719</afid><afid>60004409</afid><afid>60017161</afid></author><author seq="16"><author-url>http://api.elsevier.com/content/author/author_id:56214031100</author-url><authid>56214031100</authid><authname>Isnard R.</authname><surname>Isnard</surname><given-name>Richard</given-name><initials>R.</initials><afid>60000905</afid><afid>60001422</afid></author><author seq="16"><author-url>http://api.elsevier.com/content/author/author_id:56214031100</author-url><authid>56214031100</authid><authname>Isnard R.</authname><surname>Isnard</surname><given-name>Richard</given-name><initials>R.</initials><afid>60000905</afid><afid>60001422</afid></author><author seq="17"><author-url>http://api.elsevier.com/content/author/author_id:7006257206</author-url><authid>7006257206</authid><authname>Tiret L.</authname><surname>Tiret</surname><given-name>Laurence</given-name><initials>L.</initials><afid>60000905</afid><afid>60001422</afid><afid>113324054</afid></author><author seq="17"><author-url>http://api.elsevier.com/content/author/author_id:7006257206</author-url><authid>7006257206</authid><authname>Tiret L.</authname><surname>Tiret</surname><given-name>Laurence</given-name><initials>L.</initials><afid>60000905</afid><afid>60001422</afid><afid>113324054</afid></author><author seq="17"><author-url>http://api.elsevier.com/content/author/author_id:7006257206</author-url><authid>7006257206</authid><authname>Tiret L.</authname><surname>Tiret</surname><given-name>Laurence</given-name><initials>L.</initials><afid>60000905</afid><afid>60001422</afid><afid>113324054</afid></author><author seq="18"><author-url>http://api.elsevier.com/content/author/author_id:6602181960</author-url><authid>6602181960</authid><authname>Villard E.</authname><surname>Villard</surname><given-name>Eric</given-name><initials>E.</initials><afid>60000905</afid><afid>60001422</afid><afid>113324054</afid><afid>60001422</afid></author><author seq="18"><author-url>http://api.elsevier.com/content/author/author_id:6602181960</author-url><authid>6602181960</authid><authname>Villard E.</authname><surname>Villard</surname><given-name>Eric</given-name><initials>E.</initials><afid>60000905</afid><afid>60001422</afid><afid>113324054</afid><afid>60001422</afid></author><author seq="18"><author-url>http://api.elsevier.com/content/author/author_id:6602181960</author-url><authid>6602181960</authid><authname>Villard E.</authname><surname>Villard</surname><given-name>Eric</given-name><initials>E.</initials><afid>60000905</afid><afid>60001422</afid><afid>113324054</afid><afid>60001422</afid></author><author seq="18"><author-url>http://api.elsevier.com/content/author/author_id:6602181960</author-url><authid>6602181960</authid><authname>Villard E.</authname><surname>Villard</surname><given-name>Eric</given-name><initials>E.</initials><afid>60000905</afid><afid>60001422</afid><afid>113324054</afid><afid>60001422</afid></author><author seq="19"><author-url>http://api.elsevier.com/content/author/author_id:55499851500</author-url><authid>55499851500</authid><authname>Charron P.</authname><surname>Charron</surname><given-name>Philippe</given-name><initials>P.</initials><afid>60000905</afid><afid>113324054</afid><afid>60003335</afid><afid>60029937</afid></author><author seq="19"><author-url>http://api.elsevier.com/content/author/author_id:55499851500</author-url><authid>55499851500</authid><authname>Charron P.</authname><surname>Charron</surname><given-name>Philippe</given-name><initials>P.</initials><afid>60000905</afid><afid>113324054</afid><afid>60003335</afid><afid>60029937</afid></author><author seq="19"><author-url>http://api.elsevier.com/content/author/author_id:55499851500</author-url><authid>55499851500</authid><authname>Charron P.</authname><surname>Charron</surname><given-name>Philippe</given-name><initials>P.</initials><afid>60000905</afid><afid>113324054</afid><afid>60003335</afid><afid>60029937</afid></author><author seq="19"><author-url>http://api.elsevier.com/content/author/author_id:55499851500</author-url><authid>55499851500</authid><authname>Charron P.</authname><surname>Charron</surname><given-name>Philippe</given-name><initials>P.</initials><afid>60000905</afid><afid>113324054</afid><afid>60003335</afid><afid>60029937</afid></author><authkeywords>Association studies | Dilated cardiomyopathy | Genetics | Ischemic heart failure</authkeywords><intid>1035914264</intid><source-id>23774</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929147077"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929147077?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929147077&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929147077&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0167527315006798"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929147077</prism:url><dc:identifier>SCOPUS_ID:84929147077</dc:identifier><eid>2-s2.0-84929147077</eid><dc:title>Evidence of nitrosative stress within hearts of patients dying of Tako-tsubo cardiomyopathy</dc:title><dc:creator>Surikow S.</dc:creator><prism:publicationName>International Journal of Cardiology</prism:publicationName><prism:issn>01675273</prism:issn><prism:eIssn>18741754</prism:eIssn><prism:volume>189</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>112-114</prism:pageRange><prism:coverDate>2015-06-15</prism:coverDate><prism:coverDisplayDate>15 June 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijcard.2015.03.416</prism:doi><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60009512</affiliation-url><afid>60009512</afid><affilname>University of Adelaide</affilname><name-variant>University of Adelaide</name-variant><affiliation-city>Adelaide</affiliation-city><affiliation-country>Australia</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>le</subtype><subtypeDescription>Letter</subtypeDescription><author-count limit="100">6</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56641905200</author-url><authid>56641905200</authid><authname>Surikow S.</authname><surname>Surikow</surname><given-name>S. Y.</given-name><initials>S.Y.</initials><afid>60009512</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:55917047400</author-url><authid>55917047400</authid><authname>Raman B.</authname><surname>Raman</surname><given-name>B.</given-name><initials>B.</initials><afid>60009512</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56641291700</author-url><authid>56641291700</authid><authname>Licari J.</authname><surname>Licari</surname><given-name>J.</given-name><initials>J.</initials><afid>60009512</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:55649371600</author-url><authid>55649371600</authid><authname>Singh K.</authname><surname>Singh</surname><given-name>K.</given-name><initials>K.</initials><afid>60009512</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:7404370930</author-url><authid>7404370930</authid><authname>Nguyen T.</authname><surname>Nguyen</surname><given-name>T. H.</given-name><initials>T.H.</initials><afid>60009512</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:7201833763</author-url><authid>7201833763</authid><authname>Horowitz J.</authname><surname>Horowitz</surname><given-name>J. D.</given-name><initials>J.D.</initials><afid>60009512</afid></author><authkeywords>3-Nitrotyrosine | Nitrosative stress | Tako-tsubo cardiomyopathy</authkeywords><intid>535918046</intid><source-id>23774</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929147297"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929147297?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929147297&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929147297&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0167527315007846"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929147297</prism:url><dc:identifier>SCOPUS_ID:84929147297</dc:identifier><eid>2-s2.0-84929147297</eid><dc:title>Systemic to pulmonary venous collaterals in adults with single ventricle physiology after cavopulmonary palliation</dc:title><dc:creator>Lluri G.</dc:creator><prism:publicationName>International Journal of Cardiology</prism:publicationName><prism:issn>01675273</prism:issn><prism:eIssn>18741754</prism:eIssn><prism:volume>189</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>159-163</prism:pageRange><prism:coverDate>2015-06-15</prism:coverDate><prism:coverDisplayDate>15 June 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijcard.2015.04.065</prism:doi><dc:description>© 2015 Elsevier Ireland Ltd. All rights reserved. Objectives: To assess the frequency, anatomic characteristics, and associations of systemic to pulmonary venous collaterals in adult patients undergoing cardiac catheterization after a Fontan operation. Additionally, the embryologic basis for the presence of venous collaterals is reviewed. Methods: Cardiac catheterization data was reviewed for 66 adults with single ventricle physiology and a Fontan palliation. Results: There were a total of 66 patients that underwent catheterization between 2004 and 2014 at the Ahmanson/UCLA Adult Congenital Heart Disease Center. There were 24 males and 42 females. Systemic venous to pulmonary venous collaterals were present in 38 patients (58%), most commonly originating from the right brachiocephalic vein (35%), azygous vein (20%) and superior vena cava (13%). Trans-catheter interventional closure was performed in 27/38 (71%) of patients with venous collaterals. At baseline these patients had lower oxygen saturation when compared to those not requiring intervention, 85.6% ± 6.1% vs 89.9% ± 5.4%, p &lt; 0.05. At 6 months, the ambulatory systemic saturation improved from 85.6% ± 6.1% to 91.8% ± 6.4%, p &lt; 0.05. At two years follow-up, the ambulatory systemic saturation had decreased to 90.5% ± 4.1% (p &lt; 0.05). Conclusion: In adults with single ventricle physiology and prior Fontan surgery, systemic venous collaterals are common and can be percutaneously occluded at minimal risk with resultant improvement in systemic oxygen saturation on long term follow up. When evaluated from a developmental standpoint, 85% of collaterals are above the diaphragm and could be secondary to recanalization of the collateral veins, an embryological connection between systemic and pulmonary veins.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60005247</affiliation-url><afid>60005247</afid><affilname>David Geffen School of Medicine at UCLA</affilname><name-variant>University of California</name-variant><affiliation-city>Los Angeles</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:114597594</affiliation-url><afid>114597594</afid><affilname>UCLA Division of Pediatric Cardiology</affilname><name-variant>UCLA Division of Pediatric Cardiology</name-variant><affiliation-city/><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">3</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:8921632100</author-url><authid>8921632100</authid><authname>Lluri G.</authname><surname>Lluri</surname><given-name>Gentian</given-name><initials>G.</initials><afid>60005247</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:7101757159</author-url><authid>7101757159</authid><authname>Levi D.</authname><surname>Levi</surname><given-name>Daniel S.</given-name><initials>D.S.</initials><afid>114597594</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:6507644562</author-url><authid>6507644562</authid><authname>Aboulhosn J.</authname><surname>Aboulhosn</surname><given-name>Jamil</given-name><initials>J.</initials><afid>60005247</afid></author><authkeywords>Adult congenital heart disease | Cyanosis | Fontan | Single ventricle physiology | Venous collaterals</authkeywords><intid>1535915604</intid><source-id>23774</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929172773"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929172773?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929172773&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929172773&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0167527315006762"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929172773</prism:url><dc:identifier>SCOPUS_ID:84929172773</dc:identifier><eid>2-s2.0-84929172773</eid><dc:title>Kynurenines as predictors of acute coronary events in the Hordaland Health Study</dc:title><dc:creator>Eussen S.</dc:creator><prism:publicationName>International Journal of Cardiology</prism:publicationName><prism:issn>01675273</prism:issn><prism:eIssn>18741754</prism:eIssn><prism:volume>189</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>18-24</prism:pageRange><prism:coverDate>2015-06-15</prism:coverDate><prism:coverDisplayDate>15 June 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijcard.2015.03.413</prism:doi><dc:description>© 2015 Elsevier Ireland Ltd. All rights reserved. Background: The kynurenine pathway, the main metabolic route of tryptophan degradation, has been related to inflammatory responses. Some of its metabolites, referred to as kynurenines, have been associated with prevalence of coronary heart disease (CHD) in cross-sectional studies. This prospective study aims to investigate whether increased concentrations of kynurenines are associated with risk of acute coronary events, defined as unstable angina pectoris, acute myocardial infarction, and/or sudden death in community-dwelling elderly. Methods: The baseline examinations included 2819 individuals aged 71-74 years recruited into the Hordaland Health Study. Participants with known CHDatbaseline were excluded from analyses. Baseline plasma concentrations of tryptophan, kynurenine, kynurenic acid, anthranilic acid, 3-hydroxykynurenine, xanthurenic acid, and 3-hydroxyanthranilic acid were measured by LC-MS/MS. During a median follow-up period of 10.8 years, with linkage to acute coronary event endpoints through the CVDNOR project, hazard ratios (HRs) for acute coronary events (n = 376) were estimated using Cox proportional hazard analyses. Results: After adjustment for established cardiovascular risk factors, HRs (95% CI) comparing the 4th vs 1st quartile were 1.86 (1.19-2.92) for kynurenine and 1.72 (1.19-2.49) for 3-hydroxykynurenine. Tryptophan, kynurenic acid, anthranilic acid, xanthurenic acid and 3-hydroxyanthranilic acid were not associated with acute coronary events. Conclusions: Kynurenine and 3-hydroxykynurenine were associated with increased risk of acute coronary events in community-dwelling elderly without a known history of CHD. These results suggest the involvement of the kynurenine pathway in the early development of CHD, and their potential usefulness to estimate CHD risk.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60029622</affiliation-url><afid>60029622</afid><affilname>Universitetet i Bergen</affilname><name-variant>University of Bergen</name-variant><affiliation-city>Bergen</affiliation-city><affiliation-country>Norway</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60029622</affiliation-url><afid>60029622</afid><affilname>Universitetet i Bergen</affilname><name-variant>University of Bergen</name-variant><affiliation-city>Bergen</affiliation-city><affiliation-country>Norway</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60018869</affiliation-url><afid>60018869</afid><affilname>Maastricht University</affilname><name-variant>University of Limburg</name-variant><affiliation-city>Maastricht</affiliation-city><affiliation-country>Netherlands</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60030280</affiliation-url><afid>60030280</afid><affilname>Helse Bergen Haukeland University Hospital</affilname><name-variant>Haukeland University Hospital</name-variant><affiliation-city>Bergen</affiliation-city><affiliation-country>Norway</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:115235549</affiliation-url><afid>115235549</afid><affilname>Norwegian Institute of lic Health</affilname><name-variant>Norwegian Institute of lic Health</name-variant><affiliation-city>Bergen</affiliation-city><affiliation-country>Norway</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60030280</affiliation-url><afid>60030280</afid><affilname>Helse Bergen Haukeland University Hospital</affilname><name-variant>Haukeland University Hospital</name-variant><affiliation-city>Bergen</affiliation-city><affiliation-country>Norway</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60029622</affiliation-url><afid>60029622</afid><affilname>Universitetet i Bergen</affilname><name-variant>University of Bergen</name-variant><affiliation-city>Bergen</affiliation-city><affiliation-country>Norway</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:100679437</affiliation-url><afid>100679437</afid><affilname>Bevital A/S</affilname><name-variant>Bevital A/S</name-variant><affiliation-city>Bergen</affiliation-city><affiliation-country>Norway</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">16</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:8883699500</author-url><authid>8883699500</authid><authname>Eussen S.</authname><surname>Eussen</surname><given-name>Simone J P M</given-name><initials>S.J.P.M.</initials><afid>60029622</afid><afid>60029622</afid><afid>60018869</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:8883699500</author-url><authid>8883699500</authid><authname>Eussen S.</authname><surname>Eussen</surname><given-name>Simone J P M</given-name><initials>S.J.P.M.</initials><afid>60029622</afid><afid>60029622</afid><afid>60018869</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:8883699500</author-url><authid>8883699500</authid><authname>Eussen S.</authname><surname>Eussen</surname><given-name>Simone J P M</given-name><initials>S.J.P.M.</initials><afid>60029622</afid><afid>60029622</afid><afid>60018869</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:7102609193</author-url><authid>7102609193</authid><authname>Ueland P.</authname><surname>Ueland</surname><given-name>Per Magne</given-name><initials>P.M.</initials><afid>60029622</afid><afid>60030280</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:7102609193</author-url><authid>7102609193</authid><authname>Ueland P.</authname><surname>Ueland</surname><given-name>Per Magne</given-name><initials>P.M.</initials><afid>60029622</afid><afid>60030280</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:55150528400</author-url><authid>55150528400</authid><authname>Vollset S.</authname><surname>Vollset</surname><given-name>Stein E.</given-name><initials>S.E.</initials><afid>60029622</afid><afid>115235549</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:55150528400</author-url><authid>55150528400</authid><authname>Vollset S.</authname><surname>Vollset</surname><given-name>Stein E.</given-name><initials>S.E.</initials><afid>60029622</afid><afid>115235549</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:7005870984</author-url><authid>7005870984</authid><authname>Nygård O.</authname><surname>Nygård</surname><given-name>Ottar</given-name><initials>O.</initials><afid>60029622</afid><afid>60030280</afid><afid>60029622</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:7005870984</author-url><authid>7005870984</authid><authname>Nygård O.</authname><surname>Nygård</surname><given-name>Ottar</given-name><initials>O.</initials><afid>60029622</afid><afid>60030280</afid><afid>60029622</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:7005870984</author-url><authid>7005870984</authid><authname>Nygård O.</authname><surname>Nygård</surname><given-name>Ottar</given-name><initials>O.</initials><afid>60029622</afid><afid>60030280</afid><afid>60029622</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:6602243615</author-url><authid>6602243615</authid><authname>Midttun Ø.</authname><surname>Midttun</surname><given-name>Øivind</given-name><initials>Ø.</initials><afid>100679437</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:16242476100</author-url><authid>16242476100</authid><authname>Sulo G.</authname><surname>Sulo</surname><given-name>Gerhard</given-name><initials>G.</initials><afid>60029622</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:6701439828</author-url><authid>6701439828</authid><authname>Ulvik A.</authname><surname>Ulvik</surname><given-name>Arve</given-name><initials>A.</initials><afid>100679437</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:36657402600</author-url><authid>36657402600</authid><authname>Meyer K.</authname><surname>Meyer</surname><given-name>Klaus</given-name><initials>K.</initials><afid>100679437</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:8946883600</author-url><authid>8946883600</authid><authname>Pedersen E.</authname><surname>Pedersen</surname><given-name>Eva Ringdal</given-name><initials>E.R.</initials><afid>60029622</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:56564949700</author-url><authid>56564949700</authid><authname>Tell G.</authname><surname>Tell</surname><given-name>Grethe S.</given-name><initials>G.S.</initials><afid>60029622</afid></author><authkeywords>Acute coronary events | Inflammation | Kynurenines | Prospective cohort study</authkeywords><intid>535918638</intid><source-id>23774</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929165783"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929165783?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929165783&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929165783&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0167527315004143"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929165783</prism:url><dc:identifier>SCOPUS_ID:84929165783</dc:identifier><eid>2-s2.0-84929165783</eid><dc:title>Electrocardiographic abnormalities and risk of developing cardiac events in extracardiac sarcoidosis</dc:title><dc:creator>Nagao S.</dc:creator><prism:publicationName>International Journal of Cardiology</prism:publicationName><prism:issn>01675273</prism:issn><prism:eIssn>18741754</prism:eIssn><prism:volume>189</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>1-5</prism:pageRange><prism:coverDate>2015-06-15</prism:coverDate><prism:coverDisplayDate>15 June 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijcard.2015.03.175</prism:doi><dc:description>© 2015 Elsevier Ireland Ltd. All rights reserved. Background: Cardiac involvement is a leading cause of death from sarcoidosis. Because the efficacy of corticoste-roid treatment is limited in patients with cardiac manifestation, early diagnosis is important. However, cardiac involvement is difficult to identify at early stages and is often underdiagnosed. Therefore, this study aimed to identify electrocardiographic risk factors for cardiac events in patients with extracardiac sarcoidosis. Methods: This prospective observational cohort study included 227 patients with extracardiac sarcoidosis who did not have any cardiac manifestation (age, 49 ± 17 years; women, 63%). We studied the association of electro-cardiographic abnormalities with developing cardiac manifestations. Results: Duringa follow-up of 6.3± 3.7 years, 11 patients developed cardiac events, including advanced atrioven-tricular block (4 patients), ventricular tachycardia (4 patients), and systolic dysfunction (3 patients). All patients had electrocardiographic abnormalities prior to the development of cardiac events. In multivariate analyses, the baseline heart rate and PR interval were associated with increased risk of developing cardiac events. The QRS duration and corrected QT interval were not associated with cardiac manifestations. The multivariate analyses also revealed that baseline conduction disorder, ST segment/T wave abnormalities, and fragmented QRS complexes were associated with cardiac events. Conclusions: Electrocardiographic abnormalities occurred prior to cardiac events in extracardiac sarcoidosis. Patients with electrocardiographic abnormalities may require further evaluation for cardiac involvement and careful follow-up.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60027970</affiliation-url><afid>60027970</afid><affilname>Niigata University School of Medicine</affilname><name-variant>Niigata University</name-variant><affiliation-city>Niigata</affiliation-city><affiliation-country>Japan</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60032525</affiliation-url><afid>60032525</afid><affilname>Fujita Health University School of Medicine</affilname><name-variant>Fujita Health University School of Medicine</name-variant><affiliation-city>Toyoake</affiliation-city><affiliation-country>Japan</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60027970</affiliation-url><afid>60027970</afid><affilname>Niigata University School of Medicine</affilname><name-variant>Niigata University</name-variant><affiliation-city>Niigata</affiliation-city><affiliation-country>Japan</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60022313</affiliation-url><afid>60022313</afid><affilname>Niigata University</affilname><name-variant>Niigata University</name-variant><affiliation-city>Niigata</affiliation-city><affiliation-country>Japan</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">11</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55096745100</author-url><authid>55096745100</authid><authname>Nagao S.</authname><surname>Nagao</surname><given-name>Satomi</given-name><initials>S.</initials><afid>60027970</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:7410308267</author-url><authid>7410308267</authid><authname>Watanabe H.</authname><surname>Watanabe</surname><given-name>Hiroshi</given-name><initials>H.</initials><afid>60027970</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:15751579900</author-url><authid>15751579900</authid><authname>Sobue Y.</authname><surname>Sobue</surname><given-name>Yoshihiro</given-name><initials>Y.</initials><afid>60032525</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56640603800</author-url><authid>56640603800</authid><authname>Kodama M.</authname><surname>Kodama</surname><given-name>Makoto</given-name><initials>M.</initials><afid>60027970</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:55624942900</author-url><authid>55624942900</authid><authname>Tanaka J.</authname><surname>Tanaka</surname><given-name>Junichi</given-name><initials>J.</initials><afid>60027970</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:56432334000</author-url><authid>56432334000</authid><authname>Tanabe N.</authname><surname>Tanabe</surname><given-name>Naohito</given-name><initials>N.</initials><afid>60022313</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:56640615800</author-url><authid>56640615800</authid><authname>Suzuki E.</authname><surname>Suzuki</surname><given-name>Eiichi</given-name><initials>E.</initials><afid>60027970</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:7004779992</author-url><authid>7004779992</authid><authname>Narita I.</authname><surname>Narita</surname><given-name>Ichiei</given-name><initials>I.</initials><afid>60027970</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:56463543100</author-url><authid>56463543100</authid><authname>Watanabe E.</authname><surname>Watanabe</surname><given-name>Eiichi</given-name><initials>E.</initials><afid>60032525</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:56640675200</author-url><authid>56640675200</authid><authname>Aizawa Y.</authname><surname>Aizawa</surname><given-name>Yoshifusa</given-name><initials>Y.</initials><afid>60027970</afid></author><author seq="11"><author-url>http://api.elsevier.com/content/author/author_id:55994167300</author-url><authid>55994167300</authid><authname>Minamino T.</authname><surname>Minamino</surname><given-name>Tohru</given-name><initials>T.</initials><afid>60027970</afid></author><authkeywords>Arrhythmia | Electrocardiography | Heart failure | Risk factors | Sarcoidosis</authkeywords><intid>535917338</intid><source-id>23774</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929157830"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929157830?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929157830&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929157830&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0167527315000728"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929157830</prism:url><dc:identifier>SCOPUS_ID:84929157830</dc:identifier><eid>2-s2.0-84929157830</eid><dc:title>Predictors of outcome in patients undergoing MitraClip implantation: An aid to improve patient selection</dc:title><dc:creator>Boerlage-vanDijk K.</dc:creator><prism:publicationName>International Journal of Cardiology</prism:publicationName><prism:issn>01675273</prism:issn><prism:eIssn>18741754</prism:eIssn><prism:volume>189</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>238-243</prism:pageRange><prism:coverDate>2015-06-15</prism:coverDate><prism:coverDisplayDate>15 June 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijcard.2015.01.045</prism:doi><dc:description>© 2015 Elsevier Ireland Ltd. All rights reserved. Background: MitraClip implantation (MCI) reduces mitral regurgitation (MR) and symptoms in patients considered inoperable or with high-surgical risk. Data to determine the benefit from MCI for an individual patient are limited. The aim of this study is to determine predictors associated with the prognosis after MCI to improve the patient selection for this procedure. Methods: We included 84 consecutive patients (age: 76 ± 10 years, 51% male) who underwent MCI in our institution for symptomatic severe MR. All patients underwent transthoracic echocardiography before MCI; clinical and echocardiographic follow-up was obtained after MCI. Results: The 2-year survival was 81%. Predictors for two-year mortality in multi-variate analysis were baseline NT-proBNP ≥ 5000 μg/L (HR: 5.4, 95% CI: 1.8-16.2), previous valve surgery (HR: 4.5, 95% CI: 1.7-12.2), tricuspid regurgitation (TR) ≥ grade 3 prior to MCI (HR: 2.8, 95% CI: 1.2-6.8) and absence of MR reduction after MCI (HR: 2.1, 95% CI: 1.2-3.8). The 2-year survival of patients with 0, 1 or ≥2 of these predictors was: 87%; 78% and 38% respectively (log-rank p &lt; 0.001). The functional class at 1 month and mid-term follow-up was worse in patients with two or more of these predictors present at baseline compared to patients with zero or one of these predictors (1 month: p = 0.007 and mid-term: p &lt; 0.001). Conclusion: Heart failure, previous valve surgery, co-presence of TR and the degree of MR reduction after MCI are the independent predictors of survival and functional status after MCI in high risk patients. The pre-procedural characteristics may be used to optimize patient selection, while maximal MR reduction should be attempted to optimize the outcome of MCI.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60001157</affiliation-url><afid>60001157</afid><affilname>Academic Medical Centre, University of Amsterdam</affilname><name-variant>University of Amsterdam</name-variant><affiliation-city>Amsterdam</affiliation-city><affiliation-country>Netherlands</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:112625185</affiliation-url><afid>112625185</afid><affilname>Saiseikai Yokohama City Eastern Hospital</affilname><name-variant>Saiseikai Yokohama City Eastern Hospital</name-variant><affiliation-city>Yokohama</affiliation-city><affiliation-country>Japan</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">11</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56641810900</author-url><authid>56641810900</authid><authname>Boerlage-vanDijk K.</authname><surname>Boerlage-vanDijk</surname><given-name>Kirsten</given-name><initials>K.</initials><afid>60001157</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:25958738300</author-url><authid>25958738300</authid><authname>Wiegerinck E.</authname><surname>Wiegerinck</surname><given-name>Esther M A</given-name><initials>E.M.A.</initials><afid>60001157</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56262176100</author-url><authid>56262176100</authid><authname>Araki M.</authname><surname>Araki</surname><given-name>Motoharu</given-name><initials>M.</initials><afid>112625185</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:8646298400</author-url><authid>8646298400</authid><authname>Meregalli P.</authname><surname>Meregalli</surname><given-name>Paola G.</given-name><initials>P.G.</initials><afid>60001157</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:10144704800</author-url><authid>10144704800</authid><authname>Bindraban N.</authname><surname>Bindraban</surname><given-name>Navin R.</given-name><initials>N.R.</initials><afid>60001157</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:7401559500</author-url><authid>7401559500</authid><authname>Koch K.</authname><surname>Koch</surname><given-name>Karel T.</given-name><initials>K.T.</initials><afid>60001157</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:12786455400</author-url><authid>12786455400</authid><authname>Vis M.</authname><surname>Vis</surname><given-name>M. Marije</given-name><initials>M.M.</initials><afid>60001157</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:7102434711</author-url><authid>7102434711</authid><authname>Piek J.</authname><surname>Piek</surname><given-name>Jan J.</given-name><initials>J.J.</initials><afid>60001157</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:35412705300</author-url><authid>35412705300</authid><authname>Tijssen J.</authname><surname>Tijssen</surname><given-name>Jan G P</given-name><initials>J.G.P.</initials><afid>60001157</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:7102402026</author-url><authid>7102402026</authid><authname>Bouma B.</authname><surname>Bouma</surname><given-name>Berto J.</given-name><initials>B.J.</initials><afid>60001157</afid></author><author seq="11"><author-url>http://api.elsevier.com/content/author/author_id:26425485800</author-url><authid>26425485800</authid><authname>Baan J.</authname><surname>Baan</surname><given-name>Jan</given-name><initials>J.</initials><afid>60001157</afid></author><authkeywords>MitraClip | Mitral regurgitation | Survival</authkeywords><intid>1035912511</intid><source-id>23774</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929192600"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929192600?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929192600&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929192600&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S016752731500710X"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929192600</prism:url><dc:identifier>SCOPUS_ID:84929192600</dc:identifier><eid>2-s2.0-84929192600</eid><dc:title>Evaluation of ventricular repolarization in pregnant women with intrahepatic cholestasis</dc:title><dc:creator>Kirbas O.</dc:creator><prism:publicationName>International Journal of Cardiology</prism:publicationName><prism:issn>01675273</prism:issn><prism:eIssn>18741754</prism:eIssn><prism:volume>189</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>25-29</prism:pageRange><prism:coverDate>2015-06-15</prism:coverDate><prism:coverDisplayDate>15 June 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijcard.2015.04.001</prism:doi><dc:description>© 2015 Elsevier Ireland Ltd. All rights reserved. Background: Bile acids can induce arrhythmia by altering cardiomyocyte contractility or electrical conduction. The aim of this study was to investigate, by means of QT dispersion parameter detected by simple standard electrocardiogram (ECG), ventricular repolarization changes inpregnant women with and without intrahepatic cholestasis of pregnancy (ICP). Methods: In this case-control study including 75 pregnant women with cholestasis and 35 healthy, uncomplicated pregnancy cases, electrocardiographic QT interval durations and QT dispersion (QT-disp) parameters, corrected for the patients' heart rate using the Hodges formula, were investigated. Results: Maximum corrected QTinterval values were significantly higher in the severe ICP group than in the control group (p &lt; 0.001) and significantly higher in the severe ICP group than in the mild ICP group (p = 0.01). The values of the mild ICP and control groups were similar. Corrected QT-disp values were also significantly higher in both ICP groups than in the control group and significantly higher in the severe ICP group than in the mild ICP group. Conclusion: Cholestatic diseases predispose patients to cardiovascular complications. Our data clearly demonstrated that QT-disp values were significantly altered in pregnant women with cholestasis when compared to the normal ones. This simple ECG parameter can be used to screen high-risk women, in order to better target counseling regarding lifestyle modifications and to conduct closer follow up and management of women with a history of ICP.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:105668390</affiliation-url><afid>105668390</afid><affilname>Yuksek Ihtisas Education and Research Hospital</affilname><name-variant>Yuksek Ihtisas Education and Research Hospital</name-variant><affiliation-city>Ankara</affiliation-city><affiliation-country>Turkey</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:112603923</affiliation-url><afid>112603923</afid><affilname>Education and Research Hospital</affilname><name-variant>Education and Research Hospital</name-variant><affiliation-city>Ankara</affiliation-city><affiliation-country>Turkey</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60020936</affiliation-url><afid>60020936</afid><affilname>Ataturk Training and Research Hospital</affilname><affiliation-city>Ankara</affiliation-city><affiliation-country>Turkey</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60021416</affiliation-url><afid>60021416</afid><affilname>Gazi University, Faculty of Medicine</affilname><name-variant>Gazi University Faculty of Medicine</name-variant><affiliation-city>Ankara</affiliation-city><affiliation-country>Turkey</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">7</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:25655134800</author-url><authid>25655134800</authid><authname>Kirbas O.</authname><surname>Kirbas</surname><given-name>Ozgur</given-name><initials>O.</initials><afid>105668390</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:55839175300</author-url><authid>55839175300</authid><authname>Biberoglu E.</authname><surname>Biberoglu</surname><given-name>Ebru Hacer</given-name><initials>E.H.</initials><afid>112603923</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:55842090400</author-url><authid>55842090400</authid><authname>Kirbas A.</authname><surname>Kirbas</surname><given-name>Ayse</given-name><initials>A.</initials><afid>112603923</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56441580300</author-url><authid>56441580300</authid><authname>Daglar K.</authname><surname>Daglar</surname><given-name>Korkut</given-name><initials>K.</initials><afid>112603923</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:54924353500</author-url><authid>54924353500</authid><authname>Kurmus O.</authname><surname>Kurmus</surname><given-name>Ozge</given-name><initials>O.</initials><afid>60020936</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:15727484600</author-url><authid>15727484600</authid><authname>Danisman N.</authname><surname>Danisman</surname><given-name>Nuri</given-name><initials>N.</initials><afid>112603923</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:6603756595</author-url><authid>6603756595</authid><authname>Biberoglu K.</authname><surname>Biberoglu</surname><given-name>Kutay</given-name><initials>K.</initials><afid>60021416</afid></author><authkeywords>Arrhythmia | Bile acid | Cholestasis | Pregnancy | QT dispersion</authkeywords><intid>2035912197</intid><source-id>23774</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929162587"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929162587?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929162587&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929162587&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0167527315007147"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929162587</prism:url><dc:identifier>SCOPUS_ID:84929162587</dc:identifier><eid>2-s2.0-84929162587</eid><dc:title>SIRT1 activation rescues doxorubicin-induced loss of functional competence of human cardiac progenitor cells</dc:title><dc:creator>De Angelis A.</dc:creator><prism:publicationName>International Journal of Cardiology</prism:publicationName><prism:issn>01675273</prism:issn><prism:eIssn>18741754</prism:eIssn><prism:volume>189</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>30-44</prism:pageRange><prism:coverDate>2015-06-15</prism:coverDate><prism:coverDisplayDate>15 June 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijcard.2015.03.438</prism:doi><dc:description>© 2015 Published by Elsevier Ireland Ltd. Background: The search for compounds able to counteract chemotherapy-induced heart failure is extremely important at the age of global cancer epidemic. The role of SIRT1 in the maintenance of progenitor cell homeostasis may contribute to its cardioprotective effects. SIRT1 activators, by preserving progenitor cells, could have a clinical relevance for the prevention of doxorubicin (DOXO)-cardiotoxicity. Methods: To determine whether SIRT1 activator, resveratrol (RES), interferes with adverse effects of DOXO on cardiac progenitor cells (CPCs): 1) human CPCs (hCPCs) were exposed in vitro to DOXO or DOXO + RES and their regenerative potential was tested in vivo in an animal model of DOXO-induced heart failure; 2) the in vivo effects of DOXO + RES co-treatment on CPCs were studied in a rat model. Results: Incontrast to healthy cells, DOXO-exposed hCPCs were ineffective in a model of anthracycline cardiomyopathy. The in vitro activation of SIRT1 decreased p53 acetylation, overcame suppression of the IGF-1/Akt prosurvival and anti-apoptotic signaling, enhanced oxidative stress defense and prevented senescence and growth arrest of hCPCs. Priming with RES counterbalanced the onset of dysfunctional phenotype in DOXO-exposed hCPCs, partly restoring their ability to repair the damage with improvement in cardiac function and animal survival. The in vivo co-treatment DOXO + RES prevented the anthracycline-induced alterations in CPCs, partly preserving cardiac function. Conclusion: SIRT1 activation protects DOXO-exposed CPCs and re-establishes their proper function. Pharmacological intervention at the level of tissue-specific progenitor cells may provide cardiac benefits for the growing population of long-term cancer survivors that are at risk of chemotherapy-induced cardiovascular toxicity.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60026777</affiliation-url><afid>60026777</afid><affilname>Seconda Universita degli Studi di Napoli</affilname><name-variant>Second University of Naples</name-variant><affiliation-city>Naples</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60004969</affiliation-url><afid>60004969</afid><affilname>Universita degli Studi di Parma</affilname><name-variant>Università di Parma</name-variant><affiliation-city>Parma</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60011857</affiliation-url><afid>60011857</afid><affilname>Universita degli Studi di Parma, Facolta di Medicina e Chirurgia</affilname><name-variant>University Hospital</name-variant><affiliation-city>Parma</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">13</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:8947914800</author-url><authid>8947914800</authid><authname>De Angelis A.</authname><surname>De Angelis</surname><given-name>Antonella</given-name><initials>A.</initials><afid>60026777</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:24171734300</author-url><authid>24171734300</authid><authname>Piegari E.</authname><surname>Piegari</surname><given-name>Elena</given-name><initials>E.</initials><afid>60026777</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:35619906300</author-url><authid>35619906300</authid><authname>Cappetta D.</authname><surname>Cappetta</surname><given-name>Donato</given-name><initials>D.</initials><afid>60026777</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:7201443427</author-url><authid>7201443427</authid><authname>Russo R.</authname><surname>Russo</surname><given-name>Rosa</given-name><initials>R.</initials><afid>60026777</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:14045125700</author-url><authid>14045125700</authid><authname>Esposito G.</authname><surname>Esposito</surname><given-name>Grazia</given-name><initials>G.</initials><afid>60026777</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:55749142800</author-url><authid>55749142800</authid><authname>Ciuffreda L.</authname><surname>Ciuffreda</surname><given-name>Loreta Pia</given-name><initials>L.P.</initials><afid>60026777</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:56641576600</author-url><authid>56641576600</authid><authname>Ferraiolo F.</authname><surname>Ferraiolo</surname><given-name>Fiorella Angelica Valeria</given-name><initials>F.A.V.</initials><afid>60026777</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:36991493400</author-url><authid>36991493400</authid><authname>Frati C.</authname><surname>Frati</surname><given-name>Caterina</given-name><initials>C.</initials><afid>60004969</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:6701358623</author-url><authid>6701358623</authid><authname>Fagnoni F.</authname><surname>Fagnoni</surname><given-name>Francesco</given-name><initials>F.</initials><afid>60011857</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:7005130765</author-url><authid>7005130765</authid><authname>Berrino L.</authname><surname>Berrino</surname><given-name>Liberato</given-name><initials>L.</initials><afid>60026777</afid></author><author seq="11"><author-url>http://api.elsevier.com/content/author/author_id:7003918018</author-url><authid>7003918018</authid><authname>Quaini F.</authname><surname>Quaini</surname><given-name>Federico</given-name><initials>F.</initials><afid>60004969</afid></author><author seq="12"><author-url>http://api.elsevier.com/content/author/author_id:7401756603</author-url><authid>7401756603</authid><authname>Rossi F.</authname><surname>Rossi</surname><given-name>Francesco</given-name><initials>F.</initials><afid>60026777</afid></author><author seq="13"><author-url>http://api.elsevier.com/content/author/author_id:7006224615</author-url><authid>7006224615</authid><authname>Urbanek K.</authname><surname>Urbanek</surname><given-name>Konrad</given-name><initials>K.</initials><afid>60026777</afid></author><authkeywords>Doxorubicin-induced cardiomyopathy | Human cardiac progenitor cells | Resveratrol | SIRT1</authkeywords><intid>1535915485</intid><source-id>23774</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929163081"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929163081?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929163081&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929163081&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S016752731500772X"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929163081</prism:url><dc:identifier>SCOPUS_ID:84929163081</dc:identifier><eid>2-s2.0-84929163081</eid><dc:title>Myopericarditis and takotsubo cardiomyopathy association: Author's reply</dc:title><dc:creator>Yoshikawa T.</dc:creator><prism:publicationName>International Journal of Cardiology</prism:publicationName><prism:issn>01675273</prism:issn><prism:eIssn>18741754</prism:eIssn><prism:volume>189</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>197</prism:pageRange><prism:coverDate>2015-06-15</prism:coverDate><prism:coverDisplayDate>15 June 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijcard.2015.04.053</prism:doi><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:115054481</affiliation-url><afid>115054481</afid><affilname>Sakakibara Heart Institute</affilname><name-variant>Sakakibara Heart Institute</name-variant><affiliation-city>Okayama</affiliation-city><affiliation-country>Japan</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>le</subtype><subtypeDescription>Letter</subtypeDescription><author-count limit="100">1</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:7402718302</author-url><authid>7402718302</authid><authname>Yoshikawa T.</authname><surname>Yoshikawa</surname><given-name>Tsutomu</given-name><initials>T.</initials><afid>115054481</afid></author><authkeywords>Inflammation | Myocarditis | Pericarditis | Takotsubo cardiomyopathy</authkeywords><intid>35915986</intid><source-id>23774</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929178809"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929178809?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929178809&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929178809&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S016752731500786X"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929178809</prism:url><dc:identifier>SCOPUS_ID:84929178809</dc:identifier><eid>2-s2.0-84929178809</eid><dc:title>Melody transcatheter valve: Histopathology and clinical implications of nine explanted devices</dc:title><dc:creator>Schneider H.</dc:creator><prism:publicationName>International Journal of Cardiology</prism:publicationName><prism:issn>01675273</prism:issn><prism:eIssn>18741754</prism:eIssn><prism:volume>189</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>124-131</prism:pageRange><prism:coverDate>2015-06-15</prism:coverDate><prism:coverDisplayDate>15 June 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijcard.2015.04.067</prism:doi><dc:description>© 2015 Elsevier Ireland Ltd. All rights reserved. Objectives: We examined interventionally implanted valved Melody conduits after surgical explantation by means of histology and immunohistochemistry and matched these findings with clinical data in order to assess in vivo biocompatibility and to identify risk factors for graft failure. Methods: 9 Melody valves had been implanted in 8 patients (pulmonary n = 7, tricuspid position n = 1). Indication for explantation included significant obstruction in 7 patients and valve insufficiency in 1 patient. 4 of 8 patients had suffered from endocarditis. Mean interval between implantation and explantation was 3.2 (1.8-5.2) years. All explants were worked up using a uniform protocol with fixation in formalin and embedding in methylmethacrylate. Results: All but one valve of the explanted Melody grafts were thin and histologically intact without any pathological findings. Complete neo-endothelialization could be demonstrated by means of immunohistochemistry. All 4 Melody valves from patients with endocarditis showed dense granulocytic infiltrations, 3 of these showed thrombotic material within the valves. Conclusion: This report covers the first series of explanted Melody valves from humans applying a uniform protocol for histopathological examination. Good biocompatibility of the Melody valves could be demonstrated after a mid-term follow-up. Factors for graft failure included endocarditis, outgrowth, and residual stenosis. These findings may have significant implications for the implant procedure as well as care of the patients during long-term follow-up.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60031514</affiliation-url><afid>60031514</afid><affilname>Universitat Gottingen</affilname><name-variant>Universität Göttingen</name-variant><affiliation-city>Gottingen</affiliation-city><affiliation-country>Germany</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60019722</affiliation-url><afid>60019722</afid><affilname>Technische Universitat Munchen</affilname><name-variant>Technische Universität München</name-variant><affiliation-city>Munich</affiliation-city><affiliation-country>Germany</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60015618</affiliation-url><afid>60015618</afid><affilname>Leiden University Medical Center - LUMC</affilname><name-variant>University Hospital</name-variant><affiliation-city>Leiden</affiliation-city><affiliation-country>Netherlands</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60019722</affiliation-url><afid>60019722</afid><affilname>Technische Universitat Munchen</affilname><name-variant>Technische Universität München</name-variant><affiliation-city>Munich</affiliation-city><affiliation-country>Germany</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">9</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:26326548700</author-url><authid>26326548700</authid><authname>Schneider H.</authname><surname>Schneider</surname><given-name>Heike</given-name><initials>H.</initials><afid>60031514</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:36698474400</author-url><authid>36698474400</authid><authname>Vogt M.</authname><surname>Vogt</surname><given-name>Manfred</given-name><initials>M.</initials><afid>60019722</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:6505862496</author-url><authid>6505862496</authid><authname>Boekenkamp R.</authname><surname>Boekenkamp</surname><given-name>Regina</given-name><initials>R.</initials><afid>60015618</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:22957405000</author-url><authid>22957405000</authid><authname>Hoerer J.</authname><surname>Hoerer</surname><given-name>Juergen</given-name><initials>J.</initials><afid>60019722</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:6602165526</author-url><authid>6602165526</authid><authname>Eicken A.</authname><surname>Eicken</surname><given-name>Andreas</given-name><initials>A.</initials><afid>60019722</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:24340625600</author-url><authid>24340625600</authid><authname>Foth R.</authname><surname>Foth</surname><given-name>Rudi</given-name><initials>R.</initials><afid>60031514</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:6602466005</author-url><authid>6602466005</authid><authname>Kriebel T.</authname><surname>Kriebel</surname><given-name>Thomas</given-name><initials>T.</initials><afid>60031514</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:56589501100</author-url><authid>56589501100</authid><authname>Paul T.</authname><surname>Paul</surname><given-name>Thomas</given-name><initials>T.</initials><afid>60031514</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:55954942100</author-url><authid>55954942100</authid><authname>Sigler M.</authname><surname>Sigler</surname><given-name>Matthias</given-name><initials>M.</initials><afid>60031514</afid></author><authkeywords>Catheterization | Congenital heart defects | Histopathology | Implantable heart valves</authkeywords><intid>1535917101</intid><source-id>23774</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929208013"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929208013?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929208013&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929208013&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0167527315007858"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929208013</prism:url><dc:identifier>SCOPUS_ID:84929208013</dc:identifier><eid>2-s2.0-84929208013</eid><dc:title>Transcatheter aortic valve implantation in patients with bicuspid aortic valve: A patient level multi-center analysis</dc:title><dc:creator>Yousef A.</dc:creator><prism:publicationName>International Journal of Cardiology</prism:publicationName><prism:issn>01675273</prism:issn><prism:eIssn>18741754</prism:eIssn><prism:volume>189</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>282-288</prism:pageRange><prism:coverDate>2015-06-15</prism:coverDate><prism:coverDisplayDate>15 June 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijcard.2015.04.066</prism:doi><dc:description>© 2015 Elsevier Ireland Ltd. All rights reserved. Objective: We sought to evaluate the safety and efficacy of transcatheter aortic valve implantation (TAVI) in patients with bicuspid aortic valve (BiAV). Background: BiAV remainsarelative contraindication to TAVI resultingin exclusion from TAVI trials and thus limiting data on the clinical performance of transcatheter valves in these patients. Methodology: We conducted an international patient level multicenter analysis on outcomes in patients with BiAV undergoing TAVI. The primary outcome of the study was the combined early safety endpoint - a composite of30 day mortality, stroke, life-threatening bleeding, acute kidney injury, coronary artery obstruction, major vascular complication and valve related dysfunction. Secondary endpoints included the individual components of the primary endpoint as well as post-TAVI paravalvular leak (PVL), rehospitalization, new pacemaker insertion and device success rates at 30 days and 1 year. Results: A total of 108 patients with BiAV were identified in 21 centers in Canada, Spain, Italy, Poland and Singapore who underwent TAVI between January 2005 and March 2014. The composite primary outcome occurred in one quarter of patients (26.9%) - mainly driven by re-intervention for valve malposition (9.3%). The 30-day and 1 year mortality rates were 8.3% and 16.9% respectively with AR ≥ 3+ occurring in 9.6% of patients. Device success was achieved in 85.2% of cases with pacemaker insertion in 19.4%. While PVL was not associated with an increased risk of 30 day or 1 year mortality - Type I BiAV anatomy with left and right cusp fusion had significantly better outcomes than other valve variants.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60028897</affiliation-url><afid>60028897</afid><affilname>University of Ottawa, Canada</affilname><name-variant>University of Ottawa</name-variant><affiliation-city>Ottawa</affiliation-city><affiliation-country>Canada</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60010365</affiliation-url><afid>60010365</afid><affilname>The University of British Columbia</affilname><name-variant>University of British Columbia</name-variant><affiliation-city>Vancouver</affiliation-city><affiliation-country>Canada</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:107712773</affiliation-url><afid>107712773</afid><affilname>Quebec Heart and Lung Institute</affilname><name-variant>Quebec Heart and Lung Institute</name-variant><affiliation-city>Quebec</affiliation-city><affiliation-country>Canada</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60082964</affiliation-url><afid>60082964</afid><affilname>Fondazione San Raffaele del Monte Tabor</affilname><name-variant>Fondazione San Raffaele del Monte Tabor</name-variant><affiliation-city>Milan</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60019151</affiliation-url><afid>60019151</afid><affilname>EMO Centro Cuore Columbus</affilname><name-variant>EMO-GVM Centro Cuore Columbus</name-variant><affiliation-city>Milan</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60015150</affiliation-url><afid>60015150</afid><affilname>Imperial College London</affilname><name-variant>Imperial College</name-variant><affiliation-city>London</affiliation-city><affiliation-country>United Kingdom</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60069009</affiliation-url><afid>60069009</afid><affilname>Medical University of Warsaw</affilname><name-variant>Medical University of Warsaw</name-variant><affiliation-city>Warsaw</affiliation-city><affiliation-country>Poland</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60000252</affiliation-url><afid>60000252</afid><affilname>Hospital Universitari Virgen de la Victoria</affilname><name-variant>Hospital Clínico Universitario Virgen de la Victoria</name-variant><affiliation-city>Malaga</affiliation-city><affiliation-country>Spain</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60004409</affiliation-url><afid>60004409</afid><affilname>National Heart Centre, Singapore</affilname><name-variant>National Heart Centre Singapore</name-variant><affiliation-city>Singapore City</affiliation-city><affiliation-country>Singapore</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60030835</affiliation-url><afid>60030835</afid><affilname>University of Alberta</affilname><name-variant>University of Alberta</name-variant><affiliation-city>Edmonton</affiliation-city><affiliation-country>Canada</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60029150</affiliation-url><afid>60029150</afid><affilname>Sunnybrook Health Sciences Centre</affilname><name-variant>Sunnybrook Health Sciences Centre</name-variant><affiliation-city>Toronto</affiliation-city><affiliation-country>Canada</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60017829</affiliation-url><afid>60017829</afid><affilname>Institute for Clinical Evaluative Sciences</affilname><name-variant>Institute for Clinical Evaluative Sciences</name-variant><affiliation-city>Toronto</affiliation-city><affiliation-country>Canada</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60016849</affiliation-url><afid>60016849</afid><affilname>University of Toronto</affilname><name-variant>University of Toronto</name-variant><affiliation-city>Toronto</affiliation-city><affiliation-country>Canada</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60032461</affiliation-url><afid>60032461</afid><affilname>Hospital Clinico San Carlos de Madrid</affilname><name-variant>Hospital Universitario San Carlos</name-variant><affiliation-city>Madrid</affiliation-city><affiliation-country>Spain</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60070490</affiliation-url><afid>60070490</afid><affilname>Gruppo Ospedaliero San Donato</affilname><name-variant>IRCCS Policlinico San Donato</name-variant><affiliation-city>San Donato Milanese</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60014468</affiliation-url><afid>60014468</afid><affilname>University Health Network University of Toronto</affilname><name-variant>University Health Network</name-variant><affiliation-city>Toronto</affiliation-city><affiliation-country>Canada</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60016849</affiliation-url><afid>60016849</afid><affilname>University of Toronto</affilname><name-variant>University of Toronto</name-variant><affiliation-city>Toronto</affiliation-city><affiliation-country>Canada</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60031828</affiliation-url><afid>60031828</afid><affilname>McMaster University</affilname><name-variant>McMaster University</name-variant><affiliation-city>Hamilton</affiliation-city><affiliation-country>Canada</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">30</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:37099238200</author-url><authid>37099238200</authid><authname>Yousef A.</authname><surname>Yousef</surname><given-name>Altayyeb</given-name><initials>A.</initials><afid>60028897</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:24503519600</author-url><authid>24503519600</authid><authname>Simard T.</authname><surname>Simard</surname><given-name>Trevor</given-name><initials>T.</initials><afid>60028897</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:35400719900</author-url><authid>35400719900</authid><authname>Webb J.</authname><surname>Webb</surname><given-name>John</given-name><initials>J.</initials><afid>60010365</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:6603512990</author-url><authid>6603512990</authid><authname>Rodés-Cabau J.</authname><surname>Rodés-Cabau</surname><given-name>Josep</given-name><initials>J.</initials><afid>107712773</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:23491848300</author-url><authid>23491848300</authid><authname>Costopoulos C.</authname><surname>Costopoulos</surname><given-name>Charis</given-name><initials>C.</initials><afid>60082964</afid><afid>60019151</afid><afid>60015150</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:23491848300</author-url><authid>23491848300</authid><authname>Costopoulos C.</authname><surname>Costopoulos</surname><given-name>Charis</given-name><initials>C.</initials><afid>60082964</afid><afid>60019151</afid><afid>60015150</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:23491848300</author-url><authid>23491848300</authid><authname>Costopoulos C.</authname><surname>Costopoulos</surname><given-name>Charis</given-name><initials>C.</initials><afid>60082964</afid><afid>60019151</afid><afid>60015150</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:6701766095</author-url><authid>6701766095</authid><authname>Kochman J.</authname><surname>Kochman</surname><given-name>Janusz</given-name><initials>J.</initials><afid>60069009</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:35487653100</author-url><authid>35487653100</authid><authname>Hernández-Garcia J.</authname><surname>Hernández-Garcia</surname><given-name>José M.</given-name><initials>J.M.</initials><afid>60000252</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:55894451000</author-url><authid>55894451000</authid><authname>Chiam P.</authname><surname>Chiam</surname><given-name>Paul T L</given-name><initials>P.T.L.</initials><afid>60004409</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:35239007400</author-url><authid>35239007400</authid><authname>Welsh R.</authname><surname>Welsh</surname><given-name>Robert C.</given-name><initials>R.C.</initials><afid>60030835</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:8875771700</author-url><authid>8875771700</authid><authname>Wijeysundera H.</authname><surname>Wijeysundera</surname><given-name>Harindra C.</given-name><initials>H.C.</initials><afid>60029150</afid><afid>60017829</afid><afid>60016849</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:8875771700</author-url><authid>8875771700</authid><authname>Wijeysundera H.</authname><surname>Wijeysundera</surname><given-name>Harindra C.</given-name><initials>H.C.</initials><afid>60029150</afid><afid>60017829</afid><afid>60016849</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:8875771700</author-url><authid>8875771700</authid><authname>Wijeysundera H.</authname><surname>Wijeysundera</surname><given-name>Harindra C.</given-name><initials>H.C.</initials><afid>60029150</afid><afid>60017829</afid><afid>60016849</afid></author><author seq="11"><author-url>http://api.elsevier.com/content/author/author_id:7402249876</author-url><authid>7402249876</authid><authname>García E.</authname><surname>García</surname><given-name>Eulogio</given-name><initials>E.</initials><afid>60032461</afid></author><author seq="12"><author-url>http://api.elsevier.com/content/author/author_id:56542859000</author-url><authid>56542859000</authid><authname>Ribeiro H.</authname><surname>Ribeiro</surname><given-name>Henrique B.</given-name><initials>H.B.</initials><afid>107712773</afid></author><author seq="13"><author-url>http://api.elsevier.com/content/author/author_id:24401460900</author-url><authid>24401460900</authid><authname>Latib A.</authname><surname>Latib</surname><given-name>Azeem</given-name><initials>A.</initials><afid>60082964</afid><afid>60019151</afid></author><author seq="13"><author-url>http://api.elsevier.com/content/author/author_id:24401460900</author-url><authid>24401460900</authid><authname>Latib A.</authname><surname>Latib</surname><given-name>Azeem</given-name><initials>A.</initials><afid>60082964</afid><afid>60019151</afid></author><author seq="14"><author-url>http://api.elsevier.com/content/author/author_id:6507834220</author-url><authid>6507834220</authid><authname>Huczek Z.</authname><surname>Huczek</surname><given-name>Zenon</given-name><initials>Z.</initials><afid>60069009</afid></author><author seq="15"><author-url>http://api.elsevier.com/content/author/author_id:35192354300</author-url><authid>35192354300</authid><authname>Shanks M.</authname><surname>Shanks</surname><given-name>Miriam</given-name><initials>M.</initials><afid>60030835</afid></author><author seq="16"><author-url>http://api.elsevier.com/content/author/author_id:55387689400</author-url><authid>55387689400</authid><authname>Testa L.</authname><surname>Testa</surname><given-name>Luca</given-name><initials>L.</initials><afid>60070490</afid></author><author seq="17"><author-url>http://api.elsevier.com/content/author/author_id:6701811527</author-url><authid>6701811527</authid><authname>Farkouh M.</authname><surname>Farkouh</surname><given-name>Michael E.</given-name><initials>M.E.</initials><afid>60014468</afid><afid>60016849</afid></author><author seq="17"><author-url>http://api.elsevier.com/content/author/author_id:6701811527</author-url><authid>6701811527</authid><authname>Farkouh M.</authname><surname>Farkouh</surname><given-name>Michael E.</given-name><initials>M.E.</initials><afid>60014468</afid><afid>60016849</afid></author><author seq="18"><author-url>http://api.elsevier.com/content/author/author_id:6602127994</author-url><authid>6602127994</authid><authname>Dvir D.</authname><surname>Dvir</surname><given-name>Danny</given-name><initials>D.</initials><afid>60010365</afid></author><author seq="19"><author-url>http://api.elsevier.com/content/author/author_id:6602617374</author-url><authid>6602617374</authid><authname>Velianou J.</authname><surname>Velianou</surname><given-name>James L.</given-name><initials>J.L.</initials><afid>60031828</afid></author><author seq="20"><author-url>http://api.elsevier.com/content/author/author_id:56640798100</author-url><authid>56640798100</authid><authname>Lam B.</authname><surname>Lam</surname><given-name>Buu Khanh</given-name><initials>B.K.</initials><afid>60028897</afid></author><author seq="21"><author-url>http://api.elsevier.com/content/author/author_id:6505763436</author-url><authid>6505763436</authid><authname>Pourdjabbar A.</authname><surname>Pourdjabbar</surname><given-name>Ali</given-name><initials>A.</initials><afid>60028897</afid></author><author seq="22"><author-url>http://api.elsevier.com/content/author/author_id:7103154844</author-url><authid>7103154844</authid><authname>Glover C.</authname><surname>Glover</surname><given-name>Christopher</given-name><initials>C.</initials><afid>60028897</afid></author><author seq="23"><author-url>http://api.elsevier.com/content/author/author_id:6603019278</author-url><authid>6603019278</authid><authname>Hibbert B.</authname><surname>Hibbert</surname><given-name>Benjamin</given-name><initials>B.</initials><afid>60028897</afid></author><author seq="24"><author-url>http://api.elsevier.com/content/author/author_id:7003368608</author-url><authid>7003368608</authid><authname>Labinaz M.</authname><surname>Labinaz</surname><given-name>Marino</given-name><initials>M.</initials><afid>60028897</afid></author><authkeywords>Aortic valve stenosis | Bicuspid aortic valve | Congenital aortic valve stenosis | Transcatheter aortic valve implantation (TAVI)</authkeywords><intid>35916997</intid><source-id>23774</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929192505"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929192505?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929192505&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929192505&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0167527315006518"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929192505</prism:url><dc:identifier>SCOPUS_ID:84929192505</dc:identifier><eid>2-s2.0-84929192505</eid><dc:title>Short-term risk of arrhythmias among emergency department syncope patients with non-sinus rhythm</dc:title><dc:creator>Thiruganasambandamoorthy V.</dc:creator><prism:publicationName>International Journal of Cardiology</prism:publicationName><prism:issn>01675273</prism:issn><prism:eIssn>18741754</prism:eIssn><prism:volume>189</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>12-14</prism:pageRange><prism:coverDate>2015-06-15</prism:coverDate><prism:coverDisplayDate>15 June 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijcard.2015.03.388</prism:doi><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60028897</affiliation-url><afid>60028897</afid><affilname>University of Ottawa, Canada</affilname><name-variant>University of Ottawa</name-variant><affiliation-city>Ottawa</affiliation-city><affiliation-country>Canada</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60002173</affiliation-url><afid>60002173</afid><affilname>Ottawa Hospital Research Institute</affilname><name-variant>Ottawa Health Research Institute</name-variant><affiliation-city>Ottawa</affiliation-city><affiliation-country>Canada</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60028897</affiliation-url><afid>60028897</afid><affilname>University of Ottawa, Canada</affilname><name-variant>University of Ottawa</name-variant><affiliation-city>Ottawa</affiliation-city><affiliation-country>Canada</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60010365</affiliation-url><afid>60010365</afid><affilname>The University of British Columbia</affilname><name-variant>University of British Columbia</name-variant><affiliation-city>Vancouver</affiliation-city><affiliation-country>Canada</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60009507</affiliation-url><afid>60009507</afid><affilname>Universite de Montreal</affilname><name-variant>University of Montreal</name-variant><affiliation-city>Montreal</affiliation-city><affiliation-country>Canada</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60002306</affiliation-url><afid>60002306</afid><affilname>University of Calgary</affilname><name-variant>University of Calgary</name-variant><affiliation-city>Calgary</affiliation-city><affiliation-country>Canada</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60028897</affiliation-url><afid>60028897</afid><affilname>University of Ottawa, Canada</affilname><name-variant>University of Ottawa</name-variant><affiliation-city>Ottawa</affiliation-city><affiliation-country>Canada</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>le</subtype><subtypeDescription>Letter</subtypeDescription><author-count limit="100">17</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:25621667800</author-url><authid>25621667800</authid><authname>Thiruganasambandamoorthy V.</authname><surname>Thiruganasambandamoorthy</surname><given-name>Venkatesh</given-name><initials>V.</initials><afid>60028897</afid><afid>60002173</afid><afid>60028897</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:25621667800</author-url><authid>25621667800</authid><authname>Thiruganasambandamoorthy V.</authname><surname>Thiruganasambandamoorthy</surname><given-name>Venkatesh</given-name><initials>V.</initials><afid>60028897</afid><afid>60002173</afid><afid>60028897</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:25621667800</author-url><authid>25621667800</authid><authname>Thiruganasambandamoorthy V.</authname><surname>Thiruganasambandamoorthy</surname><given-name>Venkatesh</given-name><initials>V.</initials><afid>60028897</afid><afid>60002173</afid><afid>60028897</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56640832600</author-url><authid>56640832600</authid><authname>Kwong K.</authname><surname>Kwong</surname><given-name>Kenneth</given-name><initials>K.</initials><afid>60028897</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56601845700</author-url><authid>56601845700</authid><authname>Stiell I.</authname><surname>Stiell</surname><given-name>Ian G.</given-name><initials>I.G.</initials><afid>60028897</afid><afid>60002173</afid><afid>60028897</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56601845700</author-url><authid>56601845700</authid><authname>Stiell I.</authname><surname>Stiell</surname><given-name>Ian G.</given-name><initials>I.G.</initials><afid>60028897</afid><afid>60002173</afid><afid>60028897</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56601845700</author-url><authid>56601845700</authid><authname>Stiell I.</authname><surname>Stiell</surname><given-name>Ian G.</given-name><initials>I.G.</initials><afid>60028897</afid><afid>60002173</afid><afid>60028897</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:8345503500</author-url><authid>8345503500</authid><authname>Swampillai J.</authname><surname>Swampillai</surname><given-name>Janice</given-name><initials>J.</initials><afid>60010365</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:55698325300</author-url><authid>55698325300</authid><authname>Toarta C.</authname><surname>Toarta</surname><given-name>Cristian</given-name><initials>C.</initials><afid>60009507</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:14025021500</author-url><authid>14025021500</authid><authname>Sumner G.</authname><surname>Sumner</surname><given-name>Glen L.</given-name><initials>G.L.</initials><afid>60002306</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:23985201800</author-url><authid>23985201800</authid><authname>Kuriachan V.</authname><surname>Kuriachan</surname><given-name>Vikas P.</given-name><initials>V.P.</initials><afid>60002306</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:56336984600</author-url><authid>56336984600</authid><authname>Mukarram M.</authname><surname>Mukarram</surname><given-name>Muhammad</given-name><initials>M.</initials><afid>60002173</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:13104397100</author-url><authid>13104397100</authid><authname>Taljaard M.</authname><surname>Taljaard</surname><given-name>Monica</given-name><initials>M.</initials><afid>60002173</afid><afid>60028897</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:13104397100</author-url><authid>13104397100</authid><authname>Taljaard M.</authname><surname>Taljaard</surname><given-name>Monica</given-name><initials>M.</initials><afid>60002173</afid><afid>60028897</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:8399242300</author-url><authid>8399242300</authid><authname>Hazra S.</authname><surname>Hazra</surname><given-name>Samir</given-name><initials>S.</initials><afid>60028897</afid></author><author seq="11"><author-url>http://api.elsevier.com/content/author/author_id:56467711900</author-url><authid>56467711900</authid><authname>Wells G.</authname><surname>Wells</surname><given-name>George A.</given-name><initials>G.A.</initials><afid>60028897</afid></author><author seq="12"><author-url>http://api.elsevier.com/content/author/author_id:7202861363</author-url><authid>7202861363</authid><authname>Sheldon R.</authname><surname>Sheldon</surname><given-name>Robert</given-name><initials>R.</initials><afid>60002306</afid></author><authkeywords>30-day risk | Mortality | Non-sinus rhythm | Prognosis | Syncope</authkeywords><intid>35917423</intid><source-id>23774</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929171670"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929171670?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929171670&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929171670&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S016752731500532X"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929171670</prism:url><dc:identifier>SCOPUS_ID:84929171670</dc:identifier><eid>2-s2.0-84929171670</eid><dc:title>Immediate, same-setting paravalvular leak closure following transcatheter aortic valve replacement</dc:title><dc:creator>White J.</dc:creator><prism:publicationName>International Journal of Cardiology</prism:publicationName><prism:issn>01675273</prism:issn><prism:eIssn>18741754</prism:eIssn><prism:volume>189</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>235-237</prism:pageRange><prism:coverDate>2015-06-15</prism:coverDate><prism:coverDisplayDate>15 June 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijcard.2015.03.292</prism:doi><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60027565</affiliation-url><afid>60027565</afid><affilname>Columbia University Medical Center</affilname><name-variant>Columbia University</name-variant><affiliation-city>New York</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>le</subtype><subtypeDescription>Letter</subtypeDescription><author-count limit="100">3</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56486445000</author-url><authid>56486445000</authid><authname>White J.</authname><surname>White</surname><given-name>Jonathon M.</given-name><initials>J.M.</initials><afid>60027565</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:17342369300</author-url><authid>17342369300</authid><authname>Khalique O.</authname><surname>Khalique</surname><given-name>Omar K.</given-name><initials>O.K.</initials><afid>60027565</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56458001900</author-url><authid>56458001900</authid><authname>Kodali S.</authname><surname>Kodali</surname><given-name>Susheel K.</given-name><initials>S.K.</initials><afid>60027565</afid></author><authkeywords>Aortic stenosis | Paravalvular regurgitation | Transcatheter aortic valve replacement</authkeywords><intid>535917660</intid><source-id>23774</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929148677"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929148677?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929148677&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929148677&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0167527315007809"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929148677</prism:url><dc:identifier>SCOPUS_ID:84929148677</dc:identifier><eid>2-s2.0-84929148677</eid><dc:title>Amiodarone and Trypanosoma cruzi parasitemia in patients with Chagas disease</dc:title><dc:creator>Carmo A.</dc:creator><prism:publicationName>International Journal of Cardiology</prism:publicationName><prism:issn>01675273</prism:issn><prism:eIssn>18741754</prism:eIssn><prism:volume>189</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>182-184</prism:pageRange><prism:coverDate>2015-06-15</prism:coverDate><prism:coverDisplayDate>15 June 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijcard.2015.04.061</prism:doi><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60030074</affiliation-url><afid>60030074</afid><affilname>Universidade Federal de Minas Gerais</affilname><name-variant>Universidade Federal de Minas Gerais</name-variant><affiliation-city>Belo Horizonte</affiliation-city><affiliation-country>Brazil</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60030074</affiliation-url><afid>60030074</afid><affilname>Universidade Federal de Minas Gerais</affilname><name-variant>Universidade Federal de Minas Gerais</name-variant><affiliation-city>Belo Horizonte</affiliation-city><affiliation-country>Brazil</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60008088</affiliation-url><afid>60008088</afid><affilname>Universidade de Sao Paulo - USP</affilname><name-variant>University of São Paulo</name-variant><affiliation-city>Sao Paulo</affiliation-city><affiliation-country>Brazil</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60030070</affiliation-url><afid>60030070</afid><affilname>Instituto de Medicina Tropical de Sao Paulo</affilname><name-variant>Universidade de São Paulo</name-variant><affiliation-city>Sao Paulo</affiliation-city><affiliation-country>Brazil</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>le</subtype><subtypeDescription>Letter</subtypeDescription><author-count limit="100">7</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55437275800</author-url><authid>55437275800</authid><authname>Carmo A.</authname><surname>Carmo</surname><given-name>Andre A L</given-name><initials>A.A.L.</initials><afid>60030074</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:35869602900</author-url><authid>35869602900</authid><authname>Rocha M.</authname><surname>Rocha</surname><given-name>Manoel O C</given-name><initials>M.O.C.</initials><afid>60030074</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56640396200</author-url><authid>56640396200</authid><authname>Silva J.</authname><surname>Silva</surname><given-name>Jose L P</given-name><initials>J.L.P.</initials><afid>60030074</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:7003360633</author-url><authid>7003360633</authid><authname>Ianni B.</authname><surname>Ianni</surname><given-name>Barbara M.</given-name><initials>B.M.</initials><afid>60008088</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:7103077860</author-url><authid>7103077860</authid><authname>Fernandes F.</authname><surname>Fernandes</surname><given-name>Fabio</given-name><initials>F.</initials><afid>60008088</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:35249005100</author-url><authid>35249005100</authid><authname>Sabino E.</authname><surname>Sabino</surname><given-name>Ester C.</given-name><initials>E.C.</initials><afid>60030070</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:7201676223</author-url><authid>7201676223</authid><authname>Ribeiro A.</authname><surname>Ribeiro</surname><given-name>Antonio L P</given-name><initials>A.L.P.</initials><afid>60030074</afid></author><authkeywords>Amiodarone | Chagas disease | Parasitemia</authkeywords><intid>1035913437</intid><source-id>23774</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929224022"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929224022?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929224022&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929224022&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S016752731500769X"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929224022</prism:url><dc:identifier>SCOPUS_ID:84929224022</dc:identifier><eid>2-s2.0-84929224022</eid><dc:title>Prominent T wave in V&lt;inf&gt;2&lt;/inf&gt; with respect to V&lt;inf&gt;6&lt;/inf&gt; as a sign of lateral myocardial infarction</dc:title><dc:creator>Rovai D.</dc:creator><prism:publicationName>International Journal of Cardiology</prism:publicationName><prism:issn>01675273</prism:issn><prism:eIssn>18741754</prism:eIssn><prism:volume>189</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>148-152</prism:pageRange><prism:coverDate>2015-06-15</prism:coverDate><prism:coverDisplayDate>15 June 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijcard.2015.04.050</prism:doi><dc:description>© 2015 Elsevier Ireland Ltd. All rights reserved. Background: In the absence of confounding electrocardiographic features, a prominent R wave in leads V&lt;inf&gt;1&lt;/inf&gt;-V&lt;inf&gt;2&lt;/inf&gt; reflects a lateral myocardial infarction (MI). Wehypothesized that repolarization abnormalities in V&lt;inf&gt;1&lt;/inf&gt;-V&lt;inf&gt;2&lt;/inf&gt; could also reflect a lateral MI. Methods: We retrospectively selected a group of 57 patients with a recent or previous first Q-wave MI involving left ventricular (LV) inferior and/or lateral wall at contrast-enhanced cardiac magnetic resonance (CMR). The location and extent of the MI at CMR were compared with electrocardiographic features. Results: The infarction was located in the inferior wall in 12 patients (21%), in the lateral wall in 8 (14%), and in both walls in 37 patients (65%). Infarct size corresponded to 16.8 (SD 9.0%) of LV myocardium. Infarct extent in the inferior and lateral wall (8.3%, SD 7.2% vs. 8.4%, SD 7.5% of LV myocardium) did not differ significantly. Using multiple linear regression analysis, inferior Q-waves and inferior negative T waves were directly associated with infarct extentinthe inferior wall (p = 0.014 and p = 0.010, respectively). A prominent R wave in V&lt;inf&gt;1&lt;/inf&gt; and a prominent anterior T wave (expressed by the T wave amplitude in V&lt;inf&gt;2&lt;/inf&gt; minus its amplitude in V&lt;inf&gt;6&lt;/inf&gt;) were directly associated with MI extent in the lateral wall (p = 0.008 and p = 0.018), while inferior negative T waves were negatively associated (p = 0.006). Conclusions: In patients with MI of the inferior and/or lateral wall, a prominent T wave in V&lt;inf&gt;2&lt;/inf&gt; with respect to V&lt;inf&gt;6&lt;/inf&gt; reflects greater infarct extent in the lateral wall.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60021199</affiliation-url><afid>60021199</afid><affilname>Consiglio Nazionale delle Ricerche</affilname><name-variant>CNR</name-variant><affiliation-city>Rome</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:100441862</affiliation-url><afid>100441862</afid><affilname>Pederzoli Hospital</affilname><name-variant>Pederzoli Hospital</name-variant><affiliation-city>Verona</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:114987120</affiliation-url><afid>114987120</afid><affilname>Fondazione Toscana Gabriele Monasterio</affilname><name-variant>Fondazione Toscana Gabriele Monasterio</name-variant><affiliation-city/><affiliation-country>Italy</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60011576</affiliation-url><afid>60011576</afid><affilname>Universita degli Studi di Messina</affilname><name-variant>Università di Messina</name-variant><affiliation-city>Messina</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">6</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:7006175508</author-url><authid>7006175508</authid><authname>Rovai D.</authname><surname>Rovai</surname><given-name>Daniele</given-name><initials>D.</initials><afid>60021199</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:35611712400</author-url><authid>35611712400</authid><authname>Rossi G.</authname><surname>Rossi</surname><given-name>Giuseppe</given-name><initials>G.</initials><afid>60021199</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:35622279700</author-url><authid>35622279700</authid><authname>Pederzoli L.</authname><surname>Pederzoli</surname><given-name>Laura</given-name><initials>L.</initials><afid>100441862</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:35279306300</author-url><authid>35279306300</authid><authname>Aquaro G.</authname><surname>Aquaro</surname><given-name>Giovanni Donato</given-name><initials>G.D.</initials><afid>114987120</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:23024467000</author-url><authid>23024467000</authid><authname>Di Bella G.</authname><surname>Di Bella</surname><given-name>Gianluca</given-name><initials>G.</initials><afid>60011576</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:6701579669</author-url><authid>6701579669</authid><authname>Pingitore A.</authname><surname>Pingitore</surname><given-name>Alessandro</given-name><initials>A.</initials><afid>60021199</afid></author><authkeywords>Electrocardiogram | Magnetic resonance | Myocardial infarction | T wave</authkeywords><intid>535918587</intid><source-id>23774</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929156069"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929156069?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929156069&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929156069&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0167527315007226"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929156069</prism:url><dc:identifier>SCOPUS_ID:84929156069</dc:identifier><eid>2-s2.0-84929156069</eid><dc:title>Acute stanford type B aortic dissection occurred simultaneously with acute myocardial infarction</dc:title><dc:creator>He X.</dc:creator><prism:publicationName>International Journal of Cardiology</prism:publicationName><prism:issn>01675273</prism:issn><prism:eIssn>18741754</prism:eIssn><prism:volume>189</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>56-58</prism:pageRange><prism:coverDate>2015-06-15</prism:coverDate><prism:coverDisplayDate>15 June 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijcard.2015.04.012</prism:doi><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:113032052</affiliation-url><afid>113032052</afid><affilname>Tongji Hospital</affilname><name-variant>Tongji Hospital</name-variant><affiliation-city>Wuhan</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:115234557</affiliation-url><afid>115234557</afid><affilname>Central Hospital of Suizhou City</affilname><name-variant>Central Hospital of Suizhou City</name-variant><affiliation-city/><affiliation-country>China</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>le</subtype><subtypeDescription>Letter</subtypeDescription><author-count limit="100">5</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56599375000</author-url><authid>56599375000</authid><authname>He X.</authname><surname>He</surname><given-name>Xingwei</given-name><initials>X.</initials><afid>113032052</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56640738900</author-url><authid>56640738900</authid><authname>Liu X.</authname><surname>Liu</surname><given-name>Xintian</given-name><initials>X.</initials><afid>113032052</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56640082900</author-url><authid>56640082900</authid><authname>Liu W.</authname><surname>Liu</surname><given-name>Wanjun</given-name><initials>W.</initials><afid>113032052</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56477988600</author-url><authid>56477988600</authid><authname>Gao B.</authname><surname>Gao</surname><given-name>Bo</given-name><initials>B.</initials><afid>115234557</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:7401471931</author-url><authid>7401471931</authid><authname>Zeng H.</authname><surname>Zeng</surname><given-name>Hesong</given-name><initials>H.</initials><afid>113032052</afid></author><authkeywords>Acute aortic dissection | Acute myocardial infarction | Diagnosis</authkeywords><intid>35917968</intid><source-id>23774</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929167686"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929167686?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929167686&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929167686&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0167527315007822"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929167686</prism:url><dc:identifier>SCOPUS_ID:84929167686</dc:identifier><eid>2-s2.0-84929167686</eid><dc:title>Disease complexity in acute coronary syndrome is related to the patient's immunological status</dc:title><dc:creator>Moro-García M.</dc:creator><prism:publicationName>International Journal of Cardiology</prism:publicationName><prism:issn>01675273</prism:issn><prism:eIssn>18741754</prism:eIssn><prism:volume>189</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>115-123</prism:pageRange><prism:coverDate>2015-06-15</prism:coverDate><prism:coverDisplayDate>15 June 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijcard.2015.04.063</prism:doi><dc:description>© 2015 Elsevier Ireland Ltd. All rights reserved. Background: Our aim was to investigate whether patients with acute coronary syndrome (ACS) display an overall T cell immunosenescence that could be contributing to worsening the stage of the disease. Methods and results: We compared the immunological status of 52 ACS patients, 21 controls with absence of coronary artery disease (CAD) (C1), and 50 healthy individuals (C2). We characterized leukocyte and T lymphocyte subpopulations by flow cytometry. CAD was classified according to SYNTAX score, number of diseased coronary vessels, previous episodes of ACS and left ventricular ejection fraction (LVEF). ACS patients showed an increased number of total leukocytes, neutrophils and monocytes (p &lt; 0.001), but a decreased number of lymphocytes (p &lt; 0.05). ACS patients had significantly higher levels of NKcells and CD8+T-cells(p &lt; 0.05). ACS was associated with high differentiation in CD4+ and CD8+ T-lymphocytes. Frequencies of naïve, naïve CD31+, EM1, and pE1 subsets were significantly reduced in ACS patients (p &lt; 0.05), while EM3, EM4 (in CD4+), and E (in CD8+) subsets were increased(p &lt; 0.05). Aging of T-lymphocyte subpopulations was associated witha worse SYNTAX score (p &lt; 0.05), and aging of CD4+ T-lymphocytes withalarger number ofaffected vessels, larger number of previous ACS episodes and lower LVEF, in ACS patients (p &gt; 0.05). Furthermore, the proliferation ability of CD4+ and CD8+ T-lymphocytes was significantly impaired in ACS patients (p &lt; 0.05), although they had increased activation (p &lt; 0.05). Conclusions: We conclude that ACS patients show a higher degree of T-lymphocyte immunosenescence than healthy controls, which could contribute to disease impairment through a compromised adaptive immune response.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60016862</affiliation-url><afid>60016862</afid><affilname>Hospital Universitario Central de Asturias</affilname><name-variant>Hospital Central de Asturias</name-variant><affiliation-city>Oviedo</affiliation-city><affiliation-country>Spain</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60016862</affiliation-url><afid>60016862</afid><affilname>Hospital Universitario Central de Asturias</affilname><name-variant>Hospital Central de Asturias</name-variant><affiliation-city>Oviedo</affiliation-city><affiliation-country>Spain</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:100405505</affiliation-url><afid>100405505</afid><affilname>Fundación Renal Iñigo Alvarez de Toledo</affilname><name-variant>Fundación Renal Iñigo Alvarez de Toledo</name-variant><affiliation-city>Madrid</affiliation-city><affiliation-country>Spain</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">8</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:36716559100</author-url><authid>36716559100</authid><authname>Moro-García M.</authname><surname>Moro-García</surname><given-name>Marco Antonio</given-name><initials>M.A.</initials><afid>60016862</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56641045200</author-url><authid>56641045200</authid><authname>Iglesias F.</authname><surname>Iglesias</surname><given-name>Fernando López</given-name><initials>F.L.</initials><afid>60016862</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:6603073164</author-url><authid>6603073164</authid><authname>Avanzas P.</authname><surname>Avanzas</surname><given-name>Pablo</given-name><initials>P.</initials><afid>60016862</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:54383010600</author-url><authid>54383010600</authid><authname>Echeverría A.</authname><surname>Echeverría</surname><given-name>Ainara</given-name><initials>A.</initials><afid>60016862</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:7004945114</author-url><authid>7004945114</authid><authname>López-Larrea C.</authname><surname>López-Larrea</surname><given-name>Carlos</given-name><initials>C.</initials><afid>60016862</afid><afid>100405505</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:7004945114</author-url><authid>7004945114</authid><authname>López-Larrea C.</authname><surname>López-Larrea</surname><given-name>Carlos</given-name><initials>C.</initials><afid>60016862</afid><afid>100405505</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:6507446443</author-url><authid>6507446443</authid><authname>De La Tassa C.</authname><surname>De La Tassa</surname><given-name>Cesar Morís</given-name><initials>C.M.</initials><afid>60016862</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:24802249200</author-url><authid>24802249200</authid><authname>Alonso-Arias R.</authname><surname>Alonso-Arias</surname><given-name>Rebeca</given-name><initials>R.</initials><afid>60016862</afid></author><authkeywords>Acute coronary syndrome | Differentiation | Immunosenescence | Inflammation | T-lymphocytes</authkeywords><intid>1785919470</intid><source-id>23774</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929168520"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929168520?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929168520&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929168520&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0167527315007743"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929168520</prism:url><dc:identifier>SCOPUS_ID:84929168520</dc:identifier><eid>2-s2.0-84929168520</eid><dc:title>Prognostic value of microRNAs in acute myocardial infarction: A systematic review and meta-analysis</dc:title><dc:creator>Cao W.</dc:creator><prism:publicationName>International Journal of Cardiology</prism:publicationName><prism:issn>01675273</prism:issn><prism:eIssn>18741754</prism:eIssn><prism:volume>189</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>79-84</prism:pageRange><prism:coverDate>2015-06-15</prism:coverDate><prism:coverDisplayDate>15 June 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijcard.2015.04.055</prism:doi><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:107323050</affiliation-url><afid>107323050</afid><affilname>Zigong First People's Hospital</affilname><name-variant>Zigong First People's Hospital</name-variant><affiliation-city/><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60000196</affiliation-url><afid>60000196</afid><affilname>Chengdu University of Traditional Chinese Medicine</affilname><name-variant>Chengdu University of Traditional Chinese Medicine</name-variant><affiliation-city>Chengdu</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60073506</affiliation-url><afid>60073506</afid><affilname>Sichuan Provincial People's Hospital</affilname><name-variant>Sichuan Provincial People's Hospital</name-variant><affiliation-city>Chengdu</affiliation-city><affiliation-country>China</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>le</subtype><subtypeDescription>Letter</subtypeDescription><author-count limit="100">6</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56640380100</author-url><authid>56640380100</authid><authname>Cao W.</authname><surname>Cao</surname><given-name>Wenzhai</given-name><initials>W.</initials><afid>107323050</afid><afid>60000196</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56640380100</author-url><authid>56640380100</authid><authname>Cao W.</authname><surname>Cao</surname><given-name>Wenzhai</given-name><initials>W.</initials><afid>107323050</afid><afid>60000196</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56640320100</author-url><authid>56640320100</authid><authname>Guo Q.</authname><surname>Guo</surname><given-name>Qiang</given-name><initials>Q.</initials><afid>60000196</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56640148000</author-url><authid>56640148000</authid><authname>Zhang T.</authname><surname>Zhang</surname><given-name>Ting</given-name><initials>T.</initials><afid>107323050</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56640645600</author-url><authid>56640645600</authid><authname>Zhong D.</authname><surname>Zhong</surname><given-name>DeChao</given-name><initials>D.</initials><afid>107323050</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56640343700</author-url><authid>56640343700</authid><authname>Yu Q.</authname><surname>Yu</surname><given-name>Qian</given-name><initials>Q.</initials><afid>60073506</afid></author><authkeywords>Acute myocardial infarction | Meta-analysis | MiRNA | Prognosis</authkeywords><intid>1785918758</intid><source-id>23774</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929149824"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929149824?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929149824&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929149824&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0167527315006579"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929149824</prism:url><dc:identifier>SCOPUS_ID:84929149824</dc:identifier><eid>2-s2.0-84929149824</eid><dc:title>Is Brugada syndrome a variant of arrhythmogenic cardiomyopathy?</dc:title><dc:creator>Peters S.</dc:creator><prism:publicationName>International Journal of Cardiology</prism:publicationName><prism:issn>01675273</prism:issn><prism:eIssn>18741754</prism:eIssn><prism:volume>189</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>88-90</prism:pageRange><prism:coverDate>2015-06-15</prism:coverDate><prism:coverDisplayDate>15 June 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijcard.2015.03.394</prism:doi><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:114741330</affiliation-url><afid>114741330</afid><affilname>St. Elisabeth Hospital Salzgitter</affilname><name-variant>St. Elisabeth Hospital Salzgitter</name-variant><affiliation-city>Salzgitter</affiliation-city><affiliation-country>Germany</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>le</subtype><subtypeDescription>Letter</subtypeDescription><author-count limit="100">1</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:7201536649</author-url><authid>7201536649</authid><authname>Peters S.</authname><surname>Peters</surname><given-name>S.</given-name><initials>S.</initials><afid>114741330</afid></author><authkeywords>Arrhythmogenic cardiomyopathy | Brugada syndrome | Connexome | Plakophilin-2</authkeywords><intid>1535916696</intid><source-id>23774</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929173032"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929173032?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929173032&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929173032&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929173032</prism:url><dc:identifier>SCOPUS_ID:84929173032</dc:identifier><eid>2-s2.0-84929173032</eid><dc:title>Estimating passive mechanical properties in a myocardial infarction using MRI and finite element simulations</dc:title><dc:creator>Mojsejenko D.</dc:creator><prism:publicationName>Biomechanics and Modeling in Mechanobiology</prism:publicationName><prism:issn>16177959</prism:issn><prism:eIssn>16177940</prism:eIssn><prism:volume>14</prism:volume><prism:issueIdentifier>3</prism:issueIdentifier><prism:pageRange>633-647</prism:pageRange><prism:coverDate>2015-06-15</prism:coverDate><prism:coverDisplayDate>15 June 2015</prism:coverDisplayDate><prism:doi>10.1007/s10237-014-0627-z</prism:doi><dc:description>© 2014, Springer-Verlag Berlin Heidelberg. Myocardial infarction (MI) triggers a series of maladaptive events that lead to structural and functional changes in the left ventricle. It is crucial to better understand the progression of adverse remodeling, in order to develop effective treatment. In addition, being able to assess changes in vivo would be a powerful tool in the clinic. The goal of the current study is to quantify the in vivo material properties of infarcted and remote myocardium 1 week after MI, as well as the orientation of collagen fibers in the infarct. This will be accomplished by using a combination of magnetic resonance imaging (MRI), catheterization, finite element modeling, and numerical optimization to analyze a porcine model ($$N = 4$$N=4) of posterolateral myocardial infarction. Specifically, properties will be determined by minimizing the difference between in vivo strains and volume calculated from MRI and finite element model predicted strains and volume. The results indicate that the infarct region is stiffer than the remote region and that the infarct collagen fibers become more circumferentially oriented 1 week post-MI. These findings are consistent with previous studies, which employed ex vivo techniques. The proposed methodology will ultimately provide a means of predicting remote and infarct mechanical properties in vivo at any time point post-MI.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60015941</affiliation-url><afid>60015941</afid><affilname>University of Kentucky</affilname><name-variant>University of Kentucky</name-variant><affiliation-city>Lexington</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60006297</affiliation-url><afid>60006297</afid><affilname>University of Pennsylvania</affilname><name-variant>University of Pennsylvania</name-variant><affiliation-city>Philadelphia</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60006297</affiliation-url><afid>60006297</afid><affilname>University of Pennsylvania</affilname><name-variant>University of Pennsylvania</name-variant><affiliation-city>Philadelphia</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60006297</affiliation-url><afid>60006297</afid><affilname>University of Pennsylvania</affilname><name-variant>University of Pennsylvania</name-variant><affiliation-city>Philadelphia</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60015941</affiliation-url><afid>60015941</afid><affilname>University of Kentucky</affilname><name-variant>University of Kentucky</name-variant><affiliation-city>Lexington</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">10</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55668012200</author-url><authid>55668012200</authid><authname>Mojsejenko D.</authname><surname>Mojsejenko</surname><given-name>Dimitri</given-name><initials>D.</initials><afid>60015941</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:54967524900</author-url><authid>54967524900</authid><authname>McGarvey J.</authname><surname>McGarvey</surname><given-name>Jeremy R.</given-name><initials>J.R.</initials><afid>60006297</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:18133571400</author-url><authid>18133571400</authid><authname>Dorsey S.</authname><surname>Dorsey</surname><given-name>Shauna M.</given-name><initials>S.M.</initials><afid>60006297</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56453918600</author-url><authid>56453918600</authid><authname>Gorman J.</authname><surname>Gorman</surname><given-name>Joseph H.</given-name><initials>J.H.</initials><afid>60006297</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:7103361675</author-url><authid>7103361675</authid><authname>Burdick J.</authname><surname>Burdick</surname><given-name>Jason A.</given-name><initials>J.A.</initials><afid>60006297</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:6701379196</author-url><authid>6701379196</authid><authname>Pilla J.</authname><surname>Pilla</surname><given-name>James J.</given-name><initials>J.J.</initials><afid>60006297</afid><afid>60006297</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:6701379196</author-url><authid>6701379196</authid><authname>Pilla J.</authname><surname>Pilla</surname><given-name>James J.</given-name><initials>J.J.</initials><afid>60006297</afid><afid>60006297</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:34770566800</author-url><authid>34770566800</authid><authname>Gorman R.</authname><surname>Gorman</surname><given-name>Robert C.</given-name><initials>R.C.</initials><afid>60006297</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:56638753200</author-url><authid>56638753200</authid><authname>Wenk J.</authname><surname>Wenk</surname><given-name>Jonathan F.</given-name><initials>J.F.</initials><afid>60015941</afid><afid>60015941</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:56638753200</author-url><authid>56638753200</authid><authname>Wenk J.</authname><surname>Wenk</surname><given-name>Jonathan F.</given-name><initials>J.F.</initials><afid>60015941</afid><afid>60015941</afid></author><authkeywords>Finite element modeling | Left ventricular remodeling | MRI | Myocardial infarction | Optimization</authkeywords><intid>2035913323</intid><source-id>16294</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929170597"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929170597?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929170597&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929170597&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0167527315007263"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929170597</prism:url><dc:identifier>SCOPUS_ID:84929170597</dc:identifier><eid>2-s2.0-84929170597</eid><dc:title>Renal denervation for the treatment of atrial fibrillation in hypertensive patients or beyond?</dc:title><dc:creator>Huang B.</dc:creator><prism:publicationName>International Journal of Cardiology</prism:publicationName><prism:issn>01675273</prism:issn><prism:eIssn>18741754</prism:eIssn><prism:volume>189</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>59-60</prism:pageRange><prism:coverDate>2015-06-15</prism:coverDate><prism:coverDisplayDate>15 June 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijcard.2015.04.016</prism:doi><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60080982</affiliation-url><afid>60080982</afid><affilname>Hubei General Hospital</affilname><name-variant>Renmin Hospital of Wuhan University</name-variant><affiliation-city>Wuhan</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60029306</affiliation-url><afid>60029306</afid><affilname>Wuhan University</affilname><name-variant>Wuhan University</name-variant><affiliation-city>Wuhan</affiliation-city><affiliation-country>China</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>le</subtype><subtypeDescription>Letter</subtypeDescription><author-count limit="100">4</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56449810800</author-url><authid>56449810800</authid><authname>Huang B.</authname><surname>Huang</surname><given-name>Bing</given-name><initials>B.</initials><afid>60029306</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:35312999700</author-url><authid>35312999700</authid><authname>Yu L.</authname><surname>Yu</surname><given-name>Lilei</given-name><initials>L.</initials><afid>60029306</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56640120200</author-url><authid>56640120200</authid><authname>Zhou L.</authname><surname>Zhou</surname><given-name>Liping</given-name><initials>L.</initials><afid>60029306</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56278651700</author-url><authid>56278651700</authid><authname>Jiang H.</authname><surname>Jiang</surname><given-name>Hong</given-name><initials>H.</initials><afid>60080982</afid></author><authkeywords>Atrial fibrillation | Autonomic nervous system | Renal denervation</authkeywords><intid>1035911426</intid><source-id>23774</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929208010"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929208010?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929208010&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929208010&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0167527315006221"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929208010</prism:url><dc:identifier>SCOPUS_ID:84929208010</dc:identifier><eid>2-s2.0-84929208010</eid><dc:title>Acute peripartum cardiomyopathy rapidly evolving in cardiogenic shock</dc:title><dc:creator>Scardovi A.</dc:creator><prism:publicationName>International Journal of Cardiology</prism:publicationName><prism:issn>01675273</prism:issn><prism:eIssn>18741754</prism:eIssn><prism:volume>189</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>255-256</prism:pageRange><prism:coverDate>2015-06-15</prism:coverDate><prism:coverDisplayDate>15 June 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijcard.2015.03.364</prism:doi><citedby-count>1</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60073798</affiliation-url><afid>60073798</afid><affilname>Ospedale S. Spirito</affilname><name-variant>Ospedale Santo Spirito</name-variant><affiliation-city>Rome</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60021199</affiliation-url><afid>60021199</afid><affilname>Consiglio Nazionale delle Ricerche</affilname><name-variant>CNR</name-variant><affiliation-city>Rome</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">3</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:9280191000</author-url><authid>9280191000</authid><authname>Scardovi A.</authname><surname>Scardovi</surname><given-name>A. B.</given-name><initials>A.B.</initials><afid>60073798</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:18338941300</author-url><authid>18338941300</authid><authname>De Maria R.</authname><surname>De Maria</surname><given-name>R.</given-name><initials>R.</initials><afid>60021199</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:7103409106</author-url><authid>7103409106</authid><authname>Ricci R.</authname><surname>Ricci</surname><given-name>R.</given-name><initials>R.</initials><afid>60073798</afid></author><authkeywords>Cabergoline | Cardiogenic shock | Levosimendan | Peripartum cardiomyopathy</authkeywords><intid>1785918028</intid><source-id>23774</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929179365"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929179365?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929179365&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929179365&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0167527315004210"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929179365</prism:url><dc:identifier>SCOPUS_ID:84929179365</dc:identifier><eid>2-s2.0-84929179365</eid><dc:title>The accuracy of central blood pressure waveform by novel mathematical transformation of non-invasive measurement</dc:title><dc:creator>Sueta D.</dc:creator><prism:publicationName>International Journal of Cardiology</prism:publicationName><prism:issn>01675273</prism:issn><prism:eIssn>18741754</prism:eIssn><prism:volume>189</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>244-246</prism:pageRange><prism:coverDate>2015-06-15</prism:coverDate><prism:coverDisplayDate>15 June 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijcard.2015.03.182</prism:doi><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60021120</affiliation-url><afid>60021120</afid><affilname>Kumamoto University</affilname><name-variant>Kumamoto University</name-variant><affiliation-city>Kumamoto</affiliation-city><affiliation-country>Japan</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60021120</affiliation-url><afid>60021120</afid><affilname>Kumamoto University</affilname><name-variant>Kumamoto University</name-variant><affiliation-city>Kumamoto</affiliation-city><affiliation-country>Japan</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>le</subtype><subtypeDescription>Letter</subtypeDescription><author-count limit="100">12</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:47962595500</author-url><authid>47962595500</authid><authname>Sueta D.</authname><surname>Sueta</surname><given-name>Daisuke</given-name><initials>D.</initials><afid>60021120</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56517615000</author-url><authid>56517615000</authid><authname>Yamamoto E.</authname><surname>Yamamoto</surname><given-name>Eiichiro</given-name><initials>E.</initials><afid>60021120</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:55628539043</author-url><authid>55628539043</authid><authname>Tanaka T.</authname><surname>Tanaka</surname><given-name>Tomoko</given-name><initials>T.</initials><afid>60021120</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56089350200</author-url><authid>56089350200</authid><authname>Hirata Y.</authname><surname>Hirata</surname><given-name>Yoshihiro</given-name><initials>Y.</initials><afid>60021120</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56405911900</author-url><authid>56405911900</authid><authname>Sakamoto K.</authname><surname>Sakamoto</surname><given-name>Kenji</given-name><initials>K.</initials><afid>60021120</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:7006582087</author-url><authid>7006582087</authid><authname>Tsujita K.</authname><surname>Tsujita</surname><given-name>Kenichi</given-name><initials>K.</initials><afid>60021120</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:34973064500</author-url><authid>34973064500</authid><authname>Kojima S.</authname><surname>Kojima</surname><given-name>Sunao</given-name><initials>S.</initials><afid>60021120</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:56640622800</author-url><authid>56640622800</authid><authname>Nishiyama K.</authname><surname>Nishiyama</surname><given-name>Koichi</given-name><initials>K.</initials><afid>60021120</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:6603691533</author-url><authid>6603691533</authid><authname>Kaikita K.</authname><surname>Kaikita</surname><given-name>Koichi</given-name><initials>K.</initials><afid>60021120</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:6603712750</author-url><authid>6603712750</authid><authname>Hokimoto S.</authname><surname>Hokimoto</surname><given-name>Seiji</given-name><initials>S.</initials><afid>60021120</afid></author><author seq="11"><author-url>http://api.elsevier.com/content/author/author_id:8386100100</author-url><authid>8386100100</authid><authname>Jinnouchi H.</authname><surname>Jinnouchi</surname><given-name>Hideaki</given-name><initials>H.</initials><afid>60021120</afid></author><author seq="12"><author-url>http://api.elsevier.com/content/author/author_id:56559155300</author-url><authid>56559155300</authid><authname>Ogawa H.</authname><surname>Ogawa</surname><given-name>Hisao</given-name><initials>H.</initials><afid>60021120</afid></author><authkeywords>Central blood pressure | Non-invasive measurement | Oscillometric measurement</authkeywords><intid>535919704</intid><source-id>23774</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929161898"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929161898?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929161898&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929161898&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0167527315007780"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929161898</prism:url><dc:identifier>SCOPUS_ID:84929161898</dc:identifier><eid>2-s2.0-84929161898</eid><dc:title>Multiple arterial grafting confers survival advantage compared to percutaneous intervention with drug-eluting stents in multivessel coronary artery disease: A propensity score adjusted analysis</dc:title><dc:creator>Raja S.</dc:creator><prism:publicationName>International Journal of Cardiology</prism:publicationName><prism:issn>01675273</prism:issn><prism:eIssn>18741754</prism:eIssn><prism:volume>189</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>153-158</prism:pageRange><prism:coverDate>2015-06-15</prism:coverDate><prism:coverDisplayDate>15 June 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijcard.2015.04.059</prism:doi><dc:description>© 2015 Elsevier Ireland Ltd. All rights reserved. Background: The best revascularisation strategy for multivessel coronary artery disease (MVD) is still controversial. Percutaneous coronary intervention (PCI) utilising drug eluting stents (DES) has emerged as an acceptable alternative to conventional coronary artery bypass grafting (CABG) in the last decade. However, multiple arterial grafting (MAG) is superior revascularisation strategy compared with conventional CABG utilising single internal mammary artery and currently there isapaucity of comparison of DES and MAG. We aimed to investigate whether MAG offers advantage over DES-PCI in MVD. Methods: A total of 6126 patients with MVD (≥2 vessel) underwent CABG (n= 4652) or PCI(n= 1474) at a single institution. MAG was performed in 1372 CABG cases and DES were implanted in 1222 PCI cases. Propensity score adjusted analysis was performed to investigate the potential survival advantage of MAG over PCI. Mean follow-up was 4.9 years. Results: Risk for late death was comparable after DES-PCI and conventional CABG (HR 1.11; 95%CI 0.9 to 1.33; P = 0.25). However, DES-PCI was associated with an increased risk for late death compared to MAG (HR 1.53; 95%CI 1.08 to 2.91; P = 0.02). DES-PCI was also associated with a 3.51 fold increased risk for repeat revascularisation over MAG (95%CI 2.60 to 4.75; P &lt; 0.0001) and 2.66 fold increased risk for repeat revascularisation over conventional CABG (95%CI 2.11 to 3.36; P &lt; 0.0001). Conclusions: MAG improved late survival and offered superior freedom from repeat revascularisation compared to DES-PCI. When feasible, MAG should be strongly recommended in patients with MVD.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60024930</affiliation-url><afid>60024930</afid><affilname>Harefield Hospital</affilname><name-variant>Harefield Hospital</name-variant><affiliation-city>Harefield</affiliation-city><affiliation-country>United Kingdom</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60024930</affiliation-url><afid>60024930</afid><affilname>Harefield Hospital</affilname><name-variant>Harefield Hospital</name-variant><affiliation-city>Harefield</affiliation-city><affiliation-country>United Kingdom</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">4</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:7103346878</author-url><authid>7103346878</authid><authname>Raja S.</authname><surname>Raja</surname><given-name>Shahzad G.</given-name><initials>S.G.</initials><afid>60024930</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:13906087500</author-url><authid>13906087500</authid><authname>Benedetto U.</authname><surname>Benedetto</surname><given-name>Umberto</given-name><initials>U.</initials><afid>60024930</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:7003725175</author-url><authid>7003725175</authid><authname>Ilsley C.</authname><surname>Ilsley</surname><given-name>Charles D.</given-name><initials>C.D.</initials><afid>60024930</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:55540092100</author-url><authid>55540092100</authid><authname>Amrani M.</authname><surname>Amrani</surname><given-name>Mohamed</given-name><initials>M.</initials><afid>60024930</afid></author><authkeywords>Arterial grafting | Bare metal stents | Coronary artery bypass grafting | Coronary artery disease | Drug-eluting stents</authkeywords><intid>535917561</intid><source-id>23774</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929162833"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929162833?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929162833&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929162833&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S016752731500755X"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929162833</prism:url><dc:identifier>SCOPUS_ID:84929162833</dc:identifier><eid>2-s2.0-84929162833</eid><dc:title>Statins, atherosclerosis regression and HDL: Insights from within the plaque</dc:title><dc:creator>Feig J.</dc:creator><prism:publicationName>International Journal of Cardiology</prism:publicationName><prism:issn>01675273</prism:issn><prism:eIssn>18741754</prism:eIssn><prism:volume>189</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>168-171</prism:pageRange><prism:coverDate>2015-06-15</prism:coverDate><prism:coverDisplayDate>15 June 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijcard.2015.04.036</prism:doi><dc:description>© 2015 Elsevier Ireland Ltd. All rights reserved. The idea that atheroma can regress isno longer a dream. We and others have discovered that decreasing the lipid content can directly lead to macrophage egress and plaque healing. The question, however, has remained as to how to translate these findings to the bedside. Taking advantage of imaging modalities such as intravascular ultrasound (IVUS) and near infrared spectroscopy (NIRS), we demonstrated in the YELLOW (Reduction in Yellow Plaque by Intensive Lipid Lowering Therapy) trial that short term treatment of high dose rosuvastatin treatment can lead to a decrease in lipid content in plaques. It is important to note that optical coherence tomography (OCT), a high resolution imaging modality, was not performed during the first study and therefore, only a very limited assessment of the effect of statin therapy on measures of plaque stabilization could be made. The YELLOW II trial is the first to our knowledge to determine whether these data can be extrapolated and how it relates to HDL function, alterations in macrophage gene expression, and plaque morphology. While tremendous progress has been made, our research serves as a reminder that angiography is simply luminography and it is features such as thin cap fibroatheroma and lipid burden, for example, that likely modulate the syndromes seen in clinical practice. Ongoing studies such as ours may provide novel pathways for diagnosis and therapy, with the ultimate goal of reducing the burden of cardiovascular disease.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60004670</affiliation-url><afid>60004670</afid><affilname>The Mount Sinai Hospital</affilname><name-variant>The Mount Sinai Hospital</name-variant><affiliation-city>New York</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60024541</affiliation-url><afid>60024541</afid><affilname>New York University School of Medicine</affilname><name-variant>New York Univ. School of Medicine</name-variant><affiliation-city>New York</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>re</subtype><subtypeDescription>Review</subtypeDescription><author-count limit="100">3</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:6603208999</author-url><authid>6603208999</authid><authname>Feig J.</authname><surname>Feig</surname><given-name>Jonathan E.</given-name><initials>J.E.</initials><afid>60004670</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:55362756300</author-url><authid>55362756300</authid><authname>Feig J.</authname><surname>Feig</surname><given-name>Jessica L.</given-name><initials>J.L.</initials><afid>60024541</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:7005623021</author-url><authid>7005623021</authid><authname>Kini A.</authname><surname>Kini</surname><given-name>Annapoorna S.</given-name><initials>A.S.</initials><afid>60004670</afid></author><authkeywords>Atherosclerosis | HDL | Near infrared spectroscopy | Optical coherence tomography | Regression</authkeywords><intid>535918686</intid><source-id>23774</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929165306"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929165306?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929165306&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929165306&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0167527315007767"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929165306</prism:url><dc:identifier>SCOPUS_ID:84929165306</dc:identifier><eid>2-s2.0-84929165306</eid><dc:title>Intra-ventricular rebound flow and systolic anterior motion of the mitral valve with left ventricular outflow tract obstruction in elderly, hypertensive women</dc:title><dc:creator>Yoneyama K.</dc:creator><prism:publicationName>International Journal of Cardiology</prism:publicationName><prism:issn>01675273</prism:issn><prism:eIssn>18741754</prism:eIssn><prism:volume>189</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>164-167</prism:pageRange><prism:coverDate>2015-06-15</prism:coverDate><prism:coverDisplayDate>15 June 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijcard.2015.04.057</prism:doi><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60012275</affiliation-url><afid>60012275</afid><affilname>St. Marianna University School of Medicine</affilname><name-variant>St. Marianna University School of Medicine</name-variant><affiliation-city>Kawasaki</affiliation-city><affiliation-country>Japan</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60012275</affiliation-url><afid>60012275</afid><affilname>St. Marianna University School of Medicine</affilname><name-variant>St. Marianna University School of Medicine</name-variant><affiliation-city>Kawasaki</affiliation-city><affiliation-country>Japan</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60005248</affiliation-url><afid>60005248</afid><affilname>Johns Hopkins University</affilname><name-variant>Johns Hopkins University</name-variant><affiliation-city>Baltimore</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>le</subtype><subtypeDescription>Letter</subtypeDescription><author-count limit="100">11</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:15066358700</author-url><authid>15066358700</authid><authname>Yoneyama K.</authname><surname>Yoneyama</surname><given-name>Kihei</given-name><initials>K.</initials><afid>60012275</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56203108200</author-url><authid>56203108200</authid><authname>Suzuki K.</authname><surname>Suzuki</surname><given-name>Kengo</given-name><initials>K.</initials><afid>60012275</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:15065428100</author-url><authid>15065428100</authid><authname>Izumo M.</authname><surname>Izumo</surname><given-name>Masaki</given-name><initials>M.</initials><afid>60012275</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56401365700</author-url><authid>56401365700</authid><authname>Kobayashi Y.</authname><surname>Kobayashi</surname><given-name>Yasuyuki</given-name><initials>Y.</initials><afid>60012275</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56640883400</author-url><authid>56640883400</authid><authname>Tateishi K.</authname><surname>Tateishi</surname><given-name>Kiyoko</given-name><initials>K.</initials><afid>60012275</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:56401870700</author-url><authid>56401870700</authid><authname>Umano S.</authname><surname>Umano</surname><given-name>Seiji</given-name><initials>S.</initials><afid>60012275</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:7102429544</author-url><authid>7102429544</authid><authname>Kida K.</authname><surname>Kida</surname><given-name>Keisuke</given-name><initials>K.</initials><afid>60012275</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:6603437115</author-url><authid>6603437115</authid><authname>Kongoji K.</authname><surname>Kongoji</surname><given-name>Ken</given-name><initials>K.</initials><afid>60012275</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:56463388000</author-url><authid>56463388000</authid><authname>Harada T.</authname><surname>Harada</surname><given-name>Tomoo</given-name><initials>T.</initials><afid>60012275</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:7202778154</author-url><authid>7202778154</authid><authname>Lima J.</authname><surname>Lima</surname><given-name>Joao A C</given-name><initials>J.A.C.</initials><afid>60005248</afid></author><author seq="11"><author-url>http://api.elsevier.com/content/author/author_id:7005089745</author-url><authid>7005089745</authid><authname>Akashi Y.</authname><surname>Akashi</surname><given-name>Yoshihiro J.</given-name><initials>Y.J.</initials><afid>60012275</afid></author><authkeywords>Blood flow | Four-dimensional computed tomography | Heart failure | Hypertrophy | Magnetic resonance imaging</authkeywords><intid>35916590</intid><source-id>23774</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929173301"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929173301?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929173301&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929173301&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0167527315007731"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929173301</prism:url><dc:identifier>SCOPUS_ID:84929173301</dc:identifier><eid>2-s2.0-84929173301</eid><dc:title>An attempt of "new wavelet" analysis on electrocardiogram in locating the site of atrioventricular block</dc:title><dc:creator>Liu R.</dc:creator><prism:publicationName>International Journal of Cardiology</prism:publicationName><prism:issn>01675273</prism:issn><prism:eIssn>18741754</prism:eIssn><prism:volume>189</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>228-230</prism:pageRange><prism:coverDate>2015-06-15</prism:coverDate><prism:coverDisplayDate>15 June 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijcard.2015.04.054</prism:doi><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60084618</affiliation-url><afid>60084618</afid><affilname>Liaoning Medical University</affilname><name-variant>Liaoning Medical College</name-variant><affiliation-city>Jinzhou</affiliation-city><affiliation-country>China</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>le</subtype><subtypeDescription>Letter</subtypeDescription><author-count limit="100">2</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:16507242600</author-url><authid>16507242600</authid><authname>Liu R.</authname><surname>Liu</surname><given-name>Renguang</given-name><initials>R.</initials><afid>60084618</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:55463316100</author-url><authid>55463316100</authid><authname>Chang Q.</authname><surname>Chang</surname><given-name>Qinghua</given-name><initials>Q.</initials><afid>60084618</afid></author><authkeywords>Electrocardiogram | P-QRS-T wave | Right bundle branch block | Specialized conduction system potential | Wavelet</authkeywords><intid>1535916896</intid><source-id>23774</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929191468"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929191468?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929191468&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929191468&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0167527315007184"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929191468</prism:url><dc:identifier>SCOPUS_ID:84929191468</dc:identifier><eid>2-s2.0-84929191468</eid><dc:title>Lack of efficacy of resveratrol on C-reactive protein and selected cardiovascular risk factors - Results from a systematic review and meta-analysis of randomized controlled trials</dc:title><dc:creator>Sahebkar A.</dc:creator><prism:publicationName>International Journal of Cardiology</prism:publicationName><prism:issn>01675273</prism:issn><prism:eIssn>18741754</prism:eIssn><prism:volume>189</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>47-55</prism:pageRange><prism:coverDate>2015-06-15</prism:coverDate><prism:coverDisplayDate>15 June 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijcard.2015.04.008</prism:doi><dc:description>© 2015 Elsevier Ireland Ltd. All rights reserved. Introduction: Numerous studies have suggested that oral supplementation with resveratrol exerts cardioprotective effects, but evidence of the effects on C-reactive protein (CRP) plasma levels and other cardiovascular (CV) risk factors is inconclusive. Therefore, we performed a meta-analysis to evaluate the efficacy of resveratrol supplementation on plasma CRP concentrations and selected predictors of CV risk. Methods: The search included PUBMED, Cochrane Library, Web of Science, Scopus, and EMBASE (up to August 31, 2014) to identify RCTs investigating the effects of resveratrol supplementation on selected CV risk factors. Quantitative data synthesis was performed using a random-effects model, with weighted mean difference (WMD) and 95% confidence intervals (CI) as summary statistics. Results: Meta-analysis of data from 10 RCTs (11 treatment arms) did not support a significant effect of resveratrol supplementation in altering plasma CRP concentrations (WMD: -0.144 mg/L, 95% CI: -0.968-0.680, p = 0.731). Resveratrol supplementation was not found to alter plasma levels of total cholesterol (WMD: 1.49 mg/dL, 95% CI: - 14.96-17.93, p = 0.859), low density lipoprotein cholesterol (WMD: -0.31 mg/dL, 95% CI: - 9.57-8.95, p = 0.948), triglycerides (WMD: 2.67 mg/dL, 95% CI: - 28.34-33.67, p = 0.866), and glucose (WMD: 1.28 mg/dL, 95% CI: - 5.28-7.84, p = 0.703). It also slightly reduced high density lipoprotein cholesterol concentrations (WMD: -4.18 mg/dL, 95% CI: -6.54 to -1.82, p = 0.001). Likewise, no significant effect was observed on systolic (WMD: 0.82 mm Hg, 95% CI: -8.86-10.50, p = 0.868) and diastolic blood pressure (WMD: 1.72 mm Hg, 95% CI: - 6.29-9.73, p = 0.674). Conclusions: This meta-analysis of available RCTs does not suggest any benefit of resveratrol supplementation on CV risk factors. Larger, well-designed trials are necessary to confirm these results.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60001500</affiliation-url><afid>60001500</afid><affilname>Mashhad University of Medical Sciences</affilname><name-variant>Mashhad University of Medical Sciences</name-variant><affiliation-city>Mashad</affiliation-city><affiliation-country>Iran</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60030929</affiliation-url><afid>60030929</afid><affilname>Royal Perth Hospital</affilname><name-variant>Royal Perth Hospital</name-variant><affiliation-city>Shenton Park</affiliation-city><affiliation-country>Australia</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60016452</affiliation-url><afid>60016452</afid><affilname>Universitatea de Medicina si Farmacie Victor Babes din Timisoara</affilname><name-variant>Victor Babes University of Medicine and Pharmacy</name-variant><affiliation-city>Timisoara</affiliation-city><affiliation-country>Romania</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60016452</affiliation-url><afid>60016452</afid><affilname>Universitatea de Medicina si Farmacie Victor Babes din Timisoara</affilname><name-variant>Victor Babes University of Medicine and Pharmacy</name-variant><affiliation-city>Timisoara</affiliation-city><affiliation-country>Romania</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60005247</affiliation-url><afid>60005247</afid><affilname>David Geffen School of Medicine at UCLA</affilname><name-variant>University of California</name-variant><affiliation-city>Los Angeles</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60027086</affiliation-url><afid>60027086</afid><affilname>University of Alabama at Birmingham</affilname><name-variant>University of Alabama at Birmingham</name-variant><affiliation-city>Birmingham</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60032114</affiliation-url><afid>60032114</afid><affilname>Erasmus University Medical Center</affilname><name-variant>Erasmus Medical Center</name-variant><affiliation-city>Rotterdam</affiliation-city><affiliation-country>Netherlands</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60022148</affiliation-url><afid>60022148</afid><affilname>UCL</affilname><name-variant>University College</name-variant><affiliation-city>London</affiliation-city><affiliation-country>United Kingdom</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60017697</affiliation-url><afid>60017697</afid><affilname>Universita degli Studi di Palermo</affilname><name-variant>Università di Palermo</name-variant><affiliation-city>Palermo</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60006651</affiliation-url><afid>60006651</afid><affilname>Uniwersytet Medyczny w Lodzi</affilname><name-variant>Medical University of Lodz</name-variant><affiliation-city>Lodz</affiliation-city><affiliation-country>Poland</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60000928</affiliation-url><afid>60000928</afid><affilname>Emory University</affilname><name-variant>Emory University</name-variant><affiliation-city>Atlanta</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60019702</affiliation-url><afid>60019702</afid><affilname>University of Birmingham</affilname><name-variant>University of Birmingham</name-variant><affiliation-city>Birmingham</affiliation-city><affiliation-country>United Kingdom</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60006651</affiliation-url><afid>60006651</afid><affilname>Uniwersytet Medyczny w Lodzi</affilname><name-variant>Medical University of Lodz</name-variant><affiliation-city>Lodz</affiliation-city><affiliation-country>Poland</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">13</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:26639699900</author-url><authid>26639699900</authid><authname>Sahebkar A.</authname><surname>Sahebkar</surname><given-name>Amirhossein</given-name><initials>A.</initials><afid>60001500</afid><afid>60030929</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:26639699900</author-url><authid>26639699900</authid><authname>Sahebkar A.</authname><surname>Sahebkar</surname><given-name>Amirhossein</given-name><initials>A.</initials><afid>60001500</afid><afid>60030929</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:35146822100</author-url><authid>35146822100</authid><authname>Serban C.</authname><surname>Serban</surname><given-name>Corina</given-name><initials>C.</initials><afid>60016452</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:26435634900</author-url><authid>26435634900</authid><authname>Ursoniu S.</authname><surname>Ursoniu</surname><given-name>Sorin</given-name><initials>S.</initials><afid>60016452</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56555940700</author-url><authid>56555940700</authid><authname>Wong N.</authname><surname>Wong</surname><given-name>Nathan D.</given-name><initials>N.D.</initials><afid>60005247</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56637209600</author-url><authid>56637209600</authid><authname>Muntner P.</authname><surname>Muntner</surname><given-name>Paul</given-name><initials>P.</initials><afid>60027086</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:56640713100</author-url><authid>56640713100</authid><authname>Graham I.</authname><surname>Graham</surname><given-name>Ian M.</given-name><initials>I.M.</initials><afid>60032114</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:36042757800</author-url><authid>36042757800</authid><authname>Mikhailidis D.</authname><surname>Mikhailidis</surname><given-name>Dimitri P.</given-name><initials>D.P.</initials><afid>60022148</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:7202023733</author-url><authid>7202023733</authid><authname>Rizzo M.</authname><surname>Rizzo</surname><given-name>Manfredi</given-name><initials>M.</initials><afid>60017697</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:7004232269</author-url><authid>7004232269</authid><authname>Rysz J.</authname><surname>Rysz</surname><given-name>Jacek</given-name><initials>J.</initials><afid>60006651</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:56640849300</author-url><authid>56640849300</authid><authname>Sperling L.</authname><surname>Sperling</surname><given-name>Laurence S.</given-name><initials>L.S.</initials><afid>60000928</afid></author><author seq="11"><author-url>http://api.elsevier.com/content/author/author_id:56601772800</author-url><authid>56601772800</authid><authname>Lip G.</authname><surname>Lip</surname><given-name>Gregory Y H</given-name><initials>G.Y.H.</initials><afid>60019702</afid></author><author seq="12"><author-url>http://api.elsevier.com/content/author/author_id:22936699500</author-url><authid>22936699500</authid><authname>Banach M.</authname><surname>Banach</surname><given-name>Maciej</given-name><initials>M.</initials><afid>60006651</afid></author><authkeywords>Antioxidants | C reactive protein | CRP | Inflammation | Resveratrol</authkeywords><intid>1535917418</intid><source-id>23774</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929155473"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929155473?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929155473&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929155473&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0167527315007305"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929155473</prism:url><dc:identifier>SCOPUS_ID:84929155473</dc:identifier><eid>2-s2.0-84929155473</eid><dc:title>Brachial-ankle pulse wave velocity is associated with coronary calcification among 1131 healthy middle-aged men</dc:title><dc:creator>Vishnu A.</dc:creator><prism:publicationName>International Journal of Cardiology</prism:publicationName><prism:issn>01675273</prism:issn><prism:eIssn>18741754</prism:eIssn><prism:volume>189</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>67-72</prism:pageRange><prism:coverDate>2015-06-15</prism:coverDate><prism:coverDisplayDate>15 June 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijcard.2015.04.020</prism:doi><dc:description>© 2015 Elsevier Ireland Ltd. All rights reserved. Background: Brachial-ankle pulse wave velocity (baPWV) is a simple and reproducible measure of arterial stiffness and is extensively used to assess cardiovascular disease (CVD) risk in eastern Asia. We examined whether baPWV is associated with coronary atherosclerosis in an international study of healthy middle-aged men. Methods: A population-based sample of1131 men aged 40-49 years was recruited - 257 Whites and 75 Blacks in Pittsburgh, US, 228 Japanese-Americans in Honolulu, US, 292 Japanese in Otsu, Japan, and 279 Koreans in Ansan, Korea. baPWV was measured with an automated waveform analyzer (VP2000, Omron) and atherosclerosis was examined as coronary artery calcification (CAC) by computed-tomography (GE-Imatron EBT scanner). Association of the presence of CAC (defined as ≥10 Agatston unit) was examined with continuous measure as well as with increasing quartiles of baPWV. Results: As compared to the lowest quartile of baPWV, the multivariable-adjusted odds ratio (95% Confidence Interval [CI]) for the presence of CAC in the combined sample was 1.70 (0.98, 2.94) for 2nd quartile, 1.88 (1.08, 3.28) for 3rd quartile, and 2.16 (1.19, 3.94) for 4th quartile (p-trend = 0.01). The odds for CAC increased by 19% per 100 cm/s increase (p &lt; 0.01), or by 36% per standard-deviation increase (p &lt; 0.01) in baPWV. Similar effect-sizes were observed in individual races, and were significant among Whites, Blacks and Koreans. Conclusion: baPWV is cross-sectionally associated with CAC among healthy middle-aged men. The association was significant in Whites and Blacksin the US, and among Koreans. Longitudinal studies are needed to determine its CVD predictive ability.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60003742</affiliation-url><afid>60003742</afid><affilname>University of Pittsburgh Graduate School of Public Health</affilname><name-variant>University of Pittsburgh</name-variant><affiliation-city>Pittsburgh</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60005273</affiliation-url><afid>60005273</afid><affilname>Korea University</affilname><name-variant>Korea University</name-variant><affiliation-city>Seoul</affiliation-city><affiliation-country>South Korea</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60013791</affiliation-url><afid>60013791</afid><affilname>University of Hawaii at Manoa</affilname><name-variant>University of Hawaii at Manoa</name-variant><affiliation-city>Honolulu</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60007524</affiliation-url><afid>60007524</afid><affilname>Shiga University of Medical Science</affilname><name-variant>Shiga University of Medical Science</name-variant><affiliation-city>Otsu</affiliation-city><affiliation-country>Japan</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60007524</affiliation-url><afid>60007524</afid><affilname>Shiga University of Medical Science</affilname><name-variant>Shiga University of Medical Science</name-variant><affiliation-city>Otsu</affiliation-city><affiliation-country>Japan</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60002882</affiliation-url><afid>60002882</afid><affilname>Osaka Kyoiku University</affilname><name-variant>Osaka Kyoiku University</name-variant><affiliation-city>Kishiwada</affiliation-city><affiliation-country>Japan</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60030398</affiliation-url><afid>60030398</afid><affilname>Temple University</affilname><name-variant>Temple University</name-variant><affiliation-city>Philadelphia</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60094642</affiliation-url><afid>60094642</afid><affilname>Korea University Medical Center</affilname><name-variant>Korea University Guro Hospital</name-variant><affiliation-city>Seoul</affiliation-city><affiliation-country>South Korea</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">18</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:36515938100</author-url><authid>36515938100</authid><authname>Vishnu A.</authname><surname>Vishnu</surname><given-name>Abhishek</given-name><initials>A.</initials><afid>60003742</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56640852700</author-url><authid>56640852700</authid><authname>Choo J.</authname><surname>Choo</surname><given-name>Jina</given-name><initials>J.</initials><afid>60005273</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56640831700</author-url><authid>56640831700</authid><authname>Wilcox B.</authname><surname>Wilcox</surname><given-name>Bradley</given-name><initials>B.</initials><afid>60013791</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:55390143800</author-url><authid>55390143800</authid><authname>Hisamatsu T.</authname><surname>Hisamatsu</surname><given-name>Takashi</given-name><initials>T.</initials><afid>60007524</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:6603318812</author-url><authid>6603318812</authid><authname>Barinas-Mitchell E.</authname><surname>Barinas-Mitchell</surname><given-name>Emma J M</given-name><initials>E.J.M.</initials><afid>60003742</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:36862618800</author-url><authid>36862618800</authid><authname>Fujiyoshi A.</authname><surname>Fujiyoshi</surname><given-name>Akira</given-name><initials>A.</initials><afid>60007524</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:7005035067</author-url><authid>7005035067</authid><authname>Mackey R.</authname><surname>Mackey</surname><given-name>Rachel H.</given-name><initials>R.H.</initials><afid>60003742</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:56641037800</author-url><authid>56641037800</authid><authname>Kadota A.</authname><surname>Kadota</surname><given-name>Aya</given-name><initials>A.</initials><afid>60002882</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:56478519200</author-url><authid>56478519200</authid><authname>Ahuja V.</authname><surname>Ahuja</surname><given-name>Vasudha</given-name><initials>V.</initials><afid>60003742</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:55826859200</author-url><authid>55826859200</authid><authname>Kadowaki T.</authname><surname>Kadowaki</surname><given-name>Takashi</given-name><initials>T.</initials><afid>60007524</afid></author><author seq="11"><author-url>http://api.elsevier.com/content/author/author_id:6603014463</author-url><authid>6603014463</authid><authname>Edmundowicz D.</authname><surname>Edmundowicz</surname><given-name>Daniel</given-name><initials>D.</initials><afid>60030398</afid></author><author seq="12"><author-url>http://api.elsevier.com/content/author/author_id:34974534000</author-url><authid>34974534000</authid><authname>Miura K.</authname><surname>Miura</surname><given-name>Katsuyuki</given-name><initials>K.</initials><afid>60007524</afid></author><author seq="13"><author-url>http://api.elsevier.com/content/author/author_id:56640686700</author-url><authid>56640686700</authid><authname>Rodriguez B.</authname><surname>Rodriguez</surname><given-name>Beatriz L.</given-name><initials>B.L.</initials><afid>60013791</afid></author><author seq="14"><author-url>http://api.elsevier.com/content/author/author_id:56385078600</author-url><authid>56385078600</authid><authname>Kuller L.</authname><surname>Kuller</surname><given-name>Lewis H.</given-name><initials>L.H.</initials><afid>60003742</afid></author><author seq="15"><author-url>http://api.elsevier.com/content/author/author_id:7202571570</author-url><authid>7202571570</authid><authname>Shin C.</authname><surname>Shin</surname><given-name>Chol</given-name><initials>C.</initials><afid>60094642</afid></author><author seq="16"><author-url>http://api.elsevier.com/content/author/author_id:56385177300</author-url><authid>56385177300</authid><authname>Masaki K.</authname><surname>Masaki</surname><given-name>Kamal</given-name><initials>K.</initials><afid>60013791</afid></author><author seq="17"><author-url>http://api.elsevier.com/content/author/author_id:7005129002</author-url><authid>7005129002</authid><authname>Ueshima H.</authname><surname>Ueshima</surname><given-name>Hirotsugu</given-name><initials>H.</initials><afid>60007524</afid></author><author seq="18"><author-url>http://api.elsevier.com/content/author/author_id:7006522125</author-url><authid>7006522125</authid><authname>Sekikawa A.</authname><surname>Sekikawa</surname><given-name>Akira</given-name><initials>A.</initials><afid>60003742</afid></author><authkeywords>Arteriosclerosis | Atherosclerosis | Pulse wave analysis | Vascular calcification | Vascular stiffness</authkeywords><intid>35917028</intid><source-id>23774</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929152971"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929152971?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929152971&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929152971&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0167527315007275"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929152971</prism:url><dc:identifier>SCOPUS_ID:84929152971</dc:identifier><eid>2-s2.0-84929152971</eid><dc:title>Comorbidity and intervention in octogenarians with severe symptomatic aortic stenosis</dc:title><dc:creator>Martínez-Sellés M.</dc:creator><prism:publicationName>International Journal of Cardiology</prism:publicationName><prism:issn>01675273</prism:issn><prism:eIssn>18741754</prism:eIssn><prism:volume>189</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>61-66</prism:pageRange><prism:coverDate>2015-06-15</prism:coverDate><prism:coverDisplayDate>15 June 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijcard.2015.04.017</prism:doi><dc:description>© 2015 Elsevier Ireland Ltd. All rights reserved. Background: The benefit from intervention in elderly patients with symptomatic severe aortic stenosis (AS) and high comorbidity is unknown. Our aims were to establish the correlation between the Charlson comorbidity index and the prognosis of octogenarians with symptomatic sever AS and to identify patients who might not benefit from intervention. Methods: We used the data from PEGASO (Pronóstico de la Estenosis Grave Aórtica Sintomática del Octogenario - Prognosis of symptomatic severe aortic stenosis in octogenarians), a prospective registry that included consecutively 928 patients aged ≥80 years with severe symptomatic AS. Results: The mean Charlson comorbidity index was 3.0 ± 1.7, a total of 151 patients (16.3%) presented high comorbidity (index ≥ 5). Median survival was lower for patients with high comorbidity than for those without (16.7 ± 1.2 vs. 26.5± 0.6 months, p &lt; 0.001). In patients without high comorbidity planned interventional management was clearly associated with prognosis (log rank p &lt; 0.001), which was not the casein patients with high comorbidity (log rank p &gt; 0.10). In multivariate analysis, the only variables that were independently associated with prognosis were planned medical management and Charlson index. Patients with high comorbidity presented non-cardiac death more frequently than those who had not (28.6% vs. 19.5%, p = 0.008). Conclusions: One sixth of octogenarians with symptomatic severe AS have very high comorbidity (Charlson index ≥ 5). These patients have a poor prognosis in the short term and do not seem to benefit from interventional treatment.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60033237</affiliation-url><afid>60033237</afid><affilname>Hospital General Universitario Gregorio Maranon</affilname><name-variant>Hospital General Universitario Gregorio Marañón</name-variant><affiliation-city>Madrid</affiliation-city><affiliation-country>Spain</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60027282</affiliation-url><afid>60027282</afid><affilname>Universidad Complutense de Madrid</affilname><name-variant>Universidad Complutense</name-variant><affiliation-city>Madrid</affiliation-city><affiliation-country>Spain</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60016862</affiliation-url><afid>60016862</afid><affilname>Hospital Universitario Central de Asturias</affilname><name-variant>Hospital Central de Asturias</name-variant><affiliation-city>Oviedo</affiliation-city><affiliation-country>Spain</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60000252</affiliation-url><afid>60000252</afid><affilname>Hospital Universitari Virgen de la Victoria</affilname><name-variant>Hospital Clínico Universitario Virgen de la Victoria</name-variant><affiliation-city>Malaga</affiliation-city><affiliation-country>Spain</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60073793</affiliation-url><afid>60073793</afid><affilname>Fundacion Hospital Manacor</affilname><name-variant>Fundación Hospital Manacor</name-variant><affiliation-city>Palma</affiliation-city><affiliation-country>Spain</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:106208603</affiliation-url><afid>106208603</afid><affilname>Hospital del Sureste</affilname><name-variant>Hospital Del Sureste</name-variant><affiliation-city>Arganda del Rey</affiliation-city><affiliation-country>Spain</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60012486</affiliation-url><afid>60012486</afid><affilname>Hospital Universitari Vall d'Hebron</affilname><name-variant>Hospital Vall d'Hebron</name-variant><affiliation-city>Barcelona</affiliation-city><affiliation-country>Spain</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60020340</affiliation-url><afid>60020340</afid><affilname>Hospital Universitario de Valladolid</affilname><name-variant>Hospital Universitario</name-variant><affiliation-city>Valladolid</affiliation-city><affiliation-country>Spain</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60068628</affiliation-url><afid>60068628</afid><affilname>Hospital Son Llatzer</affilname><name-variant>Hospital Son Llàtzer</name-variant><affiliation-city>Palma</affiliation-city><affiliation-country>Spain</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60031313</affiliation-url><afid>60031313</afid><affilname>Hospital Universitario San Juan</affilname><name-variant>Hospital Universitario de San Juan</name-variant><affiliation-city>Alicante</affiliation-city><affiliation-country>Spain</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60028352</affiliation-url><afid>60028352</afid><affilname>Hospital Universitario de Salamanca</affilname><name-variant>Hospital Universitario</name-variant><affiliation-city>Salamanca</affiliation-city><affiliation-country>Spain</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:113908557</affiliation-url><afid>113908557</afid><affilname>Sección de Geriatría</affilname><name-variant>Servicio de Geriatría</name-variant><affiliation-city>Pontevedra</affiliation-city><affiliation-country>Spain</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60030315</affiliation-url><afid>60030315</afid><affilname>Hospital Clinic Barcelona</affilname><name-variant>Hospital Clinic</name-variant><affiliation-city>Barcelona</affiliation-city><affiliation-country>Spain</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60009466</affiliation-url><afid>60009466</afid><affilname>Hospital de La Santa Creu I Sant Pau</affilname><name-variant>Hospital de la Santa Creu I Sant Pau</name-variant><affiliation-city>Barcelona</affiliation-city><affiliation-country>Spain</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">18</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:6603950545</author-url><authid>6603950545</authid><authname>Martínez-Sellés M.</authname><surname>Martínez-Sellés</surname><given-name>Manuel</given-name><initials>M.</initials><afid>60033237</afid><afid>60027282</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:6603950545</author-url><authid>6603950545</authid><authname>Martínez-Sellés M.</authname><surname>Martínez-Sellés</surname><given-name>Manuel</given-name><initials>M.</initials><afid>60033237</afid><afid>60027282</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:54410397500</author-url><authid>54410397500</authid><authname>Díez-Villanueva P.</authname><surname>Díez-Villanueva</surname><given-name>Pablo</given-name><initials>P.</initials><afid>60033237</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:54411248500</author-url><authid>54411248500</authid><authname>Sánchez-Sendin D.</authname><surname>Sánchez-Sendin</surname><given-name>Domingo</given-name><initials>D.</initials><afid>60033237</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:36168243300</author-url><authid>36168243300</authid><authname>Hevia A.</authname><surname>Hevia</surname><given-name>Amelia Carro</given-name><initials>A.C.</initials><afid>60016862</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:55394346300</author-url><authid>55394346300</authid><authname>Doblas J.</authname><surname>Doblas</surname><given-name>Juan José Gómez</given-name><initials>J.J.G.</initials><afid>60000252</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:35785642000</author-url><authid>35785642000</authid><authname>De La Villa B.</authname><surname>De La Villa</surname><given-name>Bernardo García</given-name><initials>B.G.</initials><afid>60073793</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:56078972700</author-url><authid>56078972700</authid><authname>Cornide L.</authname><surname>Cornide</surname><given-name>Luis</given-name><initials>L.</initials><afid>106208603</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:56641063600</author-url><authid>56641063600</authid><authname>Tello A.</authname><surname>Tello</surname><given-name>Albert Alonso</given-name><initials>A.A.</initials><afid>60012486</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:56641473700</author-url><authid>56641473700</authid><authname>Ogando R.</authname><surname>Ogando</surname><given-name>Ramón Andión</given-name><initials>R.A.</initials><afid>60020340</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:6603347816</author-url><authid>6603347816</authid><authname>Vera T.</authname><surname>Vera</surname><given-name>Tomás Ripoll</given-name><initials>T.R.</initials><afid>60068628</afid></author><author seq="11"><author-url>http://api.elsevier.com/content/author/author_id:56640584400</author-url><authid>56640584400</authid><authname>Jiménez A.</authname><surname>Jiménez</surname><given-name>Antonio Arribas</given-name><initials>A.A.</initials><afid>60028352</afid></author><author seq="12"><author-url>http://api.elsevier.com/content/author/author_id:7005290774</author-url><authid>7005290774</authid><authname>Carrillo P.</authname><surname>Carrillo</surname><given-name>Pilar</given-name><initials>P.</initials><afid>60031313</afid></author><author seq="13"><author-url>http://api.elsevier.com/content/author/author_id:56640865800</author-url><authid>56640865800</authid><authname>Pascual C.</authname><surname>Pascual</surname><given-name>Carlos Rodríguez</given-name><initials>C.R.</initials><afid>113908557</afid></author><author seq="14"><author-url>http://api.elsevier.com/content/author/author_id:56641756700</author-url><authid>56641756700</authid><authname>Romeva M.</authname><surname>Romeva</surname><given-name>Maria Casares I</given-name><initials>M.C.I.</initials><afid>60030315</afid></author><author seq="15"><author-url>http://api.elsevier.com/content/author/author_id:6603709047</author-url><authid>6603709047</authid><authname>Borras X.</authname><surname>Borras</surname><given-name>Xavier</given-name><initials>X.</initials><afid>60009466</afid></author><author seq="16"><author-url>http://api.elsevier.com/content/author/author_id:56566181800</author-url><authid>56566181800</authid><authname>Vázquez S.</authname><surname>Vázquez</surname><given-name>Sandra</given-name><initials>S.</initials><afid>60033237</afid></author><author seq="17"><author-url>http://api.elsevier.com/content/author/author_id:7004473078</author-url><authid>7004473078</authid><authname>López-Palop R.</authname><surname>López-Palop</surname><given-name>Ramón</given-name><initials>R.</initials><afid>60031313</afid></author><authkeywords>Aortic stenosis | Charlson | Elderly | Prognosis</authkeywords><intid>2035912367</intid><source-id>23774</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84928575951"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84928575951?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84928575951&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84928575951&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0024320515001526"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84928575951</prism:url><dc:identifier>SCOPUS_ID:84928575951</dc:identifier><eid>2-s2.0-84928575951</eid><dc:title>Wine, alcohol and pills: What future for the French paradox?</dc:title><dc:creator>Biagi M.</dc:creator><prism:publicationName>Life Sciences</prism:publicationName><prism:issn>00243205</prism:issn><prism:eIssn>18790631</prism:eIssn><prism:volume>131</prism:volume><prism:pageRange>19-22</prism:pageRange><prism:coverDate>2015-06-15</prism:coverDate><prism:coverDisplayDate>15 June 2015</prism:coverDisplayDate><prism:doi>10.1016/j.lfs.2015.02.024</prism:doi><pii>S0024320515001526</pii><dc:description>© 2015 Elsevier Inc. The present review discusses the acquisitions obtained to date on the subject of wine consumption, health and cardiovascular protection. We distinguished the cardiovascular effects related to the consumption of wine and other alcoholic beverages focusing on non-alcoholic wine fraction: polyphenols and especially resveratrol. In the second part of the review we have addressed the issue of resveratrol bioavailability and the importance of wine matrix and phytocomplex highlighting the biological effects that can be obtained with nutraceuticals and resveratrol pills compared to the daily consumption of a glass of red wine.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60002838</affiliation-url><afid>60002838</afid><affilname>Universita degli Studi di Siena</affilname><name-variant>Università di Siena</name-variant><affiliation-city>Siena</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60030318</affiliation-url><afid>60030318</afid><affilname>Universita degli Studi di Milano</affilname><name-variant>University of Milan</name-variant><affiliation-city>Milan</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>re</subtype><subtypeDescription>Review</subtypeDescription><author-count limit="100">2</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:6603855853</author-url><authid>6603855853</authid><authname>Biagi M.</authname><surname>Biagi</surname><given-name>Marco</given-name><initials>M.</initials><afid>60002838</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:35360025200</author-url><authid>35360025200</authid><authname>Bertelli A.</authname><surname>Bertelli</surname><given-name>Alberto A E</given-name><initials>A.A.E.</initials><afid>60030318</afid></author><authkeywords>French paradox | Polyphenols | Resveratrol | Wine</authkeywords><intid>535803312</intid><source-id>20473</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929206847"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929206847?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929206847&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929206847&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0167527315007871"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929206847</prism:url><dc:identifier>SCOPUS_ID:84929206847</dc:identifier><eid>2-s2.0-84929206847</eid><dc:title>"Fishing" in the era of TOTAL: Thrombectomy in primary PCI</dc:title><dc:creator>Karamasis G.</dc:creator><prism:publicationName>International Journal of Cardiology</prism:publicationName><prism:issn>01675273</prism:issn><prism:eIssn>18741754</prism:eIssn><prism:volume>189</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>91-93</prism:pageRange><prism:coverDate>2015-06-15</prism:coverDate><prism:coverDisplayDate>15 June 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijcard.2015.04.068</prism:doi><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:105727886</affiliation-url><afid>105727886</afid><affilname>Essex Cardiothoracic Centre</affilname><name-variant>The Essex Cardiothoracic Centre</name-variant><affiliation-city>Basildon</affiliation-city><affiliation-country>United Kingdom</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>le</subtype><subtypeDescription>Letter</subtypeDescription><author-count limit="100">2</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55767282500</author-url><authid>55767282500</authid><authname>Karamasis G.</authname><surname>Karamasis</surname><given-name>Grigoris V.</given-name><initials>G.V.</initials><afid>105727886</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:6701849278</author-url><authid>6701849278</authid><authname>Clesham G.</authname><surname>Clesham</surname><given-name>Gerald J.</given-name><initials>G.J.</initials><afid>105727886</afid></author><authkeywords>Primary PCI | STEMI | Thrombectomy | Thrombus aspiration</authkeywords><intid>1535916783</intid><source-id>23774</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929166951"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929166951?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929166951&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929166951&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0167527315007482"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929166951</prism:url><dc:identifier>SCOPUS_ID:84929166951</dc:identifier><eid>2-s2.0-84929166951</eid><dc:title>Arterial stiffening and systemic endothelial activation induced by smoking: The role of COX-1 and COX-2</dc:title><dc:creator>Vlachopoulos C.</dc:creator><prism:publicationName>International Journal of Cardiology</prism:publicationName><prism:issn>01675273</prism:issn><prism:eIssn>18741754</prism:eIssn><prism:volume>189</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>293-298</prism:pageRange><prism:coverDate>2015-06-15</prism:coverDate><prism:coverDisplayDate>15 June 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijcard.2015.04.029</prism:doi><dc:description>© 2015 Elsevier Ireland Ltd. All rights reserved. Background: Arterial stiffness is an established predictor of cardiovascular risk. We explored the effects of acute smoking on arterial stiffness, systemic inflammation and endothelial activation in chronic smokers and the contribution of cyclooxygenases-1 and 2 (COX-1 and COX-2). Methods and results: In a randomized, double-blind, cross-over study, we investigated in 28 young smokers the vascular and systemic effects of smoking one cigarette, 3 h after receiving 1000 mg of aspirin (a non-selective COX-1 and COX-2 inhibitor) or placebo (aspirin substudy), or 200 mg of celecoxib (a selective COX-2 inhibitor) or placebo (celecoxib substudy). Smoking increased carotid-femoral pulse wave velocity (PWV, a marker of aortic stiffness), indicating an adverse effect on arterial elastic properties. Similarly, circulating levels of asymmetric dimethylarginine (ADMA) were increased after smoking. Aspirin fully prevented the smoking-induced increase of PWV after smoking. Incontrast, celecoxib only partially prevented the smoking-induced increase of PWV. Both aspirin and celecoxib prevented to a similar extent the increase of ADMA levels after smoking. Conclusions: Smoking one cigarette is associated with adeterioration of arterial stiffness and with systemic endothelial activation in chronic smokers. Both COX-1 and COX-2, but primarily COX-1, mediate these unfavorable effects of smoking.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60067083</affiliation-url><afid>60067083</afid><affilname>University of Athens Medical School</affilname><name-variant>University of Athens</name-variant><affiliation-city>Athens</affiliation-city><affiliation-country>Greece</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">8</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:7003866217</author-url><authid>7003866217</authid><authname>Vlachopoulos C.</authname><surname>Vlachopoulos</surname><given-name>Charalambos</given-name><initials>C.</initials><afid>60067083</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:55897025500</author-url><authid>55897025500</authid><authname>Aznaouridis K.</authname><surname>Aznaouridis</surname><given-name>Konstantinos</given-name><initials>K.</initials><afid>60067083</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:6503856106</author-url><authid>6503856106</authid><authname>Bratsas A.</authname><surname>Bratsas</surname><given-name>Athanassios</given-name><initials>A.</initials><afid>60067083</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:55659273300</author-url><authid>55659273300</authid><authname>Ioakeimidis N.</authname><surname>Ioakeimidis</surname><given-name>Nikolaos</given-name><initials>N.</initials><afid>60067083</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:9633632900</author-url><authid>9633632900</authid><authname>Dima I.</authname><surname>Dima</surname><given-name>Ioanna</given-name><initials>I.</initials><afid>60067083</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:22036643000</author-url><authid>22036643000</authid><authname>Xaplanteris P.</authname><surname>Xaplanteris</surname><given-name>Panagiotis</given-name><initials>P.</initials><afid>60067083</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:36045489100</author-url><authid>36045489100</authid><authname>Stefanadis C.</authname><surname>Stefanadis</surname><given-name>Christodoulos</given-name><initials>C.</initials><afid>60067083</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:35399054300</author-url><authid>35399054300</authid><authname>Tousoulis D.</authname><surname>Tousoulis</surname><given-name>Dimitris</given-name><initials>D.</initials><afid>60067083</afid></author><authkeywords>Arterial elasticity | Arterial stiffness | Cyclooxygenase | Smoking</authkeywords><intid>535918610</intid><source-id>23774</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929156272"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929156272?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929156272&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929156272&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0167527315007160"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929156272</prism:url><dc:identifier>SCOPUS_ID:84929156272</dc:identifier><eid>2-s2.0-84929156272</eid><dc:title>Redo percutaneous mitral valvuloplasty beyond 65 years, long-term follow-up of an alternative</dc:title><dc:creator>Núñez Gil I.</dc:creator><prism:publicationName>International Journal of Cardiology</prism:publicationName><prism:issn>01675273</prism:issn><prism:eIssn>18741754</prism:eIssn><prism:volume>189</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>45-46</prism:pageRange><prism:coverDate>2015-06-15</prism:coverDate><prism:coverDisplayDate>15 June 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijcard.2015.04.006</prism:doi><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60032461</affiliation-url><afid>60032461</afid><affilname>Hospital Clinico San Carlos de Madrid</affilname><name-variant>Hospital Universitario San Carlos</name-variant><affiliation-city>Madrid</affiliation-city><affiliation-country>Spain</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>le</subtype><subtypeDescription>Letter</subtypeDescription><author-count limit="100">12</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:23025470300</author-url><authid>23025470300</authid><authname>Núñez Gil I.</authname><surname>Núñez Gil</surname><given-name>I. J.</given-name><initials>I.J.</initials><afid>60032461</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:55416340000</author-url><authid>55416340000</authid><authname>Palacios-Rubio J.</authname><surname>Palacios-Rubio</surname><given-name>J.</given-name><initials>J.</initials><afid>60032461</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56482920800</author-url><authid>56482920800</authid><authname>Bautista D.</authname><surname>Bautista</surname><given-name>D.</given-name><initials>D.</initials><afid>60032461</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:26434848200</author-url><authid>26434848200</authid><authname>Salinas P.</authname><surname>Salinas</surname><given-name>P.</given-name><initials>P.</initials><afid>60032461</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56641628000</author-url><authid>56641628000</authid><authname>Perez-Vicayno M.</authname><surname>Perez-Vicayno</surname><given-name>M. J.</given-name><initials>M.J.</initials><afid>60032461</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:6504088208</author-url><authid>6504088208</authid><authname>Feltes G.</authname><surname>Feltes</surname><given-name>G.</given-name><initials>G.</initials><afid>60032461</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:24335772800</author-url><authid>24335772800</authid><authname>Nombela-Franco L.</authname><surname>Nombela-Franco</surname><given-name>L.</given-name><initials>L.</initials><afid>60032461</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:56517095000</author-url><authid>56517095000</authid><authname>Escaned J.</authname><surname>Escaned</surname><given-name>J.</given-name><initials>J.</initials><afid>60032461</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:19336972900</author-url><authid>19336972900</authid><authname>De Agustín J.</authname><surname>De Agustín</surname><given-name>J. A.</given-name><initials>J.A.</initials><afid>60032461</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:24475657200</author-url><authid>24475657200</authid><authname>Vivas D.</authname><surname>Vivas</surname><given-name>D.</given-name><initials>D.</initials><afid>60032461</afid></author><author seq="11"><author-url>http://api.elsevier.com/content/author/author_id:6506673631</author-url><authid>6506673631</authid><authname>Macaya C.</authname><surname>Macaya</surname><given-name>C.</given-name><initials>C.</initials><afid>60032461</afid></author><author seq="12"><author-url>http://api.elsevier.com/content/author/author_id:7005318939</author-url><authid>7005318939</authid><authname>Fernández-Ortiz A.</authname><surname>Fernández-Ortiz</surname><given-name>A.</given-name><initials>A.</initials><afid>60032461</afid></author><authkeywords>Long-term prognosis | Mitral stenosis | Redo | Surgery | Valvuloplasty</authkeywords><intid>2035910916</intid><source-id>23774</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929179362"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929179362?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929179362&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929179362&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0167527315006749"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929179362</prism:url><dc:identifier>SCOPUS_ID:84929179362</dc:identifier><eid>2-s2.0-84929179362</eid><dc:title>Interaction between HDL and inflammation: When the good turns to be bad</dc:title><dc:creator>Papageorgiou N.</dc:creator><prism:publicationName>International Journal of Cardiology</prism:publicationName><prism:issn>01675273</prism:issn><prism:eIssn>18741754</prism:eIssn><prism:volume>189</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>15-17</prism:pageRange><prism:coverDate>2015-06-15</prism:coverDate><prism:coverDisplayDate>15 June 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijcard.2015.03.411</prism:doi><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60067083</affiliation-url><afid>60067083</afid><affilname>University of Athens Medical School</affilname><name-variant>University of Athens</name-variant><affiliation-city>Athens</affiliation-city><affiliation-country>Greece</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>re</subtype><subtypeDescription>Review</subtypeDescription><author-count limit="100">2</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:16646330500</author-url><authid>16646330500</authid><authname>Papageorgiou N.</authname><surname>Papageorgiou</surname><given-name>Nikolaos</given-name><initials>N.</initials><afid>60067083</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:35399054300</author-url><authid>35399054300</authid><authname>Tousoulis D.</authname><surname>Tousoulis</surname><given-name>Dimitris</given-name><initials>D.</initials><afid>60067083</afid></author><authkeywords>Atherosclerosis | High-density lipoprotein | Inflammation</authkeywords><intid>535919705</intid><source-id>23774</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84921477405"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84921477405?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84921477405&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84921477405&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0308814615000436"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84921477405</prism:url><dc:identifier>SCOPUS_ID:84921477405</dc:identifier><eid>2-s2.0-84921477405</eid><dc:title>Bioactive compounds and antioxidant capacity of buriti (Mauritia flexuosa L.f.) from the Cerrado and Amazon biomes</dc:title><dc:creator>Cândido T.</dc:creator><prism:publicationName>Food Chemistry</prism:publicationName><prism:issn>03088146</prism:issn><prism:eIssn>18737072</prism:eIssn><prism:volume>177</prism:volume><prism:pageRange>313-319</prism:pageRange><prism:coverDate>2015-06-15</prism:coverDate><prism:coverDisplayDate>15 June 2015</prism:coverDisplayDate><prism:doi>10.1016/j.foodchem.2015.01.041</prism:doi><pii>S0308814615000436</pii><dc:description>Pulp of buriti palms (Mauritia flexuosa L.f.) from two Brazilian regions had their phenolic and carotenoid contents and antioxidant capacity evaluated through different methods (ABTS, DPPH, FRAP and ORAC). Buriti pulp from the Cerrado presented higher phenolic levels (435.08 mg AGE 100 g-1) and elevated antioxidant capacity in all tests. The fruits from the Amazon region had a higher total carotenoid content (52.86 mg 100 g-1). Carotenoid profile has confirmed β-carotene predominance in both regions studied. The buritis' region of origin influenced bioactive compound contents and antioxidant capacity of the fruits analyzed. A significant positive correlation (r ≤ 0.95; p &lt; 0.05) was observed between total phenolics and antioxidant capacity through the different methods applied. Results showed promising prospects for the future exploitation of buriti fruits as a potential source of carotenoids and natural antioxidants.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60027136</affiliation-url><afid>60027136</afid><affilname>Universidade Federal de Goias</affilname><name-variant>Universidade Federal de Goiás</name-variant><affiliation-city>Goiania</affiliation-city><affiliation-country>Brazil</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60009625</affiliation-url><afid>60009625</afid><affilname>Empresa Brasileira de Pesquisa Agropecuaria - Embrapa</affilname><name-variant>Brazilian Agricultural Research Corporation</name-variant><affiliation-city>Brasilia</affiliation-city><affiliation-country>Brazil</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">3</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56490960200</author-url><authid>56490960200</authid><authname>Cândido T.</authname><surname>Cândido</surname><given-name>T. L N</given-name><initials>T.L.N.</initials><afid>60027136</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56489256600</author-url><authid>56489256600</authid><authname>Silva M.</authname><surname>Silva</surname><given-name>M. R.</given-name><initials>M.R.</initials><afid>60027136</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:7801646852</author-url><authid>7801646852</authid><authname>Agostini-Costa T.</authname><surname>Agostini-Costa</surname><given-name>T. S.</given-name><initials>T.S.</initials><afid>60009625</afid></author><authkeywords>Antioxidant activity | Bioactive compounds | Buriti | Mauritia flexuosa L.f.</authkeywords><intid>2034648316</intid><source-id>24039</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84928529068"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84928529068?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84928529068&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84928529068&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0041010115001026"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84928529068</prism:url><dc:identifier>SCOPUS_ID:84928529068</dc:identifier><eid>2-s2.0-84928529068</eid><dc:title>The structure-function relationship of thrombin-like enzymes from the green pit viper (Trimeresurus albolabris)</dc:title><dc:creator>Pradniwat P.</dc:creator><prism:publicationName>Toxicon</prism:publicationName><prism:issn>00410101</prism:issn><prism:eIssn>18793150</prism:eIssn><prism:volume>100</prism:volume><prism:pageRange>53-59</prism:pageRange><prism:coverDate>2015-06-15</prism:coverDate><prism:coverDisplayDate>15 June 2015</prism:coverDisplayDate><prism:doi>10.1016/j.toxicon.2015.04.005</prism:doi><pii>S0041010115001026</pii><dc:description>©2015 Published by Elsevier Ltd. Pit viper venoms can decrease fibrinogen levels in snakebite patients. Studies have shown that the hypofibrinogenemia is a consequence of snake venom thrombin-like enzymes (TLEs), the serine proteases that have the potential to be both diagnostic and therapeutic agents. Exosites of thrombin are the molecular regions that determine the substrate specificities, but its presence and significance in TLEs are unclear. Therefore, the putative exosites of recombinant TLEs derived from Green pit viper (Trimeresurus albolabris), GPV-TL1 and GPV-TL2, were mutated in a Pichia pastoris system. In a previous report, GPV-TL1 showed a strong fibrinogenolytic activity on the Aα and Bβ chains of fibrinogen, as well as a plasma clotting activity. Compared with GPV-TL1, the GPV-TL1m mutated in the putative exosite (TRN to RRR at residues 60-62) showed a weaker fibrinogenolytic activity with a similar clotting activity of 207.1 thrombin units/mg. GPV-TL2 contained two-residue differences from GPV-TL1 in the putative exosite (N73M and V74Y). GPV-TL2 selectively cleaved only the Aα chain of fibrinogen without detectable clotting activity. The mutated GPV-TL2 (GPV-TL2m) showed a weaker fibrinogenolytic activity compared with that of the wild type. These results support the important roles of the putative exosite in snake venom TLE activities. This information is helpful for future protein engineering.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60028190</affiliation-url><afid>60028190</afid><affilname>Chulalongkorn University</affilname><name-variant>Chulalongkorn University</name-variant><affiliation-city>Bangkok</affiliation-city><affiliation-country>Thailand</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60028190</affiliation-url><afid>60028190</afid><affilname>Chulalongkorn University</affilname><name-variant>Chulalongkorn University</name-variant><affiliation-city>Bangkok</affiliation-city><affiliation-country>Thailand</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60028190</affiliation-url><afid>60028190</afid><affilname>Chulalongkorn University</affilname><name-variant>Chulalongkorn University</name-variant><affiliation-city>Bangkok</affiliation-city><affiliation-country>Thailand</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">3</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:6508198106</author-url><authid>6508198106</authid><authname>Pradniwat P.</authname><surname>Pradniwat</surname><given-name>Paweena</given-name><initials>P.</initials><afid>60028190</afid><afid>60028190</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:6508198106</author-url><authid>6508198106</authid><authname>Pradniwat P.</authname><surname>Pradniwat</surname><given-name>Paweena</given-name><initials>P.</initials><afid>60028190</afid><afid>60028190</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:6603335025</author-url><authid>6603335025</authid><authname>Rojnuckarin P.</authname><surname>Rojnuckarin</surname><given-name>Ponlapat</given-name><initials>P.</initials><afid>60028190</afid></author><authkeywords>Clotting activity | Fibrinogenolytic activity | Mutagenesis | Snake venom | Thrombin-like enzyme | Trimeresurus albolabris</authkeywords><intid>35802585</intid><source-id>22319</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929191033"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929191033?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929191033&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929191033&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929191033</prism:url><dc:identifier>SCOPUS_ID:84929191033</dc:identifier><eid>2-s2.0-84929191033</eid><dc:title>Estimation of calcium, magnesium, cadmium, and lead in biological samples from paralyzed quality control and production steel mill workers</dc:title><dc:creator>Afridi H.</dc:creator><prism:publicationName>Environmental Monitoring and Assessment</prism:publicationName><prism:issn>01676369</prism:issn><prism:eIssn>15732959</prism:eIssn><prism:volume>187</prism:volume><prism:issueIdentifier>6</prism:issueIdentifier><prism:coverDate>2015-06-15</prism:coverDate><prism:coverDisplayDate>15 June 2015</prism:coverDisplayDate><prism:doi>10.1007/s10661-015-4517-3</prism:doi><dc:description>© 2015, Springer International Publishing Switzerland. The determination of trace and toxic metals in the biological samples of human beings is an important clinical screening procedure. The aim of the present study was to compare the level of essential trace and toxic elements cadmium (Cd), calcium (Ca), lead (Pb), and magnesium (Mg) in biological samples (whole blood, urine, and scalp hair) of male paralyzed production (PPW) and quality control workers (PQW) of a steel mill, age ranged (35–55 years). For comparison purposes, healthy age-matched exposed referent subjects (EC), working in steel mill and control subjects (NEC), who were not working in industries and lived far away from the industrial areas, were selected as control subjects. The concentrations of electrolytes and toxic elements in biological samples were measured by atomic absorption spectrometry after microwave-assisted acid digestion. The validity and accuracy of the methodology were checked using certified reference materials. The results of this study showed that the mean values of Cd and Pb were significantly higher in scalp hair, blood, and urine samples of PPW and PQW as compared to NEC and EC (p &lt; 0.001), whereas the concentrations of Ca and Mg were found to be lower in the scalp hair and blood but higher in the urine samples of PPW and PQW. The results show the need for immediate improvements in workplace, ventilation, and industrial hygiene practices.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60035791</affiliation-url><afid>60035791</afid><affilname>University of Sindh</affilname><name-variant>University of Sindh</name-variant><affiliation-city>Jamshoro</affiliation-city><affiliation-country>Pakistan</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60055350</affiliation-url><afid>60055350</afid><affilname>Liaquat University of Medical and Health Sciences</affilname><name-variant>LUMHS</name-variant><affiliation-city>Jamshoro</affiliation-city><affiliation-country>Pakistan</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">6</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:8360657600</author-url><authid>8360657600</authid><authname>Afridi H.</authname><surname>Afridi</surname><given-name>Hassan Imran</given-name><initials>H.I.</initials><afid>60035791</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:14007621500</author-url><authid>14007621500</authid><authname>Talpur F.</authname><surname>Talpur</surname><given-name>Farah Naz</given-name><initials>F.N.</initials><afid>60035791</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:6603096558</author-url><authid>6603096558</authid><authname>Kazi T.</authname><surname>Kazi</surname><given-name>Tasneem Gul</given-name><initials>T.G.</initials><afid>60035791</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:23135296900</author-url><authid>23135296900</authid><authname>Kazi N.</authname><surname>Kazi</surname><given-name>Naveed</given-name><initials>N.</initials><afid>60055350</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:55258899800</author-url><authid>55258899800</authid><authname>Arain S.</authname><surname>Arain</surname><given-name>Sadaf Sadia</given-name><initials>S.S.</initials><afid>60035791</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:36021994600</author-url><authid>36021994600</authid><authname>Shah F.</authname><surname>Shah</surname><given-name>Faheem</given-name><initials>F.</initials><afid>60035791</afid></author><authkeywords>Atomic absorption spectrophotometer | Biological samples | Cadmium | Calcium | Lead | Magnesium | Paralysis</authkeywords><intid>1785918690</intid><source-id>21482</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929162422"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929162422?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929162422&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929162422&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0167527315007792"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929162422</prism:url><dc:identifier>SCOPUS_ID:84929162422</dc:identifier><eid>2-s2.0-84929162422</eid><dc:title>Embracing new paradigms in managing coronary disease: Is there yet a missing link to be connected?</dc:title><dc:creator>Wong C.</dc:creator><prism:publicationName>International Journal of Cardiology</prism:publicationName><prism:issn>01675273</prism:issn><prism:eIssn>18741754</prism:eIssn><prism:volume>189</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>85-87</prism:pageRange><prism:coverDate>2015-06-15</prism:coverDate><prism:coverDisplayDate>15 June 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijcard.2015.04.060</prism:doi><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60002798</affiliation-url><afid>60002798</afid><affilname>Chinese University of Hong Kong</affilname><name-variant>The Chinese University of Hong Kong</name-variant><affiliation-city>Hong Kong</affiliation-city><affiliation-country>China</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>le</subtype><subtypeDescription>Letter</subtypeDescription><author-count limit="100">1</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56640284300</author-url><authid>56640284300</authid><authname>Wong C.</authname><surname>Wong</surname><given-name>Cheuk Kit</given-name><initials>C.K.</initials><afid>60002798</afid></author><authkeywords>Coronary disease | Missing link | New paradigms</authkeywords><intid>2035913032</intid><source-id>23774</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84921374413"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84921374413?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84921374413&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84921374413&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0308814615000424"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84921374413</prism:url><dc:identifier>SCOPUS_ID:84921374413</dc:identifier><eid>2-s2.0-84921374413</eid><dc:title>Simple and efficient methodology to determine mycotoxins in cereal syrups</dc:title><dc:creator>Arroyo-Manzanares N.</dc:creator><prism:publicationName>Food Chemistry</prism:publicationName><prism:issn>03088146</prism:issn><prism:eIssn>18737072</prism:eIssn><prism:volume>177</prism:volume><prism:pageRange>274-279</prism:pageRange><prism:coverDate>2015-06-15</prism:coverDate><prism:coverDisplayDate>15 June 2015</prism:coverDisplayDate><prism:doi>10.1016/j.foodchem.2015.01.040</prism:doi><pii>S0308814615000424</pii><dc:description>© 2015 Elsevier Ltd. All rights reserved. Consumption of cereal syrups is increasing nowadays. Mycotoxins may be found in syrups resulting from the use of contaminated raw material or invading microorganisms in the final manufactured product. However, these matrices have been scarcely explored regarding their mycotoxin content. A sensitive, simple and rapid method for the determination of ten mycotoxins (ochratoxin A, fumonisin B1, fumonisin B2, deoxynivalenol, fusarenon-X, T-2 and HT-2 toxin, citrinin, sterigmatocystin and zearalenone) in cereal syrups (rice, wheat and barley) has been developed and characterised using ultra-high performance liquid chromatography coupled with tandem mass spectrometry (UHPLC-MS/MS) and a sample treatment based on QuEChERS procedure. Matrix-matched calibration curves were established and limits of quantification were below the limits usually established by current legislation in different foodstuff. The relative standard deviation of the whole analytical method was lower than 12% in all cases, while recoveries ranged from 70.2% to 100.6%, therefore fulfilling the current requirements for mycotoxins analysis.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60014655</affiliation-url><afid>60014655</afid><affilname>Universidad de Granada, Facultad de Ciencias</affilname><name-variant>University of Granada</name-variant><affiliation-city>Granada</affiliation-city><affiliation-country>Spain</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">4</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:36179562300</author-url><authid>36179562300</authid><authname>Arroyo-Manzanares N.</authname><surname>Arroyo-Manzanares</surname><given-name>Natalia</given-name><initials>N.</initials><afid>60014655</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:7801478063</author-url><authid>7801478063</authid><authname>Huertas-Pérez J.</authname><surname>Huertas-Pérez</surname><given-name>José F.</given-name><initials>J.F.</initials><afid>60014655</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:6601966891</author-url><authid>6601966891</authid><authname>Gámiz-Gracia L.</authname><surname>Gámiz-Gracia</surname><given-name>Laura</given-name><initials>L.</initials><afid>60014655</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:7004918727</author-url><authid>7004918727</authid><authname>García-Campaña A.</authname><surname>García-Campaña</surname><given-name>Ana M.</given-name><initials>A.M.</initials><afid>60014655</afid></author><authkeywords>Cereal syrups | Multiclass mycotoxins | QuEChERS | UHPLC-MS/MS</authkeywords><intid>1784672811</intid><source-id>24039</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84927144543"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84927144543?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84927144543&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84927144543&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0014299915002927"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84927144543</prism:url><dc:identifier>SCOPUS_ID:84927144543</dc:identifier><eid>2-s2.0-84927144543</eid><dc:title>The interactive role of cannabinoid and vanilloid systems in hippocampal synaptic plasticity in rats</dc:title><dc:creator>Tahmasebi L.</dc:creator><prism:publicationName>European Journal of Pharmacology</prism:publicationName><prism:issn>00142999</prism:issn><prism:eIssn>18790712</prism:eIssn><prism:volume>757</prism:volume><prism:pageRange>68-73</prism:pageRange><prism:coverDate>2015-06-15</prism:coverDate><prism:coverDisplayDate>15 June 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ejphar.2015.03.063</prism:doi><pii>S0014299915002927</pii><dc:description>© 2015 Elsevier B.V. All rights reserved. Long-term potentiation (LTP) has been most thoroughly studied in the hippocampus, which has a key role in learning and memory. Endocannabinoids are one of the endogenous systems that modulate this kind of synaptic plasticity. The activation of the vanillioid system has also been shown to mediate synaptic plasticity in the hippocampus. In addition, immunohistochemical studies have shown that cannabinoid receptor type 1 (CB&lt;inf&gt;1&lt;/inf&gt;) and vanilloid receptor 1 (TRPV1) are closely located in the hippocampus. In this study, we examined the hippocampal effects of co-administrating WIN55-212-2 and capsaicin, which are CB&lt;inf&gt;1&lt;/inf&gt; and TRPV1 agonists, respectively, on the induction of LTP in the dentate gyrus (DG) of rats. LTP in the hippocampal area was induced by high-frequency stimulation (HFS). Our results indicated that the cannabinoid agonist reduced both field excitatory post-synaptic potential (fEPSP) slope and population spike (PS) amplitude after HFS with respect to the control group, whereas the vanilloid agonist increased these parameters along with the increased induction of LTP as compared to the control group. We also showed that the co-administration of cannabinoid and vanilloid agonists had different effects on fEPSP slope and PS amplitude. It seems that agonists of the vanilloid system modulate cannabinoid outputs that cause an increase in synaptic plastisity, while in contemporary consumption of two agonist, TRPV1 agonist can change production of endocannabinoid, which in turn result to enhancement of LTP induction. These findings suggest that the two systems may interact or share certain common signaling pathways in the hippocampus.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60006672</affiliation-url><afid>60006672</afid><affilname>Hamedan University of Medical Sciences and Health Services</affilname><name-variant>Hamedan University of Medical Sciences</name-variant><affiliation-city>Hamadan</affiliation-city><affiliation-country>Iran</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">7</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56588025400</author-url><authid>56588025400</authid><authname>Tahmasebi L.</authname><surname>Tahmasebi</surname><given-name>Lida</given-name><initials>L.</initials><afid>60006672</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:55881461900</author-url><authid>55881461900</authid><authname>Komaki A.</authname><surname>Komaki</surname><given-name>Alireza</given-name><initials>A.</initials><afid>60006672</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56587749400</author-url><authid>56587749400</authid><authname>Karamian R.</authname><surname>Karamian</surname><given-name>Ruhollah</given-name><initials>R.</initials><afid>60006672</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:6603967242</author-url><authid>6603967242</authid><authname>Shahidi S.</authname><surname>Shahidi</surname><given-name>Siamak</given-name><initials>S.</initials><afid>60006672</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:23482681500</author-url><authid>23482681500</authid><authname>Sarihi A.</authname><surname>Sarihi</surname><given-name>Abdolrahman</given-name><initials>A.</initials><afid>60006672</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:16418053600</author-url><authid>16418053600</authid><authname>Salehi I.</authname><surname>Salehi</surname><given-name>Iraj</given-name><initials>I.</initials><afid>60006672</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:56351952700</author-url><authid>56351952700</authid><authname>Nikkhah A.</authname><surname>Nikkhah</surname><given-name>Ali</given-name><initials>A.</initials><afid>60006672</afid></author><authkeywords>Cannabinoid | Capsaicin | Hippocampus | Long-term potentiation | Rat | Vanilloid | WIN55-212-2</authkeywords><intid>2035564821</intid><source-id>21333</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84921444967"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84921444967?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84921444967&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84921444967&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0308814615000412"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84921444967</prism:url><dc:identifier>SCOPUS_ID:84921444967</dc:identifier><eid>2-s2.0-84921444967</eid><dc:title>Optimal extraction and fingerprinting of carotenoids by accelerated solvent extraction and liquid chromatography with tandem mass spectrometry</dc:title><dc:creator>Saha S.</dc:creator><prism:publicationName>Food Chemistry</prism:publicationName><prism:issn>03088146</prism:issn><prism:eIssn>18737072</prism:eIssn><prism:volume>177</prism:volume><prism:pageRange>369-375</prism:pageRange><prism:coverDate>2015-06-15</prism:coverDate><prism:coverDisplayDate>15 June 2015</prism:coverDisplayDate><prism:doi>10.1016/j.foodchem.2015.01.039</prism:doi><pii>S0308814615000412</pii><dc:description>© 2015 Published by Elsevier Ltd. Accelerated solvent extraction (ASE) is applied for the extraction of carotenoids from orange carrot and the extraction parameters were optimized. Two carotenoids, lutein and β-carotene, are selected as the validation process. Hildebrand solubility parameters and dielectric constant of solvents were taken into consideration in selecting solvent mixture. The effects of various experimental parameters, such as temperature, static time, drying agent etc., on the ASE extraction efficiency are investigated systematically. Interactions among the variables were also studied. Furthermore, two carotenoids were analyzed and characterized by LC-ESI MS. The study concluded that Hildebrand solubility parameter approach may be applicable for less polar bioactive molecules like carotenoids. The properties of solvent and extraction temperature are found to be the most important parameters affecting the ASE extraction efficiency of thermolabile natural compounds.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60014344</affiliation-url><afid>60014344</afid><affilname>Indian Agricultural Research Institute</affilname><name-variant>Indian Agricultural Research Institute</name-variant><affiliation-city>New Delhi</affiliation-city><affiliation-country>India</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60024234</affiliation-url><afid>60024234</afid><affilname>Indian Agricultural Statistics Research Institute</affilname><name-variant>Indian Agric. Stat. Res. Institute</name-variant><affiliation-city>New Delhi</affiliation-city><affiliation-country>India</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">5</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56489390900</author-url><authid>56489390900</authid><authname>Saha S.</authname><surname>Saha</surname><given-name>Supradip</given-name><initials>S.</initials><afid>60014344</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:7003364468</author-url><authid>7003364468</authid><authname>Walia S.</authname><surname>Walia</surname><given-name>Suresh</given-name><initials>S.</initials><afid>60014344</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:35086347900</author-url><authid>35086347900</authid><authname>Kundu A.</authname><surname>Kundu</surname><given-name>Aditi</given-name><initials>A.</initials><afid>60014344</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:51665966700</author-url><authid>51665966700</authid><authname>Sharma K.</authname><surname>Sharma</surname><given-name>Khushbu</given-name><initials>K.</initials><afid>60014344</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:36171195100</author-url><authid>36171195100</authid><authname>Paul R.</authname><surname>Paul</surname><given-name>Ranjit Kumar</given-name><initials>R.K.</initials><afid>60024234</afid></author><authkeywords>Accelerated solvent extractor | Carotenoid | Hildebrand solubility parameters | Liquid chromatography-mass spectrometry</authkeywords><intid>534656209</intid><source-id>24039</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84921327427"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84921327427?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84921327427&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84921327427&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0308814615000369"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84921327427</prism:url><dc:identifier>SCOPUS_ID:84921327427</dc:identifier><eid>2-s2.0-84921327427</eid><dc:title>Rapid profiling and identification of anthocyanins in fruits with Hadamard transform ion mobility mass spectrometry</dc:title><dc:creator>Liu W.</dc:creator><prism:publicationName>Food Chemistry</prism:publicationName><prism:issn>03088146</prism:issn><prism:eIssn>18737072</prism:eIssn><prism:volume>177</prism:volume><prism:pageRange>225-232</prism:pageRange><prism:coverDate>2015-06-15</prism:coverDate><prism:coverDisplayDate>15 June 2015</prism:coverDisplayDate><prism:doi>10.1016/j.foodchem.2015.01.034</prism:doi><pii>S0308814615000369</pii><dc:description>© 2015 Elsevier Ltd. All rights reserved. The use of Hadamard transform ion mobility mass spectrometry (HT-IMMS) in the profiling of anthocyanins from different fruits is presented. Samples extracted with acidic methanol and purified with solid phase extraction were analyzed with direct IMMS infusion. The separation of various anthocyanins was achieved within 30 s with resolving powers up to 110. The ion mobility drift times correlated with their mass-to-charge ratios with a correlation coefficient of 0.979 to produce a trend line that was characteristic for anthocyanins. Isomers with the same anthocyanidin but different hexoses were differentiated by ion mobility spectrometry. Furthermore, mobility separated ions underwent collision induced dissociation at the IMMS interface to provide MS/MS spectra. These fragmentation spectra aided in the identification of anthocyanidins via the loss of the saccharide groups. IMMS appears to be a rapid and efficient approach for profiling and identifying anthocyanins.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60014070</affiliation-url><afid>60014070</afid><affilname>Hunan Normal University</affilname><name-variant>Hunan Normal University</name-variant><affiliation-city>Changsha</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60009831</affiliation-url><afid>60009831</afid><affilname>Washington State University</affilname><name-variant>Washington State University</name-variant><affiliation-city>Pullman</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">6</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56028991000</author-url><authid>56028991000</authid><authname>Liu W.</authname><surname>Liu</surname><given-name>Wenjie</given-name><initials>W.</initials><afid>60014070</afid><afid>60009831</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56028991000</author-url><authid>56028991000</authid><authname>Liu W.</authname><surname>Liu</surname><given-name>Wenjie</given-name><initials>W.</initials><afid>60014070</afid><afid>60009831</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56486339900</author-url><authid>56486339900</authid><authname>Zhang X.</authname><surname>Zhang</surname><given-name>Xing</given-name><initials>X.</initials><afid>60009831</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:7102323357</author-url><authid>7102323357</authid><authname>Siems W.</authname><surname>Siems</surname><given-name>William F.</given-name><initials>W.F.</initials><afid>60009831</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:7402256448</author-url><authid>7402256448</authid><authname>Hill H.</authname><surname>Hill</surname><given-name>Herbert H.</given-name><initials>H.H.</initials><afid>60009831</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:7202455345</author-url><authid>7202455345</authid><authname>Yin D.</authname><surname>Yin</surname><given-name>Dulin</given-name><initials>D.</initials><afid>60014070</afid></author><authkeywords>Anthocyanin | Hadamard transform | Ion mobility mass spectrometry | Mobility-mass relationship</authkeywords><intid>34671057</intid><source-id>24039</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929160511"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929160511?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929160511&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929160511&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929160511</prism:url><dc:identifier>SCOPUS_ID:84929160511</dc:identifier><eid>2-s2.0-84929160511</eid><dc:title>Older Americans’ health and the Great Recession</dc:title><dc:creator>Hyclak T.</dc:creator><prism:publicationName>Review of Economics of the Household</prism:publicationName><prism:issn>15695239</prism:issn><prism:eIssn>15737152</prism:eIssn><prism:volume>13</prism:volume><prism:issueIdentifier>2</prism:issueIdentifier><prism:pageRange>413-436</prism:pageRange><prism:coverDate>2015-06-15</prism:coverDate><prism:coverDisplayDate>15 June 2015</prism:coverDisplayDate><prism:doi>10.1007/s11150-013-9197-6</prism:doi><dc:description>© 2013, Springer Science+Business Media New York. We use 2009 American Association for Retired Persons and Medical Expenditure Panel Survey (MEPS) data to determine how older Americans respond to job loss, decreases in housing and financial wealth, and threats to health insurance. Some respond by leaving prescriptions unfilled, postponing needed health care, and/or stopping 401K contributions. The MEPS confirms our conclusions about the importance of job loss and health insurance for those 45 years old and older. Furthermore, direct measures of mental well-being from the MEPS demonstrate the negative impact of the Great Recession. Overall, our study fills a gap in the economics literature on the well-being of older citizenry during economic recession.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60000060</affiliation-url><afid>60000060</afid><affilname>Lehigh University</affilname><name-variant>Lehigh University</name-variant><affiliation-city>Bethlehem</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60020337</affiliation-url><afid>60020337</afid><affilname>National Bureau of Economic Research</affilname><name-variant>NBER</name-variant><affiliation-city>Cambridge</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">4</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:6603568936</author-url><authid>6603568936</authid><authname>Hyclak T.</authname><surname>Hyclak</surname><given-name>Thomas J.</given-name><initials>T.J.</initials><afid>60000060</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:10144476800</author-url><authid>10144476800</authid><authname>Meyerhoefer C.</authname><surname>Meyerhoefer</surname><given-name>Chad D.</given-name><initials>C.D.</initials><afid>60000060</afid><afid>60020337</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:10144476800</author-url><authid>10144476800</authid><authname>Meyerhoefer C.</authname><surname>Meyerhoefer</surname><given-name>Chad D.</given-name><initials>C.D.</initials><afid>60000060</afid><afid>60020337</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:55422801300</author-url><authid>55422801300</authid><authname>Taylor L.</authname><surname>Taylor</surname><given-name>Larry W.</given-name><initials>L.W.</initials><afid>60000060</afid></author><authkeywords>Elderly | Mental health | Permanent income hypothesis | Recession</authkeywords><intid>535919927</intid><source-id>144933</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929145085"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929145085?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929145085&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929145085&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0167527315007287"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929145085</prism:url><dc:identifier>SCOPUS_ID:84929145085</dc:identifier><eid>2-s2.0-84929145085</eid><dc:title>Very late bioresorbable vascular scaffold thrombosis due to late device recoil</dc:title><dc:creator>Cortese B.</dc:creator><prism:publicationName>International Journal of Cardiology</prism:publicationName><prism:issn>01675273</prism:issn><prism:eIssn>18741754</prism:eIssn><prism:volume>189</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>132-133</prism:pageRange><prism:coverDate>2015-06-15</prism:coverDate><prism:coverDisplayDate>15 June 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijcard.2015.04.018</prism:doi><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60070412</affiliation-url><afid>60070412</afid><affilname>Azienda Ospedaliera Fatebenefratelli e Oftalmico</affilname><name-variant>Fatebenefratelli Hospital</name-variant><affiliation-city>Milan</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60086668</affiliation-url><afid>60086668</afid><affilname>Azienda Ospedaliera Bolognini Seriate</affilname><name-variant>Bolognini Hospital</name-variant><affiliation-city>Seriate</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60073281</affiliation-url><afid>60073281</afid><affilname>Azienda Ospedaliera S. Croce e Carle</affilname><affiliation-city>Cuneo</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>le</subtype><subtypeDescription>Letter</subtypeDescription><author-count limit="100">5</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:22984973300</author-url><authid>22984973300</authid><authname>Cortese B.</authname><surname>Cortese</surname><given-name>Bernardo</given-name><initials>B.</initials><afid>60070412</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:36895925900</author-url><authid>36895925900</authid><authname>Piraino D.</authname><surname>Piraino</surname><given-name>Davide</given-name><initials>D.</initials><afid>60070412</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:14520490200</author-url><authid>14520490200</authid><authname>Ielasi A.</authname><surname>Ielasi</surname><given-name>Alfonso</given-name><initials>A.</initials><afid>60086668</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56256755200</author-url><authid>56256755200</authid><authname>Steffenino G.</authname><surname>Steffenino</surname><given-name>Giuseppe</given-name><initials>G.</initials><afid>60073281</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:6602683650</author-url><authid>6602683650</authid><authname>Orrego P.</authname><surname>Orrego</surname><given-name>Pedro Silva</given-name><initials>P.S.</initials><afid>60070412</afid></author><authkeywords>Biovascular scaffold | Predilatation | Scaffold recoil | Very late scaffold thrombosis</authkeywords><intid>1535916206</intid><source-id>23774</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929224025"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929224025?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929224025&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929224025&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0167527315006701"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929224025</prism:url><dc:identifier>SCOPUS_ID:84929224025</dc:identifier><eid>2-s2.0-84929224025</eid><dc:title>Atrioventricular block in siblings with argininosuccinic aciduria</dc:title><dc:creator>Ozcan O.</dc:creator><prism:publicationName>International Journal of Cardiology</prism:publicationName><prism:issn>01675273</prism:issn><prism:eIssn>18741754</prism:eIssn><prism:volume>189</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>109-111</prism:pageRange><prism:coverDate>2015-06-15</prism:coverDate><prism:coverDisplayDate>15 June 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijcard.2015.03.407</prism:doi><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60012603</affiliation-url><afid>60012603</afid><affilname>Ankara Universitesi</affilname><name-variant>Ankara University</name-variant><affiliation-city>Ankara</affiliation-city><affiliation-country>Turkey</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>le</subtype><subtypeDescription>Letter</subtypeDescription><author-count limit="100">4</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:22935788600</author-url><authid>22935788600</authid><authname>Ozcan O.</authname><surname>Ozcan</surname><given-name>Ozgur Ulas</given-name><initials>O.U.</initials><afid>60012603</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:55965729300</author-url><authid>55965729300</authid><authname>Turhan S.</authname><surname>Turhan</surname><given-name>Sibel</given-name><initials>S.</initials><afid>60012603</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:55193619100</author-url><authid>55193619100</authid><authname>Vurgun V.</authname><surname>Vurgun</surname><given-name>Veysel Kutay</given-name><initials>V.K.</initials><afid>60012603</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:7003273404</author-url><authid>7003273404</authid><authname>Erol C.</authname><surname>Erol</surname><given-name>Cetin</given-name><initials>C.</initials><afid>60012603</afid></author><authkeywords>Electrophysiology study | Mental retardation | Symptomatic bradycardia | Syncope | Urea cycle defect | Wenckebach block</authkeywords><intid>1785916712</intid><source-id>23774</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929154139"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929154139?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929154139&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929154139&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0167527315007536"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929154139</prism:url><dc:identifier>SCOPUS_ID:84929154139</dc:identifier><eid>2-s2.0-84929154139</eid><dc:title>Associations of lipid-related genetic markers with elevated carotid intima-media thickness in middle-age adults and elders</dc:title><dc:creator>Chen Y.</dc:creator><prism:publicationName>International Journal of Cardiology</prism:publicationName><prism:issn>01675273</prism:issn><prism:eIssn>18741754</prism:eIssn><prism:volume>189</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>264-266</prism:pageRange><prism:coverDate>2015-06-15</prism:coverDate><prism:coverDisplayDate>15 June 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijcard.2015.04.034</prism:doi><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60104437</affiliation-url><afid>60104437</afid><affilname>Mackay Medical College</affilname><name-variant>Mackay Medical College</name-variant><affiliation-city>Taipei</affiliation-city><affiliation-country>Taiwan</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60020351</affiliation-url><afid>60020351</afid><affilname>Chang Gung University</affilname><name-variant>Chang Gung University</name-variant><affiliation-city>Taoyuan</affiliation-city><affiliation-country>Taiwan</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60022095</affiliation-url><afid>60022095</afid><affilname>Taipei Medical University</affilname><name-variant>Taipei Medical University</name-variant><affiliation-city>Taipei</affiliation-city><affiliation-country>Taiwan</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60104437</affiliation-url><afid>60104437</afid><affilname>Mackay Medical College</affilname><name-variant>Mackay Medical College</name-variant><affiliation-city>Taipei</affiliation-city><affiliation-country>Taiwan</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60029238</affiliation-url><afid>60029238</afid><affilname>Mackay Memorial Hospital Taiwan</affilname><name-variant>Mackay Memorial Hospital</name-variant><affiliation-city>Taipei</affiliation-city><affiliation-country>Taiwan</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>le</subtype><subtypeDescription>Letter</subtypeDescription><author-count limit="100">15</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56640014100</author-url><authid>56640014100</authid><authname>Chen Y.</authname><surname>Chen</surname><given-name>Yi Cheng</given-name><initials>Y.C.</initials><afid>60104437</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56640522600</author-url><authid>56640522600</authid><authname>Hsu K.</authname><surname>Hsu</surname><given-name>Kuang Hung</given-name><initials>K.H.</initials><afid>60020351</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56419480300</author-url><authid>56419480300</authid><authname>Chiou H.</authname><surname>Chiou</surname><given-name>Hung Yi</given-name><initials>H.Y.</initials><afid>60022095</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56640877600</author-url><authid>56640877600</authid><authname>Juang Y.</authname><surname>Juang</surname><given-name>Yue Li</given-name><initials>Y.L.</initials><afid>60104437</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:55537364600</author-url><authid>55537364600</authid><authname>Wu T.</authname><surname>Wu</surname><given-name>Tzu Wei</given-name><initials>T.W.</initials><afid>60104437</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:35782170500</author-url><authid>35782170500</authid><authname>Hung C.</authname><surname>Hung</surname><given-name>Chung Lieh</given-name><initials>C.L.</initials><afid>60029238</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:7409791980</author-url><authid>7409791980</authid><authname>Liu C.</authname><surname>Liu</surname><given-name>Chun Chieh</given-name><initials>C.C.</initials><afid>60029238</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:56179417200</author-url><authid>56179417200</authid><authname>Wu Y.</authname><surname>Wu</surname><given-name>Yih Jer</given-name><initials>Y.J.</initials><afid>60104437</afid><afid>60104437</afid><afid>60029238</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:56179417200</author-url><authid>56179417200</authid><authname>Wu Y.</authname><surname>Wu</surname><given-name>Yih Jer</given-name><initials>Y.J.</initials><afid>60104437</afid><afid>60104437</afid><afid>60029238</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:56179417200</author-url><authid>56179417200</authid><authname>Wu Y.</authname><surname>Wu</surname><given-name>Yih Jer</given-name><initials>Y.J.</initials><afid>60104437</afid><afid>60104437</afid><afid>60029238</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:56379552300</author-url><authid>56379552300</authid><authname>Yeh H.</authname><surname>Yeh</surname><given-name>Hung I.</given-name><initials>H.I.</initials><afid>60104437</afid><afid>60104437</afid><afid>60029238</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:56379552300</author-url><authid>56379552300</authid><authname>Yeh H.</authname><surname>Yeh</surname><given-name>Hung I.</given-name><initials>H.I.</initials><afid>60104437</afid><afid>60104437</afid><afid>60029238</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:56379552300</author-url><authid>56379552300</authid><authname>Yeh H.</authname><surname>Yeh</surname><given-name>Hung I.</given-name><initials>H.I.</initials><afid>60104437</afid><afid>60104437</afid><afid>60029238</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:36064040700</author-url><authid>36064040700</authid><authname>Wang L.</authname><surname>Wang</surname><given-name>Li Yu</given-name><initials>L.Y.</initials><afid>60104437</afid><afid>60104437</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:36064040700</author-url><authid>36064040700</authid><authname>Wang L.</authname><surname>Wang</surname><given-name>Li Yu</given-name><initials>L.Y.</initials><afid>60104437</afid><afid>60104437</afid></author><authkeywords>Case-control study | Common carotid intima-media thickness | Genetic risk score | Lipid-related loci | Single nucleotide polymorphism</authkeywords><intid>1785916612</intid><source-id>23774</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84927671275"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84927671275?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84927671275&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84927671275&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0924424715001533"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84927671275</prism:url><dc:identifier>SCOPUS_ID:84927671275</dc:identifier><eid>2-s2.0-84927671275</eid><dc:title>To the mechanism of polyelectrolyte gel periodic acting in the constant DC electric field</dc:title><dc:creator>Blyakhman F.</dc:creator><prism:publicationName>Sensors and Actuators, A: Physical</prism:publicationName><prism:issn>09244247</prism:issn><prism:volume>229</prism:volume><prism:pageRange>104-109</prism:pageRange><prism:coverDate>2015-06-15</prism:coverDate><prism:coverDisplayDate>15 June 2015</prism:coverDisplayDate><prism:doi>10.1016/j.sna.2015.03.030</prism:doi><pii>S0924424715001533</pii><dc:description>© 2015 Elsevier B.V. All rights reserved. If the elongated filament of sodium polyacrylate gel immersed in 0.8 mM CaCl&lt;inf&gt;2&lt;/inf&gt; solution is placed in a DC electrical field across the field lines with one end affixed, up to four consequent sways of strip's free end can be observed. This phenomenon is still not clear as it takes place in the constant electric field with the constant polarity. To disclose underlying mechanism of the periodic bending, angle of the gel free end displacement (inclination) from the vertical (initial) position, the apparent area and the lengths of the cathodal and anodal borders of the projective image of the gel stripe were monitored. It was found, both the cathodal and the anodal sides of the stripe followed the trend of the gel shrinkage, but with a substantial time lag between them. The misbalance between the cathodal and the anodal contraction of the gel resulted in the strip periodic acting. The underlying mechanism of this phenomenon based on ionic diffusion and ionic exchange due to oriented ionic flux in a DC electric field is proposed.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:</affiliation-url><afid/><affilname>Ural State Medical University</affilname><name-variant>Biomedical Physics Department</name-variant><affiliation-city>Yekaterinburg</affiliation-city><affiliation-country>Russian Federation</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:</affiliation-url><afid/><affilname>Ural Federal University Named after the First President of Russia B.N. Yeltsyn</affilname><name-variant>Physics Department</name-variant><affiliation-city>Yekaterinburg</affiliation-city><affiliation-country>Russian Federation</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:</affiliation-url><afid/><affilname>Ural Federal University Named after the First President of Russia B.N. Yeltsyn</affilname><name-variant>Chemical Department</name-variant><affiliation-city>Yekaterinburg</affiliation-city><affiliation-country>Russian Federation</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">6</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:6601994496</author-url><authid>6601994496</authid><authname>Blyakhman F.</authname><surname>Blyakhman</surname><given-name>F. A.</given-name><initials>F.A.</initials><afid/><afid/></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:6601994496</author-url><authid>6601994496</authid><authname>Blyakhman F.</authname><surname>Blyakhman</surname><given-name>F. A.</given-name><initials>F.A.</initials><afid/><afid/></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:35588399100</author-url><authid>35588399100</authid><authname>Safronov A.</authname><surname>Safronov</surname><given-name>A. P.</given-name><initials>A.P.</initials><afid/></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:6603192790</author-url><authid>6603192790</authid><authname>Shklyar T.</authname><surname>Shklyar</surname><given-name>T. F.</given-name><initials>T.F.</initials><afid/><afid/></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:6603192790</author-url><authid>6603192790</authid><authname>Shklyar T.</authname><surname>Shklyar</surname><given-name>T. F.</given-name><initials>T.F.</initials><afid/><afid/></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56593107400</author-url><authid>56593107400</authid><authname>Filipovich M.</authname><surname>Filipovich</surname><given-name>M. A.</given-name><initials>M.A.</initials><afid/></author><authkeywords>DC electric field | Mechanical behavior | Polyelectrolyte gels</authkeywords><intid>35644776</intid><source-id>13660</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84926485893"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84926485893?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84926485893&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84926485893&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0014299915001855"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84926485893</prism:url><dc:identifier>SCOPUS_ID:84926485893</dc:identifier><eid>2-s2.0-84926485893</eid><dc:title>Rapamycin ameliorates brain metabolites alterations after transient focal ischemia in rats</dc:title><dc:creator>Chauhan A.</dc:creator><prism:publicationName>European Journal of Pharmacology</prism:publicationName><prism:issn>00142999</prism:issn><prism:eIssn>18790712</prism:eIssn><prism:volume>757</prism:volume><prism:pageRange>28-33</prism:pageRange><prism:coverDate>2015-06-15</prism:coverDate><prism:coverDisplayDate>15 June 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ejphar.2015.03.006</prism:doi><pii>S0014299915001855</pii><dc:description>© 2015 Elsevier B.V. All rights reserved. Rapamycin has been shown to protect against middle cerebral artery occlusion (MCAo) induced ischemic injury. In this study, the neuroprotective effect of rapamycin on the metabolic changes induced by MCAo was evaluated using nuclear magnetic resonance (NMR) spectroscopy of brain tissues. MCAo in rats was induced by insertion of nylon filament. One hour after ischemia, rapamycin (250 μg/kg, i.p.) in dimethyl sulfoxide was administered. Reperfusion was done 2 h after ischemia. Twenty-four hours after ischemia phospholipase A&lt;inf&gt;2&lt;/inf&gt; (PLA&lt;inf&gt;2&lt;/inf&gt;) levels and metabolic changes were assessed. Perchloric acid extraction was performed on the brain of all animals (n=7; sham, vehicle; DMSO and rapamycin 250 μg/kg) and the various brain metabolites were assessed by NMR spectroscopy. In all 44 metabolites were assigned in the proton NMR spectrum of rat brain tissues. In the vehicle group, we observed increased lactate levels and decreased levels of glutamate/glutamine, choline containing compounds, creatine/phosphocreatine (Cr/PCr), taurine, myo-inositol, γ-amino butryic acid (GABA), N-aspartyl aspartate (NAA), purine and pyrimidine metabolites. In rapamycin treated rats, there was increase in the levels of choline containing compounds, NAA, myo-inositol, glutamate/glutamine, GABA, Cr/PCr and taurine as compared to those of vehicle control (P&lt;0.05). Rapamycin treatment reduced PLA&lt;inf&gt;2&lt;/inf&gt; levels as compared to vehicle group (P&lt;0.05). Our findings indicated that rapamycin reduced the increased PLA&lt;inf&gt;2&lt;/inf&gt; levels and altered brain metabolites after MCAo. These protective effects might be attributed to its effect on cell membrane metabolism; glutamate induced toxicity and calcium homeostasis in stroke.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60009790</affiliation-url><afid>60009790</afid><affilname>All India Institute of Medical Sciences</affilname><name-variant>All India Institute of Medical Sciences</name-variant><affiliation-city>New Delhi</affiliation-city><affiliation-country>India</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60009790</affiliation-url><afid>60009790</afid><affilname>All India Institute of Medical Sciences</affilname><name-variant>All India Institute of Medical Sciences</name-variant><affiliation-city>New Delhi</affiliation-city><affiliation-country>India</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">4</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55420717600</author-url><authid>55420717600</authid><authname>Chauhan A.</authname><surname>Chauhan</surname><given-name>Anjali</given-name><initials>A.</initials><afid>60009790</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:35750626200</author-url><authid>35750626200</authid><authname>Sharma U.</authname><surname>Sharma</surname><given-name>Uma</given-name><initials>U.</initials><afid>60009790</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:35480401800</author-url><authid>35480401800</authid><authname>Jagannathan N.</authname><surname>Jagannathan</surname><given-name>Naranamangalam R.</given-name><initials>N.R.</initials><afid>60009790</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:7102638557</author-url><authid>7102638557</authid><authname>Gupta Y.</authname><surname>Gupta</surname><given-name>Yogendra Kumar</given-name><initials>Y.K.</initials><afid>60009790</afid></author><authkeywords>Focal cerebral ischemia | Metabolites | Middle cerebral artery occlusion | NMR spectroscopy | Rapamycin</authkeywords><intid>1785456505</intid><source-id>21333</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84923626886"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84923626886?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84923626886&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84923626886&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0378437115001612"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84923626886</prism:url><dc:identifier>SCOPUS_ID:84923626886</dc:identifier><eid>2-s2.0-84923626886</eid><dc:title>Multifractal analysis of managed and independent float exchange rates</dc:title><dc:creator>Stošić D.</dc:creator><prism:publicationName>Physica A: Statistical Mechanics and its Applications</prism:publicationName><prism:issn>03784371</prism:issn><prism:volume>428</prism:volume><prism:pageRange>13-18</prism:pageRange><prism:coverDate>2015-06-15</prism:coverDate><prism:coverDisplayDate>15 June 2015</prism:coverDisplayDate><prism:doi>10.1016/j.physa.2015.02.055</prism:doi><pii>S0378437115001612</pii><dc:description>© 2015 Elsevier B.V. All rights reserved. We investigate multifractal properties of daily price changes in currency rates using the multifractal detrended fluctuation analysis (MF-DFA). We analyze managed and independent floating currency rates in eight countries, and determine the changes in multifractal spectrum when transitioning between the two regimes. We find that after the transition from managed to independent float regime the changes in multifractal spectrum (position of maximum and width) indicate an increase in market efficiency. The observed changes are more pronounced for developed countries that have a well established trading market. After shuffling the series, we find that the multifractality is due to both probability density function and long term correlations for managed float regime, while for independent float regime multifractality is in most cases caused by broad probability density function.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60031482</affiliation-url><afid>60031482</afid><affilname>Universidade Federal de Pernambuco</affilname><name-variant>Federal University of Pernambuco</name-variant><affiliation-city>Recife</affiliation-city><affiliation-country>Brazil</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60000958</affiliation-url><afid>60000958</afid><affilname>Universidade Federal Rural de Pernambuco</affilname><name-variant>Universidade Federal Rural de Pernambuco</name-variant><affiliation-city>Recife</affiliation-city><affiliation-country>Brazil</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60019674</affiliation-url><afid>60019674</afid><affilname>Boston University</affilname><name-variant>Boston University</name-variant><affiliation-city>Boston</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">6</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56529379600</author-url><authid>56529379600</authid><authname>Stošić D.</authname><surname>Stošić</surname><given-name>Darko</given-name><initials>D.</initials><afid>60031482</afid><afid>60019674</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56529379600</author-url><authid>56529379600</authid><authname>Stošić D.</authname><surname>Stošić</surname><given-name>Darko</given-name><initials>D.</initials><afid>60031482</afid><afid>60019674</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56529379500</author-url><authid>56529379500</authid><authname>Stošić D.</authname><surname>Stošić</surname><given-name>Dusan</given-name><initials>D.</initials><afid>60031482</afid><afid>60019674</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56529379500</author-url><authid>56529379500</authid><authname>Stošić D.</authname><surname>Stošić</surname><given-name>Dusan</given-name><initials>D.</initials><afid>60031482</afid><afid>60019674</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:6701423164</author-url><authid>6701423164</authid><authname>Stošić T.</authname><surname>Stošić</surname><given-name>Tatijana</given-name><initials>T.</initials><afid>60000958</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:35375959000</author-url><authid>35375959000</authid><authname>Stanley H.</authname><surname>Stanley</surname><given-name>H. Eugene</given-name><initials>H.E.</initials><afid>60019674</afid></author><authkeywords>Currency rate | Independent float | Managed float | Market efficiency | Multifractal detrended fluctuation analysis</authkeywords><intid>1034999028</intid><source-id>29115</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84928981969"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84928981969?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84928981969&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84928981969&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84928981969</prism:url><dc:identifier>SCOPUS_ID:84928981969</dc:identifier><eid>2-s2.0-84928981969</eid><dc:title>Firm maternal parenting associated with decreased risk of excessive snacking in overweight children</dc:title><dc:creator>Rhee K.</dc:creator><prism:publicationName>Eating and Weight Disorders</prism:publicationName><prism:issn>11244909</prism:issn><prism:eIssn>15901262</prism:eIssn><prism:volume>20</prism:volume><prism:issueIdentifier>2</prism:issueIdentifier><prism:pageRange>195-203</prism:pageRange><prism:coverDate>2015-06-12</prism:coverDate><prism:coverDisplayDate>12 June 2015</prism:coverDisplayDate><prism:doi>10.1007/s40519-014-0164-x</prism:doi><dc:description>© 2014, Springer International Publishing Switzerland. Objective: To examine the relationship between parent feeding practices (restriction, monitoring, pressure to eat), general parenting behaviors (acceptance, psychological control, firm control), and aberrant child eating behaviors (emotional eating and excessive snacking) among overweight and normal weight children. Methods: Overweight and normal weight children between 8 and 12 years old and their mothers (n = 79, parent–child dyads) participated in this study. Mothers completed surveys on parent feeding practices (Child Feeding Questionnaire) and child eating behaviors (Family Eating and Activity Habits Questionnaire). Children reported on their mothers’ general parenting behaviors (Child Report of Parent Behavior Inventory). Parent and child height and weight were measured and demographic characteristics assessed. Logistic regression models, stratified by child weight status and adjusting for parent BMI, were used to determine which parenting dimensions and feeding practices were associated with child emotional eating and snacking behavior. Results: Overweight children displayed significantly more emotional eating and excessive snacking behavior than normal weight children. Mothers of overweight children used more restrictive feeding practices and psychological control. Restrictive feeding practices were associated with emotional eating in the overweight group (OR = 1.26, 95 % CI, 1.02, 1.56) and excessive snacking behavior in the normal weight group (OR = 1.13, 95 % CI, 1.01, 1.26). When examining general parenting, firm control was associated with decreased odds of excessive snacking in the overweight group (OR = 0.51, 95 % CI, 0.28, 0.93). Conclusion: Restrictive feeding practices were associated with aberrant child eating behaviors in both normal weight and overweight children. Firm general parenting however, was associated with decreased snacking behavior among overweight children. Longitudinal studies following children from infancy are needed to better understand the direction of these relationships.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60030612</affiliation-url><afid>60030612</afid><affilname>University of California, San Diego</affilname><name-variant>University of California San Diego</name-variant><affiliation-city>San Diego</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60030612</affiliation-url><afid>60030612</afid><affilname>University of California, San Diego</affilname><name-variant>University of California San Diego</name-variant><affiliation-city>San Diego</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60009796</affiliation-url><afid>60009796</afid><affilname>The Warren Alpert Medical School of Brown University</affilname><name-variant>Brown Medical School</name-variant><affiliation-city>Providence</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60009796</affiliation-url><afid>60009796</afid><affilname>The Warren Alpert Medical School of Brown University</affilname><name-variant>Brown Medical School</name-variant><affiliation-city>Providence</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60030612</affiliation-url><afid>60030612</afid><affilname>University of California, San Diego</affilname><name-variant>University of California San Diego</name-variant><affiliation-city>San Diego</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">8</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:12761220400</author-url><authid>12761220400</authid><authname>Rhee K.</authname><surname>Rhee</surname><given-name>Kyung E.</given-name><initials>K.E.</initials><afid>60030612</afid><afid>60030612</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:12761220400</author-url><authid>12761220400</authid><authname>Rhee K.</authname><surname>Rhee</surname><given-name>Kyung E.</given-name><initials>K.E.</initials><afid>60030612</afid><afid>60030612</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:6603508115</author-url><authid>6603508115</authid><authname>Boutelle K.</authname><surname>Boutelle</surname><given-name>Kerri N.</given-name><initials>K.N.</initials><afid>60030612</afid><afid>60030612</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:6603508115</author-url><authid>6603508115</authid><authname>Boutelle K.</authname><surname>Boutelle</surname><given-name>Kerri N.</given-name><initials>K.N.</initials><afid>60030612</afid><afid>60030612</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:6602985780</author-url><authid>6602985780</authid><authname>Jelalian E.</authname><surname>Jelalian</surname><given-name>Elissa</given-name><initials>E.</initials><afid>60009796</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:7402034322</author-url><authid>7402034322</authid><authname>Barnes R.</authname><surname>Barnes</surname><given-name>Richard</given-name><initials>R.</initials><afid>60030612</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:6701724669</author-url><authid>6701724669</authid><authname>Dickstein S.</authname><surname>Dickstein</surname><given-name>Susan</given-name><initials>S.</initials><afid>60009796</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:35376710700</author-url><authid>35376710700</authid><authname>Wing R.</authname><surname>Wing</surname><given-name>Rena R.</given-name><initials>R.R.</initials><afid>60009796</afid></author><authkeywords>Child eating behaviors | Childhood obesity | Emotional eating | General parenting | Parent feeding practices | Parenting style | Snacking</authkeywords><intid>1035879739</intid><source-id>15460</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84923254076"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84923254076?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84923254076&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84923254076&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0375960115001085"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84923254076</prism:url><dc:identifier>SCOPUS_ID:84923254076</dc:identifier><eid>2-s2.0-84923254076</eid><dc:title>Agent-based financial dynamics model from stochastic interacting epidemic system and complexity analysis</dc:title><dc:creator>Lu Y.</dc:creator><prism:publicationName>Physics Letters, Section A: General, Atomic and Solid State Physics</prism:publicationName><prism:issn>03759601</prism:issn><prism:volume>379</prism:volume><prism:issueIdentifier>14-15</prism:issueIdentifier><prism:pageRange>1012-1016</prism:pageRange><prism:coverDate>2015-06-12</prism:coverDate><prism:coverDisplayDate>12 June 2015</prism:coverDisplayDate><prism:doi>10.1016/j.physleta.2015.02.004</prism:doi><pii>S0375960115001085</pii><dc:description>© 2015 Elsevier B.V. All rights reserved. An agent-based financial stock price model is developed and investigated by a stochastic interacting epidemic system, which is one of the statistical physics systems and has been used to model the spread of an epidemic or a forest fire. Numerical and statistical analysis are performed on the simulated returns of the proposed financial model. Complexity properties of the financial time series are explored by calculating the correlation dimension and using the modified multiscale entropy method. In order to verify the rationality of the financial model, the real stock market indexes, Shanghai Composite Index and Shenzhen Component Index, are studied in comparison with the simulation data of the proposed model for the different infectiousness parameters. The empirical research reveals that this financial model can reproduce some important features of the real stock markets.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60022381</affiliation-url><afid>60022381</afid><affilname>Beijing Jiaotong Daxue</affilname><name-variant>Beijing Jiaotong University</name-variant><affiliation-city>Beijing</affiliation-city><affiliation-country>China</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">3</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56517224400</author-url><authid>56517224400</authid><authname>Lu Y.</authname><surname>Lu</surname><given-name>Yunfan</given-name><initials>Y.</initials><afid>60022381</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:55946707000</author-url><authid>55946707000</authid><authname>Wang J.</authname><surname>Wang</surname><given-name>Jun</given-name><initials>J.</initials><afid>60022381</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:55286614500</author-url><authid>55286614500</authid><authname>Niu H.</authname><surname>Niu</surname><given-name>Hongli</given-name><initials>H.</initials><afid>60022381</afid></author><authkeywords>Complexity analysis | Financial time | Nonlinear analysis | series model | Statistical physics system | Stochastic interacting epidemic system</authkeywords><intid>1784941897</intid><source-id>29464</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84928991637"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84928991637?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84928991637&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84928991637&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84928991637</prism:url><dc:identifier>SCOPUS_ID:84928991637</dc:identifier><eid>2-s2.0-84928991637</eid><dc:title>Ultrasound, anthropometry and bioimpedance: a comparison in predicting fat deposition in non-alcoholic fatty liver disease</dc:title><dc:creator>Vitturi N.</dc:creator><prism:publicationName>Eating and Weight Disorders</prism:publicationName><prism:issn>11244909</prism:issn><prism:eIssn>15901262</prism:eIssn><prism:volume>20</prism:volume><prism:issueIdentifier>2</prism:issueIdentifier><prism:pageRange>241-247</prism:pageRange><prism:coverDate>2015-06-12</prism:coverDate><prism:coverDisplayDate>12 June 2015</prism:coverDisplayDate><prism:doi>10.1007/s40519-014-0146-z</prism:doi><dc:description>© 2014, Springer International Publishing Switzerland. Purpose: The aim of our study was the evaluation of anthropometric measurements [waist circumference and sagittal abdominal diameter (SAD)] and abdominal bioelectrical impedance analysis (BIA) (ViScan, TANITA) in comparison to several abdominal ultrasonographic (US) measurements to estimate visceral fat deposition and liver steatosis in a population of 105 subjects. Methods: All 105 patients underwent a complete anthropometric evaluation, blood sample for the determination of total cholesterol, HDL cholesterol, triglycerides, glucose, insulin, high-sensitivity C-reactive protein, BIA and US measurements (peritoneal, pre-peritoneal, peri-renal, para-renal and peri-hepatic fat thickness). Results: All the ultrasonographic markers considered in our study are related to the presence of non-alcoholic fatty liver disease (NAFLD), and so is true for SAD. Comparing ROC curves, peritoneal fat tissue thickness, SAD and ViScan visceral index are significantly better than waist circumference in predicting the presence of NAFLD (AUC 0.79 ± 0.04; 0.81 ± 0.05; 0.82 ± 0.04 vs 0.76 ± 0.05, respectively). Conclusions: According to our data, various methods may be useful in evaluating NAFLD, but only ViScan visceral index, US peritoneal fat thickness and SAD are better than waist circumference. Among them, SAD is the most promising, due to its small cost and time consumption.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60027298</affiliation-url><afid>60027298</afid><affilname>Azienda Ospedaliera Di Padova</affilname><affiliation-city>Padua</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60027298</affiliation-url><afid>60027298</afid><affilname>Azienda Ospedaliera Di Padova</affilname><affiliation-city>Padua</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">7</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:24176374500</author-url><authid>24176374500</authid><authname>Vitturi N.</authname><surname>Vitturi</surname><given-name>Nicola</given-name><initials>N.</initials><afid>60027298</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:55319008400</author-url><authid>55319008400</authid><authname>Soattin M.</authname><surname>Soattin</surname><given-name>Marta</given-name><initials>M.</initials><afid>60027298</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:24476301400</author-url><authid>24476301400</authid><authname>De Stefano F.</authname><surname>De Stefano</surname><given-name>Fabio</given-name><initials>F.</initials><afid>60027298</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:6603529398</author-url><authid>6603529398</authid><authname>Vianello D.</authname><surname>Vianello</surname><given-name>Daniela</given-name><initials>D.</initials><afid>60027298</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:7006480504</author-url><authid>7006480504</authid><authname>Zambon A.</authname><surname>Zambon</surname><given-name>Alberto</given-name><initials>A.</initials><afid>60027298</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:36046052600</author-url><authid>36046052600</authid><authname>Plebani M.</authname><surname>Plebani</surname><given-name>Mario</given-name><initials>M.</initials><afid>60027298</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:7005513943</author-url><authid>7005513943</authid><authname>Busetto L.</authname><surname>Busetto</surname><given-name>Luca</given-name><initials>L.</initials><afid>60027298</afid></author><authkeywords>Abdominal fat | Bioimpedance | NAFLD | Ultrasound</authkeywords><intid>1535884401</intid><source-id>15460</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84930010657"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84930010657?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84930010657&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84930010657&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84930010657</prism:url><dc:identifier>SCOPUS_ID:84930010657</dc:identifier><eid>2-s2.0-84930010657</eid><dc:title>Optimization of nanoparticles for cardiovascular tissue engineering</dc:title><dc:creator>Izadifar M.</dc:creator><prism:publicationName>Nanotechnology</prism:publicationName><prism:issn>09574484</prism:issn><prism:eIssn>13616528</prism:eIssn><prism:volume>26</prism:volume><prism:issueIdentifier>23</prism:issueIdentifier><prism:coverDate>2015-06-12</prism:coverDate><prism:coverDisplayDate>12 June 2015</prism:coverDisplayDate><prism:doi>10.1088/0957-4484/26/23/235301</prism:doi><dc:description>© 2015 IOP Publishing Ltd. Nano-particulate delivery systems have increasingly been playing important roles in cardiovascular tissue engineering. Properties of nanoparticles (e.g. size, polydispersity, loading capacity, zeta potential, morphology) are essential to system functions. Notably, these characteristics are regulated by fabrication variables, but in a complicated manner. This raises a great need to optimize fabrication process variables to ensure the desired nanoparticle characteristics. This paper presents a comprehensive experimental study on this matter, along with a novel method, the so-called Geno-Neural approach, to analyze, predict and optimize fabrication variables for desired nanoparticle characteristics. Specifically, ovalbumin was used as a protein model of growth factors used in cardiovascular tissue regeneration, and six fabrication variables were examined with regard to their influence on the characteristics of nanoparticles made from high molecular weight poly(lactide-co-glycolide). The six-factor five-level central composite rotatable design was applied to the conduction of experiments, and based on the experimental results, a geno-neural model was developed to determine the optimum fabrication conditions. For desired particle sizes of 150, 200, 250 and 300 nm, respectively, the optimum conditions to achieve the low polydispersity index, higher negative zeta potential and higher loading capacity were identified based on the developed geno-neural model and then evaluated experimentally. The experimental results revealed that the polymer and the external aqueous phase concentrations and their interactions with other fabrication variables were the most significant variables to affect the size, polydispersity index, zeta potential, loading capacity and initial burst release of the nanoparticles, while the electron microscopy images of the nanoparticles showed their spherical geometries with no sign of large pores or cracks on their surfaces. The release study revealed that the onset of the third phase of release can be affected by the polymer concentration. Circular dichroism spectroscopy indicated that ovalbumin structural integrity is preserved during the encapsulation process. Findings from this study would greatly contribute to the design of high molecular weight poly(lactide-co-glycolide) nanoparticles for prolonged release patterns in cardiovascular engineering.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60015186</affiliation-url><afid>60015186</afid><affilname>University of Saskatchewan</affilname><name-variant>University of Saskatchewan</name-variant><affiliation-city>Saskatoon</affiliation-city><affiliation-country>Canada</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60015186</affiliation-url><afid>60015186</afid><affilname>University of Saskatchewan</affilname><name-variant>University of Saskatchewan</name-variant><affiliation-city>Saskatoon</affiliation-city><affiliation-country>Canada</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60015186</affiliation-url><afid>60015186</afid><affilname>University of Saskatchewan</affilname><name-variant>University of Saskatchewan</name-variant><affiliation-city>Saskatoon</affiliation-city><affiliation-country>Canada</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60015186</affiliation-url><afid>60015186</afid><affilname>University of Saskatchewan</affilname><name-variant>University of Saskatchewan</name-variant><affiliation-city>Saskatoon</affiliation-city><affiliation-country>Canada</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60018467</affiliation-url><afid>60018467</afid><affilname>Royal University Hospital</affilname><name-variant>Royal University Hospital</name-variant><affiliation-city>Saskatoon</affiliation-city><affiliation-country>Canada</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">8</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:15831782600</author-url><authid>15831782600</authid><authname>Izadifar M.</authname><surname>Izadifar</surname><given-name>Mohammad</given-name><initials>M.</initials><afid>60015186</afid><afid>60018467</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:15831782600</author-url><authid>15831782600</authid><authname>Izadifar M.</authname><surname>Izadifar</surname><given-name>Mohammad</given-name><initials>M.</initials><afid>60015186</afid><afid>60018467</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:13105768300</author-url><authid>13105768300</authid><authname>Kelly M.</authname><surname>Kelly</surname><given-name>Michael E.</given-name><initials>M.E.</initials><afid>60015186</afid><afid>60015186</afid><afid>60018467</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:13105768300</author-url><authid>13105768300</authid><authname>Kelly M.</authname><surname>Kelly</surname><given-name>Michael E.</given-name><initials>M.E.</initials><afid>60015186</afid><afid>60015186</afid><afid>60018467</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:13105768300</author-url><authid>13105768300</authid><authname>Kelly M.</authname><surname>Kelly</surname><given-name>Michael E.</given-name><initials>M.E.</initials><afid>60015186</afid><afid>60015186</afid><afid>60018467</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:8301614000</author-url><authid>8301614000</authid><authname>Haddadi A.</authname><surname>Haddadi</surname><given-name>Azita</given-name><initials>A.</initials><afid>60015186</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:10439272200</author-url><authid>10439272200</authid><authname>Chen X.</authname><surname>Chen</surname><given-name>Xiongbiao</given-name><initials>X.</initials><afid>60015186</afid><afid>60015186</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:10439272200</author-url><authid>10439272200</authid><authname>Chen X.</authname><surname>Chen</surname><given-name>Xiongbiao</given-name><initials>X.</initials><afid>60015186</afid><afid>60015186</afid></author><authkeywords>Cardiovascular | Controlled release | Delivery systems | Nanoparticles | Tissue engineering</authkeywords><intid>1036045176</intid><article-number>235301</article-number><source-id>110040</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84930226582"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84930226582?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84930226582&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84930226582&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84930226582</prism:url><dc:identifier>SCOPUS_ID:84930226582</dc:identifier><eid>2-s2.0-84930226582</eid><dc:title>Cobalt(II)/silver relay catalytic isocyanide insertion/cycloaddition cascades: A new access to pyrrolo[2,3-b]indoles</dc:title><dc:creator>Gao Q.</dc:creator><prism:publicationName>Chemical Communications</prism:publicationName><prism:issn>13597345</prism:issn><prism:eIssn>1364548X</prism:eIssn><prism:volume>51</prism:volume><prism:issueIdentifier>46</prism:issueIdentifier><prism:pageRange>9519-9522</prism:pageRange><prism:coverDate>2015-06-11</prism:coverDate><prism:coverDisplayDate>11 June 2015</prism:coverDisplayDate><prism:doi>10.1039/c5cc02754c</prism:doi><dc:description>© The Royal Society of Chemistry 2015. The combination of Co(acac)&lt;inf&gt;2&lt;/inf&gt; and AgOTf enables the bimetallic relay catalysis reaction of 2-ethynylanilines and isocyanides, allowing easy and low-cost access to new densely functionalized pyrrolo[2,3-b]indoles. The reaction pathway involves a Co(acac)&lt;inf&gt;2&lt;/inf&gt;-catalyzed double isocyanide insertion followed by a silver-enabled 1,3-dipolar cycloaddition. The synthetic utility of these bicycloaddition reactions results in subsequent C-C and C-N bond-forming events to rapidly build up molecular complexity.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60004691</affiliation-url><afid>60004691</afid><affilname>Xuzhou Normal University</affilname><name-variant>Xuzhou Normal University</name-variant><affiliation-city>Xuzhou</affiliation-city><affiliation-country>China</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">7</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56662657000</author-url><authid>56662657000</authid><authname>Gao Q.</authname><surname>Gao</surname><given-name>Qian</given-name><initials>Q.</initials><afid>60004691</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56662659200</author-url><authid>56662659200</authid><authname>Zhou P.</authname><surname>Zhou</surname><given-name>Peng</given-name><initials>P.</initials><afid>60004691</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56662570400</author-url><authid>56662570400</authid><authname>Liu F.</authname><surname>Liu</surname><given-name>Feng</given-name><initials>F.</initials><afid>60004691</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:24179319500</author-url><authid>24179319500</authid><authname>Hao W.</authname><surname>Hao</surname><given-name>Wen Juan</given-name><initials>W.J.</initials><afid>60004691</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:7201495738</author-url><authid>7201495738</authid><authname>Yao C.</authname><surname>Yao</surname><given-name>Changsheng</given-name><initials>C.</initials><afid>60004691</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:37008365000</author-url><authid>37008365000</authid><authname>Jiang B.</authname><surname>Jiang</surname><given-name>Bo</given-name><initials>B.</initials><afid>60004691</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:7202726193</author-url><authid>7202726193</authid><authname>Tu S.</authname><surname>Tu</surname><given-name>Shu Jiang</given-name><initials>S.J.</initials><afid>60004691</afid></author><intid>2036081859</intid><source-id>22781</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84926455846"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84926455846?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84926455846&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84926455846&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S016836591500214X"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84926455846</prism:url><dc:identifier>SCOPUS_ID:84926455846</dc:identifier><eid>2-s2.0-84926455846</eid><dc:title>Sequential delivery of angiogenic growth factors improves revascularization and heart function after myocardial infarction</dc:title><dc:creator>Awada H.</dc:creator><prism:publicationName>Journal of Controlled Release</prism:publicationName><prism:issn>01683659</prism:issn><prism:eIssn>18734995</prism:eIssn><prism:volume>207</prism:volume><prism:pageRange>7-17</prism:pageRange><prism:coverDate>2015-06-10</prism:coverDate><prism:coverDisplayDate>10 June 2015</prism:coverDisplayDate><prism:doi>10.1016/j.jconrel.2015.03.034</prism:doi><pii>S016836591500214X</pii><dc:description>© 2015 Elsevier B.V. All rights reserved. Treatment of ischemia through therapeutic angiogenesis faces significant challenges. Growth factor (GF)-based therapies can be more effective when concerns such as GF spatiotemporal presentation, bioactivity, bioavailability, and localization are addressed. During angiogenesis, vascular endothelial GF (VEGF) is required early to initiate neovessel formation while platelet-derived GF (PDGF-BB) is needed later to stabilize the neovessels. The spatiotemporal delivery of multiple bioactive GFs involved in angiogenesis, in a close mimic to physiological cues, holds great potential to treat ischemic diseases. To achieve sequential release of VEGF and PDGF, we embed VEGF in fibrin gel and PDGF in a heparin-based coacervate that is distributed in the same fibrin gel. In vitro, we show the benefits of this controlled delivery approach on cell proliferation, chemotaxis, and capillary formation. A rat myocardial infarction (MI) model demonstrated the effectiveness of this delivery system in improving cardiac function, ventricular wall thickness, angiogenesis, cardiac muscle survival, and reducing fibrosis and inflammation in the infarct zone compared to saline, empty vehicle, and free GFs. Collectively, our results show that this delivery approach mitigated the injury caused by MI and may serve as a new therapy to treat ischemic hearts pending further examination.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60015543</affiliation-url><afid>60015543</afid><affilname>University of Pittsburgh</affilname><name-variant>University of Pittsburgh</name-variant><affiliation-city>Pittsburgh</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60015543</affiliation-url><afid>60015543</afid><affilname>University of Pittsburgh</affilname><name-variant>University of Pittsburgh</name-variant><affiliation-city>Pittsburgh</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60015543</affiliation-url><afid>60015543</afid><affilname>University of Pittsburgh</affilname><name-variant>University of Pittsburgh</name-variant><affiliation-city>Pittsburgh</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60015543</affiliation-url><afid>60015543</afid><affilname>University of Pittsburgh</affilname><name-variant>University of Pittsburgh</name-variant><affiliation-city>Pittsburgh</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60015543</affiliation-url><afid>60015543</afid><affilname>University of Pittsburgh</affilname><name-variant>University of Pittsburgh</name-variant><affiliation-city>Pittsburgh</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">9</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56010513800</author-url><authid>56010513800</authid><authname>Awada H.</authname><surname>Awada</surname><given-name>Hassan K.</given-name><initials>H.K.</initials><afid>60015543</afid><afid>60015543</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56010513800</author-url><authid>56010513800</authid><authname>Awada H.</authname><surname>Awada</surname><given-name>Hassan K.</given-name><initials>H.K.</initials><afid>60015543</afid><afid>60015543</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:47461204800</author-url><authid>47461204800</authid><authname>Johnson N.</authname><surname>Johnson</surname><given-name>Noah R.</given-name><initials>N.R.</initials><afid>60015543</afid><afid>60015543</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:47461204800</author-url><authid>47461204800</authid><authname>Johnson N.</authname><surname>Johnson</surname><given-name>Noah R.</given-name><initials>N.R.</initials><afid>60015543</afid><afid>60015543</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:35189997100</author-url><authid>35189997100</authid><authname>Wang Y.</authname><surname>Wang</surname><given-name>Yadong</given-name><initials>Y.</initials><afid>60015543</afid><afid>60015543</afid><afid>60015543</afid><afid>60015543</afid><afid>60015543</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:35189997100</author-url><authid>35189997100</authid><authname>Wang Y.</authname><surname>Wang</surname><given-name>Yadong</given-name><initials>Y.</initials><afid>60015543</afid><afid>60015543</afid><afid>60015543</afid><afid>60015543</afid><afid>60015543</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:35189997100</author-url><authid>35189997100</authid><authname>Wang Y.</authname><surname>Wang</surname><given-name>Yadong</given-name><initials>Y.</initials><afid>60015543</afid><afid>60015543</afid><afid>60015543</afid><afid>60015543</afid><afid>60015543</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:35189997100</author-url><authid>35189997100</authid><authname>Wang Y.</authname><surname>Wang</surname><given-name>Yadong</given-name><initials>Y.</initials><afid>60015543</afid><afid>60015543</afid><afid>60015543</afid><afid>60015543</afid><afid>60015543</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:35189997100</author-url><authid>35189997100</authid><authname>Wang Y.</authname><surname>Wang</surname><given-name>Yadong</given-name><initials>Y.</initials><afid>60015543</afid><afid>60015543</afid><afid>60015543</afid><afid>60015543</afid><afid>60015543</afid></author><authkeywords>Coacervate | Controlled release | Fibrin gel | Growth factors | Myocardial infarction | Therapeutic angiogenesis</authkeywords><intid>2035447668</intid><source-id>23010</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84930226083"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84930226083?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84930226083&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84930226083&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84930226083</prism:url><dc:identifier>SCOPUS_ID:84930226083</dc:identifier><eid>2-s2.0-84930226083</eid><dc:title>Unbreak My Heart: Targeting Mitochondrial Autophagy in Diabetic Cardiomyopathy</dc:title><dc:creator>Kubli D.</dc:creator><prism:publicationName>Antioxidants and Redox Signaling</prism:publicationName><prism:issn>15230864</prism:issn><prism:eIssn>15577716</prism:eIssn><prism:volume>22</prism:volume><prism:issueIdentifier>17</prism:issueIdentifier><prism:pageRange>1527-1544</prism:pageRange><prism:coverDate>2015-06-10</prism:coverDate><prism:coverDisplayDate>10 June 2015</prism:coverDisplayDate><prism:doi>10.1089/ars.2015.6322</prism:doi><dc:description>© Copyright 2015, Mary Ann Liebert, Inc. Significance: Diabetes is strongly associated with increased incidence of heart disease and mortality due to development of diabetic cardiomyopathy. Even in the absence of cardiovascular disease, cardiomyopathy frequently arises in diabetic patients. Current treatment options for cardiomyopathy in diabetic patients are the same as for nondiabetic patients and do not address the causes underlying the loss of contractility. Recent Advances: Although there are numerous distinctions between Type 1 and Type 2 diabetes, recent evidence suggests that the two disease states converge on mitochondria as an epicenter for cardiomyocyte damage. Critical Issues: Accumulation of dysfunctional mitochondria contributes to cardiac tissue injury in both acute and chronic conditions. Removal of damaged mitochondria by macroautophagy, termed "mitophagy," is critical for maintaining cardiomyocyte health and contractility both under normal conditions and during stress. However, very little is known about the involvement of mitophagy in the pathogenesis of diabetic cardiomyopathy. A growing interest in this topic has given rise to a wave of publications that aim at deciphering the status of autophagy and mitophagy in Type 1 and Type 2 diabetes. Future Directions: This review summarizes these recent studies with the goal of drawing conclusions about the activation or suppression of autophagy and mitophagy in the diabetic heart. A better understanding of how autophagy and mitophagy are affected in the diabetic myocardium is still needed, as well as whether they can be targeted therapeutically.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60030612</affiliation-url><afid>60030612</afid><affilname>University of California, San Diego</affilname><name-variant>University of California San Diego</name-variant><affiliation-city>San Diego</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>re</subtype><subtypeDescription>Review</subtypeDescription><author-count limit="100">2</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:18037698400</author-url><authid>18037698400</authid><authname>Kubli D.</authname><surname>Kubli</surname><given-name>Dieter A.</given-name><initials>D.A.</initials><afid>60030612</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:8787569000</author-url><authid>8787569000</authid><authname>Gustafsson Å.</authname><surname>Gustafsson</surname><given-name>Åsa B.</given-name><initials>Å.B.</initials><afid>60030612</afid></author><intid>1786088441</intid><source-id>27514</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84930226977"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84930226977?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84930226977&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84930226977&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84930226977</prism:url><dc:identifier>SCOPUS_ID:84930226977</dc:identifier><eid>2-s2.0-84930226977</eid><dc:title>Diabetic Cardiomyopathy and the Role of Mitochondrial Dysfunction: Novel Insights, Mechanisms, and Therapeutic Strategies</dc:title><dc:creator>Aon M.</dc:creator><prism:publicationName>Antioxidants and Redox Signaling</prism:publicationName><prism:issn>15230864</prism:issn><prism:eIssn>15577716</prism:eIssn><prism:volume>22</prism:volume><prism:issueIdentifier>17</prism:issueIdentifier><prism:pageRange>1499-1501</prism:pageRange><prism:coverDate>2015-06-10</prism:coverDate><prism:coverDisplayDate>10 June 2015</prism:coverDisplayDate><prism:doi>10.1089/ars.2015.6349</prism:doi><dc:description>© Copyright 2015, Mary Ann Liebert, Inc. This Forum addresses the role of mitochondrial dysfunction in the multifactorial nature of diabetic cardiomyopathy (DCM) from multiple angles. Contributors deliver a diverse and in-depth view of the state-of-the-art in DCM, from bench to bedside. What emerges is a picture of mitochondrial dysfunction as a central upstream defect, inflicted on the heart by diabetes. Collectively, the authors pinpoint high-value knowledge gaps, propose new conceptual frameworks, and highlight understudied, but promising, research themes.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60005248</affiliation-url><afid>60005248</afid><affilname>Johns Hopkins University</affilname><name-variant>Johns Hopkins University</name-variant><affiliation-city>Baltimore</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">2</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56664633300</author-url><authid>56664633300</authid><authname>Aon M.</authname><surname>Aon</surname><given-name>Miguel A.</given-name><initials>M.A.</initials><afid>60005248</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56662708500</author-url><authid>56662708500</authid><authname>Foster D.</authname><surname>Foster</surname><given-name>D. Brian</given-name><initials>D.B.</initials><afid>60005248</afid></author><intid>2036081532</intid><source-id>27514</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84927145438"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84927145438?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84927145438&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84927145438&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0168365915002163"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84927145438</prism:url><dc:identifier>SCOPUS_ID:84927145438</dc:identifier><eid>2-s2.0-84927145438</eid><dc:title>Mitochondrial biology, targets, and drug delivery</dc:title><dc:creator>Milane L.</dc:creator><prism:publicationName>Journal of Controlled Release</prism:publicationName><prism:issn>01683659</prism:issn><prism:eIssn>18734995</prism:eIssn><prism:volume>207</prism:volume><prism:pageRange>40-58</prism:pageRange><prism:coverDate>2015-06-10</prism:coverDate><prism:coverDisplayDate>10 June 2015</prism:coverDisplayDate><prism:doi>10.1016/j.jconrel.2015.03.036</prism:doi><pii>S0168365915002163</pii><dc:description>© 2015 Elsevier B.V. All rights reserved. In recent years, mitochondrial medicine has emerged as a new discipline resting at the intersection of mitochondrial biology, pathology, and pharmaceutics. The central role of mitochondria in critical cellular processes such as metabolism and apoptosis has placed mitochondria at the forefront of cell science. Advances in mitochondrial biology have revealed that these organelles continually undergo fusion and fission while functioning independently and in complex cellular networks, establishing direct membrane contacts with each other and with other organelles. Understanding the diverse cellular functions of mitochondria has contributed to understanding mitochondrial dysfunction in disease states. Polyplasmy and heteroplasmy contribute to mitochondrial phenotypes and associated dysfunction. Residing at the center of cell biology, cellular functions, and disease pathology and being laden with receptors and targets, mitochondria are beacons for pharmaceutical modification. This review presents the current state of mitochondrial medicine with a focus on mitochondrial function, dysfunction, and common disease; mitochondrial receptors, targets, and substrates; and mitochondrial drug design and drug delivery with a focus on the application of nanotechnology to mitochondrial medicine. Mitochondrial medicine is at the precipice of clinical translation; the objective of this review is to aid in the advancement of mitochondrial medicine from infancy to application.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60028628</affiliation-url><afid>60028628</afid><affilname>Northeastern University</affilname><name-variant>Northeastern University</name-variant><affiliation-city>Boston</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60019600</affiliation-url><afid>60019600</afid><affilname>Nova Southeastern University</affilname><name-variant>Nova Southeastern University</name-variant><affiliation-city>Fort Lauderdale</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>re</subtype><subtypeDescription>Review</subtypeDescription><author-count limit="100">5</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:35311609000</author-url><authid>35311609000</authid><authname>Milane L.</authname><surname>Milane</surname><given-name>Lara</given-name><initials>L.</initials><afid>60028628</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56587475600</author-url><authid>56587475600</authid><authname>Trivedi M.</authname><surname>Trivedi</surname><given-name>Malav</given-name><initials>M.</initials><afid>60019600</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:35226760800</author-url><authid>35226760800</authid><authname>Singh A.</authname><surname>Singh</surname><given-name>Amit</given-name><initials>A.</initials><afid>60028628</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:35726315000</author-url><authid>35726315000</authid><authname>Talekar M.</authname><surname>Talekar</surname><given-name>Meghna</given-name><initials>M.</initials><afid>60028628</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:7003769021</author-url><authid>7003769021</authid><authname>Amiji M.</authname><surname>Amiji</surname><given-name>Mansoor</given-name><initials>M.</initials><afid>60028628</afid></author><authkeywords>Drug delivery | Mitochondria | Mitochondriotropics | Nanomedicine | Nanoparticles</authkeywords><intid>2035565528</intid><source-id>23010</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84925939458"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84925939458?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84925939458&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84925939458&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0928098715000895"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84925939458</prism:url><dc:identifier>SCOPUS_ID:84925939458</dc:identifier><eid>2-s2.0-84925939458</eid><dc:title>In vitro and in vivo ocular biocompatibility of electrospun poly(ε-caprolactone) nanofibers</dc:title><dc:creator>Da Silva G.</dc:creator><prism:publicationName>European Journal of Pharmaceutical Sciences</prism:publicationName><prism:issn>09280987</prism:issn><prism:eIssn>18790720</prism:eIssn><prism:volume>73</prism:volume><prism:pageRange>9-19</prism:pageRange><prism:coverDate>2015-06-10</prism:coverDate><prism:coverDisplayDate>10 June 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ejps.2015.03.003</prism:doi><pii>S0928098715000895</pii><dc:description>© 2015 Elsevier B.V. All rights reserved. Abstract Biocompatibility is a requirement for the development of nanofibers for ophthalmic applications. In this study, nanofibers were elaborated using poly(ε-caprolactone) via electrospinning. The ocular biocompatibility of this material was investigated. MIO-M1 and ARPE-19 cell cultures were incubated with nanofibers and cellular responses were monitored by viability and morphology. The in vitro biocompatibility revealed that the nanofibers were not cytotoxic to the ocular cells. These cells exposed to the nanofibers proliferated and formed an organized monolayer. ARPE-19 and MIO-M1 cells were capable of expressing GFAP, respectively, demonstrating their functionality. Nanofibers were inserted into the vitreous cavity of the rat's eye for 10 days and the in vivo biocompatibility was investigated using Optical Coherence Tomography (OCT), histology and measuring the expression of pro-inflammatory genes (IL-1β, TNF-α, VEGF and iNOS) (real-time PCR). The OCT and the histological analyzes exhibited the preserved architecture of the tissues of the eye. The biomaterial did not elicit an inflammatory reaction and pro-inflammatory cytokines were not expressed by the retinal cells, and the other posterior tissues of the eye. Results from the biocompatibility studies indicated that the nanofibers exhibited a high degree of cellular biocompatibility and short-term intraocular tolerance, indicating that they might be applied as drug carrier for ophthalmic use.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:113373512</affiliation-url><afid>113373512</afid><affilname>Federal University of São João Del Rey</affilname><name-variant>Federal University of Sao Joao Del Rey</name-variant><affiliation-city/><affiliation-country>Brazil</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60030074</affiliation-url><afid>60030074</afid><affilname>Universidade Federal de Minas Gerais</affilname><name-variant>Universidade Federal de Minas Gerais</name-variant><affiliation-city>Belo Horizonte</affiliation-city><affiliation-country>Brazil</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60030074</affiliation-url><afid>60030074</afid><affilname>Universidade Federal de Minas Gerais</affilname><name-variant>Universidade Federal de Minas Gerais</name-variant><affiliation-city>Belo Horizonte</affiliation-city><affiliation-country>Brazil</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60000905</affiliation-url><afid>60000905</afid><affilname>Inserm</affilname><name-variant>INSERM</name-variant><affiliation-city>Paris</affiliation-city><affiliation-country>France</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60028950</affiliation-url><afid>60028950</afid><affilname>Universite Paris Descartes</affilname><name-variant>Université Paris Descartes</name-variant><affiliation-city>Paris</affiliation-city><affiliation-country>France</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60021567</affiliation-url><afid>60021567</afid><affilname>AP-HP Assistance Publique - Hopitaux de Paris</affilname><name-variant>Assistance Publique-Hôpitaux de Paris</name-variant><affiliation-city>Paris</affiliation-city><affiliation-country>France</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">10</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:15729298600</author-url><authid>15729298600</authid><authname>Da Silva G.</authname><surname>Da Silva</surname><given-name>Gisele Rodrigues</given-name><initials>G.R.</initials><afid>113373512</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56576059000</author-url><authid>56576059000</authid><authname>Lima T.</authname><surname>Lima</surname><given-name>Tadeu Henrique</given-name><initials>T.H.</initials><afid>60030074</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56203861400</author-url><authid>56203861400</authid><authname>Oréfice R.</authname><surname>Oréfice</surname><given-name>Rodrigo Lambert</given-name><initials>R.L.</initials><afid>60030074</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:55930510600</author-url><authid>55930510600</authid><authname>Fernandes-Cunha G.</authname><surname>Fernandes-Cunha</surname><given-name>Gabriella Maria</given-name><initials>G.M.</initials><afid>60030074</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:6505770582</author-url><authid>6505770582</authid><authname>Silva-Cunha A.</authname><surname>Silva-Cunha</surname><given-name>Armando</given-name><initials>A.</initials><afid>60030074</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:55301272300</author-url><authid>55301272300</authid><authname>Zhao M.</authname><surname>Zhao</surname><given-name>Min</given-name><initials>M.</initials><afid>60000905</afid><afid>60028950</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:55301272300</author-url><authid>55301272300</authid><authname>Zhao M.</authname><surname>Zhao</surname><given-name>Min</given-name><initials>M.</initials><afid>60000905</afid><afid>60028950</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:7005808435</author-url><authid>7005808435</authid><authname>Behar-Cohen F.</authname><surname>Behar-Cohen</surname><given-name>Francine</given-name><initials>F.</initials><afid>60000905</afid><afid>60028950</afid><afid>60021567</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:7005808435</author-url><authid>7005808435</authid><authname>Behar-Cohen F.</authname><surname>Behar-Cohen</surname><given-name>Francine</given-name><initials>F.</initials><afid>60000905</afid><afid>60028950</afid><afid>60021567</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:7005808435</author-url><authid>7005808435</authid><authname>Behar-Cohen F.</authname><surname>Behar-Cohen</surname><given-name>Francine</given-name><initials>F.</initials><afid>60000905</afid><afid>60028950</afid><afid>60021567</afid></author><authkeywords>Electrospinning | In vitro and in vivo ocular biocompatibility | Müller glial cells (MIO-M1 cells) | Poly(ε-caprolactone) nanofibers | Retinal pigment epithelial cells (ARPE-19 cells)</authkeywords><intid>1535386129</intid><article-number>3205</article-number><source-id>21331</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84926177998"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84926177998?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84926177998&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84926177998&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0168365915002096"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84926177998</prism:url><dc:identifier>SCOPUS_ID:84926177998</dc:identifier><eid>2-s2.0-84926177998</eid><dc:title>Use of hollow microneedles for targeted delivery of phenylephrine to treat fecal incontinence</dc:title><dc:creator>Jun H.</dc:creator><prism:publicationName>Journal of Controlled Release</prism:publicationName><prism:issn>01683659</prism:issn><prism:eIssn>18734995</prism:eIssn><prism:volume>207</prism:volume><prism:pageRange>1-6</prism:pageRange><prism:coverDate>2015-06-10</prism:coverDate><prism:coverDisplayDate>10 June 2015</prism:coverDisplayDate><prism:doi>10.1016/j.jconrel.2015.03.031</prism:doi><pii>S0168365915002096</pii><dc:description>© 2015 Elsevier B.V. All rights reserved. A hollow microneedle (HM) was prepared to deliver a phenylephrine (PE) solution into the anal sphincter muscle as a method for treating fecal incontinence. The goal of this study was the local targeted delivery of PE into the sphincter muscle through the perianal skin with minimal pain using hollow microneedles, resulting in the increase of resting anal sphincter pressure. PE was administered on the left and the right sides of the anus of a rat through the perianal skin using 1.5 mm long HM. An in vivo imaging system study was conducted after injection of Rhodamine B, and a histological study was performed after injection of gentian violet. The resting anal sphincter pressure in response to various drug doses was measured by using an air-charged catheter. Anal pressure change produced by HM administration was compared with change produced by intravenous injection (IV), subcutaneous (SC) injection and intramuscular (IM) injection. The change in mean blood pressure produced by HM administration as a function of PE dose was compared with change produced by PBS injection. A pharmacokinetic study of the new HM administration method was performed. A model drug solution was localized in the muscle layer under the perianal skin at the injection site and then diffused out over time. HM administration of PE induced significant contraction of internal anal sphincter pressure over 12 h after injection, and the maximum anal pressure was obtained between 5 and 6 h. Compared to IV, SC and IM treatments, HM treatment produced greater anal pressure. There was no increase in blood pressure after HM administration of PE within the range of predetermined concentration. Administration of 800 μg/kg of PE using HM produced 0.81 ± 0.38 h of t&lt;inf&gt;max&lt;/inf&gt;. Our study suggests that HM administration enables local delivery of a therapeutic dose of PE to the anal sphincter muscle layer with less pain. This new treatment has great potential as a clinical application because of the ease of the procedure, minimal pain, and dose-dependent response.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60025778</affiliation-url><afid>60025778</afid><affilname>University Michigan Ann Arbor</affilname><name-variant>University of Michigan</name-variant><affiliation-city>Ann Arbor</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60014237</affiliation-url><afid>60014237</afid><affilname>Chung-Ang University</affilname><name-variant>Chung-Ang University</name-variant><affiliation-city>Seoul</affiliation-city><affiliation-country>South Korea</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:</affiliation-url><afid/><affilname>LG Household and Health Care</affilname><affiliation-city>Daejeon</affiliation-city><affiliation-country>South Korea</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60080734</affiliation-url><afid>60080734</afid><affilname>Gachon University</affilname><name-variant>Gachon University</name-variant><affiliation-city>Seongnam-si, Gyeonggi-do</affiliation-city><affiliation-country>South Korea</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60007511</affiliation-url><afid>60007511</afid><affilname>Sungkyunkwan University</affilname><name-variant>Sungkyunkwan University</name-variant><affiliation-city>Jongno-gu</affiliation-city><affiliation-country>South Korea</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">5</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56579751600</author-url><authid>56579751600</authid><authname>Jun H.</authname><surname>Jun</surname><given-name>Hyesun</given-name><initials>H.</initials><afid>60025778</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:37124212200</author-url><authid>37124212200</authid><authname>Han M.</authname><surname>Han</surname><given-name>Mee Ree</given-name><initials>M.R.</initials><afid>60014237</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:55658832600</author-url><authid>55658832600</authid><authname>Kang N.</authname><surname>Kang</surname><given-name>Nae Gyu</given-name><initials>N.G.</initials><afid/></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:8917443800</author-url><authid>8917443800</authid><authname>Park J.</authname><surname>Park</surname><given-name>Jung Hwan</given-name><initials>J.H.</initials><afid>60080734</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:41562082200</author-url><authid>41562082200</authid><authname>Park J.</authname><surname>Park</surname><given-name>Jung Ho</given-name><initials>J.H.</initials><afid>60007511</afid></author><authkeywords>Fecal incontinence | Hollow microneedle | Locally targeting delivery | Muscle contraction</authkeywords><intid>35405295</intid><source-id>23010</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84928165151"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84928165151?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84928165151&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84928165151&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S1874391915001086"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84928165151</prism:url><dc:identifier>SCOPUS_ID:84928165151</dc:identifier><eid>2-s2.0-84928165151</eid><dc:title>Label-free quantitative proteomic analysis reveals strong involvement of complement alternative and terminal pathways in human glomerular sclerotic lesions</dc:title><dc:creator>Zhang Y.</dc:creator><prism:publicationName>Journal of Proteomics</prism:publicationName><prism:issn>18743919</prism:issn><prism:eIssn>18767737</prism:eIssn><prism:volume>123</prism:volume><prism:pageRange>89-100</prism:pageRange><prism:coverDate>2015-06-08</prism:coverDate><prism:coverDisplayDate>June 08, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.jprot.2015.03.024</prism:doi><pii>S1874391915001086</pii><dc:description>© 2015 Elsevier B.V. Since glomerular sclerosis frequently accompanies various glomerular diseases at the end stages, it is challenging to differentiate ubiquitous biological processes underlying this pathology from those critically involved in specific diseases. Furthermore, in-depth proteomic profile of human glomerular sclerosis remains limited. In this study, human glomeruli with intermediate (i-GS) and advanced (GS) sclerotic lesions, which were excluded from specific renal diseases and assumed to be aging-related, were laser captured from macroscopically normal cortex distant from urological carcinoma, and subjected to label-free quantitative proteomic analysis. We explicate an evident increase of membrane attack complex in i-GS and GS with an up-going tendency, which is accompanied by increasing of inhibitory regulators of alternative and terminal pathways. GO annotation and IPA pathway analysis agree to these results. Proteomic findings are validated by immunohistochemical studies which indicate that alternative and terminal pathways are positively involved in the glomerular sclerosis seen in distinct renal diseases. Furthermore, proteomic analysis also demonstrates remarkable increases of complement factor B in GS and TGF-ß1 in both GS and i-GS. Identification of complement factor B implicates that on-site activation of alternative pathway may occur in injured glomeruli and stepwise increase of TGF-ß1 suggests its contribution to the progression of glomerulosclerosis. Biological significance: This study provides in-depth quantitative proteomic profiles of human glomeruli with intermediate and advanced sclerotic lesions. It reveals that the over-expression of alternative and terminal pathway components is significantly involved in human glomerulosclerosis seen in distinct renal diseases. Proteomic identification of the increased TGF-ß1 provides supporting evidence for the role of podocyte apoptosis leading to human glomerulosclerosis.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60027970</affiliation-url><afid>60027970</afid><affilname>Niigata University School of Medicine</affilname><name-variant>Niigata University</name-variant><affiliation-city>Niigata</affiliation-city><affiliation-country>Japan</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60022313</affiliation-url><afid>60022313</afid><affilname>Niigata University</affilname><name-variant>Niigata University</name-variant><affiliation-city>Niigata</affiliation-city><affiliation-country>Japan</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60027970</affiliation-url><afid>60027970</afid><affilname>Niigata University School of Medicine</affilname><name-variant>Niigata University</name-variant><affiliation-city>Niigata</affiliation-city><affiliation-country>Japan</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:100364517</affiliation-url><afid>100364517</afid><affilname>Niigata National Hospital</affilname><name-variant>Niigata National Hospital</name-variant><affiliation-city>Kashiwazaki</affiliation-city><affiliation-country>Japan</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60020322</affiliation-url><afid>60020322</afid><affilname>Suez Canal University</affilname><name-variant>Suez Canal University</name-variant><affiliation-city>Ismalia</affiliation-city><affiliation-country>Egypt</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">13</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56081959100</author-url><authid>56081959100</authid><authname>Zhang Y.</authname><surname>Zhang</surname><given-name>Ying</given-name><initials>Y.</initials><afid>60027970</afid><afid>60022313</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56081959100</author-url><authid>56081959100</authid><authname>Zhang Y.</authname><surname>Zhang</surname><given-name>Ying</given-name><initials>Y.</initials><afid>60027970</afid><afid>60022313</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56599423100</author-url><authid>56599423100</authid><authname>Xu B.</authname><surname>Xu</surname><given-name>Bo</given-name><initials>B.</initials><afid>60027970</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56599951600</author-url><authid>56599951600</authid><authname>Kinoshita N.</authname><surname>Kinoshita</surname><given-name>Naohiko</given-name><initials>N.</initials><afid>60027970</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56599553100</author-url><authid>56599553100</authid><authname>Yoshida Y.</authname><surname>Yoshida</surname><given-name>Yutaka</given-name><initials>Y.</initials><afid>60027970</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56600172800</author-url><authid>56600172800</authid><authname>Tasaki M.</authname><surname>Tasaki</surname><given-name>Masayuki</given-name><initials>M.</initials><afid>60027970</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:6701731872</author-url><authid>6701731872</authid><authname>Fujinaka H.</authname><surname>Fujinaka</surname><given-name>Hidehiko</given-name><initials>H.</initials><afid>60027970</afid><afid>100364517</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:6701731872</author-url><authid>6701731872</authid><authname>Fujinaka H.</authname><surname>Fujinaka</surname><given-name>Hidehiko</given-name><initials>H.</initials><afid>60027970</afid><afid>100364517</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:22634774300</author-url><authid>22634774300</authid><authname>Magdeldin S.</authname><surname>Magdeldin</surname><given-name>Sameh</given-name><initials>S.</initials><afid>60027970</afid><afid>60020322</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:22634774300</author-url><authid>22634774300</authid><authname>Magdeldin S.</authname><surname>Magdeldin</surname><given-name>Sameh</given-name><initials>S.</initials><afid>60027970</afid><afid>60020322</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:36761968200</author-url><authid>36761968200</authid><authname>Yaoita E.</authname><surname>Yaoita</surname><given-name>Eishin</given-name><initials>E.</initials><afid>60027970</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:56272223000</author-url><authid>56272223000</authid><authname>Yamamoto T.</authname><surname>Yamamoto</surname><given-name>Tadashi</given-name><initials>T.</initials><afid>60027970</afid><afid>60022313</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:56272223000</author-url><authid>56272223000</authid><authname>Yamamoto T.</authname><surname>Yamamoto</surname><given-name>Tadashi</given-name><initials>T.</initials><afid>60027970</afid><afid>60022313</afid></author><authkeywords>Complement alternative and terminal pathways | Glomerular sclerosis | Mass spectrometry-based quantitative proteomics | Normalized spectral index</authkeywords><intid>1035730030</intid><source-id>11700154304</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84927942990"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84927942990?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84927942990&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84927942990&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S1874391915000925"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84927942990</prism:url><dc:identifier>SCOPUS_ID:84927942990</dc:identifier><eid>2-s2.0-84927942990</eid><dc:title>Proteome evolution of wheat (Triticum aestivum L.) aleurone layer at fifteen stages of grain development</dc:title><dc:creator>Nadaud I.</dc:creator><prism:publicationName>Journal of Proteomics</prism:publicationName><prism:issn>18743919</prism:issn><prism:eIssn>18767737</prism:eIssn><prism:volume>123</prism:volume><prism:pageRange>29-41</prism:pageRange><prism:coverDate>2015-06-08</prism:coverDate><prism:coverDisplayDate>June 08, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.jprot.2015.03.008</prism:doi><pii>S1874391915000925</pii><dc:description>© 2015. The aleurone layer (AL) is the grain peripheral tissue; it is rich in micronutrients, vitamins, antioxidants, and essential amino acids. This highly nutritive part of the grain has been less studied partly because its isolation is so laborious. In the present study, the ALs of Triticum aestivum (variety Récital) were separated manually at 15 stages of grain development. A total of 327 proteins were identified using 2-DE LC-MS/MS. They were classified in six main groups and 26 sub-groups according to their biochemical function. Proteomic analysis revealed seven different profiles distributed among three main development stages: (i) early AL development, with proteins involved in intense metabolic activities in the growth and development of the cell wall compounds; (ii) the intermediate stage, characterized by oxidative stress and defense proteins (65%) linked with loss of water in peripheral layers during grain filling; and (iii) AL maturation, involving the production of amino acids and the control of reactive oxidative species to enable the accumulation and maturation of globulins within the AL. The present study provides the first insights into developing proteome in the AL. We describe the numerous AL enzymes involved in the accumulation of storage protein and in the protection of the endosperm over time. Biological significance: The hand dissection of wheat aleurone layer (AL) was carried in this study for the first time on fifteen developmental stages from cell differentiation to grain maturity. Three major phases were revealed over AL development: cell division activities, globulins storage, and grain protection. Enzymes related to metabolites and vitamins were abundantly expressed during the two first phases. In parallel to the progressive globulins accumulation, the final phase was characterized by key enzyme synthesis involved in energy production, amino-acids and antioxidant synthesis plus others to face hypoxia and dehydration of grain tissues.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60001384</affiliation-url><afid>60001384</afid><affilname>INRA Centre de Clermont-Ferrand-Theix</affilname><name-variant>INRA</name-variant><affiliation-city>Saint-Genes-Champanelle</affiliation-city><affiliation-country>France</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60089631</affiliation-url><afid>60089631</afid><affilname>COMSATS Institute of Information Technology</affilname><name-variant>COMSATS Institute of Information Technology</name-variant><affiliation-city>Islamabad</affiliation-city><affiliation-country>Pakistan</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60024945</affiliation-url><afid>60024945</afid><affilname>INRA Nantes</affilname><name-variant>Inst. Natl. de la Rech. Agronomique</name-variant><affiliation-city>Nantes</affiliation-city><affiliation-country>France</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60020315</affiliation-url><afid>60020315</afid><affilname>INRA Institut National de La Recherche Agronomique</affilname><name-variant>INRA Institut National de La Recherche Agronomique</name-variant><affiliation-city>Paris</affiliation-city><affiliation-country>France</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">7</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:15028823800</author-url><authid>15028823800</authid><authname>Nadaud I.</authname><surname>Nadaud</surname><given-name>Isabelle</given-name><initials>I.</initials><afid>60001384</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:36864365600</author-url><authid>36864365600</authid><authname>Tasleem-Tahir A.</authname><surname>Tasleem-Tahir</surname><given-name>Ayesha</given-name><initials>A.</initials><afid>60001384</afid><afid>60089631</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:36864365600</author-url><authid>36864365600</authid><authname>Tasleem-Tahir A.</authname><surname>Tasleem-Tahir</surname><given-name>Ayesha</given-name><initials>A.</initials><afid>60001384</afid><afid>60089631</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:6508037453</author-url><authid>6508037453</authid><authname>Chateigner-Boutin A.</authname><surname>Chateigner-Boutin</surname><given-name>Anne Laure</given-name><initials>A.L.</initials><afid>60024945</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:7004124122</author-url><authid>7004124122</authid><authname>Chambon C.</authname><surname>Chambon</surname><given-name>Christophe</given-name><initials>C.</initials><afid>60020315</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:8619712000</author-url><authid>8619712000</authid><authname>Viala D.</authname><surname>Viala</surname><given-name>Didier</given-name><initials>D.</initials><afid>60020315</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:7004219515</author-url><authid>7004219515</authid><authname>Branlard G.</authname><surname>Branlard</surname><given-name>Gérard</given-name><initials>G.</initials><afid>60001384</afid></author><authkeywords>Aleurone layer | Grain development | Metabolites | Proteome | Triticum aestivum</authkeywords><intid>1035696929</intid><source-id>11700154304</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84930216228"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84930216228?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84930216228&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84930216228&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84930216228</prism:url><dc:identifier>SCOPUS_ID:84930216228</dc:identifier><eid>2-s2.0-84930216228</eid><dc:title>Stress phase angle depicts differences in arterial stiffness: Phantom and in vivo study</dc:title><dc:creator>Niu L.</dc:creator><prism:publicationName>Physics in Medicine and Biology</prism:publicationName><prism:issn>00319155</prism:issn><prism:eIssn>13616560</prism:eIssn><prism:volume>60</prism:volume><prism:issueIdentifier>11</prism:issueIdentifier><prism:pageRange>4281-4294</prism:pageRange><prism:coverDate>2015-06-07</prism:coverDate><prism:coverDisplayDate>7 June 2015</prism:coverDisplayDate><prism:doi>10.1088/0031-9155/60/11/4281</prism:doi><dc:description>© 2015 Institute of Physics and Engineering in Medicine. The endothelial cells (ECs) lining of a blood vessel wall are exposed to both the wall shear stress (WSS) of blood flow and the circumferential strain (CS) of pulsing artery wall motion. Both WSS and CS keep involved in the modulation of ECs' biochemical response and function and the temporal phase angle between the two is called stress phase angle (SPA). Previous studies at the cellular level have indicated that SPA is highly negative at sites that are prone to atherosclerosis, and hypothesized that large SPA may contribute to atherogenesis. Till now, there is no experimental data to support this hypothesis, probably due to the lack of a proper tool for measuring WSS and CS simultaneously and real time. In this study, a non-invasive ultrasonic biomechanics method was utilized to quantitatively calculate the SPA and experimentally evaluate the role of SPA in predicting early atherosclerosis. Three silicon tubes with a stiffness of 1.15, 3.62, 9.38 MPa were assembled in a pulsatile flow circuit and the values of SPA were measured to be -101.86 ± 3.65°,-170.19 ± 17.77° and -260.63 ± 18.62°, respectively. For the PVA-c phantoms, stiffness was 162.45, 235.68 and 374.24 kPa, the SPA corresponding to -170.32 ± 17.55°,-207.56 ± 10.78° and -261.08 ± 10.90°, respectively. Both phantom studies results demonstrated that SPA was highly negative in stiffer arteries. Further, experiments were taken in healthy living rats as control group (n = 3), atherosclerotic model group (n = 3), and drug treated group (n = 3), and the results showed that SPA was most negative in the model group, and SPA was least negative in the control group. Together, this study suggested that highly negative SPA appeared to be a prominent mechanical feature of vessels prone to atherosclerotic disease.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60102083</affiliation-url><afid>60102083</afid><affilname>Shenzhen Institute of Advanced Technology</affilname><name-variant>Chinese Academy of Sciences</name-variant><affiliation-city>Qingshuihe, Shenzhen</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60031863</affiliation-url><afid>60031863</afid><affilname>Northeastern University China</affilname><name-variant>Northeastern University</name-variant><affiliation-city>Shenyang</affiliation-city><affiliation-country>China</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">8</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:35198710600</author-url><authid>35198710600</authid><authname>Niu L.</authname><surname>Niu</surname><given-name>Lili</given-name><initials>L.</initials><afid>60102083</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56662681700</author-url><authid>56662681700</authid><authname>Meng L.</authname><surname>Meng</surname><given-name>Long</given-name><initials>L.</initials><afid>60102083</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56662560400</author-url><authid>56662560400</authid><authname>Xu L.</authname><surname>Xu</surname><given-name>Lisheng</given-name><initials>L.</initials><afid>60031863</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:55364992900</author-url><authid>55364992900</authid><authname>Liu J.</authname><surname>Liu</surname><given-name>Jia</given-name><initials>J.</initials><afid>60031863</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56662572100</author-url><authid>56662572100</authid><authname>Wang Q.</authname><surname>Wang</surname><given-name>Qiwen</given-name><initials>Q.</initials><afid>60031863</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:56297642400</author-url><authid>56297642400</authid><authname>Xiao Y.</authname><surname>Xiao</surname><given-name>Yang</given-name><initials>Y.</initials><afid>60102083</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:35199904200</author-url><authid>35199904200</authid><authname>Qian M.</authname><surname>Qian</surname><given-name>Ming</given-name><initials>M.</initials><afid>60102083</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:7403440733</author-url><authid>7403440733</authid><authname>Zheng H.</authname><surname>Zheng</surname><given-name>Hairong</given-name><initials>H.</initials><afid>60102083</afid></author><authkeywords>biomechanics | hemodynamics | plaque | ultrasound imaging</authkeywords><intid>2036081676</intid><article-number>4281</article-number><source-id>29203</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84927605364"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84927605364?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84927605364&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84927605364&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0022519315001277"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84927605364</prism:url><dc:identifier>SCOPUS_ID:84927605364</dc:identifier><eid>2-s2.0-84927605364</eid><dc:title>A sampling formula for ecological communities with multiple dispersal syndromes</dc:title><dc:creator>Janzen T.</dc:creator><prism:publicationName>Journal of Theoretical Biology</prism:publicationName><prism:issn>00225193</prism:issn><prism:eIssn>10958541</prism:eIssn><prism:volume>374</prism:volume><prism:pageRange>94-106</prism:pageRange><prism:coverDate>2015-06-07</prism:coverDate><prism:coverDisplayDate>June 07, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.jtbi.2015.03.018</prism:doi><pii>S0022519315001277</pii><dc:description>© 2015 Elsevier Ltd. Over the past decade, the neutral theory of biodiversity has stirred up community assembly theory considerably by suggesting that stochasticity in the form of ecological drift is an important factor determining community composition and community turnover. The neutral theory assumes that all species within a community are functionally equivalent (the neutrality assumption), and therefore applies best to communities of trophically similar species. Evidently, trophically similar species may still differ in dispersal ability, and therefore may not be completely functionally equivalent. Here we present a new sampling formula that takes into account the partitioning of a community into two guilds that differ in immigration rate. We show that, using this sampling formula, we can accurately detect a subdivision into guilds from species abundance distributions, given ecological data about dispersal ability. We apply our sampling formula to tropical tree data from Barro Colorado Island, Panama. Tropical trees are divided depending on their dispersal mode, where biotically dispersed trees are grouped as one guild, and abiotically dispersed trees represent another guild. We find that breaking neutrality by adding guild structure to the neutral model significantly improves the fit to data and provides a better understanding of community assembly on BCI. Our findings are thus an important step towards an integration of neutral and niche theory.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60010023</affiliation-url><afid>60010023</afid><affilname>Rijksuniversiteit Groningen</affilname><name-variant>University of Groningen</name-variant><affiliation-city>Groningen</affiliation-city><affiliation-country>Netherlands</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:113030785</affiliation-url><afid>113030785</afid><affilname>2 route du CNRS</affilname><name-variant>2 route du CNRS</name-variant><affiliation-city>Moulis</affiliation-city><affiliation-country>France</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">3</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55215458100</author-url><authid>55215458100</authid><authname>Janzen T.</authname><surname>Janzen</surname><given-name>Thijs</given-name><initials>T.</initials><afid>60010023</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:6507062894</author-url><authid>6507062894</authid><authname>Haegeman B.</authname><surname>Haegeman</surname><given-name>Bart</given-name><initials>B.</initials><afid>113030785</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:7007068615</author-url><authid>7007068615</authid><authname>Etienne R.</authname><surname>Etienne</surname><given-name>Rampal S.</given-name><initials>R.S.</initials><afid>60010023</afid></author><authkeywords>BCI | Dispersal syndromes | Guilds | Neutral theory</authkeywords><intid>535648411</intid><source-id>29663</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84930202911"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84930202911?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84930202911&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84930202911&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84930202911</prism:url><dc:identifier>SCOPUS_ID:84930202911</dc:identifier><eid>2-s2.0-84930202911</eid><dc:title>Mesoporous silica nanoparticles for glutathione-triggered long-range and stable release of hydrogen sulfide</dc:title><dc:creator>Sun X.</dc:creator><prism:publicationName>Journal of Materials Chemistry B</prism:publicationName><prism:issn>20507518</prism:issn><prism:eIssn>2050750X</prism:eIssn><prism:volume>3</prism:volume><prism:issueIdentifier>21</prism:issueIdentifier><prism:pageRange>4451-4457</prism:pageRange><prism:coverDate>2015-06-07</prism:coverDate><prism:coverDisplayDate>7 June 2015</prism:coverDisplayDate><prism:doi>10.1039/c5tb00354g</prism:doi><dc:description>© 2015 The Royal Society of Chemistry. Mesoporous silica nanoparticles (MSNs) that can stably load therapeutic drugs and release them in response to a specific trigger are of great interest in disease diagnosis and treatment. However, the controlled-release of gaseous drug molecules such as hydrogen sulfide (H&lt;inf&gt;2&lt;/inf&gt;S) from a long-range and stable MSN-based system still presents a great challenge. Herein, a MSN-based glutathione (GSH)-triggered controlled-release H&lt;inf&gt;2&lt;/inf&gt;S system has been fabricated with high entrapment efficiency (99.0 ± 0.3%) and loading content (44.2 ± 0.1%) of diallyl trisulfide (DATS). After the addition of GSH (2 mM), DATS-MSN (100 μg mL&lt;sup&gt;-1&lt;/sup&gt;) steadily releases moderate amounts of H&lt;inf&gt;2&lt;/inf&gt;S (peaking at the 4th hour, ∼60 μM) in phosphate buffer solution (PBS). The release of H&lt;inf&gt;2&lt;/inf&gt;S in plasma is similar to a physiological process (peaking at the 4th hour) and the DATS-MSN remains in the plasma of a rat's system over 9 hours without significantly affecting the blood pressure, heart rate and cardiac function. Moderate quantities of nanoparticles can be taken up by cardiomyocytes in vitro, while in vivo study shows that nanoparticles mainly accumulate in the liver and spleen, affecting the H&lt;inf&gt;2&lt;/inf&gt;S level in these organs. Furthermore, DATS-MSN shows excellent biocompatibility, as well as superior cytoprotection and an isolated heart protection effect of H&lt;inf&gt;2&lt;/inf&gt;S under ischemic/reperfusion injury. This study provides a new insight into controlled-release applications of MSN-based H&lt;inf&gt;2&lt;/inf&gt;S releasing systems both in vitro and in vivo.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60009860</affiliation-url><afid>60009860</afid><affilname>Fudan University</affilname><name-variant>Fudan University</name-variant><affiliation-city>Shanghai</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60009860</affiliation-url><afid>60009860</afid><affilname>Fudan University</affilname><name-variant>Fudan University</name-variant><affiliation-city>Shanghai</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:110486740</affiliation-url><afid>110486740</afid><affilname>Laboratory of Advanced Materials</affilname><name-variant>Laboratory of Advanced Materials</name-variant><affiliation-city>Shanghai</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60019578</affiliation-url><afid>60019578</afid><affilname>Monash University</affilname><name-variant>Monash University</name-variant><affiliation-city>Melbourne</affiliation-city><affiliation-country>Australia</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60025084</affiliation-url><afid>60025084</afid><affilname>Shanghai Jiaotong University</affilname><name-variant>Shanghai Jiaotong University</name-variant><affiliation-city>Shanghai</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60009860</affiliation-url><afid>60009860</afid><affilname>Fudan University</affilname><name-variant>Fudan University</name-variant><affiliation-city>Shanghai</affiliation-city><affiliation-country>China</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">15</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56580656600</author-url><authid>56580656600</authid><authname>Sun X.</authname><surname>Sun</surname><given-name>Xiaotian</given-name><initials>X.</initials><afid>60009860</afid><afid>60009860</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56580656600</author-url><authid>56580656600</authid><authname>Sun X.</authname><surname>Sun</surname><given-name>Xiaotian</given-name><initials>X.</initials><afid>60009860</afid><afid>60009860</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:55838620600</author-url><authid>55838620600</authid><authname>Kong B.</authname><surname>Kong</surname><given-name>Biao</given-name><initials>B.</initials><afid>110486740</afid><afid>60019578</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:55838620600</author-url><authid>55838620600</authid><authname>Kong B.</authname><surname>Kong</surname><given-name>Biao</given-name><initials>B.</initials><afid>110486740</afid><afid>60019578</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56595769800</author-url><authid>56595769800</authid><authname>Wang W.</authname><surname>Wang</surname><given-name>Wenshuo</given-name><initials>W.</initials><afid>60009860</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:36981241700</author-url><authid>36981241700</authid><authname>Chandran P.</authname><surname>Chandran</surname><given-name>Paurnami</given-name><initials>P.</initials><afid>60019578</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:6506872151</author-url><authid>6506872151</authid><authname>Selomulya C.</authname><surname>Selomulya</surname><given-name>Cordelia</given-name><initials>C.</initials><afid>60019578</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:24178990400</author-url><authid>24178990400</authid><authname>Zhang H.</authname><surname>Zhang</surname><given-name>Huili</given-name><initials>H.</initials><afid>60025084</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:56596053300</author-url><authid>56596053300</authid><authname>Zhu K.</authname><surname>Zhu</surname><given-name>Kai</given-name><initials>K.</initials><afid>60009860</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:56662549700</author-url><authid>56662549700</authid><authname>Liu Y.</authname><surname>Liu</surname><given-name>Ye</given-name><initials>Y.</initials><afid>60009860</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:7407759655</author-url><authid>7407759655</authid><authname>Yang W.</authname><surname>Yang</surname><given-name>Wuli</given-name><initials>W.</initials><afid>60009860</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:15839611900</author-url><authid>15839611900</authid><authname>Guo C.</authname><surname>Guo</surname><given-name>Changfa</given-name><initials>C.</initials><afid>60009860</afid></author><author seq="11"><author-url>http://api.elsevier.com/content/author/author_id:7403489871</author-url><authid>7403489871</authid><authname>Zhao D.</authname><surname>Zhao</surname><given-name>Dongyuan</given-name><initials>D.</initials><afid>110486740</afid><afid>60019578</afid></author><author seq="11"><author-url>http://api.elsevier.com/content/author/author_id:7403489871</author-url><authid>7403489871</authid><authname>Zhao D.</authname><surname>Zhao</surname><given-name>Dongyuan</given-name><initials>D.</initials><afid>110486740</afid><afid>60019578</afid></author><author seq="12"><author-url>http://api.elsevier.com/content/author/author_id:23010721800</author-url><authid>23010721800</authid><authname>Wang C.</authname><surname>Wang</surname><given-name>Chunsheng</given-name><initials>C.</initials><afid>60009860</afid></author><intid>1786088569</intid><source-id>21100229202</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84926390685"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84926390685?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84926390685&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84926390685&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0022519315001253"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84926390685</prism:url><dc:identifier>SCOPUS_ID:84926390685</dc:identifier><eid>2-s2.0-84926390685</eid><dc:title>A numerical study of the benefits of driving jellyfish bells at their natural frequency</dc:title><dc:creator>Hoover A.</dc:creator><prism:publicationName>Journal of Theoretical Biology</prism:publicationName><prism:issn>00225193</prism:issn><prism:eIssn>10958541</prism:eIssn><prism:volume>374</prism:volume><prism:pageRange>13-25</prism:pageRange><prism:coverDate>2015-06-07</prism:coverDate><prism:coverDisplayDate>June 07, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.jtbi.2015.03.016</prism:doi><pii>S0022519315001253</pii><dc:description>© 2015. A current question in swimming and flight is whether or not driving flexible appendages at their resonant frequency results in faster or more efficient locomotion. It has been suggested that jellyfish swim faster when the bell is driven at its resonant frequency. The goal of this study was to determine whether or not driving a jellyfish bell at its resonant frequency results in a significant increase in swimming velocity. To address this question, the immersed boundary method was used to solve the fully coupled fluid structure interaction problem of a flexible bell in a viscous fluid. Free vibration numerical experiments were used to determine the resonant frequency of the jellyfish bell. The jellyfish bells were then driven at frequencies ranging from above and below the resonant frequency. We found that jellyfish do swim fastest for a given amount of applied force when the bells are driven near their resonant frequency. Nonlinear effects were observed for larger deformations, shifting the optimal frequency to higher than the resonant frequency. We also found that the benefit of resonant forcing decreases for lower Reynolds numbers.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60025111</affiliation-url><afid>60025111</afid><affilname>The University of North Carolina at Chapel Hill</affilname><name-variant>University of North Carolina at Chapel Hill</name-variant><affiliation-city>Chapel Hill</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60025111</affiliation-url><afid>60025111</afid><affilname>The University of North Carolina at Chapel Hill</affilname><name-variant>University of North Carolina at Chapel Hill</name-variant><affiliation-city>Chapel Hill</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">3</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55872221800</author-url><authid>55872221800</authid><authname>Hoover A.</authname><surname>Hoover</surname><given-name>Alexander</given-name><initials>A.</initials><afid>60025111</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:35849038000</author-url><authid>35849038000</authid><authname>Miller L.</authname><surname>Miller</surname><given-name>Laura</given-name><initials>L.</initials><afid>60025111</afid><afid>60025111</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:35849038000</author-url><authid>35849038000</authid><authname>Miller L.</authname><surname>Miller</surname><given-name>Laura</given-name><initials>L.</initials><afid>60025111</afid><afid>60025111</afid></author><authkeywords>Animal swimming | Biological fluid dynamics | Biomechanics | Fluid-structure interaction | Immersed boundary method</authkeywords><intid>1785432883</intid><source-id>29663</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84930203523"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84930203523?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84930203523&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84930203523&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0304394015003584"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84930203523</prism:url><dc:identifier>SCOPUS_ID:84930203523</dc:identifier><eid>2-s2.0-84930203523</eid><dc:title>Lentivirus mediated over expression of CGRP inhibited oxidative stress in Schwann cell line</dc:title><dc:creator>Wu Y.</dc:creator><prism:publicationName>Neuroscience Letters</prism:publicationName><prism:issn>03043940</prism:issn><prism:eIssn>18727972</prism:eIssn><prism:volume>598</prism:volume><prism:pageRange>52-58</prism:pageRange><prism:coverDate>2015-06-06</prism:coverDate><prism:coverDisplayDate>June 06, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.neulet.2015.05.009</prism:doi><pii>S0304394015003584</pii><dc:description>© 2015 Elsevier Ireland Ltd. CGRP is reported to be implicated in the process of diabetes and neuronal disease. However, the role and underlying mechanism of CGRP involved in diabetic neuropathy is unknown. Schwann cells play a central role in diabetic neuropathy, therefore the protective effect of CGRP on Schwann cells exposed to high glucose is determined. In the present study, full-length CGRP cDNA was isolated and then transferred to gateway adapted lentivirus expression vector by LR recombination reaction. Afterwards, the CGRP bearing recombinant virus was prepared in 293FT cells and used to infect Schwann cells. The viability and superoxide anions of Schwann cells were evaluated following stimulation with high glucose, and levels of SOD, MDA and NOX1 were assessed.The results suggested that CGRP expression was up-regulated following lentivirus transfection. Lenti-CGRP increased cell viability in high glucose, but the effect was transient. Further lenti-CGRP protected against oxidative stress in Schwann cells triggered by high glucose and lenti-CGRP was effective in increasing SOD and decreasing MDA level. Meanwhile, the increased level of NOX1 caused by high glucose was reversed by lenti-CGRP overexpression. We therefore, suggest that lenti-CGRP may play a role in inhibiting oxidative stress in Schwann cell lines following hyperglycemic stimulation.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60016424</affiliation-url><afid>60016424</afid><affilname>Beijing University of Chinese Medicine</affilname><name-variant>Beijing University of Traditional Chinese Medicine</name-variant><affiliation-city>Beijing</affiliation-city><affiliation-country>China</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">9</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56150775900</author-url><authid>56150775900</authid><authname>Wu Y.</authname><surname>Wu</surname><given-name>Yan</given-name><initials>Y.</initials><afid>60016424</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56662781100</author-url><authid>56662781100</authid><authname>Hao G.</authname><surname>Hao</surname><given-name>Gai mei</given-name><initials>G.m.</initials><afid>60016424</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56662566600</author-url><authid>56662566600</authid><authname>He J.</authname><surname>He</surname><given-name>Jie</given-name><initials>J.</initials><afid>60016424</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56662797000</author-url><authid>56662797000</authid><authname>Lv T.</authname><surname>Lv</surname><given-name>Tian tian</given-name><initials>T.t.</initials><afid>60016424</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56662610500</author-url><authid>56662610500</authid><authname>Wang H.</authname><surname>Wang</surname><given-name>Hong liang</given-name><initials>H.l.</initials><afid>60016424</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:56662663700</author-url><authid>56662663700</authid><authname>Mao Y.</authname><surname>Mao</surname><given-name>Ying qiu</given-name><initials>Y.q.</initials><afid>60016424</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:56662807200</author-url><authid>56662807200</authid><authname>Wang X.</authname><surname>Wang</surname><given-name>Xue</given-name><initials>X.</initials><afid>60016424</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:56433768200</author-url><authid>56433768200</authid><authname>Wang W.</authname><surname>Wang</surname><given-name>Wei</given-name><initials>W.</initials><afid>60016424</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:56662556800</author-url><authid>56662556800</authid><authname>Han J.</authname><surname>Han</surname><given-name>Jing</given-name><initials>J.</initials><afid>60016424</afid></author><authkeywords>CGRP | Oxidative stress | Schwann cell</authkeywords><intid>2036082301</intid><source-id>18046</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84925305228"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84925305228?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84925305228&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84925305228&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S000925091500127X"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84925305228</prism:url><dc:identifier>SCOPUS_ID:84925305228</dc:identifier><eid>2-s2.0-84925305228</eid><dc:title>Robust model predictive control of nonlinear processes represented by Wiener or Hammerstein models</dc:title><dc:creator>Khani F.</dc:creator><prism:publicationName>Chemical Engineering Science</prism:publicationName><prism:issn>00092509</prism:issn><prism:volume>129</prism:volume><prism:pageRange>223-231</prism:pageRange><prism:coverDate>2015-06-06</prism:coverDate><prism:coverDisplayDate>June 06, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ces.2015.02.021</prism:doi><pii>S000925091500127X</pii><dc:description>© 2015 Elsevier Ltd. Representing nonlinear systems by linear models along with structured or unstructured uncertainties and applying robust control strategies could reduce the computational complexity in comparison with implementing the nonlinear model predictive controllers. In this paper design of robust model predictive controllers which are based on special classes of nonlinear systems representations called Wiener and Hammerstein are presented. The proposed algorithms approximate the nonlinear systems by uncertain linear models and reduce online the computational demands in the control implementation. The advantages of the proposed approaches are illustrated by two examples.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60031777</affiliation-url><afid>60031777</afid><affilname>Daneshgahe Azad Eslami</affilname><name-variant>Islamic Azad University</name-variant><affiliation-city>Tehran</affiliation-city><affiliation-country>Iran</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60027666</affiliation-url><afid>60027666</afid><affilname>Sharif University of Technology</affilname><name-variant>Sharif University of Technology</name-variant><affiliation-city>Tehran</affiliation-city><affiliation-country>Iran</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">2</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55302975000</author-url><authid>55302975000</authid><authname>Khani F.</authname><surname>Khani</surname><given-name>Fatemeh</given-name><initials>F.</initials><afid>60031777</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:12143471600</author-url><authid>12143471600</authid><authname>Haeri M.</authname><surname>Haeri</surname><given-name>Mohammad</given-name><initials>M.</initials><afid>60027666</afid></author><authkeywords>Hammerstein | Level control | LMI | PH process | Robust MPC | Wiener</authkeywords><intid>35280619</intid><source-id>16413</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84921033869"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84921033869?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84921033869&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84921033869&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84921033869</prism:url><dc:identifier>SCOPUS_ID:84921033869</dc:identifier><eid>2-s2.0-84921033869</eid><dc:title>Flow-driven waves and phase-locked self-organization in quasi-one-dimensional colonies of Dictyostelium discoideum</dc:title><dc:creator>Gholami A.</dc:creator><prism:publicationName>Physical Review Letters</prism:publicationName><prism:issn>00319007</prism:issn><prism:eIssn>10797114</prism:eIssn><prism:volume>114</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:coverDate>2015-06-06</prism:coverDate><prism:coverDisplayDate>6 June 2015</prism:coverDisplayDate><prism:doi>10.1103/PhysRevLett.114.018103</prism:doi><dc:description>© 2015 American Physical Society. We report experiments on flow-driven waves in a microfluidic channel containing the signaling slime mold Dictyostelium discoideum. The observed cyclic adenosine monophosphate (cAMP) wave trains developed spontaneously in the presence of flow and propagated with the velocity proportional to the imposed flow velocity. The period of the wave trains was independent of the flow velocity. Perturbations of flow-driven waves via external periodic pulses of the signaling agent cAMP induced 1?1, 2?1, 3?1, and 1?2 frequency responses, reminiscent of Arnold tongues in forced oscillatory systems. We expect our observations to be generic to active media governed by reaction-diffusion-advection dynamics, where spatially bound autocatalytic processes occur under flow conditions.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60027924</affiliation-url><afid>60027924</afid><affilname>Max Planck Institut fur Dynamik Und Selbstorganisation Gottingen</affilname><name-variant>Max Planck Institute for Dynamics and Self-Organization</name-variant><affiliation-city>Gottingen</affiliation-city><affiliation-country>Germany</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60031514</affiliation-url><afid>60031514</afid><affilname>Universitat Gottingen</affilname><name-variant>Universität Göttingen</name-variant><affiliation-city>Gottingen</affiliation-city><affiliation-country>Germany</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60007776</affiliation-url><afid>60007776</afid><affilname>Cornell University</affilname><name-variant>Cornell University</name-variant><affiliation-city>Ithaca</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60002092</affiliation-url><afid>60002092</afid><affilname>Florida State University</affilname><name-variant>Florida State University</name-variant><affiliation-city>Tallahassee</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">6</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:36858038600</author-url><authid>36858038600</authid><authname>Gholami A.</authname><surname>Gholami</surname><given-name>A.</given-name><initials>A.</initials><afid>60027924</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:7003781889</author-url><authid>7003781889</authid><authname>Steinbock O.</authname><surname>Steinbock</surname><given-name>O.</given-name><initials>O.</initials><afid>60002092</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:7004533804</author-url><authid>7004533804</authid><authname>Zykov V.</authname><surname>Zykov</surname><given-name>V.</given-name><initials>V.</initials><afid>60027924</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:7004288217</author-url><authid>7004288217</authid><authname>Bodenschatz E.</authname><surname>Bodenschatz</surname><given-name>E.</given-name><initials>E.</initials><afid>60027924</afid><afid>60031514</afid><afid>60007776</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:7004288217</author-url><authid>7004288217</authid><authname>Bodenschatz E.</authname><surname>Bodenschatz</surname><given-name>E.</given-name><initials>E.</initials><afid>60027924</afid><afid>60031514</afid><afid>60007776</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:7004288217</author-url><authid>7004288217</authid><authname>Bodenschatz E.</authname><surname>Bodenschatz</surname><given-name>E.</given-name><initials>E.</initials><afid>60027924</afid><afid>60031514</afid><afid>60007776</afid></author><intid>1034572058</intid><article-number>018103</article-number><source-id>29150</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84925064669"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84925064669?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84925064669&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84925064669&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0009250915001591"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84925064669</prism:url><dc:identifier>SCOPUS_ID:84925064669</dc:identifier><eid>2-s2.0-84925064669</eid><dc:title>Fully resolved simulations of the flow through a packed bed of cylinders: Effect of size distribution</dc:title><dc:creator>Dorai F.</dc:creator><prism:publicationName>Chemical Engineering Science</prism:publicationName><prism:issn>00092509</prism:issn><prism:volume>129</prism:volume><prism:pageRange>180-192</prism:pageRange><prism:coverDate>2015-06-06</prism:coverDate><prism:coverDisplayDate>June 06, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ces.2015.01.070</prism:doi><pii>S0009250915001591</pii><dc:description>© 2015 Elsevier Ltd. Fully resolved simulations of the flow through a fixed bed of pellets are performed to better understand the effect of the local microstructure on the energy loss, i.e., pressure drop through the bed. Both mono-disperse and poly-disperse systems as well as spherical and cylindrical pellets (solid particles) are investigated. Using a DEM-DLM/FD simulation method inspired by "Wachs, A. (2009). A DEM-DLM/FD method for direct numerical simulation of particulate flows: sedimentation of polygonal isometric particles in a Newtonian fluid with collisions. Comput. Fluids 38(8), 1608-1628" and implemented here in a Finite Volume context with second order reconstruction of the particle boundary as in "Rahmani, M., Wachs, A. (2014). Free falling and rising of spherical and angular particles. Phys. Fluids 26, 083301", we evidence that the computed solution converges nicely with mesh refinement and provide guidelines on the grid size to guarantee a satisfactory level of accuracy. Based on these trustworthy simulation results, we investigate the impact of the particle shape as well as the degree of poly-dispersity in the system on the pressure drop over the fixed bed in the viscous regime. Unprecedented simulation results on the flow through a bed of poly-disperse cylinders indicate that the correlation for poly-disperse spheres suggested in "Van der Hoef, M.A., Beetstra, R., Kuipers, J.A.M. (2005). Lattice-Boltzmann simulations of low-Reynolds-number flow past mono- and bidisperse arrays of spheres: results for the permeability and drag force. J. Fluid Mech. 528, 233-254" may still be valid for cylinders of moderate aspect ratio.</dc:description><citedby-count>1</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:</affiliation-url><afid/><affilname>Rond-point de l'Echangeur de Solaize</affilname><name-variant>IFP Energies nouvelles</name-variant><name-variant>Process Intensification Department</name-variant><affiliation-city>Solaize</affiliation-city><affiliation-country>France</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:</affiliation-url><afid/><affilname>2 Allée du Professeur Camille Soula</affilname><name-variant>Institut de Mécanique des Fluides de Toulouse</name-variant><affiliation-city>Toulouse</affiliation-city><affiliation-country>France</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:</affiliation-url><afid/><affilname>Rond-point de l'Echangeur de Solaize</affilname><name-variant>IFP Energies nouvelles</name-variant><name-variant>Fluid Mechanics Department</name-variant><affiliation-city>Solaize</affiliation-city><affiliation-country>France</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">6</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:36924889400</author-url><authid>36924889400</authid><authname>Dorai F.</authname><surname>Dorai</surname><given-name>Ferdaous</given-name><initials>F.</initials><afid/></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56560089500</author-url><authid>56560089500</authid><authname>Moura Teixeira C.</authname><surname>Moura Teixeira</surname><given-name>Carlos</given-name><initials>C.</initials><afid/></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:35330963300</author-url><authid>35330963300</authid><authname>Rolland M.</authname><surname>Rolland</surname><given-name>Matthieu</given-name><initials>M.</initials><afid/></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:6602811928</author-url><authid>6602811928</authid><authname>Climent E.</authname><surname>Climent</surname><given-name>Eric</given-name><initials>E.</initials><afid/></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:55987130700</author-url><authid>55987130700</authid><authname>Marcoux M.</authname><surname>Marcoux</surname><given-name>Manuel</given-name><initials>M.</initials><afid/></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:13907903800</author-url><authid>13907903800</authid><authname>Wachs A.</authname><surname>Wachs</surname><given-name>Anthony</given-name><initials>A.</initials><afid/></author><authkeywords>Catalyst reactor | Granular dynamics | Packed bed | Parallel computing | Particulate flow</authkeywords><intid>1535265093</intid><source-id>16413</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84928152375"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84928152375?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84928152375&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84928152375&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0165027015001399"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84928152375</prism:url><dc:identifier>SCOPUS_ID:84928152375</dc:identifier><eid>2-s2.0-84928152375</eid><dc:title>Surgical preparation of mice for recording cardiorespiratory parameters in vivo</dc:title><dc:creator>Farnham M.</dc:creator><prism:publicationName>Journal of Neuroscience Methods</prism:publicationName><prism:issn>01650270</prism:issn><prism:eIssn>1872678X</prism:eIssn><prism:volume>248</prism:volume><prism:pageRange>41-45</prism:pageRange><prism:coverDate>2015-06-05</prism:coverDate><prism:coverDisplayDate>June 05, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.jneumeth.2015.03.038</prism:doi><pii>S0165027015001399</pii><dc:description>© 2015 Elsevier B.V. Background: The explosion in the use of genetically modified mouse strains to investigate function in biology has an enormous potential to expand on pharmacological studies traditionally conducted in rats. A key limitation to date is the inability to record from multiple nerves in an anaesthetised mouse for long periods. New method: Here we describe an in vivo preparation that maintains mice in a suitable physiological state, under anaesthesia, for at least 6hr and also enables multiple cardiorespiratory recordings over that time. Results: Using the method described, blood pressure, heart rate, phrenic nerve activity, splanchnic nerve activity and heart rate were able to be recorded for hours in an anaesthetised, paralysed and mechanically ventilated mouse. Comparison with existing method: Existing anaesthetised mouse preparations are limited by difficulties in maintaining mice under anaesthesia for long periods. This time constraint therefore limits the surgical time and number of cardiorespiratory variables recorded. It also limits the type of stimuli that can be administered and the length of recorded responses. The method described here optimises these variables to overcome these challenges. Conclusions: In summary, we report an approach that enables physiological and pharmacological studies previously undertaken in larger animals or 'reduced' preparations, to be conducted in vivo in mice. We anticipate that the use of this preparation will enable a deeper understanding of genetic variation, and allow a much greater level of phenotypic characterisation in genetically modified mice.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60088314</affiliation-url><afid>60088314</afid><affilname>Macquarie University, Australian School of Advanced Medicine</affilname><name-variant>Macquarie University</name-variant><affiliation-city/><affiliation-country>Australia</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60002306</affiliation-url><afid>60002306</afid><affilname>University of Calgary</affilname><name-variant>University of Calgary</name-variant><affiliation-city>Calgary</affiliation-city><affiliation-country>Canada</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60025709</affiliation-url><afid>60025709</afid><affilname>University of Sydney</affilname><name-variant>University of Sydney</name-variant><affiliation-city>Sydney</affiliation-city><affiliation-country>Australia</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">5</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:23767976200</author-url><authid>23767976200</authid><authname>Farnham M.</authname><surname>Farnham</surname><given-name>Melissa M J</given-name><initials>M.M.J.</initials><afid>60088314</afid><afid>60025709</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:23767976200</author-url><authid>23767976200</authid><authname>Farnham M.</authname><surname>Farnham</surname><given-name>Melissa M J</given-name><initials>M.M.J.</initials><afid>60088314</afid><afid>60025709</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:36627551300</author-url><authid>36627551300</authid><authname>O'Connor E.</authname><surname>O'Connor</surname><given-name>Edward T.</given-name><initials>E.T.</initials><afid>60002306</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:55740134800</author-url><authid>55740134800</authid><authname>Wilson R.</authname><surname>Wilson</surname><given-name>Richard J A</given-name><initials>R.J.A.</initials><afid>60002306</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:7005042372</author-url><authid>7005042372</authid><authname>Pilowsky P.</authname><surname>Pilowsky</surname><given-name>Paul M.</given-name><initials>P.M.</initials><afid>60025709</afid></author><authkeywords>Anaesthesia | Blood pressure | Phrenic nerve | Sympathetic nerve activity | Ventilation</authkeywords><intid>1785735382</intid><source-id>16765</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84928562874"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84928562874?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84928562874&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84928562874&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0022283614005816"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84928562874</prism:url><dc:identifier>SCOPUS_ID:84928562874</dc:identifier><eid>2-s2.0-84928562874</eid><dc:title>Comparative proteome profiling during cardiac hypertrophy and myocardial infarction reveals altered glucose oxidation by differential activation of pyruvate dehydrogenase E1 component subunit β</dc:title><dc:creator>Mitra A.</dc:creator><prism:publicationName>Journal of Molecular Biology</prism:publicationName><prism:issn>00222836</prism:issn><prism:eIssn>10898638</prism:eIssn><prism:volume>427</prism:volume><prism:issueIdentifier>11</prism:issueIdentifier><prism:pageRange>2104-2120</prism:pageRange><prism:coverDate>2015-06-05</prism:coverDate><prism:coverDisplayDate>5 June 2015</prism:coverDisplayDate><prism:doi>10.1016/j.jmb.2014.10.026</prism:doi><pii>S0022283614005816</pii><dc:description>© 2014 Elsevier Ltd. All rights reserved. Cardiac hypertrophy and myocardial infarction (MI) are two etiologically different disease forms with varied pathological characteristics. However, the precise molecular mechanisms and specific causal proteins associated with these diseases are obscure to date. In this study, a comparative cardiac proteome profiling was performed in Wistar rat models for diseased and control (sham) groups using two-dimensional difference gel electrophoresis followed by matrix-assisted laser desorption/ionization tandem time-of-flight mass spectrometry. Proteins were identified using Protein Pilot™ software (version 4.0) and were subjected to stringent statistical analysis. Alteration of key proteins was validated by Western blot analysis. The differentially expressed protein sets identified in this study were associated with different functional groups, involving various metabolic pathways, stress responses, cytoskeletal organization, apoptotic signaling and other miscellaneous functions. It was further deciphered that altered energy metabolism during hypertrophy in comparison to MI may be predominantly attributed to induced glucose oxidation level, via reduced phosphorylation of pyruvate dehydrogenase E1 component subunit β (PDHE1-B) protein during hypertrophy. This study reports for the first time the global changes in rat cardiac proteome during two etiologically different cardiac diseases and identifies key signaling regulators modulating ontogeny of these two diseases culminating in heart failure. This study also pointed toward differential activation of PDHE1-B that accounts for upregulation of glucose oxidation during hypertrophy. Downstream analysis of altered proteome and the associated modulators would enhance our present knowledge regarding altered pathophysiology of these two etiologically different cardiac disease forms.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60024232</affiliation-url><afid>60024232</afid><affilname>University of Calcutta</affilname><name-variant>University of Calcutta</name-variant><affiliation-city>Kolkata</affiliation-city><affiliation-country>India</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60004009</affiliation-url><afid>60004009</afid><affilname>Institute of Genomics and Integrative Biology India</affilname><name-variant>Institute of Genomics and Integrative Biology</name-variant><affiliation-city>New Delhi</affiliation-city><affiliation-country>India</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">7</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:53881637000</author-url><authid>53881637000</authid><authname>Mitra A.</authname><surname>Mitra</surname><given-name>Arkadeep</given-name><initials>A.</initials><afid>60024232</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:51763202200</author-url><authid>51763202200</authid><authname>Basak T.</authname><surname>Basak</surname><given-name>Trayambak</given-name><initials>T.</initials><afid>60004009</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:35195214100</author-url><authid>35195214100</authid><authname>Ahmad S.</authname><surname>Ahmad</surname><given-name>Shadab</given-name><initials>S.</initials><afid>60004009</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:24786705400</author-url><authid>24786705400</authid><authname>Datta K.</authname><surname>Datta</surname><given-name>Kaberi</given-name><initials>K.</initials><afid>60024232</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56175453900</author-url><authid>56175453900</authid><authname>Datta R.</authname><surname>Datta</surname><given-name>Ritwik</given-name><initials>R.</initials><afid>60024232</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:7402546468</author-url><authid>7402546468</authid><authname>Sengupta S.</authname><surname>Sengupta</surname><given-name>Shantanu</given-name><initials>S.</initials><afid>60004009</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:54908444500</author-url><authid>54908444500</authid><authname>Sarkar S.</authname><surname>Sarkar</surname><given-name>Sagartirtha</given-name><initials>S.</initials><afid>60024232</afid></author><authkeywords>2D-DIGE | cardiac hypertrophy | comparative proteome profiling | myocardial infarction</authkeywords><intid>1785803343</intid><source-id>17618</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84928637174"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84928637174?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84928637174&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84928637174&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0306452215003383"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84928637174</prism:url><dc:identifier>SCOPUS_ID:84928637174</dc:identifier><eid>2-s2.0-84928637174</eid><dc:title>Brainstem areas activated by intermittent apnea in awake unrestrained rats</dc:title><dc:creator>Ferreira C.</dc:creator><prism:publicationName>Neuroscience</prism:publicationName><prism:issn>03064522</prism:issn><prism:eIssn>18737544</prism:eIssn><prism:volume>297</prism:volume><prism:pageRange>262-271</prism:pageRange><prism:coverDate>2015-06-05</prism:coverDate><prism:coverDisplayDate>June 05, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.neuroscience.2015.04.007</prism:doi><pii>S0306452215003383</pii><dc:description>© 2015 IBRO. We investigated the role of the autonomic nervous system to cardiovascular responses to obstructive apnea in awake, unrestrained rats, and measured expression of Fos induced by apnea in the brainstem. We implanted a tracheal balloon contained in a rigid tube to allow the induction of apnea without inducing pain in the trachea. During bouts of 15s of apnea, heart rate fell from 371±8 to 161±11bpm (mean±SEM, n=15, p&lt;0.01) and arterial pressure increased from 115±2 to 131±4mmHg (p&lt;0.01). Bradycardia was due to parasympathetic activity because it was blocked by the muscarinic antagonist, methylatropine. The pressor response was due to vasoconstriction caused by sympathetic activation because it was blocked by the α&lt;inf&gt;1&lt;/inf&gt; antagonist, prazosin. Apnea induced Fos expression in several brainstem areas involved in cardiorespiratory control such as the nucleus of the solitary tract (NTS), ventrolateral medulla (VLM), and pons. Ligation of the carotid body artery reduced apnea-induced bradycardia, blocked heart rate responses to i.v. injection of cyanide, reduced Fos expression in the caudal NTS, and increased Fos expression in the rostral VLM. In conclusion, apnea activates neurons in regions that process signals from baroreceptors, chemoreceptors, pulmonary receptors, and regions responsible for autonomic and respiratory activity both in the presence and absence of carotid chemoreceptors.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60014992</affiliation-url><afid>60014992</afid><affilname>Universidade Federal de Sao Paulo</affilname><name-variant>Federal University of São Paulo</name-variant><affiliation-city>Sao Paulo</affiliation-city><affiliation-country>Brazil</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60008088</affiliation-url><afid>60008088</afid><affilname>Universidade de Sao Paulo - USP</affilname><name-variant>University of São Paulo</name-variant><affiliation-city>Sao Paulo</affiliation-city><affiliation-country>Brazil</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60008088</affiliation-url><afid>60008088</afid><affilname>Universidade de Sao Paulo - USP</affilname><name-variant>University of São Paulo</name-variant><affiliation-city>Sao Paulo</affiliation-city><affiliation-country>Brazil</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">7</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56608648300</author-url><authid>56608648300</authid><authname>Ferreira C.</authname><surname>Ferreira</surname><given-name>C. B.</given-name><initials>C.B.</initials><afid>60014992</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:6602923337</author-url><authid>6602923337</authid><authname>Schoorlemmer G.</authname><surname>Schoorlemmer</surname><given-name>G. H.</given-name><initials>G.H.</initials><afid>60014992</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:35312112700</author-url><authid>35312112700</authid><authname>Rossi M.</authname><surname>Rossi</surname><given-name>M. V.</given-name><initials>M.V.</initials><afid>60014992</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:7003321511</author-url><authid>7003321511</authid><authname>Takakura A.</authname><surname>Takakura</surname><given-name>A. C.</given-name><initials>A.C.</initials><afid>60008088</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:55210330100</author-url><authid>55210330100</authid><authname>Barna B.</authname><surname>Barna</surname><given-name>B. F.</given-name><initials>B.F.</initials><afid>60008088</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:7004203019</author-url><authid>7004203019</authid><authname>Moreira T.</authname><surname>Moreira</surname><given-name>T. S.</given-name><initials>T.S.</initials><afid>60008088</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:6603725082</author-url><authid>6603725082</authid><authname>Cravo S.</authname><surname>Cravo</surname><given-name>S. L.</given-name><initials>S.L.</initials><afid>60014992</afid></author><authkeywords>Arterial chemoreceptors | CFos immunoreactivity | Hypoxia | Medulla oblongata | Obstructive apnea</authkeywords><intid>35813261</intid><source-id>18042</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84928716760"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84928716760?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84928716760&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84928716760&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0009898115001990"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84928716760</prism:url><dc:identifier>SCOPUS_ID:84928716760</dc:identifier><eid>2-s2.0-84928716760</eid><dc:title>A clinical and laboratory approach used to elucidate discordant results of high-sensitivity troponin T and troponin I</dc:title><dc:creator>Franeková J.</dc:creator><prism:publicationName>Clinica Chimica Acta</prism:publicationName><prism:issn>00098981</prism:issn><prism:eIssn>18733492</prism:eIssn><prism:volume>446</prism:volume><prism:pageRange>128-131</prism:pageRange><prism:coverDate>2015-06-05</prism:coverDate><prism:coverDisplayDate>June 05, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.cca.2015.03.046</prism:doi><pii>S0009898115001990</pii><dc:description>© 2015 Elsevier B.V. Background: Careful interpretation of discordant results in high-sensitivity troponin measurements is necessary in cases of suspect immunoassay interferences. We describe several procedures taken in a case of a polymorbid patient with chest pain, without clear evidence of myocardial necrosis and with increased high-sensitivity cardiac troponin T (hs-cTnT). We checked the Vafaie's algorithm for the evaluation of suspect interference in troponin measurements. Methods: We conducted a case report analysis, additional measurements, a dilution test and pretreatment of plasma with blocking agents. Results: Concentration of hs-cTnT (99th percentile of "healthy" population 14. ng/L) increased from 120.1. ng/L to 280.4. ng/L during an 8-month period and decreased to 216.3. ng/L during the following month with repeatedly negative troponin I (TnI), hs-cTnI, myoglobin and creatine kinase MB (CK-MB). Suspected false positivity of hs-cTnT was further confirmed by treatment of plasma with an antiheterophile blocking agent (hs-cTnT before treatment 280.4. ng/L, after 16.53/16.23. ng/L). This outcome was further confirmed by the manufacturer's experiments. Conclusions: The false-positive results of hs-cTnT were caused by the presence of extremely rare high molecular weight protein, presumably IgM, most likely HAMA (human anti-mouse antibody). Only the pre-treatment of plasma with a blocking agent provided a reliable indication of the interference. Cooperation among clinicians, laboratory personnel and the manufacturer is essential.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60020529</affiliation-url><afid>60020529</afid><affilname>Institutu Klinicke a Experimentalni Mediciny</affilname><name-variant>IKEM</name-variant><affiliation-city>Prague</affiliation-city><affiliation-country>Czech Republic</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60020529</affiliation-url><afid>60020529</afid><affilname>Institutu Klinicke a Experimentalni Mediciny</affilname><name-variant>IKEM</name-variant><affiliation-city>Prague</affiliation-city><affiliation-country>Czech Republic</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60020529</affiliation-url><afid>60020529</afid><affilname>Institutu Klinicke a Experimentalni Mediciny</affilname><name-variant>IKEM</name-variant><affiliation-city>Prague</affiliation-city><affiliation-country>Czech Republic</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60016605</affiliation-url><afid>60016605</afid><affilname>Charles University in Prague</affilname><name-variant>Charles University in Prague</name-variant><affiliation-city>Prague</affiliation-city><affiliation-country>Czech Republic</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">10</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:15757077900</author-url><authid>15757077900</authid><authname>Franeková J.</authname><surname>Franeková</surname><given-name>Janka</given-name><initials>J.</initials><afid>60020529</afid><afid>60016605</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:15757077900</author-url><authid>15757077900</authid><authname>Franeková J.</authname><surname>Franeková</surname><given-name>Janka</given-name><initials>J.</initials><afid>60020529</afid><afid>60016605</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56611488000</author-url><authid>56611488000</authid><authname>Bláha M.</authname><surname>Bláha</surname><given-name>Martin</given-name><initials>M.</initials><afid>60020529</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:24166161700</author-url><authid>24166161700</authid><authname>Bělohoubek J.</authname><surname>Bělohoubek</surname><given-name>Jiří</given-name><initials>J.</initials><afid>60020529</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:54585571900</author-url><authid>54585571900</authid><authname>Kotrbatá M.</authname><surname>Kotrbatá</surname><given-name>Markéta</given-name><initials>M.</initials><afid>60020529</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:6507802113</author-url><authid>6507802113</authid><authname>Sečník P.</authname><surname>Sečník</surname><given-name>Peter</given-name><initials>P.</initials><afid>60020529</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:36668676700</author-url><authid>36668676700</authid><authname>Kubíček Z.</authname><surname>Kubíček</surname><given-name>Zdenek</given-name><initials>Z.</initials><afid>60020529</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:56116769700</author-url><authid>56116769700</authid><authname>Kettner J.</authname><surname>Kettner</surname><given-name>Jiří</given-name><initials>J.</initials><afid>60020529</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:7005645380</author-url><authid>7005645380</authid><authname>Jabor A.</authname><surname>Jabor</surname><given-name>Antonín</given-name><initials>A.</initials><afid>60020529</afid><afid>60016605</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:7005645380</author-url><authid>7005645380</authid><authname>Jabor A.</authname><surname>Jabor</surname><given-name>Antonín</given-name><initials>A.</initials><afid>60020529</afid><afid>60016605</afid></author><authkeywords>Heterophile antibodies | Immunoassay interference | Troponin</authkeywords><intid>1035834576</intid><source-id>29286</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84927644824"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84927644824?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84927644824&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84927644824&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0009898115001862"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84927644824</prism:url><dc:identifier>SCOPUS_ID:84927644824</dc:identifier><eid>2-s2.0-84927644824</eid><dc:title>Release of cardiac troponin using a high sensitivity assay after exercise: Type 2 acute myocardial infarction?</dc:title><dc:creator>Aw T.</dc:creator><prism:publicationName>Clinica Chimica Acta</prism:publicationName><prism:issn>00098981</prism:issn><prism:eIssn>18733492</prism:eIssn><prism:volume>446</prism:volume><prism:pageRange>6-8</prism:pageRange><prism:coverDate>2015-06-05</prism:coverDate><prism:coverDisplayDate>June 05, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.cca.2015.04.002</prism:doi><pii>S0009898115001862</pii><dc:description>© 2015 Elsevier B.V. Background: Cardiac troponin is used as a marker for all types of myocardial infarction. Methods: Assays for high-sensitivity troponin T and I were performed before, immediately and 24. h after a 40. km bicycle ride in two middle aged individuals. Results: There was a significant increase in cardiac troponin immediately after exercise in both individuals. This was accompanied by a return to baseline levels within 24. h. A CT angiogram was normal in one while the other had a significant occlusion in the mid-right coronary artery. After a stent placement, in this latter individual, there was no major increase in troponin after a second bicycle ride. Conclusions: Using high sensitivity assays, at least one of these two subjects may have suffered a type 2 myocardial infarction had the increases in hs-cTnI were accompanied by other acceptable evidence of myocardial ischemia (symptoms, ECG, etc.). demand imbalance.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60013022</affiliation-url><afid>60013022</afid><affilname>Changi General Hospital</affilname><name-variant>Changi General Hospital</name-variant><affiliation-city>Singapore City</affiliation-city><affiliation-country>Singapore</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60030612</affiliation-url><afid>60030612</afid><affilname>University of California, San Diego</affilname><name-variant>University of California San Diego</name-variant><affiliation-city>San Diego</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60023691</affiliation-url><afid>60023691</afid><affilname>University of California, San Francisco</affilname><name-variant>University of California, San Francisco</name-variant><affiliation-city>San Francisco</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60005558</affiliation-url><afid>60005558</afid><affilname>Mayo Clinic</affilname><name-variant>Mayo Clinic</name-variant><affiliation-city>Rochester</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">4</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55627921038</author-url><authid>55627921038</authid><authname>Aw T.</authname><surname>Aw</surname><given-name>Tar Choon</given-name><initials>T.C.</initials><afid>60013022</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:36497514800</author-url><authid>36497514800</authid><authname>van Wijk X.</authname><surname>van Wijk</surname><given-name>Xander M R</given-name><initials>X.M.R.</initials><afid>60030612</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:55273946700</author-url><authid>55273946700</authid><authname>Wu A.</authname><surname>Wu</surname><given-name>Alan H B</given-name><initials>A.H.B.</initials><afid>60023691</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:35275132200</author-url><authid>35275132200</authid><authname>Jaffe A.</authname><surname>Jaffe</surname><given-name>Allan S.</given-name><initials>A.S.</initials><afid>60005558</afid></author><authkeywords>Cardiac troponin | CT angiogram | High sensitivity | Type 2 myocardial infarction</authkeywords><intid>2035640933</intid><source-id>29286</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84928804760"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84928804760?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84928804760&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84928804760&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0009898115002314"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84928804760</prism:url><dc:identifier>SCOPUS_ID:84928804760</dc:identifier><eid>2-s2.0-84928804760</eid><dc:title>Relationship between plasma phospholipase A&lt;inf&gt;2&lt;/inf&gt; concentrations and lipoprotein subfractions in patients with stable coronary artery disease</dc:title><dc:creator>Xu R.</dc:creator><prism:publicationName>Clinica Chimica Acta</prism:publicationName><prism:issn>00098981</prism:issn><prism:eIssn>18733492</prism:eIssn><prism:volume>446</prism:volume><prism:pageRange>195-200</prism:pageRange><prism:coverDate>2015-06-05</prism:coverDate><prism:coverDisplayDate>June 05, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.cca.2015.04.032</prism:doi><pii>S0009898115002314</pii><dc:description>© 2015 Elsevier B.V. Background: Both increased lipoprotein-associated phospholipase A&lt;inf&gt;2&lt;/inf&gt; (Lp-PLA&lt;inf&gt;2&lt;/inf&gt;) concentrations and atherogenic lipoprotein subfractions have been shown to reflect unfavourable cardiovascular risk. However, the correlation between Lp-PLA&lt;inf&gt;2&lt;/inf&gt; and lipoprotein subfractions in patients with coronary artery disease (CAD) has not been assessed yet. Methods: A total of 324 consecutive subjects who were not treated with lipid-lowering drugs were enrolled (angiographically proven CAD: n=253; non-CAD: n=71). Plasma Lp-PLA&lt;inf&gt;2&lt;/inf&gt; concentrations were measured using ELISA. The low-density lipoprotein (LDL) and high-density lipoprotein (HDL) subfractions were determined by Lipoprint System. Results: Plasma Lp-PLA&lt;inf&gt;2&lt;/inf&gt; concentrations were higher in patients with CAD compared with those without CAD (153.61±78.73 vs. 131.41±65.49ng/ml, p=0.028). The univariable correlation analysis revealed that Lp-PLA&lt;inf&gt;2&lt;/inf&gt; concentrations were positively correlated with the cholesterol concentrations of each LDL subfractions and the intermediate as well as small HDL subfractions, while negatively linked with the LDL particle size and large HDL-cholesterol (HDL-C) concentrations in CAD group. However, no similar results were observed in the non-CAD group. Furthermore, multivariable regression analysis was performed in patients with CAD and showed that plasma Lp-PLA&lt;inf&gt;2&lt;/inf&gt; concentrations were independently correlated with the cholesterol concentrations of each LDL subfractions [large LDL-cholesterol (LDL-C): β=0.263, p&lt;0.001; intermediate LDL-C: β=0.327, p&lt;0.001; small LDL-C: β=0.135, p=0.033] and small HDL-C (β=0.133, p=0.034). Conclusion: Lp-PLA&lt;inf&gt;2&lt;/inf&gt; concentrations were positively associated with all LDL subfractions and small HDL subfraction, suggesting an interaction between Lp-PLA&lt;inf&gt;2&lt;/inf&gt; and lipoprotein subfraction phenotypes in the status of CAD.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60026701</affiliation-url><afid>60026701</afid><affilname>Fuwai Hospital</affilname><name-variant>Fu Wai Hospital</name-variant><affiliation-city>Beijing</affiliation-city><affiliation-country>China</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">8</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56479738400</author-url><authid>56479738400</authid><authname>Xu R.</authname><surname>Xu</surname><given-name>Rui Xia</given-name><initials>R.X.</initials><afid>60026701</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56080557000</author-url><authid>56080557000</authid><authname>Zhang Y.</authname><surname>Zhang</surname><given-name>Yan</given-name><initials>Y.</initials><afid>60026701</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56056507900</author-url><authid>56056507900</authid><authname>Li X.</authname><surname>Li</surname><given-name>Xiao Lin</given-name><initials>X.L.</initials><afid>60026701</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:55671365100</author-url><authid>55671365100</authid><authname>Li S.</authname><surname>Li</surname><given-name>Sha</given-name><initials>S.</initials><afid>60026701</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:55671635900</author-url><authid>55671635900</authid><authname>Guo Y.</authname><surname>Guo</surname><given-name>Yuan Lin</given-name><initials>Y.L.</initials><afid>60026701</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:55670154900</author-url><authid>55670154900</authid><authname>Dong Q.</authname><surname>Dong</surname><given-name>Qian</given-name><initials>Q.</initials><afid>60026701</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:55670304800</author-url><authid>55670304800</authid><authname>Liu G.</authname><surname>Liu</surname><given-name>Geng</given-name><initials>G.</initials><afid>60026701</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:56056504900</author-url><authid>56056504900</authid><authname>Li J.</authname><surname>Li</surname><given-name>Jian Jun</given-name><initials>J.J.</initials><afid>60026701</afid></author><authkeywords>Coronary artery disease | High-density lipoprotein subfraction | Lipoprotein associated phospholipase A&lt;inf&gt;2&lt;/inf&gt; | Low-density lipoprotein subfraction</authkeywords><intid>35851535</intid><source-id>29286</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84928574797"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84928574797?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84928574797&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84928574797&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0009898115002089"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84928574797</prism:url><dc:identifier>SCOPUS_ID:84928574797</dc:identifier><eid>2-s2.0-84928574797</eid><dc:title>Mean corpuscular volume and red blood cell distribution width are independent predictors of serum potassium concentration in healthy individuals</dc:title><dc:creator>Lippi G.</dc:creator><prism:publicationName>Clinica Chimica Acta</prism:publicationName><prism:issn>00098981</prism:issn><prism:eIssn>18733492</prism:eIssn><prism:volume>446</prism:volume><prism:pageRange>117-118</prism:pageRange><prism:coverDate>2015-06-05</prism:coverDate><prism:coverDisplayDate>June 05, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.cca.2015.04.017</prism:doi><pii>S0009898115002089</pii><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:100875651</affiliation-url><afid>100875651</afid><affilname>Academic Hospital of Parma</affilname><name-variant>Academic Hospital of Parma</name-variant><affiliation-city>Parma</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:106708661</affiliation-url><afid>106708661</afid><affilname>U.O. Diagnostica Ematochimica</affilname><name-variant>U.O. Diagnostica Ematochimica</name-variant><affiliation-city>Parma</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60060733</affiliation-url><afid>60060733</afid><affilname>Ospedale Policlinico</affilname><name-variant>University Hospital</name-variant><affiliation-city>Verona</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>le</subtype><subtypeDescription>Letter</subtypeDescription><author-count limit="100">4</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:23989140600</author-url><authid>23989140600</authid><authname>Lippi G.</authname><surname>Lippi</surname><given-name>Giuseppe</given-name><initials>G.</initials><afid>100875651</afid><afid>106708661</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:23989140600</author-url><authid>23989140600</authid><authname>Lippi G.</authname><surname>Lippi</surname><given-name>Giuseppe</given-name><initials>G.</initials><afid>100875651</afid><afid>106708661</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:8878046000</author-url><authid>8878046000</authid><authname>Salvagno G.</authname><surname>Salvagno</surname><given-name>Gian Luca</given-name><initials>G.L.</initials><afid>60060733</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:7102950987</author-url><authid>7102950987</authid><authname>Guidi G.</authname><surname>Guidi</surname><given-name>Gian Cesare</given-name><initials>G.C.</initials><afid>60060733</afid></author><intid>2035797230</intid><source-id>29286</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84928729925"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84928729925?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84928729925&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84928729925&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S037842741500137X"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84928729925</prism:url><dc:identifier>SCOPUS_ID:84928729925</dc:identifier><eid>2-s2.0-84928729925</eid><dc:title>Endogenous hydrogen peroxide in the hypothalamic paraventricular nucleus regulates neurohormonal excitation in high salt-induced hypertension</dc:title><dc:creator>Zhang M.</dc:creator><prism:publicationName>Toxicology Letters</prism:publicationName><prism:issn>03784274</prism:issn><prism:eIssn>18793169</prism:eIssn><prism:volume>235</prism:volume><prism:issueIdentifier>3</prism:issueIdentifier><prism:pageRange>206-215</prism:pageRange><prism:coverDate>2015-06-05</prism:coverDate><prism:coverDisplayDate>June 05, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.toxlet.2015.04.008</prism:doi><pii>S037842741500137X</pii><dc:description>© 2015 Elsevier Ireland Ltd. Reactive oxygen species (ROS) in the brain plays an important role in the progression of hypertension and hydrogen peroxide (H&lt;inf&gt;2&lt;/inf&gt;O&lt;inf&gt;2&lt;/inf&gt;) is a major component of ROS. The aim of this study is to explore whether endogenous H&lt;inf&gt;2&lt;/inf&gt;O&lt;inf&gt;2&lt;/inf&gt; changed by polyethylene glycol-catalase (PEG-CAT) and aminotriazole (ATZ) in the hypothalamic paraventricular nucleus (PVN) regulates neurotransmitters, renin-angiotensin system (RAS), and cytokines, and whether subsequently affects the renal sympathetic nerve activity (RSNA) and mean arterial pressure (MAP) in high salt-induced hypertension. Male Sprague-Dawley rats received a high-salt diet (HS, 8% NaCl) or a normal-salt diet (NS, 0.3% NaCl) for 10 weeks. Then rats were treated with bilateral PVN microinjection of PEG-CAT (0.2 i.u./50nl), an analog of endogenous catalase, the catalase inhibitor ATZ (10nmol/50nl) or vehicle. High salt-fed rats had significantly increased MAP, RSNA, plasma norepinephrine (NE) and pro-inflammatory cytokines (PICs). In addition, rats with high-salt diet had higher levels of NOX-2, NOX-4 (subunits of NAD(P)H oxidase), angiotensin-converting enzyme (ACE), interleukin-1beta (IL-1β), glutamate and NE, and lower levels of gamma-aminobutyric acid (GABA) and interleukin-10 (IL-10) in the PVN than normal diet rats. Bilateral PVN microinjection of PEG-CAT attenuated the levels of RAS and restored the balance of neurotransmitters and cytokines, while microinjection of ATZ into the PVN augmented those changes occurring in hypertensive rats. Our findings demonstrate that ROS component H&lt;inf&gt;2&lt;/inf&gt;O&lt;inf&gt;2&lt;/inf&gt; in the PVN regulating MAP and RSNA are partly due to modulate neurotransmitters, renin-angiotensin system, and cytokines within the PVN in salt-induced hypertension.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60018308</affiliation-url><afid>60018308</afid><affilname>Xi'an Jiaotong University</affilname><name-variant>Xi'an Jiaotong University</name-variant><affiliation-city>Xi'an</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60010687</affiliation-url><afid>60010687</afid><affilname>Shantou University, Medical College (SUMC)</affilname><name-variant>Medical College of Shantou University</name-variant><affiliation-city>Shantou</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60073704</affiliation-url><afid>60073704</afid><affilname>Shaanxi Provincial People's Hospital</affilname><name-variant>Shanxi Provincial People's Hospital</name-variant><affiliation-city>Xi'an</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60018308</affiliation-url><afid>60018308</afid><affilname>Xi'an Jiaotong University</affilname><name-variant>Xi'an Jiaotong University</name-variant><affiliation-city>Xi'an</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60018310</affiliation-url><afid>60018310</afid><affilname>Nanjing Medical University</affilname><name-variant>Nanjing Medical University</name-variant><affiliation-city>Nanjing</affiliation-city><affiliation-country>China</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">13</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56062532900</author-url><authid>56062532900</authid><authname>Zhang M.</authname><surname>Zhang</surname><given-name>Meng</given-name><initials>M.</initials><afid>60018308</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56611356200</author-url><authid>56611356200</authid><authname>Qin D.</authname><surname>Qin</surname><given-name>Da Nian</given-name><initials>D.N.</initials><afid>60010687</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:55353994200</author-url><authid>55353994200</authid><authname>Suo Y.</authname><surname>Suo</surname><given-name>Yu Ping</given-name><initials>Y.P.</initials><afid>60073704</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56003193500</author-url><authid>56003193500</authid><authname>Su Q.</authname><surname>Su</surname><given-name>Qing</given-name><initials>Q.</initials><afid>60018308</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56611477800</author-url><authid>56611477800</authid><authname>Li H.</authname><surname>Li</surname><given-name>Hong Bao</given-name><initials>H.B.</initials><afid>60018308</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:56062576400</author-url><authid>56062576400</authid><authname>Miao Y.</authname><surname>Miao</surname><given-name>Yu Wang</given-name><initials>Y.W.</initials><afid>60018308</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:56610979700</author-url><authid>56610979700</authid><authname>Guo J.</authname><surname>Guo</surname><given-name>Jing</given-name><initials>J.</initials><afid>60018308</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:56611085200</author-url><authid>56611085200</authid><authname>Feng Z.</authname><surname>Feng</surname><given-name>Zhi Peng</given-name><initials>Z.P.</initials><afid>60018308</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:56553596200</author-url><authid>56553596200</authid><authname>Qi J.</authname><surname>Qi</surname><given-name>Jie</given-name><initials>J.</initials><afid>60018308</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:56611041600</author-url><authid>56611041600</authid><authname>Gao H.</authname><surname>Gao</surname><given-name>Hong Li</given-name><initials>H.L.</initials><afid>60018308</afid></author><author seq="11"><author-url>http://api.elsevier.com/content/author/author_id:56611351600</author-url><authid>56611351600</authid><authname>Mu J.</authname><surname>Mu</surname><given-name>Jian Jun</given-name><initials>J.J.</initials><afid>60018308</afid></author><author seq="12"><author-url>http://api.elsevier.com/content/author/author_id:28168112900</author-url><authid>28168112900</authid><authname>Zhu G.</authname><surname>Zhu</surname><given-name>Guo Qing</given-name><initials>G.Q.</initials><afid>60018310</afid></author><author seq="13"><author-url>http://api.elsevier.com/content/author/author_id:7402784628</author-url><authid>7402784628</authid><authname>Kang Y.</authname><surname>Kang</surname><given-name>Yu Ming</given-name><initials>Y.M.</initials><afid>60018308</afid></author><authkeywords>Cytokines | Hypertension | Hypothalamic paraventricular nucleus | Neurotransmitters | Reactive oxygen species | Renin-angiotensin system</authkeywords><intid>35839785</intid><source-id>25240</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84928558308"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84928558308?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84928558308&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84928558308&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0009898115002053"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84928558308</prism:url><dc:identifier>SCOPUS_ID:84928558308</dc:identifier><eid>2-s2.0-84928558308</eid><dc:title>Targeted next-generation sequencing (NGS) of nine candidate genes with custom AmpliSeq in patients and a cardiomyopathy risk group</dc:title><dc:creator>Glotov A.</dc:creator><prism:publicationName>Clinica Chimica Acta</prism:publicationName><prism:issn>00098981</prism:issn><prism:eIssn>18733492</prism:eIssn><prism:volume>446</prism:volume><prism:pageRange>132-140</prism:pageRange><prism:coverDate>2015-06-05</prism:coverDate><prism:coverDisplayDate>June 05, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.cca.2015.04.014</prism:doi><pii>S0009898115002053</pii><dc:description>© 2015 Elsevier B.V. Background: Hypertrophic cardiomyopathy is a common genetic cardiac disease. Prevention and early diagnosis of this disease are very important. Because of the large number of causative genes and the high rate of mutations involved in the pathogenesis of this disease, traditional methods of early diagnosis are ineffective. Methods: We developed a custom AmpliSeq panel for NGS sequencing of the coding sequences of ACTC1, MYBPC3, MYH7, MYL2, MYL3, TNNI3, TNNT2, TPM1, and CASQ2. A genetic analysis of student cohorts (with and without cardiomyopathy risk in their medical histories) and patients with cardiomyopathies was performed. For the statistical and bioinformatics analysis, Polyphen2, SIFT, SnpSift and PLINK software were used. To select genetic markers in the patients with cardiomyopathy and in the students of the high risk group, four additive models were applied. Results: Our AmpliSeq custom panel allowed us to efficiently explore targeted sequences. Based on the score analysis, we detected three substitutions in the MYBPC3 and CASQ2 genes and six combinations between loci in the MYBPC3, MYH7 and CASQ2 genes that were responsible for cardiomyopathy risk in our cohorts. We also detected substitutions in the TNNT2 gene that can be considered as protective against cardiomyopathy. Conclusion: We used NGS with AmpliSeq libraries and Ion PGM sequencing to develop improved predictive information for patients at risk of cardiomyopathy.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60031888</affiliation-url><afid>60031888</afid><affilname>Saint Petersburg State University</affilname><name-variant>St. Petersburg State University</name-variant><affiliation-city>Saint Petersburg (ex Leningrad)</affiliation-city><affiliation-country>Russian Federation</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:114718935</affiliation-url><afid>114718935</afid><affilname>Federal State Budget Scientific Institution The Research Inst. of Obstetrics</affilname><name-variant>Fed. State Budget Inst. Sci.-Res. Inst. of Children's Infections of the Russ. Fed. Biomedical Agency</name-variant><affiliation-city>Saint Petersburg (ex Leningrad)</affiliation-city><affiliation-country>Russian Federation</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60072485</affiliation-url><afid>60072485</afid><affilname>Saint Petersburg National Research University of Information Technologies, Mechanics and Optics University ITMO</affilname><name-variant>St. Petersburg State University of Information Technologies</name-variant><affiliation-city>Saint Petersburg (ex Leningrad)</affiliation-city><affiliation-country>Russian Federation</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60045578</affiliation-url><afid>60045578</afid><affilname>National Academy of Sciences of Belarus</affilname><name-variant>Academy of Sciences of the Belorussian SSR</name-variant><affiliation-city>Minsk</affiliation-city><affiliation-country>Belarus</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:115191877</affiliation-url><afid>115191877</afid><affilname>Scientific and Practical center of Cardiology</affilname><name-variant>Scientific and Practical center of Cardiology</name-variant><affiliation-city/><affiliation-country>Belarus</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:112731631</affiliation-url><afid>112731631</afid><affilname>Saint-Petersburg State Pediatric Medical University</affilname><name-variant>Saint-Petersburg State Pediatric Medical University</name-variant><affiliation-city>Saint Petersburg (ex Leningrad)</affiliation-city><affiliation-country>Russian Federation</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:113178238</affiliation-url><afid>113178238</afid><affilname>City Hospital No</affilname><name-variant>Municipal Hospital No.</name-variant><affiliation-city>Saint Petersburg (ex Leningrad)</affiliation-city><affiliation-country>Russian Federation</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">23</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:7004340255</author-url><authid>7004340255</authid><authname>Glotov A.</authname><surname>Glotov</surname><given-name>Andrey S.</given-name><initials>A.S.</initials><afid>60031888</afid><afid>114718935</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:7004340255</author-url><authid>7004340255</authid><authname>Glotov A.</authname><surname>Glotov</surname><given-name>Andrey S.</given-name><initials>A.S.</initials><afid>60031888</afid><afid>114718935</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:48161610600</author-url><authid>48161610600</authid><authname>Kazakov S.</authname><surname>Kazakov</surname><given-name>Sergey V.</given-name><initials>S.V.</initials><afid>60072485</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56606893200</author-url><authid>56606893200</authid><authname>Zhukova E.</authname><surname>Zhukova</surname><given-name>Elena A.</given-name><initials>E.A.</initials><afid>114718935</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56606762300</author-url><authid>56606762300</authid><authname>Alexandrov A.</authname><surname>Alexandrov</surname><given-name>Anton V.</given-name><initials>A.V.</initials><afid>60072485</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:23988449900</author-url><authid>23988449900</authid><authname>Glotov O.</authname><surname>Glotov</surname><given-name>Oleg S.</given-name><initials>O.S.</initials><afid>60031888</afid><afid>114718935</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:23988449900</author-url><authid>23988449900</authid><authname>Glotov O.</authname><surname>Glotov</surname><given-name>Oleg S.</given-name><initials>O.S.</initials><afid>60031888</afid><afid>114718935</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:56142526600</author-url><authid>56142526600</authid><authname>Pakin V.</authname><surname>Pakin</surname><given-name>Vladimir S.</given-name><initials>V.S.</initials><afid>60031888</afid><afid>114718935</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:56142526600</author-url><authid>56142526600</authid><authname>Pakin V.</authname><surname>Pakin</surname><given-name>Vladimir S.</given-name><initials>V.S.</initials><afid>60031888</afid><afid>114718935</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:56606945000</author-url><authid>56606945000</authid><authname>Danilova M.</authname><surname>Danilova</surname><given-name>Maria M.</given-name><initials>M.M.</initials><afid>60031888</afid><afid>114718935</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:56606945000</author-url><authid>56606945000</authid><authname>Danilova M.</authname><surname>Danilova</surname><given-name>Maria M.</given-name><initials>M.M.</initials><afid>60031888</afid><afid>114718935</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:56606998800</author-url><authid>56606998800</authid><authname>Poliakova I.</authname><surname>Poliakova</surname><given-name>Irina V.</given-name><initials>I.V.</initials><afid>60031888</afid><afid>114718935</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:56606998800</author-url><authid>56606998800</authid><authname>Poliakova I.</authname><surname>Poliakova</surname><given-name>Irina V.</given-name><initials>I.V.</initials><afid>60031888</afid><afid>114718935</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:56607399000</author-url><authid>56607399000</authid><authname>Niyazova S.</authname><surname>Niyazova</surname><given-name>Svetlana S.</given-name><initials>S.S.</initials><afid>60045578</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:6507810295</author-url><authid>6507810295</authid><authname>Chakova N.</authname><surname>Chakova</surname><given-name>Natalia N.</given-name><initials>N.N.</initials><afid>60045578</afid></author><author seq="11"><author-url>http://api.elsevier.com/content/author/author_id:56607146900</author-url><authid>56607146900</authid><authname>Komissarova S.</authname><surname>Komissarova</surname><given-name>Svetlana M.</given-name><initials>S.M.</initials><afid>115191877</afid></author><author seq="12"><author-url>http://api.elsevier.com/content/author/author_id:56609156000</author-url><authid>56609156000</authid><authname>Kurnikova E.</authname><surname>Kurnikova</surname><given-name>Elena A.</given-name><initials>E.A.</initials><afid>112731631</afid></author><author seq="13"><author-url>http://api.elsevier.com/content/author/author_id:56636941400</author-url><authid>56636941400</authid><authname>Sarana A.</authname><surname>Sarana</surname><given-name>Andrey M.</given-name><initials>A.M.</initials><afid>113178238</afid></author><author seq="14"><author-url>http://api.elsevier.com/content/author/author_id:56607351400</author-url><authid>56607351400</authid><authname>Sherbak S.</authname><surname>Sherbak</surname><given-name>Sergey G.</given-name><initials>S.G.</initials><afid>113178238</afid></author><author seq="15"><author-url>http://api.elsevier.com/content/author/author_id:55772694000</author-url><authid>55772694000</authid><authname>Sergushichev A.</authname><surname>Sergushichev</surname><given-name>Alexey A.</given-name><initials>A.A.</initials><afid>60072485</afid></author><author seq="16"><author-url>http://api.elsevier.com/content/author/author_id:56131789500</author-url><authid>56131789500</authid><authname>Shalyto A.</authname><surname>Shalyto</surname><given-name>Anatoly A.</given-name><initials>A.A.</initials><afid>60072485</afid></author><author seq="17"><author-url>http://api.elsevier.com/content/author/author_id:56057974100</author-url><authid>56057974100</authid><authname>Baranov V.</authname><surname>Baranov</surname><given-name>Vladislav S.</given-name><initials>V.S.</initials><afid>60031888</afid><afid>114718935</afid></author><author seq="17"><author-url>http://api.elsevier.com/content/author/author_id:56057974100</author-url><authid>56057974100</authid><authname>Baranov V.</authname><surname>Baranov</surname><given-name>Vladislav S.</given-name><initials>V.S.</initials><afid>60031888</afid><afid>114718935</afid></author><authkeywords>Cardiomyopathy | Group risk | Mutations | NGS | SNP | Students</authkeywords><intid>2035797582</intid><source-id>29286</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84928718915"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84928718915?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84928718915&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84928718915&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0009898115002223"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84928718915</prism:url><dc:identifier>SCOPUS_ID:84928718915</dc:identifier><eid>2-s2.0-84928718915</eid><dc:title>Is enhanced platelet activation the missing link leading to increased cardiovascular risk in psoriasis?</dc:title><dc:creator>Chandrashekar L.</dc:creator><prism:publicationName>Clinica Chimica Acta</prism:publicationName><prism:issn>00098981</prism:issn><prism:eIssn>18733492</prism:eIssn><prism:volume>446</prism:volume><prism:pageRange>181-185</prism:pageRange><prism:coverDate>2015-06-05</prism:coverDate><prism:coverDisplayDate>June 05, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.cca.2015.04.023</prism:doi><pii>S0009898115002223</pii><dc:description>© 2015 Published by Elsevier B.V. Background: Psoriasis is an immune mediated inflammatory skin disease associated with systemic inflammation resulting in increased risk for associated cardiovascular co-morbidities. The role of platelet activation in the pathophysiology of this condition has not been clearly studied. We undertook to study the platelet activation markers in psoriasis, as compared to controls and to identify its association with disease severity in psoriasis. Methods: Sixty-two patients with psoriasis and 62 age and gender matched healthy controls were enrolled in this cross-sectional study. The severity of the disease was assessed using the psoriasis area severity index (PASI) scoring. The platelet indices [mean platelet volume (MPV) and platelet distribution width (PDW)] were estimated by an automated haematological laser optical analyzer. Plasma soluble P-selectin and platelet derived microparticle (PDMP) concentrations, serum high sensitivity C-reactive protein (hs-CRP) and interleukin (IL)-6 concentrations were estimated in all study participants. Platelet aggregation was assessed using adenosine diphosphate (ADP) as aggregating agent. Results: We observed that there was significantly higher platelet indices (MPV and PDW) in patients with psoriasis, when compared to controls. Plasma soluble P-selectin concentrations, PDMP and platelet aggregation were significantly elevated in patients with psoriasis, as compared to controls. We also found significantly higher concentrations of hs-CRP and IL-6 in patients with psoriasis, as compared to controls. Platelet activation and systemic inflammation markers correlated positively with PASI, except PDW. We also observed significant positive correlation between platelet activation and systemic inflammation in psoriasis. Conclusion: Significant platelet activation and systemic inflammation were observed in patients with psoriasis, especially when associated with severe disease. The increased platelet activation might be the missing link between the persistent inflammation and the development of atherosclerotic plaque leading onto cardiovascular co-morbidities seen associated with psoriasis.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:106540011</affiliation-url><afid>106540011</afid><affilname>Jawaharlal Institute of Post Graduate Medical Education and Research</affilname><name-variant>Jawaharlal Institute of Post-Graduate Medical Education and Research</name-variant><affiliation-city>Puducherry</affiliation-city><affiliation-country>India</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:106540011</affiliation-url><afid>106540011</afid><affilname>Jawaharlal Institute of Post Graduate Medical Education and Research</affilname><name-variant>Jawaharlal Institute of Post-Graduate Medical Education and Research</name-variant><affiliation-city>Puducherry</affiliation-city><affiliation-country>India</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:106540011</affiliation-url><afid>106540011</afid><affilname>Jawaharlal Institute of Post Graduate Medical Education and Research</affilname><name-variant>Jawaharlal Institute of Post-Graduate Medical Education and Research</name-variant><affiliation-city>Puducherry</affiliation-city><affiliation-country>India</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">8</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56056706600</author-url><authid>56056706600</authid><authname>Chandrashekar L.</authname><surname>Chandrashekar</surname><given-name>Laxmisha</given-name><initials>L.</initials><afid>106540011</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:22938827700</author-url><authid>22938827700</authid><authname>Rajappa M.</authname><surname>Rajappa</surname><given-name>Medha</given-name><initials>M.</initials><afid>106540011</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56524535900</author-url><authid>56524535900</authid><authname>Revathy G.</authname><surname>Revathy</surname><given-name>G.</given-name><initials>G.</initials><afid>106540011</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:55614724700</author-url><authid>55614724700</authid><authname>Sundar I.</authname><surname>Sundar</surname><given-name>Indhumathi</given-name><initials>I.</initials><afid>106540011</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:55673271200</author-url><authid>55673271200</authid><authname>Munisamy M.</authname><surname>Munisamy</surname><given-name>Malathi</given-name><initials>M.</initials><afid>106540011</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:6506342284</author-url><authid>6506342284</authid><authname>Ananthanarayanan P.</authname><surname>Ananthanarayanan</surname><given-name>P. H.</given-name><initials>P.H.</initials><afid>106540011</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:7006485484</author-url><authid>7006485484</authid><authname>Thappa D.</authname><surname>Thappa</surname><given-name>Devinder Mohan</given-name><initials>D.M.</initials><afid>106540011</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:7101895622</author-url><authid>7101895622</authid><authname>Basu D.</authname><surname>Basu</surname><given-name>Debdatta</given-name><initials>D.</initials><afid>106540011</afid></author><authkeywords>Platelet activation | Psoriasis | Systemic inflammation</authkeywords><intid>2035834368</intid><source-id>29286</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84923250114"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84923250114?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84923250114&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84923250114&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0144861715000685"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84923250114</prism:url><dc:identifier>SCOPUS_ID:84923250114</dc:identifier><eid>2-s2.0-84923250114</eid><dc:title>The oxidative degradation of barley β-glucan in the presence of ascorbic acid or hydrogen peroxide</dc:title><dc:creator>Mäkelä N.</dc:creator><prism:publicationName>Carbohydrate Polymers</prism:publicationName><prism:issn>01448617</prism:issn><prism:volume>123</prism:volume><prism:pageRange>390-395</prism:pageRange><prism:coverDate>2015-06-05</prism:coverDate><prism:coverDisplayDate>5 June 2015</prism:coverDisplayDate><prism:doi>10.1016/j.carbpol.2015.01.037</prism:doi><pii>S0144861715000685</pii><dc:description>© 2015 Elsevier Ltd. All rights reserved. Cereal β-glucans are polysaccharides with health benefits that have been linked to their ability to increase luminal viscosity. However, the functional properties of cereal β-glucans may be diminished by the susceptibility of this polysaccharide to oxidative degradation. In this study, barley β-glucan was oxidised with hydrogen peroxide or ascorbic acid and the oxidative degradation of β-glucan was investigated using both asymmetrical flow field-flow fractionation (AsFlFFF) with aqueous solvent and high performance size exclusion chromatography (HPSEC) with LiBr in DMSO as the solvent. Oxidation was shown to cause degradation of β-glucan, the reaction being faster when oxidised with hydrogen peroxide compared with ascorbic acid. Both HPSEC and AsFlFFF showed comparable results as long as aggregates (only observed in AsFlFFF) were not included in the integration. The compact aggregates observed in oxidised samples suggest oxidation driven interactions between β-glucan molecules.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60002952</affiliation-url><afid>60002952</afid><affilname>Helsingin Yliopisto</affilname><name-variant>University of Helsinki</name-variant><affiliation-city>Helsinki</affiliation-city><affiliation-country>Finland</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">3</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56524468100</author-url><authid>56524468100</authid><authname>Mäkelä N.</authname><surname>Mäkelä</surname><given-name>Noora</given-name><initials>N.</initials><afid>60002952</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:6603084303</author-url><authid>6603084303</authid><authname>Sontag-Strohm T.</authname><surname>Sontag-Strohm</surname><given-name>Tuula</given-name><initials>T.</initials><afid>60002952</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:24080931700</author-url><authid>24080931700</authid><authname>Maina N.</authname><surname>Maina</surname><given-name>Ndegwa Henry</given-name><initials>N.H.</initials><afid>60002952</afid></author><authkeywords>AsFlFFF | HPEC | Oxidation | β-Glucan</authkeywords><intid>2034936231</intid><source-id>25801</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929223990"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929223990?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929223990&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929223990&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0009898115002041"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929223990</prism:url><dc:identifier>SCOPUS_ID:84929223990</dc:identifier><eid>2-s2.0-84929223990</eid><dc:title>Bone matrix vesicle-bound alkaline phosphatase for the assessment of peripheral blood admixture to human bone marrow aspirates</dc:title><dc:creator>Nollet E.</dc:creator><prism:publicationName>Clinica Chimica Acta</prism:publicationName><prism:issn>00098981</prism:issn><prism:eIssn>18733492</prism:eIssn><prism:volume>446</prism:volume><prism:pageRange>253-260</prism:pageRange><prism:coverDate>2015-06-05</prism:coverDate><prism:coverDisplayDate>June 05, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.cca.2015.04.013</prism:doi><pii>S0009898115002041</pii><dc:description>© 2015. Purpose: Peripheral blood (PB) admixture should be minimized during numerical and functional, as well as cytokinetic analysis of bone marrow (BM) aspirates for research purposes. Therefore, purity assessment of the BM aspirate should be performed in advance. We investigated whether bone matrix vesicle (BMV)-bound bone alkaline phosphatase (ALP) could serve as a marker for the purity of BM aspirates. Results: Total ALP activity was significantly higher in BM serum (97 (176-124). U/L, median (range)) compared to PB serum (63 (52-73). U/L, p. &lt;. 0.001). Agarose gel electrophoresis showed a unique bone ALP fraction in BM, which was absent in PB. Native polyacrylamide gel electrophoresis revealed the high molecular weight of this fraction, corresponding with membrane-bound ALP from bone matrix vesicles (BMV), as evidenced by electron microscopy. A serial PB admixture experiment of bone cylinder supernatant samples, rich in BMV-bound ALP, confirmed the sensitivity of this proposed quality assessment method. Furthermore, a BMV ALP fraction of ≥. 15% is suggested as cut-off value for minimal BM quality. Moreover, the BM purity declines rapidly with larger aspirated BM volumes. Conclusion: The exclusive presence of BMV-bound ALP in BM could serve as a novel marker to assess purity of BM aspirates.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60013703</affiliation-url><afid>60013703</afid><affilname>Universitair Ziekenhuis Antwerpen</affilname><name-variant>Antwerp University Hospital</name-variant><affiliation-city>Edegem</affiliation-city><affiliation-country>Belgium</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60012937</affiliation-url><afid>60012937</afid><affilname>Universiteit Antwerpen</affilname><name-variant>University of Antwerp</name-variant><affiliation-city>Antwerpen</affiliation-city><affiliation-country>Belgium</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60013703</affiliation-url><afid>60013703</afid><affilname>Universitair Ziekenhuis Antwerpen</affilname><name-variant>Antwerp University Hospital</name-variant><affiliation-city>Edegem</affiliation-city><affiliation-country>Belgium</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60012937</affiliation-url><afid>60012937</afid><affilname>Universiteit Antwerpen</affilname><name-variant>University of Antwerp</name-variant><affiliation-city>Antwerpen</affiliation-city><affiliation-country>Belgium</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60013703</affiliation-url><afid>60013703</afid><affilname>Universitair Ziekenhuis Antwerpen</affilname><name-variant>Antwerp University Hospital</name-variant><affiliation-city>Edegem</affiliation-city><affiliation-country>Belgium</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60012937</affiliation-url><afid>60012937</afid><affilname>Universiteit Antwerpen</affilname><name-variant>University of Antwerp</name-variant><affiliation-city>Antwerpen</affiliation-city><affiliation-country>Belgium</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60012937</affiliation-url><afid>60012937</afid><affilname>Universiteit Antwerpen</affilname><name-variant>University of Antwerp</name-variant><affiliation-city>Antwerpen</affiliation-city><affiliation-country>Belgium</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60013703</affiliation-url><afid>60013703</afid><affilname>Universitair Ziekenhuis Antwerpen</affilname><name-variant>Antwerp University Hospital</name-variant><affiliation-city>Edegem</affiliation-city><affiliation-country>Belgium</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60012937</affiliation-url><afid>60012937</afid><affilname>Universiteit Antwerpen</affilname><name-variant>University of Antwerp</name-variant><affiliation-city>Antwerpen</affiliation-city><affiliation-country>Belgium</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60013703</affiliation-url><afid>60013703</afid><affilname>Universitair Ziekenhuis Antwerpen</affilname><name-variant>Antwerp University Hospital</name-variant><affiliation-city>Edegem</affiliation-city><affiliation-country>Belgium</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60012937</affiliation-url><afid>60012937</afid><affilname>Universiteit Antwerpen</affilname><name-variant>University of Antwerp</name-variant><affiliation-city>Antwerpen</affiliation-city><affiliation-country>Belgium</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">20</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:6506479720</author-url><authid>6506479720</authid><authname>Nollet E.</authname><surname>Nollet</surname><given-name>Evelien</given-name><initials>E.</initials><afid>60013703</afid><afid>60012937</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:6506479720</author-url><authid>6506479720</authid><authname>Nollet E.</authname><surname>Nollet</surname><given-name>Evelien</given-name><initials>E.</initials><afid>60013703</afid><afid>60012937</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:23394000300</author-url><authid>23394000300</authid><authname>Van Craenenbroeck E.</authname><surname>Van Craenenbroeck</surname><given-name>Emeline M.</given-name><initials>E.M.</initials><afid>60013703</afid><afid>60012937</afid><afid>60013703</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:23394000300</author-url><authid>23394000300</authid><authname>Van Craenenbroeck E.</authname><surname>Van Craenenbroeck</surname><given-name>Emeline M.</given-name><initials>E.M.</initials><afid>60013703</afid><afid>60012937</afid><afid>60013703</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:23394000300</author-url><authid>23394000300</authid><authname>Van Craenenbroeck E.</authname><surname>Van Craenenbroeck</surname><given-name>Emeline M.</given-name><initials>E.M.</initials><afid>60013703</afid><afid>60012937</afid><afid>60013703</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:6701384193</author-url><authid>6701384193</authid><authname>Martinet W.</authname><surname>Martinet</surname><given-name>Wim</given-name><initials>W.</initials><afid>60012937</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:7003291012</author-url><authid>7003291012</authid><authname>Rodrigus I.</authname><surname>Rodrigus</surname><given-name>Inez</given-name><initials>I.</initials><afid>60013703</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:35299215700</author-url><authid>35299215700</authid><authname>De Bock D.</authname><surname>De Bock</surname><given-name>Dina</given-name><initials>D.</initials><afid>60013703</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:7006377517</author-url><authid>7006377517</authid><authname>Berneman Z.</authname><surname>Berneman</surname><given-name>Zwi</given-name><initials>Z.</initials><afid>60012937</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:6504269292</author-url><authid>6504269292</authid><authname>Pintelon I.</authname><surname>Pintelon</surname><given-name>Isabel</given-name><initials>I.</initials><afid>60012937</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:7003839289</author-url><authid>7003839289</authid><authname>Ysebaert D.</authname><surname>Ysebaert</surname><given-name>Dirk</given-name><initials>D.</initials><afid>60013703</afid><afid>60012937</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:7003839289</author-url><authid>7003839289</authid><authname>Ysebaert D.</authname><surname>Ysebaert</surname><given-name>Dirk</given-name><initials>D.</initials><afid>60013703</afid><afid>60012937</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:35452176900</author-url><authid>35452176900</authid><authname>Vrints C.</authname><surname>Vrints</surname><given-name>Christiaan J.</given-name><initials>C.J.</initials><afid>60013703</afid><afid>60012937</afid><afid>60013703</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:35452176900</author-url><authid>35452176900</authid><authname>Vrints C.</authname><surname>Vrints</surname><given-name>Christiaan J.</given-name><initials>C.J.</initials><afid>60013703</afid><afid>60012937</afid><afid>60013703</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:35452176900</author-url><authid>35452176900</authid><authname>Vrints C.</authname><surname>Vrints</surname><given-name>Christiaan J.</given-name><initials>C.J.</initials><afid>60013703</afid><afid>60012937</afid><afid>60013703</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:7003649488</author-url><authid>7003649488</authid><authname>Conraads V.</authname><surname>Conraads</surname><given-name>Viviane M.</given-name><initials>V.M.</initials><afid>60013703</afid><afid>60012937</afid><afid>60013703</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:7003649488</author-url><authid>7003649488</authid><authname>Conraads V.</authname><surname>Conraads</surname><given-name>Viviane M.</given-name><initials>V.M.</initials><afid>60013703</afid><afid>60012937</afid><afid>60013703</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:7003649488</author-url><authid>7003649488</authid><authname>Conraads V.</authname><surname>Conraads</surname><given-name>Viviane M.</given-name><initials>V.M.</initials><afid>60013703</afid><afid>60012937</afid><afid>60013703</afid></author><author seq="11"><author-url>http://api.elsevier.com/content/author/author_id:6603815348</author-url><authid>6603815348</authid><authname>Van Hoof V.</authname><surname>Van Hoof</surname><given-name>Viviane O M</given-name><initials>V.O.M.</initials><afid>60013703</afid><afid>60012937</afid></author><author seq="11"><author-url>http://api.elsevier.com/content/author/author_id:6603815348</author-url><authid>6603815348</authid><authname>Van Hoof V.</authname><surname>Van Hoof</surname><given-name>Viviane O M</given-name><initials>V.O.M.</initials><afid>60013703</afid><afid>60012937</afid></author><authkeywords>Alkaline phosphatase | Blood | Bone marrow | Bone marrow examination/methods | Quality control</authkeywords><intid>1535915997</intid><source-id>29286</source-id></entry></search-results>
